Query 010214
Match_columns 515
No_of_seqs 481 out of 2898
Neff 8.0
Searched_HMMs 46136
Date Thu Mar 28 22:23:04 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/010214.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/010214hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0588 Serine/threonine prote 100.0 4.2E-66 9.2E-71 536.1 24.7 326 13-338 8-342 (786)
2 KOG0615 Serine/threonine prote 100.0 2E-63 4.4E-68 492.6 18.5 263 12-274 167-443 (475)
3 KOG0575 Polo-like serine/threo 100.0 2.6E-60 5.7E-65 491.6 24.9 261 17-278 18-280 (592)
4 KOG0583 Serine/threonine prote 100.0 1.2E-59 2.6E-64 485.4 25.6 262 13-274 13-281 (370)
5 KOG0598 Ribosomal protein S6 k 100.0 2.7E-58 5.8E-63 453.2 21.8 260 14-274 22-287 (357)
6 KOG4717 Serine/threonine prote 100.0 3.1E-58 6.7E-63 464.1 20.3 318 14-335 15-339 (864)
7 KOG0616 cAMP-dependent protein 100.0 5.6E-58 1.2E-62 437.2 18.1 258 14-274 41-303 (355)
8 KOG0611 Predicted serine/threo 100.0 8.5E-58 1.8E-62 450.1 15.3 258 14-272 50-307 (668)
9 KOG0595 Serine/threonine-prote 100.0 5.1E-56 1.1E-60 440.5 22.9 260 14-275 7-275 (429)
10 KOG0592 3-phosphoinositide-dep 100.0 1.7E-56 3.7E-61 456.4 18.5 259 15-274 71-344 (604)
11 KOG0581 Mitogen-activated prot 100.0 2.1E-55 4.5E-60 432.8 23.4 255 16-274 78-341 (364)
12 KOG0586 Serine/threonine prote 100.0 2.9E-55 6.3E-60 454.5 22.2 322 11-335 50-371 (596)
13 KOG0605 NDR and related serine 100.0 8.2E-54 1.8E-58 437.1 21.3 260 14-275 138-452 (550)
14 KOG0033 Ca2+/calmodulin-depend 100.0 2E-55 4.2E-60 409.4 7.8 259 14-274 8-273 (355)
15 KOG0694 Serine/threonine prote 100.0 5.1E-53 1.1E-57 441.9 20.2 259 14-274 365-630 (694)
16 KOG0585 Ca2+/calmodulin-depend 100.0 8.1E-53 1.8E-57 423.1 17.0 260 14-274 94-378 (576)
17 KOG0591 NIMA (never in mitosis 100.0 1.3E-53 2.9E-58 404.3 7.6 252 15-273 17-281 (375)
18 KOG0597 Serine-threonine prote 100.0 2E-52 4.4E-57 426.5 14.3 255 17-274 2-257 (808)
19 KOG0593 Predicted protein kina 100.0 2.8E-52 6E-57 398.9 14.1 256 17-274 2-290 (396)
20 KOG0032 Ca2+/calmodulin-depend 100.0 6.4E-51 1.4E-55 420.7 25.3 261 12-274 30-299 (382)
21 PTZ00263 protein kinase A cata 100.0 1E-50 2.2E-55 415.3 26.1 258 13-273 14-276 (329)
22 KOG0580 Serine/threonine prote 100.0 2.2E-52 4.8E-57 388.5 12.3 267 6-274 11-279 (281)
23 KOG0599 Phosphorylase kinase g 100.0 4.4E-52 9.6E-57 392.2 13.6 264 11-274 11-289 (411)
24 cd05612 STKc_PRKX_like Catalyt 100.0 1.5E-50 3.2E-55 406.7 21.7 254 17-273 1-259 (291)
25 cd05571 STKc_PKB Catalytic dom 100.0 4.7E-50 1E-54 409.2 24.3 251 23-274 1-257 (323)
26 KOG0198 MEKK and related serin 100.0 9.5E-51 2.1E-55 405.1 18.5 258 16-276 16-284 (313)
27 KOG0600 Cdc2-related protein k 100.0 4.5E-50 9.7E-55 406.5 21.0 261 11-273 111-405 (560)
28 PTZ00426 cAMP-dependent protei 100.0 1.7E-49 3.7E-54 408.4 25.0 260 12-274 25-290 (340)
29 KOG0661 MAPK related serine/th 100.0 4.5E-51 9.7E-56 411.1 12.1 260 14-276 7-299 (538)
30 KOG0610 Putative serine/threon 100.0 8.6E-50 1.9E-54 396.2 20.0 268 10-278 70-402 (459)
31 cd05585 STKc_YPK1_like Catalyt 100.0 3.7E-49 7.9E-54 400.6 24.7 249 25-274 1-253 (312)
32 KOG0659 Cdk activating kinase 100.0 1.3E-49 2.7E-54 375.0 18.3 256 17-274 2-287 (318)
33 KOG0660 Mitogen-activated prot 100.0 1.7E-49 3.7E-54 389.5 20.0 258 15-274 20-316 (359)
34 cd05631 STKc_GRK4 Catalytic do 100.0 8.1E-49 1.8E-53 392.7 25.4 256 18-274 1-267 (285)
35 cd05593 STKc_PKB_gamma Catalyt 100.0 7.9E-49 1.7E-53 401.3 25.1 250 23-273 1-256 (328)
36 cd05628 STKc_NDR1 Catalytic do 100.0 9.7E-49 2.1E-53 406.0 25.4 256 17-274 1-299 (363)
37 cd05595 STKc_PKB_beta Catalyti 100.0 9.5E-49 2.1E-53 399.8 24.4 251 23-274 1-257 (323)
38 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 2.6E-48 5.7E-53 397.8 26.0 255 17-274 1-263 (333)
39 cd05587 STKc_cPKC Catalytic do 100.0 2.6E-48 5.7E-53 396.4 25.7 255 18-273 1-262 (324)
40 cd05599 STKc_NDR_like Catalyti 100.0 2E-48 4.4E-53 403.3 25.1 256 17-274 1-302 (364)
41 KOG0690 Serine/threonine prote 100.0 6.1E-50 1.3E-54 385.3 11.8 260 14-274 165-430 (516)
42 cd05590 STKc_nPKC_eta Catalyti 100.0 1.9E-48 4.1E-53 397.0 23.3 251 23-274 1-259 (320)
43 cd05594 STKc_PKB_alpha Catalyt 100.0 1.5E-48 3.1E-53 398.5 21.9 251 23-274 1-258 (325)
44 cd05629 STKc_NDR_like_fungal C 100.0 3.6E-48 7.7E-53 403.7 25.0 255 17-273 1-310 (377)
45 cd05573 STKc_ROCK_NDR_like Cat 100.0 2.3E-48 4.9E-53 400.2 23.0 256 17-274 1-291 (350)
46 KOG0578 p21-activated serine/t 100.0 4.7E-49 1E-53 405.0 17.7 256 13-273 269-528 (550)
47 cd05588 STKc_aPKC Catalytic do 100.0 4.5E-48 9.8E-53 395.8 24.9 250 23-273 1-267 (329)
48 cd05591 STKc_nPKC_epsilon Cata 100.0 3.8E-48 8.3E-53 394.7 24.1 250 23-273 1-259 (321)
49 cd05626 STKc_LATS2 Catalytic d 100.0 7.9E-48 1.7E-52 401.9 27.0 257 17-274 1-311 (381)
50 cd05616 STKc_cPKC_beta Catalyt 100.0 7E-48 1.5E-52 393.1 25.2 255 18-273 1-262 (323)
51 cd05589 STKc_PKN Catalytic dom 100.0 6.5E-48 1.4E-52 393.5 24.8 254 19-274 1-263 (324)
52 cd05625 STKc_LATS1 Catalytic d 100.0 1E-47 2.2E-52 401.0 26.5 255 18-274 2-311 (382)
53 cd05620 STKc_nPKC_delta Cataly 100.0 8.2E-48 1.8E-52 391.7 23.7 251 23-274 1-254 (316)
54 KOG0582 Ste20-like serine/thre 100.0 1.4E-47 3E-52 383.3 24.5 265 10-276 19-301 (516)
55 cd05575 STKc_SGK Catalytic dom 100.0 1E-47 2.2E-52 392.0 23.5 250 23-273 1-256 (323)
56 cd05584 STKc_p70S6K Catalytic 100.0 2E-47 4.4E-52 389.9 25.5 251 22-273 1-261 (323)
57 cd05618 STKc_aPKC_iota Catalyt 100.0 1.8E-47 4E-52 391.4 25.0 251 23-274 1-268 (329)
58 cd05570 STKc_PKC Catalytic dom 100.0 1E-47 2.2E-52 391.2 23.0 251 23-274 1-258 (318)
59 cd07848 STKc_CDKL5 Catalytic d 100.0 1.4E-47 3.1E-52 383.0 23.5 253 17-271 1-287 (287)
60 cd05596 STKc_ROCK Catalytic do 100.0 2.2E-47 4.8E-52 397.1 25.9 260 14-274 40-310 (370)
61 cd05598 STKc_LATS Catalytic do 100.0 1.1E-47 2.4E-52 399.8 23.6 256 17-274 1-307 (376)
62 cd05592 STKc_nPKC_theta_delta 100.0 1.6E-47 3.4E-52 389.6 24.1 250 23-273 1-253 (316)
63 cd05627 STKc_NDR2 Catalytic do 100.0 1.1E-47 2.5E-52 397.5 23.3 256 17-274 1-299 (360)
64 cd07871 STKc_PCTAIRE3 Catalyti 100.0 2.3E-47 5E-52 382.7 24.7 253 16-271 4-288 (288)
65 cd05621 STKc_ROCK2 Catalytic d 100.0 3E-47 6.4E-52 396.1 25.4 261 13-274 39-310 (370)
66 cd05614 STKc_MSK2_N N-terminal 100.0 3.9E-47 8.4E-52 388.8 25.3 257 18-274 1-273 (332)
67 cd05615 STKc_cPKC_alpha Cataly 100.0 3.6E-47 7.8E-52 388.1 24.8 256 18-274 1-263 (323)
68 cd05601 STKc_CRIK Catalytic do 100.0 2.3E-47 4.9E-52 390.2 22.8 256 17-273 1-268 (330)
69 cd07869 STKc_PFTAIRE1 Catalyti 100.0 3.6E-47 7.8E-52 383.9 23.6 256 16-274 4-294 (303)
70 cd05605 STKc_GRK4_like Catalyt 100.0 7.5E-47 1.6E-51 378.5 25.1 255 18-273 1-266 (285)
71 cd05619 STKc_nPKC_theta Cataly 100.0 4.9E-47 1.1E-51 386.0 23.5 251 23-274 1-254 (316)
72 cd05617 STKc_aPKC_zeta Catalyt 100.0 8E-47 1.7E-51 386.2 24.8 251 23-274 1-266 (327)
73 cd05586 STKc_Sck1_like Catalyt 100.0 2.4E-47 5.3E-52 390.1 20.7 250 25-274 1-259 (330)
74 cd05603 STKc_SGK2 Catalytic do 100.0 6E-47 1.3E-51 385.8 23.4 250 23-273 1-256 (321)
75 cd05582 STKc_RSK_N N-terminal 100.0 3.2E-47 6.8E-52 387.3 20.8 249 23-273 2-259 (318)
76 cd05604 STKc_SGK3 Catalytic do 100.0 4.9E-47 1.1E-51 387.2 22.1 251 23-274 1-257 (325)
77 KOG0604 MAP kinase-activated p 100.0 3E-48 6.4E-53 370.6 12.1 255 11-274 55-328 (400)
78 cd05622 STKc_ROCK1 Catalytic d 100.0 1.8E-46 3.9E-51 390.4 26.4 262 12-274 38-310 (371)
79 KOG0589 Serine/threonine prote 100.0 1E-47 2.2E-52 392.9 16.5 257 16-274 3-264 (426)
80 cd05602 STKc_SGK1 Catalytic do 100.0 8.1E-47 1.8E-51 385.6 22.9 250 23-273 1-256 (325)
81 KOG0663 Protein kinase PITSLRE 100.0 1.2E-47 2.7E-52 371.4 15.4 257 16-274 75-367 (419)
82 cd05608 STKc_GRK1 Catalytic do 100.0 2.1E-46 4.6E-51 374.3 22.6 249 25-274 1-263 (280)
83 cd05597 STKc_DMPK_like Catalyt 100.0 6.1E-46 1.3E-50 380.3 26.5 257 17-273 1-271 (331)
84 cd07859 STKc_TDY_MAPK_plant Ca 100.0 3E-46 6.4E-51 382.2 24.0 254 18-274 1-296 (338)
85 cd06649 PKc_MEK2 Catalytic dom 100.0 9.2E-46 2E-50 378.9 27.4 255 16-274 4-307 (331)
86 KOG0594 Protein kinase PCTAIRE 100.0 9.2E-47 2E-51 371.2 19.0 257 16-274 10-308 (323)
87 cd07876 STKc_JNK2 Catalytic do 100.0 8.6E-46 1.9E-50 383.2 26.7 258 14-276 18-323 (359)
88 PTZ00036 glycogen synthase kin 100.0 3.5E-46 7.6E-51 396.6 24.4 252 16-275 65-358 (440)
89 cd07862 STKc_CDK6 Catalytic do 100.0 8.5E-46 1.9E-50 370.7 23.9 252 17-271 1-290 (290)
90 cd05623 STKc_MRCK_alpha Cataly 100.0 1.5E-45 3.2E-50 377.5 26.2 257 17-273 1-271 (332)
91 cd05580 STKc_PKA Catalytic dom 100.0 1.9E-45 4E-50 368.9 26.2 255 17-274 1-260 (290)
92 KOG0192 Tyrosine kinase specif 100.0 8.8E-46 1.9E-50 379.5 24.0 248 16-267 40-298 (362)
93 cd05624 STKc_MRCK_beta Catalyt 100.0 1.4E-45 2.9E-50 377.8 25.4 257 17-273 1-271 (331)
94 cd05630 STKc_GRK6 Catalytic do 100.0 2.1E-45 4.5E-50 368.2 24.8 255 18-273 1-266 (285)
95 KOG0658 Glycogen synthase kina 100.0 2.5E-46 5.4E-51 367.8 17.3 252 16-275 23-313 (364)
96 cd07872 STKc_PCTAIRE2 Catalyti 100.0 2.9E-45 6.2E-50 371.1 25.1 259 16-277 5-295 (309)
97 KOG0607 MAP kinase-interacting 100.0 5.8E-47 1.2E-51 364.3 11.7 264 11-277 71-370 (463)
98 PHA03212 serine/threonine kina 100.0 2.4E-45 5.3E-50 384.4 25.0 249 15-274 90-382 (391)
99 KOG0986 G protein-coupled rece 100.0 4.2E-47 9.1E-52 379.6 10.6 258 16-274 184-452 (591)
100 cd05607 STKc_GRK7 Catalytic do 100.0 2.6E-45 5.6E-50 365.8 23.5 249 25-274 1-260 (277)
101 cd06625 STKc_MEKK3_like Cataly 100.0 7.1E-45 1.5E-49 358.0 26.1 254 17-271 2-263 (263)
102 cd07875 STKc_JNK1 Catalytic do 100.0 2.9E-45 6.2E-50 380.0 24.3 257 14-275 21-325 (364)
103 cd07863 STKc_CDK4 Catalytic do 100.0 3.6E-45 7.8E-50 365.5 24.0 251 18-271 1-288 (288)
104 cd07874 STKc_JNK3 Catalytic do 100.0 3.1E-45 6.7E-50 378.3 24.2 257 14-275 14-318 (355)
105 cd05632 STKc_GRK5 Catalytic do 100.0 7.4E-45 1.6E-49 364.0 26.1 256 18-274 1-267 (285)
106 KOG0201 Serine/threonine prote 100.0 1.7E-47 3.7E-52 382.4 7.0 255 16-273 12-268 (467)
107 cd07853 STKc_NLK Catalytic dom 100.0 2.1E-45 4.5E-50 382.2 22.7 255 18-274 1-294 (372)
108 PLN00034 mitogen-activated pro 100.0 3.7E-45 8.1E-50 377.7 23.9 256 14-275 71-335 (353)
109 PTZ00284 protein kinase; Provi 100.0 3.9E-45 8.5E-50 391.6 24.4 256 15-278 127-448 (467)
110 cd06650 PKc_MEK1 Catalytic dom 100.0 7.7E-45 1.7E-49 372.6 25.5 256 15-274 3-305 (333)
111 PTZ00267 NIMA-related protein 100.0 8E-45 1.7E-49 390.2 26.5 254 16-273 66-328 (478)
112 PTZ00283 serine/threonine prot 100.0 7.9E-45 1.7E-49 391.3 26.5 262 11-274 26-303 (496)
113 PF00069 Pkinase: Protein kina 100.0 2E-45 4.3E-50 360.7 18.8 251 19-271 1-260 (260)
114 cd05578 STKc_Yank1 Catalytic d 100.0 6E-45 1.3E-49 358.1 21.7 253 18-271 1-258 (258)
115 cd07873 STKc_PCTAIRE1 Catalyti 100.0 2.3E-44 5E-49 362.9 25.0 260 16-278 5-296 (301)
116 KOG0667 Dual-specificity tyros 100.0 6.6E-45 1.4E-49 380.9 21.4 253 14-274 183-508 (586)
117 KOG0696 Serine/threonine prote 100.0 4.6E-46 1E-50 367.8 11.0 261 13-274 345-612 (683)
118 KOG0612 Rho-associated, coiled 100.0 2.4E-46 5.2E-51 407.4 9.4 261 14-275 72-345 (1317)
119 cd07878 STKc_p38beta_MAPK11 Ca 100.0 1.9E-44 4E-49 370.6 22.9 256 14-274 12-304 (343)
120 cd08223 STKc_Nek4 Catalytic do 100.0 9E-44 1.9E-48 349.0 26.6 252 18-271 1-257 (257)
121 cd05574 STKc_phototropin_like 100.0 7.7E-44 1.7E-48 361.4 25.7 257 17-274 1-295 (316)
122 cd05572 STKc_cGK_PKG Catalytic 100.0 7.3E-44 1.6E-48 351.2 24.4 249 25-274 1-258 (262)
123 cd06615 PKc_MEK Catalytic doma 100.0 1.2E-43 2.5E-48 359.5 26.2 254 17-274 1-293 (308)
124 cd05609 STKc_MAST Catalytic do 100.0 1.6E-43 3.6E-48 357.6 26.7 256 17-273 1-278 (305)
125 cd06628 STKc_MAPKKK_Byr2_like 100.0 1.4E-43 3E-48 349.9 25.6 253 18-271 1-267 (267)
126 cd08529 STKc_FA2-like Catalyti 100.0 2.6E-43 5.6E-48 345.2 26.8 252 18-271 1-256 (256)
127 cd07861 STKc_CDK1_euk Catalyti 100.0 1.3E-43 2.9E-48 353.4 24.1 252 18-271 1-285 (285)
128 cd07847 STKc_CDKL1_4 Catalytic 100.0 1.5E-43 3.2E-48 352.9 24.4 254 17-271 1-286 (286)
129 cd05577 STKc_GRK Catalytic dom 100.0 1.1E-43 2.3E-48 353.6 22.8 249 25-274 1-260 (277)
130 cd06630 STKc_MEKK1 Catalytic d 100.0 1.4E-43 3.1E-48 349.7 23.0 254 18-272 1-268 (268)
131 cd05102 PTKc_VEGFR3 Catalytic 100.0 1.3E-43 2.7E-48 363.6 23.4 249 16-267 6-329 (338)
132 cd05633 STKc_GRK3 Catalytic do 100.0 2E-43 4.3E-48 352.8 24.1 250 24-274 1-261 (279)
133 cd07868 STKc_CDK8 Catalytic do 100.0 1.3E-43 2.9E-48 359.8 23.2 244 22-271 6-317 (317)
134 cd08220 STKc_Nek8 Catalytic do 100.0 6.1E-43 1.3E-47 342.6 26.6 252 18-271 1-256 (256)
135 cd06610 STKc_OSR1_SPAK Catalyt 100.0 4.2E-43 9.1E-48 345.5 25.6 253 17-271 1-267 (267)
136 cd06631 STKc_YSK4 Catalytic do 100.0 3.5E-43 7.7E-48 346.9 24.9 252 18-271 1-265 (265)
137 PTZ00266 NIMA-related protein 100.0 2.3E-43 5E-48 394.3 26.2 267 9-276 5-303 (1021)
138 cd07839 STKc_CDK5 Catalytic do 100.0 5.8E-44 1.3E-48 356.1 19.2 252 18-271 1-284 (284)
139 cd05606 STKc_beta_ARK Catalyti 100.0 3.2E-43 7E-48 350.9 24.4 250 24-274 1-261 (278)
140 cd06651 STKc_MEKK3 Catalytic d 100.0 5.6E-43 1.2E-47 346.1 25.8 254 17-272 2-265 (266)
141 cd06645 STKc_MAP4K3 Catalytic 100.0 2E-43 4.3E-48 349.1 22.3 251 16-270 8-267 (267)
142 PHA02988 hypothetical protein; 100.0 3.7E-43 7.9E-48 351.9 24.5 240 23-267 26-274 (283)
143 PHA03207 serine/threonine kina 100.0 3.6E-43 7.9E-48 368.2 25.3 252 15-276 90-383 (392)
144 cd08227 PK_STRAD_alpha Pseudok 100.0 2E-43 4.4E-48 360.7 22.7 253 21-274 2-313 (327)
145 cd06654 STKc_PAK1 Catalytic do 100.0 6E-43 1.3E-47 352.3 25.7 260 10-274 13-276 (296)
146 cd07832 STKc_CCRK Catalytic do 100.0 4.8E-43 1E-47 349.3 24.8 253 18-272 1-286 (286)
147 cd06619 PKc_MKK5 Catalytic dom 100.0 6.1E-43 1.3E-47 348.7 25.5 250 17-274 1-259 (279)
148 cd06611 STKc_SLK_like Catalyti 100.0 2.4E-43 5.3E-48 351.1 22.5 256 16-274 4-268 (280)
149 cd08217 STKc_Nek2 Catalytic do 100.0 7.3E-43 1.6E-47 342.8 25.4 252 18-271 1-265 (265)
150 cd06632 STKc_MEKK1_plant Catal 100.0 6.4E-43 1.4E-47 342.5 24.9 254 18-271 1-258 (258)
151 cd06652 STKc_MEKK2 Catalytic d 100.0 9.9E-43 2.1E-47 343.9 26.3 254 17-272 2-265 (265)
152 cd08221 STKc_Nek9 Catalytic do 100.0 1.4E-42 3E-47 340.7 27.1 252 18-271 1-256 (256)
153 cd06655 STKc_PAK2 Catalytic do 100.0 6.5E-43 1.4E-47 352.1 25.3 260 11-275 13-276 (296)
154 cd08218 STKc_Nek1 Catalytic do 100.0 8.3E-43 1.8E-47 342.2 25.3 252 18-271 1-256 (256)
155 cd06646 STKc_MAP4K5 Catalytic 100.0 3.9E-43 8.4E-48 347.0 22.9 252 16-270 8-267 (267)
156 cd06613 STKc_MAP4K3_like Catal 100.0 9.4E-43 2E-47 342.4 25.5 250 17-270 3-262 (262)
157 cd06609 STKc_MST3_like Catalyt 100.0 4.6E-43 1E-47 348.0 23.5 254 17-274 1-257 (274)
158 cd06644 STKc_STK10_LOK Catalyt 100.0 1.1E-42 2.4E-47 348.9 26.0 256 16-274 11-275 (292)
159 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 4.9E-43 1.1E-47 350.0 23.3 255 17-274 1-268 (286)
160 cd07850 STKc_JNK Catalytic dom 100.0 7.9E-43 1.7E-47 360.2 25.5 257 15-276 14-319 (353)
161 PHA03209 serine/threonine kina 100.0 3.6E-43 7.7E-48 363.7 22.8 246 17-273 66-356 (357)
162 KOG4236 Serine/threonine prote 100.0 1.4E-44 3E-49 366.0 11.6 253 17-274 562-825 (888)
163 cd07846 STKc_CDKL2_3 Catalytic 100.0 3E-43 6.5E-48 351.0 21.1 254 17-271 1-286 (286)
164 cd06643 STKc_SLK Catalytic dom 100.0 1.4E-42 3E-47 346.2 25.6 253 18-274 6-268 (282)
165 cd05581 STKc_PDK1 Catalytic do 100.0 3.4E-43 7.4E-48 348.6 20.9 254 17-271 1-280 (280)
166 cd06656 STKc_PAK3 Catalytic do 100.0 6E-43 1.3E-47 352.4 22.8 261 11-276 13-277 (297)
167 cd07841 STKc_CDK7 Catalytic do 100.0 7.2E-43 1.6E-47 350.9 22.7 256 18-274 1-288 (298)
168 cd05579 STKc_MAST_like Catalyt 100.0 6.2E-43 1.3E-47 343.3 21.7 249 25-274 1-263 (265)
169 KOG0614 cGMP-dependent protein 100.0 3.5E-45 7.5E-50 369.6 5.5 260 14-274 417-683 (732)
170 cd07833 STKc_CDKL Catalytic do 100.0 1.1E-42 2.4E-47 347.1 23.3 254 17-271 1-288 (288)
171 cd07845 STKc_CDK10 Catalytic d 100.0 1.2E-42 2.5E-47 351.8 23.8 258 15-274 5-296 (309)
172 cd07860 STKc_CDK2_3 Catalytic 100.0 1E-42 2.3E-47 347.0 22.7 252 18-271 1-284 (284)
173 cd06637 STKc_TNIK Catalytic do 100.0 1.3E-42 2.8E-47 343.9 23.2 252 16-271 5-272 (272)
174 cd07831 STKc_MOK Catalytic dom 100.0 1.5E-42 3.3E-47 345.0 23.7 249 19-271 1-282 (282)
175 cd05611 STKc_Rim15_like Cataly 100.0 2E-42 4.4E-47 340.5 23.9 248 23-274 2-257 (260)
176 cd06617 PKc_MKK3_6 Catalytic d 100.0 3.5E-42 7.6E-47 342.8 25.8 255 17-274 1-267 (283)
177 cd06612 STKc_MST1_2 Catalytic 100.0 1.1E-42 2.4E-47 340.7 21.8 249 17-271 3-256 (256)
178 cd06639 STKc_myosinIIIB Cataly 100.0 5.5E-42 1.2E-46 343.5 27.2 258 11-272 16-291 (291)
179 cd06605 PKc_MAPKK Catalytic do 100.0 6.2E-43 1.4E-47 344.6 20.1 254 17-274 1-263 (265)
180 cd07865 STKc_CDK9 Catalytic do 100.0 2.3E-42 5.1E-47 348.3 24.6 259 11-271 6-310 (310)
181 cd06626 STKc_MEKK4 Catalytic d 100.0 5.7E-42 1.2E-46 337.3 26.6 253 18-271 1-264 (264)
182 cd08219 STKc_Nek3 Catalytic do 100.0 3.5E-42 7.6E-47 337.9 25.0 248 18-268 1-252 (255)
183 cd07843 STKc_CDC2L1 Catalytic 100.0 1.1E-42 2.5E-47 348.8 21.8 254 16-271 4-293 (293)
184 cd06629 STKc_MAPKKK_Bck1_like 100.0 3.4E-42 7.3E-47 341.2 24.6 254 18-271 2-272 (272)
185 cd05064 PTKc_EphR_A10 Catalyti 100.0 2.8E-42 6.2E-47 341.5 23.7 249 16-267 4-260 (266)
186 cd06638 STKc_myosinIIIA Cataly 100.0 3.8E-42 8.3E-47 343.3 24.6 256 11-271 12-286 (286)
187 cd06623 PKc_MAPKK_plant_like C 100.0 5.2E-42 1.1E-46 337.2 25.2 255 17-274 1-262 (264)
188 cd06608 STKc_myosinIII_like Ca 100.0 3.5E-42 7.6E-47 340.1 24.1 252 16-271 5-275 (275)
189 KOG0197 Tyrosine kinases [Sign 100.0 7.7E-43 1.7E-47 358.3 19.8 244 17-266 206-455 (468)
190 cd05048 PTKc_Ror Catalytic Dom 100.0 2.4E-42 5.1E-47 344.3 22.8 250 16-268 4-279 (283)
191 cd07867 STKc_CDC2L6 Catalytic 100.0 2.1E-42 4.7E-47 350.5 22.8 244 22-271 6-317 (317)
192 cd07844 STKc_PCTAIRE_like Cata 100.0 4.9E-42 1.1E-46 343.6 24.6 253 16-271 4-291 (291)
193 KOG0695 Serine/threonine prote 100.0 1.5E-43 3.2E-48 342.3 12.8 258 16-274 249-522 (593)
194 cd05096 PTKc_DDR1 Catalytic do 100.0 6E-42 1.3E-46 345.8 25.1 248 16-266 4-299 (304)
195 KOG0579 Ste20-like serine/thre 100.0 7.8E-44 1.7E-48 366.5 11.4 254 17-274 32-295 (1187)
196 PHA03211 serine/threonine kina 100.0 3E-42 6.6E-47 366.8 24.1 248 15-273 167-460 (461)
197 cd05088 PTKc_Tie2 Catalytic do 100.0 4.5E-42 9.7E-47 347.1 24.0 250 16-268 6-276 (303)
198 PHA03390 pk1 serine/threonine- 100.0 3.5E-42 7.6E-47 341.6 22.6 250 12-273 9-267 (267)
199 cd05123 STKc_AGC Catalytic dom 100.0 4.2E-42 9E-47 335.5 22.7 246 25-271 1-250 (250)
200 cd06606 STKc_MAPKKK Catalytic 100.0 1.4E-41 3.1E-46 331.5 26.3 252 18-271 1-260 (260)
201 cd06636 STKc_MAP4K4_6 Catalyti 100.0 5.9E-42 1.3E-46 341.5 24.0 254 13-271 12-282 (282)
202 cd08215 STKc_Nek Catalytic dom 100.0 1.3E-41 2.8E-46 332.3 25.9 252 18-271 1-258 (258)
203 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 3.3E-42 7.1E-47 344.1 22.2 254 16-273 4-271 (284)
204 cd07870 STKc_PFTAIRE2 Catalyti 100.0 8.7E-42 1.9E-46 342.1 25.0 253 16-271 4-291 (291)
205 cd07837 STKc_CdkB_plant Cataly 100.0 6.8E-42 1.5E-46 343.0 24.2 254 17-272 1-295 (295)
206 cd07849 STKc_ERK1_2_like Catal 100.0 8.3E-42 1.8E-46 350.1 25.3 257 15-275 3-299 (336)
207 cd06640 STKc_MST4 Catalytic do 100.0 5.3E-42 1.1E-46 341.4 22.9 254 17-274 4-259 (277)
208 cd05106 PTKc_CSF-1R Catalytic 100.0 3.4E-42 7.3E-47 358.7 22.2 249 16-267 37-367 (374)
209 cd07836 STKc_Pho85 Catalytic d 100.0 7.4E-42 1.6E-46 340.6 23.7 251 18-271 1-284 (284)
210 cd07858 STKc_TEY_MAPK_plant Ca 100.0 8E-42 1.7E-46 350.5 24.4 258 15-274 3-297 (337)
211 cd06917 STKc_NAK1_like Catalyt 100.0 6.9E-42 1.5E-46 339.9 23.1 254 18-274 2-261 (277)
212 cd06653 STKc_MEKK3_like_1 Cata 100.0 2.2E-41 4.8E-46 334.4 26.5 253 17-271 2-264 (264)
213 cd08228 STKc_Nek6 Catalytic do 100.0 1.3E-41 2.9E-46 335.8 24.9 252 16-268 1-261 (267)
214 cd07855 STKc_ERK5 Catalytic do 100.0 5.9E-42 1.3E-46 350.9 22.9 257 16-274 4-300 (334)
215 cd06627 STKc_Cdc7_like Catalyt 100.0 2.7E-41 5.8E-46 329.9 26.4 252 18-271 1-254 (254)
216 cd06658 STKc_PAK5 Catalytic do 100.0 3.2E-42 7E-47 346.4 20.2 255 15-274 20-278 (292)
217 cd05049 PTKc_Trk Catalytic dom 100.0 8E-42 1.7E-46 339.7 22.7 249 16-267 4-276 (280)
218 cd08225 STKc_Nek5 Catalytic do 100.0 9.9E-42 2.2E-46 334.2 23.0 252 18-271 1-257 (257)
219 KOG0596 Dual specificity; seri 100.0 1.8E-42 4E-47 353.7 17.9 258 12-273 356-632 (677)
220 cd06607 STKc_TAO Catalytic dom 100.0 2.4E-41 5.3E-46 342.0 26.1 257 14-274 12-273 (307)
221 cd05114 PTKc_Tec_Rlk Catalytic 100.0 2E-41 4.3E-46 332.9 24.5 245 17-267 4-253 (256)
222 cd06624 STKc_ASK Catalytic dom 100.0 3.5E-41 7.6E-46 333.4 26.4 253 16-271 7-268 (268)
223 cd05104 PTKc_Kit Catalytic dom 100.0 6.7E-42 1.4E-46 356.6 22.3 250 16-268 34-370 (375)
224 cd05052 PTKc_Abl Catalytic dom 100.0 1.9E-41 4.2E-46 334.6 24.4 247 16-267 5-257 (263)
225 cd07842 STKc_CDK8_like Catalyt 100.0 1E-41 2.2E-46 344.9 22.9 253 18-271 1-316 (316)
226 cd00192 PTKc Catalytic domain 100.0 1.9E-41 4.2E-46 331.7 24.2 243 23-268 1-260 (262)
227 PLN00009 cyclin-dependent kina 100.0 1.8E-41 3.9E-46 340.2 24.4 257 16-274 1-290 (294)
228 cd07835 STKc_CDK1_like Catalyt 100.0 1.1E-41 2.4E-46 339.5 22.5 251 19-271 1-283 (283)
229 KOG4721 Serine/threonine prote 100.0 5.8E-43 1.3E-47 357.1 13.2 235 22-269 129-365 (904)
230 cd06648 STKc_PAK_II Catalytic 100.0 3.2E-41 7E-46 337.7 25.6 252 18-274 20-275 (285)
231 cd05613 STKc_MSK1_N N-terminal 100.0 2.2E-41 4.9E-46 338.9 24.5 257 18-274 1-274 (290)
232 cd07834 STKc_MAPK Catalytic do 100.0 1.2E-41 2.6E-46 347.4 22.7 256 18-275 1-296 (330)
233 PTZ00024 cyclin-dependent prot 100.0 1.6E-41 3.5E-46 347.5 23.6 260 15-275 6-320 (335)
234 cd06641 STKc_MST3 Catalytic do 100.0 2.5E-41 5.3E-46 336.6 24.3 254 17-274 4-259 (277)
235 cd07851 STKc_p38 Catalytic dom 100.0 1.7E-41 3.7E-46 349.0 23.8 259 12-275 10-305 (343)
236 cd06642 STKc_STK25-YSK1 Cataly 100.0 3.5E-42 7.5E-47 342.5 18.0 254 17-274 4-259 (277)
237 cd05089 PTKc_Tie1 Catalytic do 100.0 2.7E-41 5.9E-46 340.1 24.7 249 17-268 2-271 (297)
238 cd05084 PTKc_Fes Catalytic dom 100.0 2.4E-41 5.3E-46 331.3 23.6 242 23-267 1-248 (252)
239 cd05093 PTKc_TrkB Catalytic do 100.0 2.9E-41 6.3E-46 338.2 24.6 248 16-267 4-274 (288)
240 cd07854 STKc_MAPK4_6 Catalytic 100.0 1.6E-41 3.4E-46 349.2 23.2 255 15-274 3-306 (342)
241 cd05062 PTKc_IGF-1R Catalytic 100.0 2.6E-41 5.7E-46 336.2 23.9 251 15-268 4-274 (277)
242 cd05122 PKc_STE Catalytic doma 100.0 5.5E-41 1.2E-45 326.1 25.5 249 18-270 1-253 (253)
243 cd07880 STKc_p38gamma_MAPK12 C 100.0 2.1E-41 4.6E-46 348.4 23.8 258 13-275 11-305 (343)
244 cd05033 PTKc_EphR Catalytic do 100.0 5.5E-41 1.2E-45 331.7 25.6 249 17-268 4-261 (266)
245 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 6.2E-41 1.3E-45 330.4 25.9 250 17-267 2-260 (267)
246 cd07840 STKc_CDK9_like Catalyt 100.0 2.6E-41 5.7E-46 336.3 22.9 251 19-271 1-287 (287)
247 cd08229 STKc_Nek7 Catalytic do 100.0 2.1E-41 4.5E-46 334.3 22.0 251 16-267 1-260 (267)
248 cd08530 STKc_CNK2-like Catalyt 100.0 3.4E-41 7.4E-46 329.9 23.3 251 18-271 1-256 (256)
249 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 8.4E-41 1.8E-45 334.7 26.5 254 17-274 1-272 (287)
250 KOG0603 Ribosomal protein S6 k 100.0 2.5E-42 5.4E-47 360.0 15.4 245 14-271 319-566 (612)
251 cd06616 PKc_MKK4 Catalytic dom 100.0 2E-41 4.4E-46 338.7 21.4 255 17-274 4-273 (288)
252 cd06647 STKc_PAK_I Catalytic d 100.0 3.6E-41 7.8E-46 338.8 23.2 260 11-275 13-276 (293)
253 cd05061 PTKc_InsR Catalytic do 100.0 6.7E-41 1.4E-45 335.6 24.9 255 16-273 5-285 (288)
254 cd05032 PTKc_InsR_like Catalyt 100.0 6.2E-41 1.4E-45 332.7 24.4 249 16-267 5-273 (277)
255 cd05090 PTKc_Ror1 Catalytic do 100.0 6.6E-41 1.4E-45 334.3 24.5 250 16-268 4-279 (283)
256 cd07866 STKc_BUR1 Catalytic do 100.0 2.2E-41 4.8E-46 341.3 21.3 254 16-271 7-311 (311)
257 cd05036 PTKc_ALK_LTK Catalytic 100.0 4.7E-41 1E-45 334.6 23.3 250 16-268 5-274 (277)
258 cd06659 STKc_PAK6 Catalytic do 100.0 2E-41 4.3E-46 341.5 20.9 254 16-274 20-277 (297)
259 cd07864 STKc_CDK12 Catalytic d 100.0 2.8E-41 6E-46 339.8 21.8 256 14-271 4-302 (302)
260 cd05116 PTKc_Syk Catalytic dom 100.0 7E-41 1.5E-45 329.5 23.8 241 24-267 2-250 (257)
261 cd07838 STKc_CDK4_6_like Catal 100.0 9.3E-41 2E-45 332.6 24.5 250 19-271 1-287 (287)
262 KOG0574 STE20-like serine/thre 100.0 3.5E-44 7.6E-49 342.4 -0.4 251 18-274 34-289 (502)
263 cd05072 PTKc_Lyn Catalytic dom 100.0 8.2E-41 1.8E-45 329.3 23.6 246 16-267 5-256 (261)
264 cd05059 PTKc_Tec_like Catalyti 100.0 5.3E-41 1.2E-45 330.1 22.2 246 17-268 4-254 (256)
265 KOG1989 ARK protein kinase fam 100.0 1.1E-41 2.3E-46 367.0 18.7 246 17-270 37-309 (738)
266 cd05113 PTKc_Btk_Bmx Catalytic 100.0 6.3E-41 1.4E-45 330.0 22.7 247 16-268 3-254 (256)
267 cd05035 PTKc_Axl_like Catalyti 100.0 1.1E-40 2.3E-45 329.8 24.4 248 19-268 1-268 (273)
268 cd07877 STKc_p38alpha_MAPK14 C 100.0 4.4E-41 9.6E-46 346.3 22.5 259 13-276 13-308 (345)
269 KOG0577 Serine/threonine prote 100.0 2.5E-42 5.4E-47 353.7 12.9 251 19-274 28-284 (948)
270 cd06614 STKc_PAK Catalytic dom 100.0 1.1E-40 2.4E-45 333.2 24.6 255 14-273 16-275 (286)
271 cd05108 PTKc_EGFR Catalytic do 100.0 7.6E-41 1.6E-45 340.0 23.7 249 16-268 6-264 (316)
272 cd05053 PTKc_FGFR Catalytic do 100.0 1.3E-40 2.7E-45 333.8 24.8 253 13-268 8-287 (293)
273 PRK13184 pknD serine/threonine 100.0 7.4E-41 1.6E-45 372.8 25.4 252 16-268 1-285 (932)
274 cd07857 STKc_MPK1 Catalytic do 100.0 7.6E-41 1.6E-45 342.4 23.2 255 18-274 1-298 (332)
275 cd05075 PTKc_Axl Catalytic dom 100.0 9.7E-41 2.1E-45 330.5 23.0 248 19-268 1-267 (272)
276 cd05068 PTKc_Frk_like Catalyti 100.0 2E-40 4.2E-45 326.8 25.0 246 16-267 5-256 (261)
277 cd08226 PK_STRAD_beta Pseudoki 100.0 5.7E-41 1.2E-45 342.8 21.9 251 23-274 4-314 (328)
278 PHA03210 serine/threonine kina 100.0 2E-41 4.2E-46 365.7 19.4 260 13-274 144-460 (501)
279 cd05051 PTKc_DDR Catalytic dom 100.0 1.4E-40 3E-45 333.7 24.0 249 16-267 4-292 (296)
280 cd05098 PTKc_FGFR1 Catalytic d 100.0 1.6E-40 3.5E-45 336.1 24.5 254 12-268 13-295 (307)
281 cd05039 PTKc_Csk_like Catalyti 100.0 1.9E-40 4E-45 325.8 24.3 243 16-267 5-251 (256)
282 cd06635 STKc_TAO1 Catalytic do 100.0 3.9E-40 8.5E-45 335.0 27.4 256 16-276 24-285 (317)
283 cd05148 PTKc_Srm_Brk Catalytic 100.0 4.9E-41 1.1E-45 330.6 19.9 247 16-267 5-256 (261)
284 cd07830 STKc_MAK_like Catalyti 100.0 1.3E-40 2.8E-45 331.5 23.1 250 19-271 1-283 (283)
285 cd05094 PTKc_TrkC Catalytic do 100.0 1.8E-40 3.8E-45 333.0 24.2 248 16-267 4-277 (291)
286 cd05060 PTKc_Syk_like Catalyti 100.0 2.2E-40 4.8E-45 325.7 24.2 241 23-267 1-250 (257)
287 cd05610 STKc_MASTL Catalytic d 100.0 1.6E-40 3.5E-45 369.6 26.0 150 16-165 3-152 (669)
288 cd05091 PTKc_Ror2 Catalytic do 100.0 6.8E-41 1.5E-45 334.0 20.7 250 16-268 4-279 (283)
289 cd06633 STKc_TAO3 Catalytic do 100.0 4.2E-40 9E-45 334.3 26.7 254 17-274 21-279 (313)
290 cd05118 STKc_CMGC Catalytic do 100.0 7.4E-41 1.6E-45 332.7 20.6 251 19-271 1-283 (283)
291 cd05071 PTKc_Src Catalytic dom 100.0 2E-40 4.3E-45 327.6 23.5 245 16-267 5-255 (262)
292 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 2.2E-40 4.7E-45 326.3 23.4 246 15-267 4-255 (260)
293 cd07852 STKc_MAPK15 Catalytic 100.0 8.7E-41 1.9E-45 342.6 21.4 258 14-274 4-301 (337)
294 cd06657 STKc_PAK4 Catalytic do 100.0 1.8E-40 3.9E-45 333.8 23.0 252 19-275 22-277 (292)
295 cd05583 STKc_MSK_N N-terminal 100.0 2.1E-40 4.5E-45 331.6 23.1 258 18-275 1-273 (288)
296 cd05099 PTKc_FGFR4 Catalytic d 100.0 3.7E-40 8E-45 334.6 25.1 250 15-267 10-288 (314)
297 cd05066 PTKc_EphR_A Catalytic 100.0 3.4E-40 7.4E-45 326.4 24.2 249 16-267 3-261 (267)
298 cd05109 PTKc_HER2 Catalytic do 100.0 4.1E-40 8.8E-45 328.0 24.8 248 16-267 6-263 (279)
299 cd05047 PTKc_Tie Catalytic dom 100.0 2.9E-40 6.3E-45 327.7 23.6 242 23-267 1-263 (270)
300 cd05082 PTKc_Csk Catalytic dom 100.0 2.9E-40 6.3E-45 324.7 23.3 242 16-267 5-251 (256)
301 cd05092 PTKc_TrkA Catalytic do 100.0 3E-40 6.5E-45 329.5 23.7 248 16-267 4-276 (280)
302 cd07829 STKc_CDK_like Catalyti 100.0 1.3E-40 2.7E-45 330.9 20.9 251 19-271 1-282 (282)
303 cd05054 PTKc_VEGFR Catalytic d 100.0 1.4E-40 3E-45 341.8 21.7 249 17-268 7-329 (337)
304 cd05067 PTKc_Lck_Blk Catalytic 100.0 3.9E-40 8.4E-45 324.5 23.9 246 15-267 4-255 (260)
305 KOG0662 Cyclin-dependent kinas 100.0 2.1E-41 4.6E-46 302.6 13.4 256 17-274 2-289 (292)
306 cd07879 STKc_p38delta_MAPK13 C 100.0 3.1E-40 6.6E-45 339.6 24.0 256 14-275 12-304 (342)
307 cd05065 PTKc_EphR_B Catalytic 100.0 5.2E-40 1.1E-44 325.2 24.6 249 16-267 3-263 (269)
308 cd05105 PTKc_PDGFR_alpha Catal 100.0 3.1E-40 6.7E-45 346.6 24.2 251 14-267 34-392 (400)
309 cd05101 PTKc_FGFR2 Catalytic d 100.0 4.7E-40 1E-44 332.0 24.6 257 9-268 7-292 (304)
310 cd06634 STKc_TAO2 Catalytic do 100.0 2.3E-40 5E-45 335.3 22.4 255 16-274 14-273 (308)
311 cd05034 PTKc_Src_like Catalyti 100.0 4.6E-40 9.9E-45 323.7 23.6 247 15-267 4-256 (261)
312 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 6.8E-40 1.5E-44 327.0 25.2 248 16-267 2-276 (283)
313 KOG2345 Serine/threonine prote 100.0 1.6E-41 3.4E-46 317.4 12.2 254 12-268 16-296 (302)
314 KOG0983 Mitogen-activated prot 100.0 3E-41 6.5E-46 319.0 14.2 256 16-274 91-355 (391)
315 cd06618 PKc_MKK7 Catalytic dom 100.0 4.8E-40 1E-44 330.6 23.9 258 14-274 12-279 (296)
316 smart00219 TyrKc Tyrosine kina 100.0 6E-40 1.3E-44 321.1 24.0 246 19-267 1-256 (258)
317 cd05055 PTKc_PDGFR Catalytic d 100.0 5.2E-40 1.1E-44 332.0 24.1 250 15-267 33-296 (302)
318 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 7.5E-40 1.6E-44 334.9 25.3 256 14-274 7-294 (328)
319 PF07714 Pkinase_Tyr: Protein 100.0 1.2E-40 2.5E-45 329.2 18.3 245 20-267 2-257 (259)
320 cd05112 PTKc_Itk Catalytic dom 100.0 8.3E-40 1.8E-44 320.9 24.2 246 17-268 4-254 (256)
321 KOG0584 Serine/threonine prote 100.0 2.3E-41 5E-46 351.5 13.7 251 20-274 43-302 (632)
322 cd05069 PTKc_Yes Catalytic dom 100.0 7.1E-40 1.5E-44 322.9 23.8 245 16-267 5-255 (260)
323 cd05045 PTKc_RET Catalytic dom 100.0 6.1E-40 1.3E-44 328.7 23.5 247 18-267 1-281 (290)
324 cd05097 PTKc_DDR_like Catalyti 100.0 5.9E-40 1.3E-44 329.9 23.3 249 16-267 4-291 (295)
325 cd08222 STKc_Nek11 Catalytic d 100.0 2.6E-40 5.5E-45 325.6 19.9 252 18-271 1-260 (260)
326 cd05040 PTKc_Ack_like Catalyti 100.0 8.1E-40 1.8E-44 321.2 23.4 241 23-267 1-253 (257)
327 cd05063 PTKc_EphR_A2 Catalytic 100.0 1.1E-39 2.5E-44 322.4 24.6 249 16-267 4-262 (268)
328 cd05057 PTKc_EGFR_like Catalyt 100.0 1.4E-39 3.1E-44 324.0 25.2 248 16-267 6-263 (279)
329 cd05085 PTKc_Fer Catalytic dom 100.0 1.5E-39 3.1E-44 318.1 24.7 241 23-267 1-246 (250)
330 cd05115 PTKc_Zap-70 Catalytic 100.0 1.1E-39 2.3E-44 321.7 23.7 240 24-267 2-250 (257)
331 cd05050 PTKc_Musk Catalytic do 100.0 7.4E-40 1.6E-44 327.6 22.9 249 16-267 4-284 (288)
332 cd05576 STKc_RPK118_like Catal 100.0 2.7E-40 5.8E-45 322.2 19.0 229 28-271 4-237 (237)
333 cd05111 PTK_HER3 Pseudokinase 100.0 1.5E-39 3.3E-44 324.5 24.7 248 16-267 6-263 (279)
334 cd05046 PTK_CCK4 Pseudokinase 100.0 9.9E-40 2.1E-44 324.0 23.0 249 17-268 5-272 (275)
335 cd08216 PK_STRAD Pseudokinase 100.0 5.4E-40 1.2E-44 332.7 21.4 245 29-274 12-301 (314)
336 KOG4279 Serine/threonine prote 100.0 2.3E-41 5.1E-46 351.4 11.6 248 24-274 582-838 (1226)
337 cd05100 PTKc_FGFR3 Catalytic d 100.0 1.4E-39 3E-44 333.4 24.5 256 10-268 5-289 (334)
338 cd05041 PTKc_Fes_like Catalyti 100.0 1.4E-39 3.1E-44 318.3 23.4 241 23-267 1-247 (251)
339 cd05095 PTKc_DDR2 Catalytic do 100.0 1.3E-39 2.9E-44 327.4 23.8 249 16-267 4-292 (296)
340 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 2.9E-40 6.2E-45 325.5 18.6 239 23-268 1-256 (258)
341 KOG0608 Warts/lats-like serine 100.0 7.4E-41 1.6E-45 345.0 14.4 257 16-274 628-934 (1034)
342 cd05056 PTKc_FAK Catalytic dom 100.0 2.7E-39 5.8E-44 320.3 25.0 249 16-268 5-261 (270)
343 KOG4645 MAPKKK (MAP kinase kin 100.0 3.5E-42 7.5E-47 379.2 4.7 260 13-273 1231-1499(1509)
344 cd05073 PTKc_Hck Catalytic dom 100.0 4.9E-39 1.1E-43 316.9 26.0 246 15-267 4-255 (260)
345 cd05043 PTK_Ryk Pseudokinase d 100.0 3.1E-39 6.6E-44 321.6 24.5 250 15-267 4-271 (280)
346 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 3.1E-39 6.8E-44 322.6 23.7 249 17-268 4-279 (284)
347 cd05103 PTKc_VEGFR2 Catalytic 100.0 1.7E-39 3.7E-44 334.2 22.1 250 16-268 6-335 (343)
348 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 2.9E-39 6.2E-44 319.7 22.8 239 23-268 1-260 (262)
349 cd05107 PTKc_PDGFR_beta Cataly 100.0 2.2E-39 4.8E-44 340.1 22.6 251 15-268 35-395 (401)
350 KOG0666 Cyclin C-dependent kin 100.0 7E-41 1.5E-45 321.4 10.0 258 15-274 22-343 (438)
351 cd08528 STKc_Nek10 Catalytic d 100.0 5.7E-39 1.2E-43 317.6 23.1 250 18-268 1-266 (269)
352 KOG0193 Serine/threonine prote 100.0 2.4E-40 5.2E-45 341.9 13.5 250 13-267 388-648 (678)
353 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 3.6E-39 7.9E-44 321.1 21.6 238 24-268 2-272 (274)
354 cd05083 PTKc_Chk Catalytic dom 100.0 6.4E-39 1.4E-43 314.7 22.7 241 16-267 5-249 (254)
355 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 8.8E-39 1.9E-43 319.0 23.7 247 17-267 4-278 (284)
356 cd05044 PTKc_c-ros Catalytic d 100.0 5.4E-39 1.2E-43 317.5 21.2 242 23-267 1-265 (269)
357 KOG0194 Protein tyrosine kinas 100.0 2E-39 4.3E-44 337.7 18.8 251 16-267 156-415 (474)
358 cd05058 PTKc_Met_Ron Catalytic 100.0 1.2E-38 2.6E-43 313.8 23.4 243 23-268 1-255 (262)
359 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 6.9E-39 1.5E-43 314.4 21.4 236 23-267 1-256 (259)
360 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 1.8E-38 3.9E-43 314.5 23.9 242 23-267 1-265 (269)
361 cd05110 PTKc_HER4 Catalytic do 100.0 1.2E-38 2.6E-43 321.8 22.9 249 16-268 6-264 (303)
362 cd05074 PTKc_Tyro3 Catalytic d 100.0 2E-38 4.3E-43 314.1 22.6 248 19-268 1-268 (273)
363 cd05042 PTKc_Aatyk Catalytic d 100.0 1.8E-38 3.9E-43 314.2 22.2 242 23-267 1-265 (269)
364 PHA02882 putative serine/threo 100.0 3.1E-38 6.8E-43 317.8 23.2 252 13-267 8-291 (294)
365 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 2.8E-38 6.1E-43 314.3 22.2 249 16-267 3-278 (284)
366 KOG1026 Nerve growth factor re 100.0 7.6E-39 1.7E-43 343.5 17.1 248 16-266 485-756 (774)
367 KOG0671 LAMMER dual specificit 100.0 1.8E-39 4E-44 319.9 10.7 255 12-274 84-412 (415)
368 KOG1187 Serine/threonine prote 100.0 4.2E-38 9E-43 324.4 20.4 249 14-267 72-347 (361)
369 cd05086 PTKc_Aatyk2 Catalytic 100.0 1.6E-37 3.4E-42 307.9 23.8 242 23-267 1-264 (268)
370 KOG1035 eIF-2alpha kinase GCN2 100.0 5.6E-39 1.2E-43 352.5 13.6 253 15-272 477-875 (1351)
371 KOG0665 Jun-N-terminal kinase 100.0 5.6E-39 1.2E-43 310.0 11.6 253 16-274 16-316 (369)
372 KOG4250 TANK binding protein k 100.0 9.8E-39 2.1E-43 335.6 12.6 242 17-260 13-296 (732)
373 smart00220 S_TKc Serine/Threon 100.0 3E-37 6.6E-42 297.4 21.9 240 29-271 1-244 (244)
374 PLN03225 Serine/threonine-prot 100.0 4E-37 8.7E-42 335.1 25.2 253 15-275 130-457 (566)
375 KOG1151 Tousled-like protein k 100.0 8.8E-39 1.9E-43 318.5 10.5 264 11-274 457-747 (775)
376 KOG1095 Protein tyrosine kinas 100.0 2.8E-37 6.2E-42 342.2 21.3 249 16-267 691-956 (1025)
377 KOG0669 Cyclin T-dependent kin 100.0 1.5E-39 3.3E-44 304.3 0.8 257 16-274 16-321 (376)
378 KOG0668 Casein kinase II, alph 100.0 3E-38 6.4E-43 292.0 8.7 251 15-274 36-328 (338)
379 KOG1006 Mitogen-activated prot 100.0 4.6E-38 9.9E-43 296.5 5.2 254 17-274 64-333 (361)
380 KOG0587 Traf2- and Nck-interac 100.0 3.1E-36 6.8E-41 322.1 19.5 254 16-273 18-287 (953)
381 PLN03224 probable serine/threo 100.0 2.1E-35 4.6E-40 315.1 25.6 260 14-273 142-505 (507)
382 KOG4257 Focal adhesion tyrosin 100.0 6.9E-36 1.5E-40 308.1 16.3 244 20-267 392-644 (974)
383 KOG0670 U4/U6-associated splic 100.0 2.7E-36 5.9E-41 306.0 10.6 255 12-273 427-751 (752)
384 KOG0664 Nemo-like MAPK-related 100.0 3.9E-37 8.5E-42 290.9 3.5 256 17-274 53-349 (449)
385 KOG1094 Discoidin domain recep 100.0 1.8E-35 3.8E-40 303.6 14.3 247 17-267 538-799 (807)
386 KOG0199 ACK and related non-re 100.0 2.1E-35 4.6E-40 307.9 13.5 252 17-272 110-372 (1039)
387 KOG1152 Signal transduction se 100.0 9.3E-36 2E-40 305.5 10.5 204 15-219 559-771 (772)
388 PLN00113 leucine-rich repeat r 100.0 1.2E-34 2.7E-39 336.5 18.6 239 15-268 688-947 (968)
389 KOG0196 Tyrosine kinase, EPH ( 100.0 2.9E-35 6.3E-40 310.6 11.8 249 17-268 629-887 (996)
390 KOG4278 Protein tyrosine kinas 100.0 1.7E-34 3.6E-39 297.4 16.8 268 17-305 267-541 (1157)
391 KOG1027 Serine/threonine prote 100.0 1.6E-35 3.4E-40 315.5 9.4 243 20-274 512-773 (903)
392 KOG1290 Serine/threonine prote 100.0 2.2E-34 4.8E-39 290.9 16.9 136 11-151 71-222 (590)
393 KOG0200 Fibroblast/platelet-de 100.0 6.1E-32 1.3E-36 297.2 21.9 248 17-267 296-574 (609)
394 cd00180 PKc Catalytic domain o 100.0 2.3E-31 5E-36 249.5 21.4 212 25-269 1-215 (215)
395 KOG0984 Mitogen-activated prot 100.0 2E-32 4.4E-37 250.0 13.0 216 12-231 41-267 (282)
396 smart00221 STYKc Protein kinas 100.0 4E-31 8.8E-36 252.7 21.6 215 19-236 1-221 (225)
397 KOG1167 Serine/threonine prote 100.0 2.2E-32 4.7E-37 273.3 12.0 254 12-273 31-386 (418)
398 KOG0576 Mitogen-activated prot 100.0 5.4E-33 1.2E-37 289.4 5.4 257 16-276 14-279 (829)
399 KOG1345 Serine/threonine kinas 100.0 2.4E-32 5.2E-37 258.5 6.5 252 14-272 21-291 (378)
400 KOG1025 Epidermal growth facto 100.0 2.5E-31 5.3E-36 281.8 14.1 245 19-267 698-952 (1177)
401 KOG2052 Activin A type IB rece 100.0 4.8E-31 1E-35 264.5 15.0 254 5-267 194-498 (513)
402 KOG3653 Transforming growth fa 100.0 1.2E-30 2.7E-35 263.3 12.3 240 16-264 209-495 (534)
403 PLN00181 protein SPA1-RELATED; 100.0 2E-30 4.4E-35 294.7 8.9 196 74-273 29-270 (793)
404 KOG0590 Checkpoint kinase and 100.0 1.5E-30 3.3E-35 283.3 3.6 258 16-274 316-591 (601)
405 COG0515 SPS1 Serine/threonine 100.0 5.8E-27 1.2E-31 232.5 23.8 252 19-273 2-280 (384)
406 smart00750 KIND kinase non-cat 100.0 1.4E-28 2.9E-33 228.2 10.2 158 102-272 1-169 (176)
407 KOG0603 Ribosomal protein S6 k 99.9 9.3E-29 2E-33 258.6 2.1 242 24-276 1-251 (612)
408 PRK09188 serine/threonine prot 99.9 1.5E-26 3.2E-31 237.6 18.2 170 10-190 11-194 (365)
409 KOG1024 Receptor-like protein 99.9 3.4E-27 7.3E-32 233.2 12.5 251 14-267 281-550 (563)
410 KOG1164 Casein kinase (serine/ 99.9 6.1E-25 1.3E-29 224.3 20.5 246 18-268 19-293 (322)
411 KOG1165 Casein kinase (serine/ 99.9 6.3E-25 1.4E-29 213.5 17.7 247 8-261 19-288 (449)
412 KOG1163 Casein kinase (serine/ 99.9 2.1E-24 4.5E-29 201.8 15.0 244 10-260 8-272 (341)
413 KOG0606 Microtubule-associated 99.9 5.1E-25 1.1E-29 240.6 7.2 219 15-274 81-321 (1205)
414 PRK10359 lipopolysaccharide co 99.9 5.3E-24 1.2E-28 204.5 12.5 176 13-211 27-216 (232)
415 cd05147 RIO1_euk RIO kinase fa 99.9 4.4E-24 9.5E-29 201.5 11.7 142 22-167 2-167 (190)
416 KOG1240 Protein kinase contain 99.9 3.3E-25 7.2E-30 242.1 4.5 240 15-268 21-291 (1431)
417 cd05145 RIO1_like RIO kinase f 99.9 6.6E-23 1.4E-27 193.5 15.2 143 22-168 2-168 (190)
418 PF14531 Kinase-like: Kinase-l 99.9 6.8E-24 1.5E-28 209.6 8.7 236 17-259 12-288 (288)
419 PRK12274 serine/threonine prot 99.9 5.3E-22 1.1E-26 187.1 13.4 190 19-221 4-211 (218)
420 PRK10345 hypothetical protein; 99.9 1.9E-21 4.1E-26 185.8 15.4 134 22-164 7-156 (210)
421 KOG0590 Checkpoint kinase and 99.9 3.6E-23 7.8E-28 225.7 0.4 257 16-273 19-291 (601)
422 smart00090 RIO RIO-like kinase 99.8 8E-21 1.7E-25 185.3 11.9 145 18-167 29-198 (237)
423 KOG4158 BRPK/PTEN-induced prot 99.8 4.3E-21 9.3E-26 190.7 9.7 187 75-263 274-505 (598)
424 KOG1166 Mitotic checkpoint ser 99.8 2.8E-20 6E-25 207.5 10.5 199 12-215 693-901 (974)
425 PRK14879 serine/threonine prot 99.8 3E-19 6.5E-24 170.7 16.1 137 23-166 2-143 (211)
426 KOG1033 eIF-2alpha kinase PEK/ 99.8 1.5E-20 3.2E-25 193.9 3.3 245 17-271 244-515 (516)
427 TIGR03724 arch_bud32 Kae1-asso 99.8 1.1E-18 2.3E-23 165.4 13.3 134 24-167 1-139 (199)
428 cd05144 RIO2_C RIO kinase fami 99.8 9.2E-19 2E-23 166.1 12.2 141 18-169 16-177 (198)
429 KOG0195 Integrin-linked kinase 99.8 7.2E-20 1.6E-24 173.9 4.5 241 17-266 190-440 (448)
430 PRK09605 bifunctional UGMP fam 99.8 9.3E-18 2E-22 182.9 16.0 140 17-167 333-477 (535)
431 cd05119 RIO RIO kinase family, 99.7 9.7E-18 2.1E-22 157.1 11.9 140 22-168 2-165 (187)
432 KOG1023 Natriuretic peptide re 99.7 2E-17 4.2E-22 173.7 11.8 197 71-267 1-219 (484)
433 PRK01723 3-deoxy-D-manno-octul 99.7 1.3E-16 2.8E-21 156.0 14.9 138 23-167 37-192 (239)
434 cd05120 APH_ChoK_like Aminogly 99.7 4.7E-16 1E-20 138.6 11.9 132 21-166 2-138 (155)
435 KOG0606 Microtubule-associated 99.7 2E-17 4.2E-22 181.8 3.1 262 14-276 801-1100(1205)
436 KOG0601 Cyclin-dependent kinas 99.6 1.5E-16 3.2E-21 167.2 5.9 261 9-274 106-385 (524)
437 PRK04750 ubiB putative ubiquin 99.5 7E-15 1.5E-19 158.0 5.0 148 13-168 116-315 (537)
438 TIGR01982 UbiB 2-polyprenylphe 99.5 1.4E-13 3E-18 146.0 12.9 142 23-168 123-308 (437)
439 KOG1243 Protein kinase [Genera 99.5 6.8E-13 1.5E-17 141.1 15.0 185 18-214 14-200 (690)
440 cd05146 RIO3_euk RIO kinase fa 99.5 7.3E-13 1.6E-17 124.8 13.6 142 22-168 2-175 (197)
441 KOG0601 Cyclin-dependent kinas 99.4 1.1E-13 2.5E-18 145.6 6.9 254 12-272 260-518 (524)
442 KOG1266 Protein kinase [Signal 99.4 3.2E-14 6.8E-19 139.2 2.5 204 65-272 115-335 (458)
443 cd05151 ChoK Choline Kinase (C 99.4 8.2E-13 1.8E-17 121.4 10.6 127 22-165 3-135 (170)
444 COG3642 Mn2+-dependent serine/ 99.3 4.2E-11 9.1E-16 109.8 13.2 135 23-167 2-141 (204)
445 KOG3087 Serine/threonine prote 99.3 1.4E-10 3E-15 106.0 14.4 145 21-167 11-166 (229)
446 cd05154 ACAD10_11_like Acyl-Co 99.2 6.2E-11 1.4E-15 113.4 10.6 140 23-166 4-206 (223)
447 KOG3741 Poly(A) ribonuclease s 99.1 5.2E-10 1.1E-14 116.0 13.4 211 30-268 289-521 (655)
448 PF02149 KA1: Kinase associate 99.1 1E-10 2.2E-15 83.4 5.1 44 471-514 3-47 (47)
449 PRK15123 lipopolysaccharide co 99.0 7.2E-09 1.6E-13 102.8 16.3 134 31-166 36-194 (268)
450 PF01163 RIO1: RIO1 family; I 99.0 1.2E-09 2.6E-14 102.5 10.2 128 32-167 1-156 (188)
451 KOG2137 Protein kinase [Signal 99.0 3.2E-10 7E-15 121.4 3.4 150 124-274 106-271 (700)
452 PF06293 Kdo: Lipopolysacchari 98.9 2.2E-08 4.9E-13 95.7 13.4 127 41-167 31-171 (206)
453 COG0478 RIO-like serine/threon 98.8 2.7E-08 5.9E-13 96.6 11.7 138 19-166 93-251 (304)
454 COG4248 Uncharacterized protei 98.8 4.8E-08 1.1E-12 99.4 13.9 235 20-263 14-291 (637)
455 PF06176 WaaY: Lipopolysacchar 98.7 1E-07 2.2E-12 90.8 11.2 141 14-165 28-182 (229)
456 PRK09902 hypothetical protein; 98.6 6.2E-07 1.4E-11 85.1 14.1 138 26-166 27-179 (216)
457 KOG0576 Mitogen-activated prot 98.6 1.5E-08 3.3E-13 107.7 2.0 250 7-274 232-490 (829)
458 COG0661 AarF Predicted unusual 98.6 1.4E-07 3E-12 101.4 9.2 138 23-169 131-317 (517)
459 COG1718 RIO1 Serine/threonine 98.6 4.2E-07 9.1E-12 87.5 11.5 138 24-168 55-217 (268)
460 TIGR02172 Fb_sc_TIGR02172 Fibr 98.5 1.2E-06 2.7E-11 84.9 13.2 133 23-165 7-181 (226)
461 KOG1035 eIF-2alpha kinase GCN2 98.5 9.8E-07 2.1E-11 99.8 12.9 204 61-273 226-439 (1351)
462 PF01636 APH: Phosphotransfera 98.5 2.1E-06 4.6E-11 82.3 12.7 137 22-165 2-196 (239)
463 cd05150 APH Aminoglycoside 3'- 98.3 8.8E-06 1.9E-10 79.6 12.4 133 25-165 6-192 (244)
464 KOG1235 Predicted unusual prot 98.2 4.8E-06 1E-10 89.4 10.3 139 23-168 167-356 (538)
465 PF10707 YrbL-PhoP_reg: PhoP r 98.2 2.4E-05 5.3E-10 74.1 13.9 130 23-160 7-165 (199)
466 PLN02876 acyl-CoA dehydrogenas 98.1 3.1E-05 6.7E-10 89.0 14.4 144 21-166 42-257 (822)
467 COG2112 Predicted Ser/Thr prot 98.1 1.6E-05 3.4E-10 72.9 8.9 130 20-167 25-156 (201)
468 PF13095 FTA2: Kinetochore Sim 98.1 6E-05 1.3E-09 71.1 12.8 129 16-164 36-206 (207)
469 KOG1826 Ras GTPase activating 97.9 2.8E-07 6E-12 105.9 -6.8 208 64-272 1276-1496(2724)
470 cd05155 APH_ChoK_like_1 Unchar 97.9 5.2E-05 1.1E-09 73.8 9.8 73 23-105 3-82 (235)
471 PRK10593 hypothetical protein; 97.8 0.00038 8.3E-09 70.4 14.0 77 21-104 18-100 (297)
472 PRK09550 mtnK methylthioribose 97.8 0.00066 1.4E-08 71.1 15.3 80 22-103 31-117 (401)
473 cd05157 ETNK_euk Ethanolamine 97.7 0.00046 9.9E-09 66.9 12.6 75 22-104 3-79 (235)
474 PF12260 PIP49_C: Protein-kina 97.7 0.00012 2.6E-09 68.9 7.8 99 65-167 7-112 (188)
475 TIGR02721 ycfN_thiK thiamine k 97.6 0.00018 3.9E-09 70.9 8.5 132 24-165 3-174 (256)
476 PRK05231 homoserine kinase; Pr 97.4 0.0015 3.3E-08 66.4 12.7 147 11-165 11-216 (319)
477 KOG1093 Predicted protein kina 97.4 0.00051 1.1E-08 72.5 8.7 159 63-274 28-200 (725)
478 cd05153 HomoserineK_II Homoser 97.4 0.0023 5E-08 64.3 13.1 136 22-165 19-204 (296)
479 TIGR00938 thrB_alt homoserine 97.4 0.0012 2.6E-08 67.0 10.9 137 22-165 27-216 (307)
480 cd05156 ChoK_euk Choline Kinas 97.4 0.0014 3.1E-08 66.1 11.1 76 22-105 3-85 (302)
481 KOG2268 Serine/threonine prote 97.3 0.00023 4.9E-09 71.3 4.3 134 19-163 94-248 (465)
482 TIGR01767 MTRK 5-methylthiorib 97.1 0.0041 8.8E-08 64.1 11.3 76 24-101 2-84 (370)
483 COG3173 Predicted aminoglycosi 97.1 0.0049 1.1E-07 62.5 11.5 144 20-167 28-229 (321)
484 KOG2270 Serine/threonine prote 97.1 0.0025 5.5E-08 65.0 9.2 143 21-167 148-314 (520)
485 PLN02756 S-methyl-5-thioribose 96.9 0.01 2.2E-07 62.2 12.2 77 21-101 36-119 (418)
486 PLN02236 choline kinase 96.9 0.0084 1.8E-07 61.9 11.2 139 19-165 38-230 (344)
487 TIGR02906 spore_CotS spore coa 96.6 0.024 5.2E-07 57.3 12.5 28 136-164 187-214 (313)
488 PLN02421 phosphotransferase, a 96.5 0.013 2.9E-07 60.1 9.9 136 22-165 19-212 (330)
489 PF03881 Fructosamin_kin: Fruc 96.5 0.015 3.3E-07 58.4 9.9 74 21-102 21-97 (288)
490 cd05152 MPH2' Macrolide 2'-Pho 96.5 0.024 5.1E-07 56.7 10.9 30 137-166 186-216 (276)
491 PRK12396 5-methylribose kinase 96.4 0.022 4.7E-07 59.5 10.4 78 22-101 34-117 (409)
492 TIGR02904 spore_ysxE spore coa 96.0 0.1 2.3E-06 52.8 13.3 29 137-165 197-225 (309)
493 PF01633 Choline_kinase: Choli 95.7 0.016 3.6E-07 55.2 5.5 30 137-166 144-174 (211)
494 COG5072 ALK1 Serine/threonine 95.6 0.035 7.7E-07 56.8 7.2 86 76-167 284-371 (488)
495 KOG1236 Predicted unusual prot 95.4 0.053 1.1E-06 56.3 7.7 61 91-152 319-380 (565)
496 PTZ00384 choline kinase; Provi 95.3 0.13 2.8E-06 53.9 10.6 78 20-105 53-137 (383)
497 PRK11768 serine/threonine prot 95.0 0.43 9.2E-06 48.9 13.4 70 29-103 37-113 (325)
498 PRK06148 hypothetical protein; 94.3 1.2 2.6E-05 52.7 16.4 31 136-166 203-236 (1013)
499 PF02958 EcKinase: Ecdysteroid 93.5 0.34 7.3E-06 48.6 8.8 74 26-99 2-98 (294)
500 COG3001 Uncharacterized protei 93.4 0.91 2E-05 44.0 10.8 75 23-105 22-99 (286)
No 1
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.2e-66 Score=536.13 Aligned_cols=326 Identities=48% Similarity=0.825 Sum_probs=298.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
...++-|+++++||.|+.|.|.+|+|..||+.+|||++.+..-........+.+||-+|+.+.||||+++|+++++..++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 34578999999999999999999999999999999999988555555678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+|.||++||+|++|+.++|+++|.+++++|.||+.|+.|||..+|+||||||||+|||..++|||+|||+|..-.++..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
+.|.||+|.|+|||++.|.+|.|.++||||||||||+||+|++||+++++..++.+++.|.+.+|..+|+++++||.+||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRML 247 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCccccccc--CcccCCCCC-----CchhhhhccCHHHHHHHHHcC--CCHHHHHHHHHhcccChh
Q 010214 253 IVDPMKRITIPEIRQHPWFQAHL--PRYLAVPPP-----DTMQQAKKIDEEILKEVVKMG--FDQNQLVESLRNRLQNEA 323 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~~~ 323 (515)
.+||.+|+|.+||++|||++... +.....+++ ........||+.+++-|+-.+ -+.+.+.+.|.....|..
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~~n~E 327 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLCILWCGRDPEKLVEKLLSPDDNDE 327 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhhheeecCChHHHHHHHcCCCcchh
Confidence 99999999999999999998542 111111122 122234689999999987554 489999999999999999
Q ss_pred HHHHHHHhhcccccc
Q 010214 324 TVAYYLLLDNRFRVS 338 (515)
Q Consensus 324 ~~~y~ll~~~~~~~~ 338 (515)
..-|.||++.+.+.+
T Consensus 328 K~~Y~LLl~~k~r~~ 342 (786)
T KOG0588|consen 328 KTLYFLLLRRKRRDS 342 (786)
T ss_pred HHHHHHHHHhhccch
Confidence 999999999876543
No 2
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2e-63 Score=492.56 Aligned_cols=263 Identities=43% Similarity=0.763 Sum_probs=241.1
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC----hHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~ 87 (515)
...+.+.|.+.++||+|+||.|.+|..+.||+.||||++++.+... ......+.+|+++|++|+|||||+++++|+
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3446788999999999999999999999999999999999876654 223445789999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceEEeecccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLS 164 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vKL~DFGls 164 (515)
.++..||||||++||+|++++..++.+.|...+.++.||+.||.|||+.||+||||||+|||+..+ ..+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999999876 78999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-HHHHHhcCccCCC----
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTLP---- 237 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~~~~i~~~~~~~p---- 237 (515)
+....+.+++|.||||.|.|||++.++ .++..++|+||+||+||.+|+|.+||.+..... +.++|..|.+.+-
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 999999999999999999999999754 344568999999999999999999999876555 8999999988764
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+|.++.+||++||.+||++|||++|+|+||||+..
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 4689999999999999999999999999999999853
No 3
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.6e-60 Score=491.63 Aligned_cols=261 Identities=40% Similarity=0.720 Sum_probs=249.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|..++.||+|||+.||.+++..+|+.||+|++.++.+......+++.+||+|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 34999999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~ 175 (515)
|+|+.++|..++++.+.++|.+++.++.||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.... +++...|
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 999999999999999999999999999999999999999999999999999999999999999999999887 5588899
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.||||+|.|||++....+ +.++||||+||+||.||+|++||...+..+.+.+|+...+.+|..+|.++++||.+||+.|
T Consensus 178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 999999999999997766 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHhcCcccc-cccCcc
Q 010214 256 PMKRITIPEIRQHPWFQ-AHLPRY 278 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f~-~~~~~~ 278 (515)
|.+|||+++++.|+||+ ...|..
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred cccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999994 344443
No 4
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-59 Score=485.40 Aligned_cols=262 Identities=61% Similarity=1.071 Sum_probs=249.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh--HHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--EMEEKVRREIKILRLFM-HPHIIRLYEVIETP 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 89 (515)
....++|.+++.||+|+||+|++|.+..+|..||+|+++++..... ...+.+.||+.++++++ ||||+++++++.++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4567899999999999999999999999999999999887644311 35678889999999999 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeeccccccc-
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIM- 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~- 167 (515)
..+|+|||||.||+|+++|.+.++++|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 99999999999998
Q ss_pred ccCCccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCC-ChhHH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL-SPGAR 245 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~ 245 (515)
..+....+.||||.|+|||++.+.. |.+.++|||||||+||.|++|..||++.+...++.+|..+.+.+|..+ |++++
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHH
Confidence 5778899999999999999999988 999999999999999999999999999999999999999999999999 99999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|+.+||..||.+|+|+.+|+.||||+..
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999999999999999999999999973
No 5
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-58 Score=453.15 Aligned_cols=260 Identities=38% Similarity=0.690 Sum_probs=246.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.-.++|+++++||+|+||+|+.++++.|++.||+|+++|..+........+..|..||..++||+||+++..|++++.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34689999999999999999999999999999999999999888778899999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~ 172 (515)
+|+||+.||+|+.+|++.+.++|..++.++.+|+.||.|||++||+||||||||||||.+|+++|+|||+++. ...+..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999984 456677
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
.++.|||+.|||||++.+..| +.++|+||||+++|+|++|.+||.+.+.....++|..+. ...|..+|.+++++|+++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL 260 (357)
T ss_pred cccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence 888999999999999999988 799999999999999999999999999999999999998 555566999999999999
Q ss_pred CCCCCCCCC----CHHHHhcCcccccc
Q 010214 252 LIVDPMKRI----TIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rp----t~~eil~hp~f~~~ 274 (515)
|+.||.+|. ++.+|.+||||...
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999996 68999999999865
No 6
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-58 Score=464.06 Aligned_cols=318 Identities=40% Similarity=0.722 Sum_probs=285.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.+=|.+.++||+|.|++|.+|+|.-||.+||||++++.++... ....+.+|+++|+.++|||||++|+++.+...+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 456889999999999999999999999999999999999887654 3467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC-CCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~-~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+|.-+||+|++||-++ ..++|+.++++|.||+.|+.|||+..+||||||||||.+- .-|-|||.|||+++.+.+|.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999999999764 5799999999999999999999999999999999998765 56899999999999999999
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.+.|.||+..|.|||++.|..|+.|++||||||||||.|+||.+||...+..+.+..|....|..|+++|.++++||.+|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccC----HHHHHHHHHcCC-CHHHHHHHHHhcccChhHHH
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID----EEILKEVVKMGF-DQNQLVESLRNRLQNEATVA 326 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~ 326 (515)
|+.||.+|.|.+||..|+|++...+.....-|. .....+. ..|++.|+.-.+ +.++|.+.|.+...|..+++
T Consensus 254 LvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPL---vsr~~L~ee~Ha~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTAT 330 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPL---VSRHHLPEEAHATIIQQMVAGAIASEEDILRALENNEYNHITAT 330 (864)
T ss_pred HhcCchhhccHHHHhccccccCCCCCccccCce---eehhhCChHHHHHHHHHHhcccccCHHHHHHHHhccccchhhhH
Confidence 999999999999999999999765443222111 1112223 346777776555 78999999999999999999
Q ss_pred HHHHhhccc
Q 010214 327 YYLLLDNRF 335 (515)
Q Consensus 327 y~ll~~~~~ 335 (515)
||||.+.+.
T Consensus 331 YfLLAEr~L 339 (864)
T KOG4717|consen 331 YFLLAERVL 339 (864)
T ss_pred HHHHHHHHH
Confidence 999988653
No 7
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-58 Score=437.17 Aligned_cols=258 Identities=39% Similarity=0.740 Sum_probs=247.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
--+++|+++++||.|+||.|-+++++.+|..+|+|++++.++-.....+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34789999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||||++||+|++++.+.++++|..++.++.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|...... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887554 6
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
-|.||||.|+|||++.++.| +.++|.|||||++|||++|.+||.+.+...++++|..+.+.+|+.+++++++||+++|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred EEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence 78999999999999999988 79999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccccc
Q 010214 254 VDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
+|-.+|. ...+|..||||+..
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccc
Confidence 9999994 56799999999864
No 8
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8.5e-58 Score=450.07 Aligned_cols=258 Identities=51% Similarity=0.887 Sum_probs=249.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
....+|++.++||+|.||+|.+|.....|+.||||.|.++++++....-.++|||+||..|+||||+++|++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34568999999999999999999998899999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||||..+|+|.|||.+.+.++|.+++.+|+||++|+.|||.++++|||||.||||+|.++++||+|||+++.+.++.++
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
.|+||+|.|++||++.|.+|.++++|-|||||+||.|+.|..||++.+...+.++|..|.|.-|.. +.++.-||+.||-
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999999999877754 5678999999999
Q ss_pred CCCCCCCCHHHHhcCcccc
Q 010214 254 VDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~ 272 (515)
+||++|.|+.+|..|=|+.
T Consensus 289 VNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWWVN 307 (668)
T ss_pred cCcccchhHHHHhhhheee
Confidence 9999999999999998885
No 9
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-56 Score=440.55 Aligned_cols=260 Identities=42% Similarity=0.726 Sum_probs=243.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|.+.+.||+|+||+||+|+|+.++..||||.+.++++ .....+.+..||++|+.++|||||++++++++++++|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 347899999999999999999999999999999999998876 4466788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC------CceEEeeccccccc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK------WNVKIADFGLSNIM 167 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~------~~vKL~DFGls~~~ 167 (515)
+|||||+||+|.+||.+++.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875 45899999999999
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC---CCCCCChhH
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGA 244 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~ 244 (515)
.++....|.||||.|||||++....| +.|+|+||+|+|+|+|++|+.||+..+..+++..+..+... +|..+++..
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence 99999999999999999999988888 68999999999999999999999999999999998887643 446788889
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+|+...|+.+|..|.+..+-+.|+++....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 9999999999999999999999999987553
No 10
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-56 Score=456.39 Aligned_cols=259 Identities=37% Similarity=0.669 Sum_probs=244.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
-..+|.+++.||.|+|++|++|+.+.+++.||||++.|+-+......+.+.+|-.+|.+| .||.|++||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 357899999999999999999999999999999999998887777788899999999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
+|+||+++|+|.++|.+.|.++|..++.++.||+.||+|||++|||||||||||||||.+|++||+|||.+..+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988753211
Q ss_pred -------------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCC
Q 010214 173 -------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239 (515)
Q Consensus 173 -------------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 239 (515)
..+.+||..|.+||++..... ++.+|||+||||||.|+.|.+||.+.+...++++|....+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 145789999999999998754 899999999999999999999999999999999999999999999
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++.++|||+++|..||.+|+|+.+|.+||||...
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 99999999999999999999999999999999864
No 11
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-55 Score=432.77 Aligned_cols=255 Identities=32% Similarity=0.545 Sum_probs=235.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-EEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~i 94 (515)
..+.+.++.||+|+.|+||+|.|+.|++.+|+|++. ...+....+++.+|+++++.++||+||++|+.|..+.. ++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~--~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL--LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec--ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 457788999999999999999999999999999994 23355678899999999999999999999999999985 999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
+||||+||+|.+++...++++|.....++.++++||.|||+ ++|+||||||+|||++..|.|||||||.|..+-+. ..
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA 234 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence 99999999999999999999999999999999999999995 99999999999999999999999999999988665 66
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcC-ccCCCCC-CChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~~ 246 (515)
++.+||..|||||.+.|..| +.++||||||+.+.|+++|+.||... ..-+++..|..+ ...+|.. +|+++++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred ccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 89999999999999999988 78999999999999999999999874 677888888884 4577886 9999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..||++||.+|||+.|+++|||++..
T Consensus 314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 314 FVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 9999999999999999999999999865
No 12
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.9e-55 Score=454.46 Aligned_cols=322 Identities=42% Similarity=0.727 Sum_probs=290.8
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......+.|.+.++||+|.|++|.+|+|..||..||||++++....... ..++.+|+++|+.++|||||+++.+++++.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3455678999999999999999999999999999999999988766544 455999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+||||+.+|++++|+.+++++.+.+++.+|.|+++|++|||+++|||||||++||||+.+.++||+|||+++.+..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
..+.+.||+|.|+|||++.|..|.++++|+||+|+++|.|++|.+||++.+...+..+...+.+.+|-.++.++.++|++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHHHcCCCHHHHHHHHHhcccChhHHHHHHH
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLL 330 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll 330 (515)
+|..+|.+|++++++++|.|.......-.-.| ........++..-+..+..+|+....+.++|.+..+++...+|.++
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p--~~e~~~~~~~~~r~~~m~~~G~~~~~i~~sL~~~k~d~i~a~y~ll 366 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEARLLAP--LIERSTPFILAKRILHMNSIGHRRLKIEESLAKQKFDDINATYLLL 366 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhhhhhhc--ccccCccchhhHHHHHHHhhccchhhHHHHHhhhhHHHHHHHHhhc
Confidence 99999999999999999999976554411111 1111222334444556778999999999999999999999999887
Q ss_pred hhccc
Q 010214 331 LDNRF 335 (515)
Q Consensus 331 ~~~~~ 335 (515)
-.+..
T Consensus 367 ~~~~~ 371 (596)
T KOG0586|consen 367 GYRKQ 371 (596)
T ss_pred chhhh
Confidence 66543
No 13
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=8.2e-54 Score=437.11 Aligned_cols=260 Identities=37% Similarity=0.654 Sum_probs=238.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.-+++|++++.||+|+||.||+|+.+.||+.+|+|+++|+.+......+.++.|-.+|...++|+||++|..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34789999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc----
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---- 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~---- 169 (515)
+||||++||++..+|.+.+.|+|+.++.++.+++.||+.+|+.|++||||||+|+|||..|++||+|||+|.....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999853210
Q ss_pred ------------------CC--------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHH
Q 010214 170 ------------------GH--------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 205 (515)
Q Consensus 170 ------------------~~--------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGv 205 (515)
.. .....+|||.|+|||++.++.| +..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHH
Confidence 00 0123579999999999999987 89999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhHHHHhcccCCCCCCCCCC---HHHHhcCccccccc
Q 010214 206 ILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL 275 (515)
Q Consensus 206 ily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~~ 275 (515)
|+||||.|.+||.+++..+.+++|.+.. +.+|. .++++++|||.+||. ||.+|.. ++||.+||||+...
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999999999999999998876 55554 678999999999999 9999985 89999999998754
No 14
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=2e-55 Score=409.40 Aligned_cols=259 Identities=44% Similarity=0.745 Sum_probs=243.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.+.++|++.+.||+|.|+.|+++.+..||+.+|+|+++..++... .-+++.+|++|-+.|+||||+++.+.+.+....|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 356899999999999999999999999999999999998877765 5688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeecccccccccC
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DFGls~~~~~~ 170 (515)
+|+|++.|++|..-|.++..++|..+..+++||+.||.|||.+||||||+||+|+|+.+ ..-+||+|||++....++
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 99999999999999988888999999999999999999999999999999999999964 346999999999998888
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 246 (515)
.......|||.|||||++...+| +..+|||++|||||-||.|.+||.+++...+++.|..+.+.+|+ .+++++++
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~ 245 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS 245 (355)
T ss_pred cccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence 88888899999999999999888 78999999999999999999999999999999999999988774 78999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+++||..||.+|+|+.|+|+|||+.+.
T Consensus 246 LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 246 LIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999753
No 15
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-53 Score=441.93 Aligned_cols=259 Identities=36% Similarity=0.623 Sum_probs=245.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
.-+++|.+.++||+|+||+|++|..+.+++.||||++.|..+-..+..+.+..|.+|+...+ ||++++++..|++++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34689999999999999999999999999999999999999988899999999999999887 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~ 171 (515)
|+||||+.||++.. +.+.+.++|..++.++..++.||.|||++||+|||||.+|||||.+|++||+|||+++.- ..+.
T Consensus 445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99999999999544 445678999999999999999999999999999999999999999999999999999864 4777
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
...|.||||.|+|||++.+..| +.++|.|||||+||+||.|..||.+++.+++++.|....+.+|..+|.++.++++++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~l 602 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRL 602 (694)
T ss_pred ccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHH
Confidence 8899999999999999999998 799999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCH-----HHHhcCcccccc
Q 010214 252 LIVDPMKRITI-----PEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~-----~eil~hp~f~~~ 274 (515)
|.+||++|... ++|..||||+..
T Consensus 603 l~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 603 LRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred hccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999964 789999999875
No 16
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=8.1e-53 Score=423.08 Aligned_cols=260 Identities=41% Similarity=0.737 Sum_probs=233.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----------HHHHHHHHHHHHHHhCCCCCccEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------EMEEKVRREIKILRLFMHPHIIRL 82 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----------~~~~~i~~Ei~il~~l~hpnIv~l 82 (515)
..+++|++.+.||+|.||+|.+|++..+++.||||++++...... ...+++++||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 457899999999999999999999999999999999987654321 124789999999999999999999
Q ss_pred EEEEEcC--CeEEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 83 YEVIETP--SDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 83 ~~~~~~~--~~~~iVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
+++..++ +.+|||+|||..|.+...= ..+. +++.+++.++..++.||+|||.+||+||||||+|+||+++|.|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9999775 5699999999999885532 2334 9999999999999999999999999999999999999999999999
Q ss_pred eccccccccc------CCccccCCCCCCccCCCcccC---CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh
Q 010214 160 DFGLSNIMRD------GHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 160 DFGls~~~~~------~~~~~~~~gt~~Y~aPE~i~~---~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~ 230 (515)
|||.+..... ...+...+|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|..||-++...+++++|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9999987632 233455789999999999987 5678899999999999999999999999999999999999
Q ss_pred cCccCCCCC--CChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 231 GGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 231 ~~~~~~p~~--~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+....+|.. +.++++|||.+||.+||++|+++.+|..|||....
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 999998875 79999999999999999999999999999999765
No 17
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-53 Score=404.34 Aligned_cols=252 Identities=33% Similarity=0.582 Sum_probs=226.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE-EE-EcCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-VI-ETPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-~~-~~~~~~ 92 (515)
-..+|++.++||.|+||.||++.+..+|..+|.|.++-.. .+....+.+..||.+|++|+|||||++|+ -| ++..-+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3567999999999999999999999999999999997433 34456778889999999999999999998 34 555559
Q ss_pred EEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEECCCCceEEeecccc
Q 010214 93 YVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR--NM--VVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~--~g--IvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+||||||.+|+|...|+. +..++|..+|+++.|++.||..||+ .. |+||||||.||+|+.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999974 4579999999999999999999998 44 999999999999999999999999999
Q ss_pred cccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CC-CCCC
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LP-SHLS 241 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s 241 (515)
+.+... .+..+.+|||.||+||.+.+..| ++++||||+||++|||+.-..||.+.+...+.++|..+.++ +| .++|
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence 988654 45567899999999999999988 79999999999999999999999999999999999999876 77 7899
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++..+|..|+.+||..||+. +|++++
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 999999999999999999986 555544
No 18
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=2e-52 Score=426.54 Aligned_cols=255 Identities=33% Similarity=0.610 Sum_probs=241.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.|....+ ...+.+.+|++|++.++||||+.+++.|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 68999999999999999999999999999999999876444 45688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc-c
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-T 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~-~ 175 (515)
|||.| +|+.++...+.++|+.++.++.|+++||.|||+++|+|||+||.|||++.+|.+|+||||+++.+..+..+. .
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 99987 999999999999999999999999999999999999999999999999999999999999999998766544 4
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.-|||.|||||++.+..| +..+|+||+|||+|||.+|++||...++.++.+.|.......|...|.++++|++.+|.+|
T Consensus 160 ikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred ccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence 569999999999999988 7899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 010214 256 PMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f~~~ 274 (515)
|.+|+|+.+++.|||.+..
T Consensus 239 P~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhhcccHHHHhcChHHhhh
Confidence 9999999999999999865
No 19
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=2.8e-52 Score=398.92 Aligned_cols=256 Identities=26% Similarity=0.498 Sum_probs=224.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.|+.+..+|+|+||+|++++++.||+.||||++-.+ -.+....+-..|||++|++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 5788999999999999999999999999999998533 234455677789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~ 174 (515)
|||+. ++.+-+.+ ...++++.++.++.|++.|+.|||+++++||||||||||++.+|.+||||||+|+... ++....
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 99987 55555554 3469999999999999999999999999999999999999999999999999999887 677777
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------- 235 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 235 (515)
..+.|.+|+|||.+.|...+++.+||||+||++.||++|.+.|.+.+..++.-.|......
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 8899999999999999666699999999999999999999999998877766555432211
Q ss_pred CC------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 LP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ~p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+| +.++.-+.||++.||..||.+|+|++|++.||+|...
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 22 2466778999999999999999999999999999654
No 20
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-51 Score=420.69 Aligned_cols=261 Identities=44% Similarity=0.770 Sum_probs=244.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 90 (515)
.+.+...|.+.+.||.|.||.||++.++.||+.+|+|++.+.........+.+.+|+.+|+++. ||||+.++++|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3556778999999999999999999999999999999999988877666789999999999999 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CceEEeecccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNI 166 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~----~~vKL~DFGls~~ 166 (515)
.+++|||+|.||+|++.|.+. .++|..+..++.|++.|+.|||+.||+||||||||+|+... +.+|++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999887 59999999999999999999999999999999999999643 4799999999999
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCCh
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSP 242 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 242 (515)
...+....+.||||.|+|||++.+..| +.++||||+||++|.|++|..||.+.+....+.+|..+.+.++ +.+|.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 988888999999999999999998887 7999999999999999999999999999999999999987665 46799
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+++||.+||..||.+|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
No 21
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=1e-50 Score=415.32 Aligned_cols=258 Identities=38% Similarity=0.698 Sum_probs=238.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34468999999999999999999999999999999999876554445567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999866443
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|..++..+++||.+||
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLL 250 (329)
T ss_pred cceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHh
Confidence 235689999999999988876 7899999999999999999999999888888899999988899999999999999999
Q ss_pred CCCCCCCCC-----HHHHhcCccccc
Q 010214 253 IVDPMKRIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 253 ~~dP~~Rpt-----~~eil~hp~f~~ 273 (515)
+.||.+|++ +++++.||||+.
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 999999997 799999999975
No 22
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.2e-52 Score=388.47 Aligned_cols=267 Identities=37% Similarity=0.677 Sum_probs=251.4
Q ss_pred CCCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE
Q 010214 6 NRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV 85 (515)
Q Consensus 6 ~~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~ 85 (515)
+++...-..-+++|.+++.||+|.||.||+|+.+.++-.||+|++.++.+........++||++|-..|+||||+++|++
T Consensus 11 ~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 11 FGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred cccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34444555678999999999999999999999999999999999999998888888999999999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
|-+...+|+++||..+|+|+..+. ...+++|..+..++.|++.|+.|||.++|+||||||+|+|++..|.+||+|||.
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 999999999999999999999998 567899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChh
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 243 (515)
+.... ...-.|.|||..|.+||...+..+ +..+|+|++|++.|+++.|.+||...+..+.+++|.+..+.+|+.++.+
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~ 248 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGG 248 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChh
Confidence 87765 556689999999999999999987 6899999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++|||.+||.++|.+|.+..|++.|||+...
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999999999998753
No 23
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=4.4e-52 Score=392.18 Aligned_cols=264 Identities=41% Similarity=0.694 Sum_probs=240.6
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----ChHHHHHHHHHHHHHHhCC-CCCccEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFM-HPHIIRLYE 84 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~-hpnIv~l~~ 84 (515)
..+.+..+|.-.+.||.|..++|.++.++.||+.+|+|++....-. .....+...+|+.||+++. ||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3445678899999999999999999999999999999999643221 2345677789999999886 999999999
Q ss_pred EEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 85 VIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 85 ~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+++++..+|+|+|.|+.|+|+||+.+.-.++|.+++++++|++.|++|||.++||||||||||||+|++.++||+|||++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC--
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-- 237 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-- 237 (515)
+.+..|..++..||||+|.|||.+.. .+.++.++|+|++|||+|.||.|.+||......-+.+.|..|.+.+.
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 99999999999999999999999852 33347899999999999999999999998877778899999988764
Q ss_pred --CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 --SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 --~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++|.+++|||++||++||.+|+|++|+|.||||...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 4789999999999999999999999999999999654
No 24
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.5e-50 Score=406.72 Aligned_cols=254 Identities=36% Similarity=0.697 Sum_probs=234.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655444455677899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..+.
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998866442 2356
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...+|..+++.+++||++||+.||
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 159 CGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred cCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 79999999999988776 78999999999999999999999999988889999999889999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccc
Q 010214 257 MKRIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 257 ~~Rpt-----~~eil~hp~f~~ 273 (515)
.+|++ ++++++||||+.
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHccCCccCCHHHHhcCccccC
Confidence 99995 999999999975
No 25
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=4.7e-50 Score=409.22 Aligned_cols=251 Identities=38% Similarity=0.625 Sum_probs=230.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544455667889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPN 181 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~ 181 (515)
+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++... ..+....+.+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999998889999999999999999999999999999999999999999999999999998753 23334456789999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC-
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp- 260 (515)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++.+||++||..||.+||
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred ccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 999999988777 789999999999999999999999988888888888888889999999999999999999999999
Q ss_pred ----CHHHHhcCcccccc
Q 010214 261 ----TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 ----t~~eil~hp~f~~~ 274 (515)
++.++++||||+..
T Consensus 240 ~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 240 GGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 89999999999753
No 26
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.5e-51 Score=405.12 Aligned_cols=258 Identities=34% Similarity=0.574 Sum_probs=223.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--eEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--DIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 93 (515)
..+|..++.||+|+||.||++.+..+|...|||.+..... ...+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 5779999999999999999999999999999999876521 12677899999999999999999999754444 699
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeeccccccccc--
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD-- 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~-- 169 (515)
+.|||++||+|.+++.+.+ +++|..++.+.+||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999999 79999999999887653
Q ss_pred --CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcC--ccCCCCCCChhH
Q 010214 170 --GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGG--IYTLPSHLSPGA 244 (515)
Q Consensus 170 --~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~ 244 (515)
........|||.|||||++......++++||||+||++.||+||..||.. ....+..-.+... .+.+|..+|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 22344678999999999999643445699999999999999999999987 3433433334333 357889999999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
++||.+|+..||.+|||+.++|+|||.+...+
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987655
No 27
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.5e-50 Score=406.46 Aligned_cols=261 Identities=31% Similarity=0.482 Sum_probs=230.7
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP- 89 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~- 89 (515)
++....+.|+.++.||+|.||.||+|++..||+.||+|.+..+.... .......|||.||++|+||||++|.+++.+.
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 44455678999999999999999999999999999999997765433 4456778999999999999999999998776
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|||+|||+. +|.-++... -.+++.+++.++.||++||+|||.+||+|||||.+|||||.+|.+||+|||+|+++
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999976 998888763 37999999999999999999999999999999999999999999999999999987
Q ss_pred ccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc----------C
Q 010214 168 RDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------T 235 (515)
Q Consensus 168 ~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~----------~ 235 (515)
.... .+...+-|.+|+|||.+.|..-++.++|+||+||||.||+.|++.|.+.+..++.++|.+... .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 6543 466778899999999999988779999999999999999999999999999888888855321 1
Q ss_pred CC-------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 236 LP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 236 ~p-------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+| ..+++.+.+|+..||..||.+|.|+.++|.|+||..
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 22 247888999999999999999999999999999943
No 28
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=1.7e-49 Score=408.35 Aligned_cols=260 Identities=33% Similarity=0.584 Sum_probs=236.9
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCC-cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.....++|++.+.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4445789999999999999999999977665 689999997665544455677889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999866432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.....+.+..+...+|..++++++++|++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261 (340)
T ss_pred --cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 346689999999999988766 78999999999999999999999998888888999999888999999999999999
Q ss_pred cCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 251 MLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||+.||.+|+ |++++++||||+..
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999995 89999999999753
No 29
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-51 Score=411.05 Aligned_cols=260 Identities=34% Similarity=0.527 Sum_probs=230.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC-e
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS-D 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~-~ 91 (515)
.+.++|.+++.||.|+||.||+|+.+.+|..||||.+.++... .+. -.=.||++-|++++ |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4568999999999999999999999999999999999765433 222 23358999999999 999999999998877 9
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
+|+|||||+. +|.+.++.+ ..++|..++.|+.||++||+|+|.+|+.|||+||||||+..+..|||+|||+|+.....
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999965 999999865 46999999999999999999999999999999999999998889999999999999988
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-----------------
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------- 233 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (515)
......+.|.+|+|||++....+++..+|+|++|||++|+.+-++.|.+.+..+.+-+|..-.
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 888999999999999999888788999999999999999999999999988777777764321
Q ss_pred --cCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 234 --YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 234 --~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
+.+| +..++++.+||.+||.+||.+|||+.|+++||||+...+
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1222 347899999999999999999999999999999986543
No 30
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8.6e-50 Score=396.25 Aligned_cols=268 Identities=32% Similarity=0.536 Sum_probs=241.1
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
.+...-.++|++++.||.|.-|+||+|+.+.++..+|+|++++..+.......+++.|-+||+.++||+++.||..|+++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44445568899999999999999999999999999999999999888878889999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+..|+|||||+||+|....+++ +.+++..++.++.+++.||+|||-.|||+||||||||||.++|+|.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999988764 46999999999999999999999999999999999999999999999999986432
Q ss_pred c----------------------------------c-C----------------------CccccCCCCCCccCCCcccC
Q 010214 168 R----------------------------------D-G----------------------HFLKTSCGSPNYAAPEVISG 190 (515)
Q Consensus 168 ~----------------------------------~-~----------------------~~~~~~~gt~~Y~aPE~i~~ 190 (515)
. . . ......+||-.|.|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 01123468999999999999
Q ss_pred CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC--CCChhHHHHhcccCCCCCCCCCC----HHH
Q 010214 191 KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRIT----IPE 264 (515)
Q Consensus 191 ~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~mL~~dP~~Rpt----~~e 264 (515)
... +.++|+|+|||.+|||+.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|.. +.|
T Consensus 310 ~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e 388 (459)
T KOG0610|consen 310 EGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE 388 (459)
T ss_pred CCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence 876 88999999999999999999999999999999999999888875 57899999999999999999998 999
Q ss_pred HhcCcccccccCcc
Q 010214 265 IRQHPWFQAHLPRY 278 (515)
Q Consensus 265 il~hp~f~~~~~~~ 278 (515)
|.+||||+......
T Consensus 389 IK~HpFF~gVnWaL 402 (459)
T KOG0610|consen 389 IKRHPFFEGVNWAL 402 (459)
T ss_pred hhcCccccCCChhh
Confidence 99999998754433
No 31
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=3.7e-49 Score=400.62 Aligned_cols=249 Identities=33% Similarity=0.604 Sum_probs=228.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999766554555567788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCCCcc
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYA 183 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~Y~ 183 (515)
.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99999888999999999999999999999999999999999999999999999999999875432 23345668999999
Q ss_pred CCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC---
Q 010214 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI--- 260 (515)
Q Consensus 184 aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp--- 260 (515)
|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..+++++++||.+||..||.+||
T Consensus 161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 9999998776 789999999999999999999999999999999999988899999999999999999999999997
Q ss_pred CHHHHhcCcccccc
Q 010214 261 TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 t~~eil~hp~f~~~ 274 (515)
++.|++.||||...
T Consensus 240 ~~~e~l~hp~~~~~ 253 (312)
T cd05585 240 GAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHcCCCcCCC
Confidence 57999999999753
No 32
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=1.3e-49 Score=374.99 Aligned_cols=256 Identities=34% Similarity=0.557 Sum_probs=226.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|...+.||+|.||.||+|++..||+.||||.+......+ .......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 57889999999999999999999999999999998765543 33456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||++. +|...|+.+ ..++..+++.++.+++.||+|||++.|+||||||+|+|++++|.+||+|||+++.+.......+
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99976 999999754 4699999999999999999999999999999999999999999999999999999876554443
Q ss_pred -CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----------CC------
Q 010214 176 -SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----------LP------ 237 (515)
Q Consensus 176 -~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-----------~p------ 237 (515)
.+-|.+|+|||.+.|...++..+|+||.|||+.||+-|.+-|.++++-++...|.....+ +|
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 488999999999988776799999999999999999999999999888877777542211 11
Q ss_pred -----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 -----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 -----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+..+.++.||+.+||..||.+|+|+.|+++|+||++.
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 2457889999999999999999999999999999863
No 33
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-49 Score=389.47 Aligned_cols=258 Identities=34% Similarity=0.562 Sum_probs=225.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-----C
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-----P 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-----~ 89 (515)
+...|...+.||+|+||.|+.|.++.||+.||||.+... +...-..++..||+++|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 446677789999999999999999999999999998642 4455667899999999999999999999999855 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
+++|+|+|+|+ -+|...|+.+..++++.+..++.||+.||+|+|+.+|+||||||+|+|++.++.+||+|||+|+....
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 57999999994 59999998888899999999999999999999999999999999999999999999999999998863
Q ss_pred ---CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----------
Q 010214 170 ---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----------- 235 (515)
Q Consensus 170 ---~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~----------- 235 (515)
...++..+.|.+|.|||++.....++.++||||+|||+.||++|++.|.+.+...+++.|..-..+
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 556677889999999999876555589999999999999999999999988765555554332111
Q ss_pred ------------CC--------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ------------LP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ------------~p--------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.| ++.++.+.+|+++||..||.+|+|++|+|.||||...
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11 4688999999999999999999999999999999864
No 34
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=8.1e-49 Score=392.69 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=226.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987665544455677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....+.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999999888653 3689999999999999999999999999999999999999999999999999987655555566
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
..||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... .....+......++..+++++.+|+++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 789999999999998877 78999999999999999999999875432 3344455555667788999999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
|+.||.+||| ++++++||||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999997 8999999999764
No 35
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=7.9e-49 Score=401.28 Aligned_cols=250 Identities=38% Similarity=0.633 Sum_probs=228.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544455678889999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPN 181 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~ 181 (515)
+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 999999888899999999999999999999999999999999999999999999999999987532 2233455689999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC-
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp- 260 (515)
|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||++||..||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988776 789999999999999999999999888888888888888889999999999999999999999997
Q ss_pred ----CHHHHhcCccccc
Q 010214 261 ----TIPEIRQHPWFQA 273 (515)
Q Consensus 261 ----t~~eil~hp~f~~ 273 (515)
++.++++||||..
T Consensus 240 ~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 240 GGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 8999999999964
No 36
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=9.7e-49 Score=406.03 Aligned_cols=256 Identities=31% Similarity=0.568 Sum_probs=225.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999988999999999999999999999999999999999999999999999999999987543211
Q ss_pred -------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC
Q 010214 172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (515)
Q Consensus 172 -------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~ 220 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 1124589999999999988876 68999999999999999999999998
Q ss_pred ChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCCCCCC---CCCCHHHHhcCcccccc
Q 010214 221 NIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDPM---KRITIPEIRQHPWFQAH 274 (515)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~~dP~---~Rpt~~eil~hp~f~~~ 274 (515)
+......++... ...+|. .+++++++||.+|+. +|. .||+++|+++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 888888888763 234443 478999999999775 444 46899999999999764
No 37
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=9.5e-49 Score=399.75 Aligned_cols=251 Identities=37% Similarity=0.623 Sum_probs=229.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+++++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444455667789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPN 181 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~ 181 (515)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 999999888899999999999999999999999999999999999999999999999999987532 2333455689999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC-
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp- 260 (515)
|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||..||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 999999988776 789999999999999999999999988888888888888889999999999999999999999998
Q ss_pred ----CHHHHhcCcccccc
Q 010214 261 ----TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 ----t~~eil~hp~f~~~ 274 (515)
++.++++||||...
T Consensus 240 ~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 89999999999753
No 38
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=2.6e-48 Score=397.77 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=228.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...+.
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999976543 34567
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC------CCChhHHHHh
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS------HLSPGARDLI 248 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~li 248 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+.... ...|. .+++++.+||
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 89999999999998866 789999999999999999999999988877777665432 12222 4589999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+||..+|.+|||+.++++||||+..
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999864
No 39
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=2.6e-48 Score=396.41 Aligned_cols=255 Identities=36% Similarity=0.591 Sum_probs=231.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iVm 96 (515)
+|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+..|+++++.+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544445567788899999999865 5888999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~ 175 (515)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999999988899999999999999999999999999999999999999999999999999986432 2333456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+......+|..+++++.+++.+||..|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 689999999999998877 7899999999999999999999999998889999998888899999999999999999999
Q ss_pred CCCCCCH-----HHHhcCccccc
Q 010214 256 PMKRITI-----PEIRQHPWFQA 273 (515)
Q Consensus 256 P~~Rpt~-----~eil~hp~f~~ 273 (515)
|.+|++. +++++||||+.
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999987 89999999975
No 40
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=2e-48 Score=403.29 Aligned_cols=256 Identities=34% Similarity=0.645 Sum_probs=226.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998665444455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986543211
Q ss_pred ----------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCC
Q 010214 172 ----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF 217 (515)
Q Consensus 172 ----------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf 217 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 1123579999999999988776 78999999999999999999999
Q ss_pred CCCChHHHHHHHhcCc--cCCCC--CCChhHHHHhcccCCCCCCCCCC---HHHHhcCcccccc
Q 010214 218 DDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (515)
Q Consensus 218 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~ 274 (515)
.+.+.......+.... ..+|. .+++++++||.+||. +|.+|++ +.|++.||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988877777776543 23333 578999999999996 9999998 9999999999753
No 41
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-50 Score=385.35 Aligned_cols=260 Identities=37% Similarity=0.621 Sum_probs=247.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
+..++|.++++||+|.||+|-+++.+.||+.||||++.++.+...+....-..|-++|+..+||++..+-..|++.+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 35689999999999999999999999999999999999998888888888889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~ 172 (515)
+||||+.||+|+-++.+...++|+.++.+-.+|++||.|||+++||+||||.+|+|+|.+|++||+|||+++. +..+..
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999974 567788
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccC
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL 252 (515)
.+|.||||.|.|||++....| +.++|.|.+||++|||+||++||...+...++.-|......+|..+|++++.|+..+|
T Consensus 325 ~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL 403 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLL 403 (516)
T ss_pred eccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHh
Confidence 899999999999999998887 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCC-----HHHHhcCcccccc
Q 010214 253 IVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
.+||.+|.. +.||..|+||...
T Consensus 404 ~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 404 KKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999984 7899999999764
No 42
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=1.9e-48 Score=397.00 Aligned_cols=251 Identities=37% Similarity=0.654 Sum_probs=227.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765544444556777888888876 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .+....+.+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999999988899999999999999999999999999999999999999999999999999987542 333445668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+...+..+...+|..+++++.+||++||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999988776 789999999999999999999999999999999999988889999999999999999999999999
Q ss_pred CH------HHHhcCcccccc
Q 010214 261 TI------PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~------~eil~hp~f~~~ 274 (515)
++ ++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 98 999999999753
No 43
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=1.5e-48 Score=398.49 Aligned_cols=251 Identities=39% Similarity=0.632 Sum_probs=229.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+++++.++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544455677789999999999999999999999999999999999999
Q ss_pred CHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 103 ~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888899999999999999999999997 799999999999999999999999999987532 333445678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 161 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 9999999988776 789999999999999999999999988888888888888889999999999999999999999997
Q ss_pred -----CHHHHhcCcccccc
Q 010214 261 -----TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 -----t~~eil~hp~f~~~ 274 (515)
++.++++||||...
T Consensus 240 ~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 89999999999753
No 44
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=3.6e-48 Score=403.74 Aligned_cols=255 Identities=31% Similarity=0.581 Sum_probs=223.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++.+|+.||||++.+...........+.+|+++++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986321100
Q ss_pred -------------------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 172 -------------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 172 -------------------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0013579999999999988777 78999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCCCCCCCC---CCHHHHhcCccccc
Q 010214 209 ALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQA 273 (515)
Q Consensus 209 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~~dP~~R---pt~~eil~hp~f~~ 273 (515)
+|++|..||.+.+....+..+... ...+|. .++.++++||.+||. +|.+| +|+.|++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777653 234444 579999999999997 67665 59999999999975
No 45
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=2.3e-48 Score=400.22 Aligned_cols=256 Identities=35% Similarity=0.660 Sum_probs=230.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.+.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987664433
Q ss_pred -------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHH
Q 010214 172 -------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226 (515)
Q Consensus 172 -------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~ 226 (515)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 2345679999999999998876 78999999999999999999999998877777
Q ss_pred HHHhc--CccCCCCC--CChhHHHHhcccCCCCCCCCCC-HHHHhcCcccccc
Q 010214 227 KKIKG--GIYTLPSH--LSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQAH 274 (515)
Q Consensus 227 ~~i~~--~~~~~p~~--~s~~~~~li~~mL~~dP~~Rpt-~~eil~hp~f~~~ 274 (515)
.++.. ....+|.. +++++.+||.+||. ||.+|++ +.++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 77776 44445543 59999999999997 9999999 9999999999753
No 46
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-49 Score=405.01 Aligned_cols=256 Identities=32% Similarity=0.572 Sum_probs=229.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..-...|...+.||+|+.|.||.|....+++.||||.++...... .+.+.+|+.+|+..+|+|||++++.|-..+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 344567889999999999999999999999999999998766544 56789999999999999999999999888999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||++||+|.|.+. ...++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+....
T Consensus 346 WVVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999999999875 4569999999999999999999999999999999999999999999999999998876654
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH-hcCc--cCCCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGI--YTLPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i-~~~~--~~~p~~~s~~~~~li 248 (515)
.-.+.+|||+|||||++..+.| ++++||||||+++.||+-|.+||-.++.-.....| .++. ...|..+|+.+++||
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 4568899999999999999988 89999999999999999999999866554433333 4444 456789999999999
Q ss_pred cccCCCCCCCCCCHHHHhcCccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+||++|+.+|+|+.|+|+||||+.
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhh
Confidence 9999999999999999999999953
No 47
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=4.5e-48 Score=395.76 Aligned_cols=250 Identities=31% Similarity=0.574 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876655555567788999999988 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~ 180 (515)
|+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++... ..+....+.+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 999999988889999999999999999999999999999999999999999999999999998753 3344455678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---------ChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.|+|||++.+..+ +.++|+||+||++|+|++|..||+.. ......+.+......+|..++.++.++|.+|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999998776 78999999999999999999999632 1233566677778888999999999999999
Q ss_pred CCCCCCCCCC------HHHHhcCccccc
Q 010214 252 LIVDPMKRIT------IPEIRQHPWFQA 273 (515)
Q Consensus 252 L~~dP~~Rpt------~~eil~hp~f~~ 273 (515)
|+.||.+|+| ++++++||||..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999997 789999999964
No 48
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=3.8e-48 Score=394.70 Aligned_cols=250 Identities=35% Similarity=0.592 Sum_probs=227.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||.||+|+++.+++.||+|++.+...........+..|+++++.+ +||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544445566778899998866 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 9999999988899999999999999999999999999999999999999999999999999987543 233345668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..+...+|..+++++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 161 DYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred cccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999988776 789999999999999999999999999999999999988888999999999999999999999999
Q ss_pred -------CHHHHhcCccccc
Q 010214 261 -------TIPEIRQHPWFQA 273 (515)
Q Consensus 261 -------t~~eil~hp~f~~ 273 (515)
++.++++||||..
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCCHHHHhcCCccCC
Confidence 8999999999965
No 49
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=7.9e-48 Score=401.89 Aligned_cols=257 Identities=31% Similarity=0.519 Sum_probs=223.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998766555566778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC------
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~------ 170 (515)
||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999987532100
Q ss_pred ------------------------------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 171 ------------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 171 ------------------------------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
....+.+||+.|+|||++.+..+ +.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 01124579999999999988776 68999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCC--CCCCCCCCHHHHhcCcccccc
Q 010214 209 ALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLI--VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 209 ~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~--~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|++|..||...+......++... ....|. .+++++++||.+|+. .+|..|+|+.+++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999987776666666532 233443 589999999999654 455569999999999999753
No 50
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=7e-48 Score=393.11 Aligned_cols=255 Identities=36% Similarity=0.582 Sum_probs=231.6
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVm 96 (515)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+. ||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999998765444445566778888888775 899999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~ 175 (515)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... .+.....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999987543 2334456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+...+......+|..++.++.+++.+||+.|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 789999999999998877 7899999999999999999999999998899999999888899999999999999999999
Q ss_pred CCCCCCH-----HHHhcCccccc
Q 010214 256 PMKRITI-----PEIRQHPWFQA 273 (515)
Q Consensus 256 P~~Rpt~-----~eil~hp~f~~ 273 (515)
|.+|+++ .++++||||+.
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999984 89999999974
No 51
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=6.5e-48 Score=393.50 Aligned_cols=254 Identities=34% Similarity=0.563 Sum_probs=227.9
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH---HhCCCCCccEEEEEEEcCCeEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL---RLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|++++ +.++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866544444556777777765 466799999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~ 174 (515)
|||++||+|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 99999999998885 4579999999999999999999999999999999999999999999999999986532 233345
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+....|..+++++.++|.+||+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 6789999999999988776 789999999999999999999999998888889998888889999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 010214 255 DPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||.+|| ++.++++||||+..
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999 79999999999753
No 52
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=1e-47 Score=400.98 Aligned_cols=255 Identities=33% Similarity=0.560 Sum_probs=223.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987655444566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc--------
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-------- 169 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-------- 169 (515)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999753210
Q ss_pred ----------------------------------------CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHH
Q 010214 170 ----------------------------------------GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA 209 (515)
Q Consensus 170 ----------------------------------------~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ 209 (515)
.....+.+||+.|+|||++.+..+ +.++||||+||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHHH
Confidence 001124579999999999988877 689999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhHHHHhcccCCCCCCCCCC---HHHHhcCcccccc
Q 010214 210 LLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (515)
Q Consensus 210 lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~ 274 (515)
|++|..||.+.+..+...++.... ...| ..+++++.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999887766666665432 2333 468999999999986 59999997 9999999999753
No 53
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=8.2e-48 Score=391.65 Aligned_cols=251 Identities=33% Similarity=0.604 Sum_probs=224.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999976543323345566778888875 4899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~ 180 (515)
|+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999999888999999999999999999999999999999999999999999999999999875322 23345678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+.+.+......+|..++.++++||.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999998877 789999999999999999999999998888889888888888889999999999999999999999
Q ss_pred CH-HHHhcCcccccc
Q 010214 261 TI-PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~-~eil~hp~f~~~ 274 (515)
|+ +++++||||+..
T Consensus 240 ~~~~~~~~h~~f~~~ 254 (316)
T cd05620 240 GVVGNIRGHPFFKTI 254 (316)
T ss_pred CChHHHHcCCCcCCC
Confidence 98 589999999754
No 54
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-47 Score=383.29 Aligned_cols=265 Identities=30% Similarity=0.494 Sum_probs=230.1
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
.....-.+.|++...||.|..++||+|++..+++.||||+++.++..+. .+.+++|+..|+.++||||++++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3455567899999999999999999999999999999999998887653 78999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+||.||.+|++.+.++.. ..++|..+..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999864 45999999999999999999999999999999999999999999999999987765
Q ss_pred cc-CCc----cccCCCCCCccCCCcc-cCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-HHHHHhcCccC-----
Q 010214 168 RD-GHF----LKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYT----- 235 (515)
Q Consensus 168 ~~-~~~----~~~~~gt~~Y~aPE~i-~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~~~~i~~~~~~----- 235 (515)
.+ |.. .++.+|||+|||||++ ..-..++.|+||||+|++..||.+|..||....... +..++.+..+.
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 43 221 2677999999999994 333334799999999999999999999998876544 45555554431
Q ss_pred CC----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 236 LP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 236 ~p----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
++ ..++..++.+|..||+.||.+|||++++++|+||+....
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 12 246778999999999999999999999999999987543
No 55
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=1e-47 Score=391.97 Aligned_cols=250 Identities=34% Similarity=0.594 Sum_probs=223.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999997665443334455555555 56889999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 9999999988899999999999999999999999999999999999999999999999999987542 223344568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+..++...+......++..+++++.++|.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 9999999988776 789999999999999999999999998888899998888888888999999999999999999999
Q ss_pred CH----HHHhcCccccc
Q 010214 261 TI----PEIRQHPWFQA 273 (515)
Q Consensus 261 t~----~eil~hp~f~~ 273 (515)
++ .++++||||..
T Consensus 240 ~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 240 GAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCHHHHHcCCCcCC
Confidence 97 69999999964
No 56
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=2e-47 Score=389.86 Aligned_cols=251 Identities=36% Similarity=0.623 Sum_probs=225.8
Q ss_pred eeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
++.||+|+||.||+|.+. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 57899999999765432 22334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~ 176 (515)
|++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999987543 23334456
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+...+|..+++++.+||.+||+.||
T Consensus 161 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 89999999999988766 78999999999999999999999999888888899888889999999999999999999999
Q ss_pred CCCC-----CHHHHhcCccccc
Q 010214 257 MKRI-----TIPEIRQHPWFQA 273 (515)
Q Consensus 257 ~~Rp-----t~~eil~hp~f~~ 273 (515)
.+|| +++++++||||+.
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCC
Confidence 9999 8999999999975
No 57
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=1.8e-47 Score=391.35 Aligned_cols=251 Identities=31% Similarity=0.566 Sum_probs=222.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++.++ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555667788999998776 799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .+....+.+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 9999999888899999999999999999999999999999999999999999999999999987532 333445678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC---------CChHHHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.. .......+.+......+|..++.++.+||++|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999998876 7899999999999999999999952 12233556677777889999999999999999
Q ss_pred CCCCCCCCCC------HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT------IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt------~~eil~hp~f~~~ 274 (515)
|+.||.+||| +.++++||||+..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999998 5799999999753
No 58
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=1e-47 Score=391.17 Aligned_cols=251 Identities=37% Similarity=0.638 Sum_probs=228.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876554445567778899999888 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 9999999988899999999999999999999999999999999999999999999999999986532 233344568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+||++||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 9999999998877 689999999999999999999999988888888898888888999999999999999999999999
Q ss_pred CH-----HHHhcCcccccc
Q 010214 261 TI-----PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~-----~eil~hp~f~~~ 274 (515)
|+ .++++||||+..
T Consensus 240 s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 99 999999999753
No 59
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.4e-47 Score=383.00 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=215.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999765332 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--ccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~ 174 (515)
||++++.+..+....+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 999987776665556679999999999999999999999999999999999999999999999999998764332 223
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------- 235 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------- 235 (515)
...||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 4579999999999988776 78999999999999999999999876654433332221100
Q ss_pred C-------------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 L-------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ~-------------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. ...+|.++.+||++||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1 12368889999999999999999999999999998
No 60
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=2.2e-47 Score=397.07 Aligned_cols=260 Identities=30% Similarity=0.527 Sum_probs=228.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34678999999999999999999999999999999997655444445566789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999999998864 468999999999999999999999999999999999999999999999999997764332
Q ss_pred ccccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhH
Q 010214 172 FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGA 244 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 244 (515)
...+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.++.... ..+|. .+|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 224568999999999987542 34789999999999999999999999998888888887643 34454 579999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
++||.+||+.+|.+ |+|++|+++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999988 9999999999999863
No 61
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=1.1e-47 Score=399.82 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=222.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654444345577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC------
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~------ 170 (515)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999997432100
Q ss_pred --------------------------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh
Q 010214 171 --------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212 (515)
Q Consensus 171 --------------------------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt 212 (515)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 00123579999999999988776 789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhHHHHhcccCCCCCCCCC---CHHHHhcCcccccc
Q 010214 213 GTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 213 G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~mL~~dP~~Rp---t~~eil~hp~f~~~ 274 (515)
|..||.+.+.......+.... ..+| ..+++++.++|.+|+ .+|.+|+ |+.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999888776666665432 2233 368999999999976 5999999 99999999999753
No 62
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=1.6e-47 Score=389.59 Aligned_cols=250 Identities=38% Similarity=0.656 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++.. .+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999986544333445556667777764 4799999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~ 180 (515)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999999888999999999999999999999999999999999999999999999999999976433 23345668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+||.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999988776 789999999999999999999999998888888888888888999999999999999999999999
Q ss_pred CHH-HHhcCccccc
Q 010214 261 TIP-EIRQHPWFQA 273 (515)
Q Consensus 261 t~~-eil~hp~f~~ 273 (515)
++. ++++||||+.
T Consensus 240 ~~~~~l~~h~~~~~ 253 (316)
T cd05592 240 GVDGDIRQHPFFRG 253 (316)
T ss_pred CChHHHHcCcccCC
Confidence 874 8999999975
No 63
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=1.1e-47 Score=397.51 Aligned_cols=256 Identities=31% Similarity=0.603 Sum_probs=225.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655444456678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----- 171 (515)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986542210
Q ss_pred -------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC
Q 010214 172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (515)
Q Consensus 172 -------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~ 220 (515)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 0124579999999999988877 68999999999999999999999998
Q ss_pred ChHHHHHHHhcC--ccCCCC--CCChhHHHHhcccCCCCCCCCC---CHHHHhcCcccccc
Q 010214 221 NIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 221 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~mL~~dP~~Rp---t~~eil~hp~f~~~ 274 (515)
+......++... ...+|. .+++++++||.+|+ .||.+|+ ++.|+++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 888877777653 233443 47899999999987 4999998 48999999999864
No 64
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=2.3e-47 Score=382.74 Aligned_cols=253 Identities=28% Similarity=0.494 Sum_probs=215.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57899999999999999999999999999999998654322 2235677999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999975 9999987654 5799999999999999999999999999999999999999999999999998765322 233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (515)
....|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 456789999999998765444789999999999999999999998877665544432211 0
Q ss_pred CC-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 TL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ~~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+ ...+++++++||++||+.||.+|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 01 13468899999999999999999999999999998
No 65
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=3e-47 Score=396.15 Aligned_cols=261 Identities=29% Similarity=0.554 Sum_probs=227.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
....++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34468899999999999999999999999999999999765544444556788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999999999999864 4689999999999999999999999999999999999999999999999999987643322
Q ss_pred --cccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChh
Q 010214 173 --LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPG 243 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 243 (515)
..+.+||+.|+|||++.+.. +.+.++||||+||++|+|++|..||.+.+....+.++.... ..+|. .++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 24678999999999997543 24789999999999999999999999988888888877643 44454 56999
Q ss_pred HHHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
+++++.+||..++.+ |+|+.|+++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999866544 8999999999999764
No 66
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=3.9e-47 Score=388.81 Aligned_cols=257 Identities=34% Similarity=0.588 Sum_probs=224.3
Q ss_pred CceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||+|+||+||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 57899999999764432 2234567889999999995 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||++||+|.+++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999997653322
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC----ChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2335679999999999987654578999999999999999999999643 33445556666677788889999999
Q ss_pred HhcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
||.+||+.||.+|| +++++++||||+..
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88899999999753
No 67
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=3.6e-47 Score=388.12 Aligned_cols=256 Identities=36% Similarity=0.584 Sum_probs=230.8
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVm 96 (515)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.+++.+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444445567788999998886 577889999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~ 175 (515)
||++||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... +.....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432 233456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+......+|..++.++.+++.+||+.|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 679999999999988776 7899999999999999999999999988888899998888899999999999999999999
Q ss_pred CCCCCC-----HHHHhcCcccccc
Q 010214 256 PMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rpt-----~~eil~hp~f~~~ 274 (515)
|.+|++ ..++++||||+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCC
Confidence 999997 4789999999754
No 68
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=2.3e-47 Score=390.20 Aligned_cols=256 Identities=29% Similarity=0.526 Sum_probs=225.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|.+.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544456678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--c
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--~ 173 (515)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999876 6899999999999999999999999999999999999999999999999999987654332 2
Q ss_pred ccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhH
Q 010214 174 KTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~ 244 (515)
....||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+....+.++.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 34579999999999863 2233689999999999999999999999888777777776543 2333 3579999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+||.+||+ ||.+|||+.+++.||||+.
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 999999998 9999999999999999975
No 69
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=3.6e-47 Score=383.91 Aligned_cols=256 Identities=26% Similarity=0.460 Sum_probs=212.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||+||+|.++.+++.||+|++...... .....+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998754322 2234677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~ 173 (515)
|||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 99996 5888888654 5799999999999999999999999999999999999999999999999999875432 2233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCc-----------cC------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-----------YT------ 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~-----------~~------ 235 (515)
...+||+.|+|||++.+....+.++||||+||++|+|++|..||.+... ......+.... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 4567899999999987765557899999999999999999999987532 22222221100 00
Q ss_pred ------CC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ------LP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ------~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.| ...++++.+|+.+||+.||.+|||+.|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 1245788999999999999999999999999999865
No 70
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=7.5e-47 Score=378.46 Aligned_cols=255 Identities=29% Similarity=0.477 Sum_probs=225.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999976655444445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988653 4689999999999999999999999999999999999999999999999999987765555556
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH----HHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL----FKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
.+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+...... ...+......+|..+++.+.+|+.+|
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 161 RVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred ccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 689999999999987766 7899999999999999999999987655332 33444555566778999999999999
Q ss_pred CCCCCCCCC-----CHHHHhcCccccc
Q 010214 252 LIVDPMKRI-----TIPEIRQHPWFQA 273 (515)
Q Consensus 252 L~~dP~~Rp-----t~~eil~hp~f~~ 273 (515)
|..||.+|| +++++++||||..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999 8999999999975
No 71
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=4.9e-47 Score=386.03 Aligned_cols=251 Identities=35% Similarity=0.606 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976543323344566678888875 5899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~ 180 (515)
|+|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....+.+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875322 22345567999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+...+.+.+......+|..++.++++||.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 9999999988776 789999999999999999999999988888888888777778888999999999999999999999
Q ss_pred CHH-HHhcCcccccc
Q 010214 261 TIP-EIRQHPWFQAH 274 (515)
Q Consensus 261 t~~-eil~hp~f~~~ 274 (515)
++. +++.||||+..
T Consensus 240 ~~~~~l~~h~~~~~~ 254 (316)
T cd05619 240 GVKGDIRQHPFFREI 254 (316)
T ss_pred CChHHHHcCcccCCC
Confidence 996 89999999764
No 72
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=8e-47 Score=386.20 Aligned_cols=251 Identities=29% Similarity=0.556 Sum_probs=223.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++.++ +||||+++++++++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876655555667788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++... ..+....+.+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 999999988889999999999999999999999999999999999999999999999999998753 2334455678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-------CChHHHHHHHhcCccCCCCCCChhHHHHhcccCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.. .........+......+|..++..+.++|.+||+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999988777 7899999999999999999999953 2233456667777778899999999999999999
Q ss_pred CCCCCCCC------HHHHhcCcccccc
Q 010214 254 VDPMKRIT------IPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt------~~eil~hp~f~~~ 274 (515)
.||.+|++ ++++++||||+..
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999998 5699999999754
No 73
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=2.4e-47 Score=390.14 Aligned_cols=250 Identities=33% Similarity=0.570 Sum_probs=221.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
||+|+||+||+|.++.+|+.||+|++.+..............|..++... +||||+++++++++.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765544433445556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 9999999988899999999999999999999999999999999999999999999999999987543 233445678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC-CCChhHHHHhcccCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~mL~~dP~~R 259 (515)
.|+|||++.+....+.++|||||||++|+|++|..||...+.....+.+..+...+|. .+++++++||++||..||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 9999999987654578999999999999999999999999888888888888777775 479999999999999999999
Q ss_pred C----CHHHHhcCcccccc
Q 010214 260 I----TIPEIRQHPWFQAH 274 (515)
Q Consensus 260 p----t~~eil~hp~f~~~ 274 (515)
| ++.++++||||+..
T Consensus 241 ~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 241 LGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHhcCccccCC
Confidence 8 79999999999753
No 74
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=6e-47 Score=385.76 Aligned_cols=250 Identities=33% Similarity=0.575 Sum_probs=222.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999997655433334445555554 67899999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999987532 223344568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|...+.++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 9999999988776 689999999999999999999999998888889998888888889999999999999999999999
Q ss_pred CH----HHHhcCccccc
Q 010214 261 TI----PEIRQHPWFQA 273 (515)
Q Consensus 261 t~----~eil~hp~f~~ 273 (515)
++ .++++||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 240 GAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCHHHHhCCCCcCC
Confidence 75 59999999964
No 75
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=3.2e-47 Score=387.31 Aligned_cols=249 Identities=31% Similarity=0.591 Sum_probs=225.0
Q ss_pred eeecccCceEEEEEEE---cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~---~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||++.+ ..+|+.||+|++.+..... .....+.+|++++++++||||+++++++.++..+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999986 3578999999997654332 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-CccccCCC
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCG 178 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~g 178 (515)
++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....+.+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998765443 33445689
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~ 258 (515)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||.+
T Consensus 161 ~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 161 TVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred ChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence 999999999988766 7899999999999999999999999888888888888888899999999999999999999999
Q ss_pred CCC-----HHHHhcCccccc
Q 010214 259 RIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 259 Rpt-----~~eil~hp~f~~ 273 (515)
||| +.+++.||||+.
T Consensus 240 R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCC
Confidence 999 788999999975
No 76
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=4.9e-47 Score=387.24 Aligned_cols=251 Identities=34% Similarity=0.578 Sum_probs=223.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHH-HHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|.. +++.++||||++++++++.++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433344455556655 56789999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 9999999988899999999999999999999999999999999999999999999999999987532 223345668999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++..+.......++..+..+.++|.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 9999999988877 689999999999999999999999998888888888888778888999999999999999999999
Q ss_pred CH----HHHhcCcccccc
Q 010214 261 TI----PEIRQHPWFQAH 274 (515)
Q Consensus 261 t~----~eil~hp~f~~~ 274 (515)
++ .++++||||+..
T Consensus 240 ~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 240 GAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 87 589999999753
No 77
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=3e-48 Score=370.63 Aligned_cols=255 Identities=38% Similarity=0.667 Sum_probs=228.6
Q ss_pred CccccCCCceEe-eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 11 GVDMFLPNYKLG-KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 11 ~~~~~~~~Y~i~-~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
....+.++|.+. ++||-|-.|+|-.+.++.||+++|+|++.- ..+.+||+++.-+.. |||||+++++|+.
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 334478889884 579999999999999999999999998742 357789999876554 9999999999854
Q ss_pred ----CCeEEEEEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEe
Q 010214 89 ----PSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIA 159 (515)
Q Consensus 89 ----~~~~~iVmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~ 159 (515)
...+.+|||.++||+|++.|..++. ++|.++..|+.||..|+.|||+.+|.||||||||+|... +..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4568999999999999999998776 999999999999999999999999999999999999975 4579999
Q ss_pred ecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccC
Q 010214 160 DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYT 235 (515)
Q Consensus 160 DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~ 235 (515)
|||+++.......+.|.|-||.|+|||++....| +..+|+||+|||+|-||||.+||.... .+.+..+|..+.+.
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9999998887788999999999999999998887 789999999999999999999998654 45678899999999
Q ss_pred CCC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 LPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ~p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|. .+|.+++|+|+.+|..+|.+|.|+.++++|||+...
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 984 689999999999999999999999999999999754
No 78
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=1.8e-46 Score=390.38 Aligned_cols=262 Identities=30% Similarity=0.540 Sum_probs=227.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.....++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34456899999999999999999999999999999999976554444455678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999999999999865 468999999999999999999999999999999999999999999999999998764332
Q ss_pred --ccccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCCh
Q 010214 172 --FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSP 242 (515)
Q Consensus 172 --~~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~ 242 (515)
...+.+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+| ..++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 224668999999999987543 24789999999999999999999999998888888887643 3344 36899
Q ss_pred hHHHHhcccCCCCCCC--CCCHHHHhcCcccccc
Q 010214 243 GARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~--Rpt~~eil~hp~f~~~ 274 (515)
++++||.+||..++.+ |++++++++||||+..
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999844443 7899999999999764
No 79
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1e-47 Score=392.92 Aligned_cols=257 Identities=31% Similarity=0.552 Sum_probs=240.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe-EEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~i 94 (515)
.++|..++.+|+|+||.+++++|+..++.|++|.++........ .....+|+.+++++.|||||.+++.|+.++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999887766644 3478899999999999999999999988887 999
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
||+||+||+|.+.|.+. .-++|+.+..|+.||+.|+.|||++.|+|||||+.||+++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999999764 359999999999999999999999999999999999999999999999999999998776
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
...+..|||.||+||++.+.+| +.++|||||||++|||++-+++|.+.+...+..+|..+. .++|...|.+++.+|+.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKS 240 (426)
T ss_pred hhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHH
Confidence 7889999999999999999998 799999999999999999999999999999999999988 67899999999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..+|..||++.++|.+|.++..
T Consensus 241 ~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999887644
No 80
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=8.1e-47 Score=385.59 Aligned_cols=250 Identities=34% Similarity=0.581 Sum_probs=221.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHH-HHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI-KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei-~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|. .+++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999765433323333444444 457889999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccccCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~ 180 (515)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ......+.+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 9999999988889999999999999999999999999999999999999999999999999987542 233345678999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......++.+++++.++|.+||+.||.+|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999998776 689999999999999999999999988888888888888888889999999999999999999999
Q ss_pred CHH----HHhcCccccc
Q 010214 261 TIP----EIRQHPWFQA 273 (515)
Q Consensus 261 t~~----eil~hp~f~~ 273 (515)
++. ++++|+||..
T Consensus 240 ~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 240 GAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCHHHHhcCcccCC
Confidence 876 8999999964
No 81
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.2e-47 Score=371.36 Aligned_cols=257 Identities=32% Similarity=0.438 Sum_probs=223.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~ 93 (515)
+++|+.+..|++|+||.||+|+++.|++.||+|.++-++-+. ..--.-.|||.+|.+++|||||.+-++.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 578999999999999999999999999999999987655222 22234579999999999999999999874 456799
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-C
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~ 171 (515)
||||||+. +|...+..-+ ++.+.+++.++.|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+... .
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 99999987 9999998754 8999999999999999999999999999999999999999999999999999988655 3
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (515)
.....+-|.+|+|||.+.|...++.++|+||+|||+.||+++++.|.+.+..++..+|....
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 45566889999999999998777999999999999999999999999998888877774321
Q ss_pred -cCCC------------C-CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 -YTLP------------S-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 -~~~p------------~-~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++ . .+|....+|+..+|..||.+|.|+.|.|+|+||.+.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 1111 1 156888999999999999999999999999999863
No 82
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=2.1e-46 Score=374.27 Aligned_cols=249 Identities=34% Similarity=0.535 Sum_probs=217.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.++||||+++++++.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999766554444456778899999999999999999999999999999999999999
Q ss_pred HHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cccCCCC
Q 010214 105 FDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGS 179 (515)
Q Consensus 105 ~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt 179 (515)
.+++.. +..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....+.. .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988753 34699999999999999999999999999999999999999999999999999976654332 3445799
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
+.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+......+|..+++++.+++.+||+.|
T Consensus 161 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 99999999998877 6899999999999999999999976532 233444555556677889999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 010214 256 PMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 256 P~~Rp-----t~~eil~hp~f~~~ 274 (515)
|.+|| |++++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999 88999999999864
No 83
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=6.1e-46 Score=380.34 Aligned_cols=257 Identities=30% Similarity=0.572 Sum_probs=221.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997654444445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998765443322
Q ss_pred ccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhH
Q 010214 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~ 244 (515)
...+||+.|+|||++.+ ....+.++||||+||++|+|++|..||.+.+..+....+.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23469999999999863 2334789999999999999999999999888777777775432 3333 3479999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~ 273 (515)
++||.+||..++.+ |+++.++++||||..
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999998765444 889999999999965
No 84
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=3e-46 Score=382.16 Aligned_cols=254 Identities=33% Similarity=0.561 Sum_probs=211.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----CeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----SDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 92 (515)
+|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 59999999999999999999999999999999864322 223345788999999999999999999988543 358
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987643221
Q ss_pred ---ccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------
Q 010214 172 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------- 232 (515)
Q Consensus 172 ---~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (515)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2234579999999999875 344 78999999999999999999999876543322211100
Q ss_pred ------------ccCC-----CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 ------------IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 ------------~~~~-----p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.... .+.+++++.++|.+||+.||.+|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0000 12467889999999999999999999999999999764
No 85
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=9.2e-46 Score=378.89 Aligned_cols=255 Identities=24% Similarity=0.448 Sum_probs=220.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999987542 234567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 160 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN 160 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-ccc
Confidence 99999999999999888899999999999999999999985 6999999999999999999999999998765432 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-----------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG----------------------- 231 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~----------------------- 231 (515)
...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......++...+..
T Consensus 161 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 5679999999999988776 7899999999999999999999976554443222111
Q ss_pred -----------------------Cc-cCC-CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 232 -----------------------GI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 232 -----------------------~~-~~~-p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.. ... ...+++++++||.+||+.||++|||+.|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 011 12467899999999999999999999999999999754
No 86
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=9.2e-47 Score=371.18 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=224.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCC----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPS---- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 90 (515)
...|..++.||+|+||+||+|+++.+|+.||+|.+..+.-. ........||+.+|+.++|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888999999999999999999999999999765432 224466789999999999999 999999998877
Q ss_pred --eEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 --DIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 --~~~iVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
.+++|+||++. +|..|+.... .++...++.++.||+.||+|||+++|+||||||.|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 9999998755 5888899999999999999999999999999999999999999999999999
Q ss_pred cccc-cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------
Q 010214 165 NIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------- 234 (515)
Q Consensus 165 ~~~~-~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------- 234 (515)
+... +.....+.++|.+|+|||++.|...++..+||||+|||++||+++...|.+.+..++..+|-....
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 9776 445567778999999999999986678999999999999999999999999988777777643211
Q ss_pred ---------CCC------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------~~p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+| +..+++..+++.+||+.+|.+|.|+..++.||||+..
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111 1234689999999999999999999999999999865
No 87
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=8.6e-46 Score=383.20 Aligned_cols=258 Identities=31% Similarity=0.507 Sum_probs=215.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 90 (515)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 45799999999999999999999999999999999987543 23344567889999999999999999999986543
Q ss_pred ---eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 91 ---~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999975 6777664 35899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------- 232 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--------------- 232 (515)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 55555556789999999999998877 68999999999999999999999876543322221110
Q ss_pred -------ccC--------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 233 -------IYT--------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 233 -------~~~--------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
... .+...++++++||.+||+.||.+|||+.|+++||||+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 000 01124678999999999999999999999999999986543
No 88
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=3.5e-46 Score=396.60 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=211.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999885432 2345799999999999999999887432
Q ss_pred --CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFG 162 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFG 162 (515)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999975 78777653 46799999999999999999999999999999999999999664 69999999
Q ss_pred cccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---------
Q 010214 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------- 233 (515)
Q Consensus 163 ls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--------- 233 (515)
++.....+....+.+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++....
T Consensus 217 la~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 217 SAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred cchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 99877665555667899999999998876544789999999999999999999999876655444442210
Q ss_pred --------------------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 --------------------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
..+|...++++++||.+||++||.+|||+.|+++||||+...
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 113445788999999999999999999999999999998653
No 89
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=8.5e-46 Score=370.68 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=211.0
Q ss_pred CCceEeeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEE-----
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIE----- 87 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~----- 87 (515)
++|++.+.||+|+||+||+|.+.. +|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46889999987544322 2234556777777665 6999999999985
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
....+++||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999996 5999999753 358999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------- 234 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~----------- 234 (515)
............||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+..+...++.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 7665555566789999999999987766 6899999999999999999999998877666665543211
Q ss_pred ----------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 ----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ----------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.+.+++.+++|+.+||+.||++|||+.|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999998
No 90
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.5e-45 Score=377.53 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=222.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||++.++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--c
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--~ 173 (515)
||++||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987 46799999999999999999999999999999999999999999999999999876533222 2
Q ss_pred ccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhH
Q 010214 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~ 244 (515)
...+||+.|+|||++.+ ....+.++|||||||++|+|++|+.||...+......++.... ..+| ..+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34579999999999862 2233789999999999999999999999988888888876643 2333 3579999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~ 273 (515)
++||.+||..++.+ |+|+.|+++||||+.
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999999765544 789999999999975
No 91
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=1.9e-45 Score=368.92 Aligned_cols=255 Identities=42% Similarity=0.748 Sum_probs=234.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997765555556678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||+++++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876544 3456
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+|++.|+|||.+.+... +.++||||||+++|+|++|..||...+.......+..+...+|..+++.++++|.+||..||
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 159 CGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence 79999999999987755 68999999999999999999999988877778888888888899999999999999999999
Q ss_pred CCCC-----CHHHHhcCcccccc
Q 010214 257 MKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 257 ~~Rp-----t~~eil~hp~f~~~ 274 (515)
.+|+ +++|+++||||+..
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCcccCCHHHHHcCcccccC
Confidence 9999 99999999999754
No 92
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=8.8e-46 Score=379.51 Aligned_cols=248 Identities=31% Similarity=0.528 Sum_probs=218.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE-EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-eEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~ 93 (515)
.....+.+.||.|+||+||.|.+. |+. ||+|++......... .+.+.+|+.+|++++|||||++++++.++. .++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 345567778999999999999985 555 999999876655544 789999999999999999999999998887 799
Q ss_pred EEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEECCCC-ceEEeeccccccccc
Q 010214 94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRD 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~g-IvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~ 169 (515)
+||||+++|+|.+++.. +..++...+..++.||+.|++|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999987 678999999999999999999999999 99999999999999998 999999999988765
Q ss_pred C-CccccCCCCCCccCCCccc--CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh--cCccCCCCCCChhH
Q 010214 170 G-HFLKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--GGIYTLPSHLSPGA 244 (515)
Q Consensus 170 ~-~~~~~~~gt~~Y~aPE~i~--~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~ 244 (515)
. .......||+.|||||++. ...| +.++||||+|+++|||+||..||.+....+....+. .....+|..+++.+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l 275 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHL 275 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 4 3334468999999999999 4566 799999999999999999999999988755555543 33456778899999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..|+.+||..||.+||++.+|+.
T Consensus 276 ~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 276 SSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999865
No 93
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.4e-45 Score=377.76 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=222.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++++++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999997654444445566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998766443222
Q ss_pred ccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCC---CCChhH
Q 010214 174 KTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS---HLSPGA 244 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~ 244 (515)
...+||+.|+|||++.+. ...+.++||||+||++|+|++|+.||...+......++.... ..+|. .+++++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 345799999999998752 223689999999999999999999999888877777776543 33443 468999
Q ss_pred HHHhcccCCCCCCC--CCCHHHHhcCccccc
Q 010214 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (515)
Q Consensus 245 ~~li~~mL~~dP~~--Rpt~~eil~hp~f~~ 273 (515)
+++|.+||..++.+ |++++++++||||+.
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999876654 579999999999974
No 94
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=2.1e-45 Score=368.19 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=221.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|++|+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987655554445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|++|++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....+.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999999999986543 589999999999999999999999999999999999999999999999999987655544455
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
..|++.|+|||++.+..+ +.++||||+||++|+|++|..||...... .............+..+++++++|+.+|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 689999999999988776 78999999999999999999999864321 1111112223345677899999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQA 273 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~ 273 (515)
|+.||.+||| +.|+++||||+.
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999 899999999975
No 95
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.5e-46 Score=367.83 Aligned_cols=252 Identities=31% Similarity=0.495 Sum_probs=220.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C---
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S--- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~--- 90 (515)
.=.|.-.+.+|.|+||.||.|....+++.||||.+-.+.- .-.+|+.+|+.++|||||++..+|... +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 3468889999999999999999999999999998754432 124799999999999999999988532 2
Q ss_pred eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeeccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSN 165 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~ 165 (515)
...+||||++. +|.++++. +.+++.-.++-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 35689999976 99999974 5789999999999999999999999999999999999999976 999999999999
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
....++...+...|..|+|||.+.|...++.+.||||+||++.||+-|.+.|.+++...+...|.+-.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 99999988889999999999999987777899999999999999999999999988777666553311
Q ss_pred -----cC------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 -----YT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 -----~~------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.. +....++++.+|+.++|+.+|.+|.|+.|++.||||....
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11 1245789999999999999999999999999999998653
No 96
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=2.9e-45 Score=371.08 Aligned_cols=259 Identities=26% Similarity=0.484 Sum_probs=217.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|.+.+.||+|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 47899999999999999999999999999999998754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 999975 888888764 45899999999999999999999999999999999999999999999999998765332 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (515)
....+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.... .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 445789999999998765545789999999999999999999998876655444332210 0
Q ss_pred CC-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 235 TL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 235 ~~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
.. ...+++++++||.+||+.||.+|||+.|+++||||+....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence 11 12468899999999999999999999999999999865433
No 97
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.8e-47 Score=364.29 Aligned_cols=264 Identities=34% Similarity=0.587 Sum_probs=232.3
Q ss_pred CccccCCCceE-eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 11 GVDMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 11 ~~~~~~~~Y~i-~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
....+.+-|++ .+.||+|+++.|-.+....||..||||++.|.. .....++.||++++..++ |+||++++++|++
T Consensus 71 ~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 71 LSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred ccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 33345556776 568999999999999999999999999998763 346789999999999987 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSN 165 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~ 165 (515)
++.+|+|||-+.||.|..+|.++..++|.++.++.++|++||+|||.+||.||||||||||..... -||||||.+..
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 999999999999999999999999999999999999999999999999999999999999997654 48999999875
Q ss_pred cccc--------CCccccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCC------------
Q 010214 166 IMRD--------GHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------------ 221 (515)
Q Consensus 166 ~~~~--------~~~~~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~------------ 221 (515)
.+.- ...+.|.||+..|||||+.. ...+++.++|.||||||||-||+|.+||.+.-
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 4421 12356789999999999873 23345899999999999999999999996531
Q ss_pred ---hHHHHHHHhcCccCCCC----CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCc
Q 010214 222 ---IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (515)
Q Consensus 222 ---~~~~~~~i~~~~~~~p~----~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~ 277 (515)
...+++.|+.|.|.+|+ ++|.++++|++.+|..|+.+|.++.++++|||++...+.
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 46789999999999995 799999999999999999999999999999999877655
No 98
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.4e-45 Score=384.35 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=209.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
...+|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++++.++||||+++++++..+...++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34689999999999999999999999999999996432 346789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--Cc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~--~~ 172 (515)
|||++. ++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999995 699999988888999999999999999999999999999999999999999999999999998754322 23
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-------hHHHHHHHhc--------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKG-------------- 231 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-------~~~~~~~i~~-------------- 231 (515)
....+||+.|+|||++.+..+ ++++||||+||++|+|++|..||.... .......+..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345689999999999988776 789999999999999999998874321 1111111110
Q ss_pred ------------CccCCC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 232 ------------GIYTLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 232 ------------~~~~~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.....| ..++.++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000001 1246689999999999999999999999999999874
No 99
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-47 Score=379.64 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=241.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.|+.-++||+|+||.||-++.+.||+.||+|.+.++.++.........+|-.||.+++.++||.+-..|++++.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 46788899999999999999999999999999999999988888888889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|..|+||+|.-+|.+.+ .++|..++.++.+|+.||++||+.+||+|||||+|||+|+.|+|+|+|+|+|..+..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999999999998866 7999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHHHHhc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~li~ 249 (515)
...+||.+|||||++.+..| +...|.|||||++|+|+.|+.||.... .+++-+.+......+|+.+|++++++.+
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~ 422 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCE 422 (591)
T ss_pred ccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHH
Confidence 99999999999999999887 789999999999999999999997633 3456667777788889999999999999
Q ss_pred ccCCCCCCCCCC-----HHHHhcCcccccc
Q 010214 250 RMLIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 250 ~mL~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
.+|++||.+|.. ++++.+||||+..
T Consensus 423 ~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 423 GLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 999999999985 5699999999874
No 100
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=2.6e-45 Score=365.81 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=213.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||+|+||.||++.++.+|+.||+|.+.+...........+..|+++++.++||||++++++++++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765554434445667799999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCc
Q 010214 105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182 (515)
Q Consensus 105 ~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y 182 (515)
.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....+.......|++.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 99886543 5889999999999999999999999999999999999999999999999999877655544556799999
Q ss_pred cCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccCCC-CCCChhHHHHhcccCCCCCC
Q 010214 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLP-SHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 183 ~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~li~~mL~~dP~ 257 (515)
+|||++.+..+ +.++||||+||++|+|++|..||.+... ......+.......+ ..+++++++|+.+||+.||.
T Consensus 161 ~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 99999988775 7899999999999999999999976432 233333333333332 46899999999999999999
Q ss_pred CCCCH----HHHhcCcccccc
Q 010214 258 KRITI----PEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rpt~----~eil~hp~f~~~ 274 (515)
+|||+ ++++.||||+..
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 678899999764
No 101
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=7.1e-45 Score=358.05 Aligned_cols=254 Identities=34% Similarity=0.560 Sum_probs=222.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC--hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
++|.+.+.||.|++|.||.|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++++...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999999999999987553322 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-- 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-- 172 (515)
|+||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 999999999999999888899999999999999999999999999999999999999999999999999876533211
Q ss_pred --cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHh
Q 010214 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLI 248 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 248 (515)
.....|++.|+|||++.+..+ +.++||||+|+++|+|++|+.||.+.+......++... ...+|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 134568899999999988765 78999999999999999999999876655544444333 4456778899999999
Q ss_pred cccCCCCCCCCCCHHHHhcCccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
No 102
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.9e-45 Score=379.99 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=217.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 357899999999999999999999999999999999875432 234456788999999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+||||+++ +|.+++.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999965 78887753 4889999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------ 235 (515)
.......+..||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++......
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 65555566789999999999988776 78999999999999999999999887765555444321100
Q ss_pred ------------------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 236 ------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 236 ------------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+...+.++++||.+||+.||.+|||+.|+++||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0011346789999999999999999999999999998643
No 103
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=3.6e-45 Score=365.53 Aligned_cols=251 Identities=31% Similarity=0.517 Sum_probs=209.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEc-----C
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIET-----P 89 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 89 (515)
+|++.+.||+|+||.||+|.++.+|+.||+|.+....... .....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5999999999999999999999999999999987543222 1223455677777655 69999999999864 3
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 899988764 34899999999999999999999999999999999999999999999999999877
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-----------c--
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----------Y-- 234 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-----------~-- 234 (515)
..........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+........++.... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 65544556678999999999987766 789999999999999999999998876655554443210 0
Q ss_pred --------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 --------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 --------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...+.++..+.+||.+||+.||.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112467888999999999999999999999999998
No 104
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=3.1e-45 Score=378.33 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=215.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 357899999999999999999999999999999999875432 334456788999999999999999999998643
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
...|+||||+++ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999975 77777753 5899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 65555566789999999999988876 689999999999999999999998776443332221100
Q ss_pred -------------c---------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 -------------Y---------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 -------------~---------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
. ..+...+.++++||.+||..||.+|||+.|+++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 01122456789999999999999999999999999998653
No 105
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=7.4e-45 Score=364.04 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=225.0
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|+..+.||.|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977665554455667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999988654 3699999999999999999999999999999999999999999999999999977655444456
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH----HHHHhcCccCCCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL----FKKIKGGIYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li~~m 251 (515)
..|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.+...... ...+......++..+++++.+|+.+|
T Consensus 161 ~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 689999999999988766 7899999999999999999999987655433 33344444556678899999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
|+.||.+||| +.+++.||||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8899999999764
No 106
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-47 Score=382.43 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=227.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|+..+.||+|+||.||+|.+..|++.||||+++.+... +..+.+++|+.+|.++++|||.++|+.+-....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 35688889999999999999999999999999999877654 4568899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~ 174 (515)
||||.||++.+.+.....+.|.++..++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||.+..+..... ..
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999998887789999999999999999999999999999999999999999999999999988765433 37
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh-cCccCCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK-GGIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~mL~ 253 (515)
|.+|||.|||||++.+..| +.++||||||++.+||++|.+|+.+.......-.|- .....+..++|+.+++||..||.
T Consensus 170 tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~ 248 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLD 248 (467)
T ss_pred cccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhh
Confidence 8999999999999998777 789999999999999999999998876533222222 22233345789999999999999
Q ss_pred CCCCCCCCHHHHhcCccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~ 273 (515)
+||+.|||+.++++|+|++.
T Consensus 249 k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 249 KNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred cCcccCcCHHHHhhhHHHHh
Confidence 99999999999999999986
No 107
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=2.1e-45 Score=382.23 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=218.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----eE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 92 (515)
+|++.+.||+|+||.||+|.+..+|+.||||++.... .......++.+|+.+++.++||||+++++++..+. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5789999999999999999999999999999986432 23344567889999999999999999999998876 79
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 589999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------------
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------------ 232 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~------------------ 232 (515)
.......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 22334568999999999988655578999999999999999999999887765554444221
Q ss_pred -----c---------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 -----I---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 -----~---------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. +......++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 1 12234568899999999999999999999999999999864
No 108
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=3.7e-45 Score=377.67 Aligned_cols=256 Identities=31% Similarity=0.481 Sum_probs=216.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
....+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+++++.++||||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34678999999999999999999999999999999986432 3345577899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~ 172 (515)
+||||+++|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999999998653 34678888999999999999999999999999999999999999999999999876432 22
Q ss_pred cccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHH---HHHHHh-cCccCCCCCCChhH
Q 010214 173 LKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIK-GGIYTLPSHLSPGA 244 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~---~~~~i~-~~~~~~p~~~s~~~ 244 (515)
.....||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||....... ....+. ......+..++.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 345679999999999853 2344678999999999999999999997533222 222222 22344567789999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
++||.+||..||.+|||+.|+++||||....
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9999999999999999999999999998754
No 109
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=3.9e-45 Score=391.62 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=208.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC------CCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h------pnIv~l~~~~~~ 88 (515)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3578999999999999999999999999999999986422 123345667777777654 458899999876
Q ss_pred C-CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCC------------
Q 010214 89 P-SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKW------------ 154 (515)
Q Consensus 89 ~-~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~------------ 154 (515)
+ ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5789999998 77999999988899999999999999999999998 5999999999999998765
Q ss_pred ----ceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh
Q 010214 155 ----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ----~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||.+.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||++.+..+....+.
T Consensus 282 ~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 49999999875432 23346689999999999998877 789999999999999999999998876554443332
Q ss_pred cCccCCCC------------------------------------------CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIYTLPS------------------------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~~~p~------------------------------------------~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.....+|. ..++.+.|||.+||++||.+|||++|+++|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 21111110 114567899999999999999999999999
Q ss_pred cccccccCcc
Q 010214 269 PWFQAHLPRY 278 (515)
Q Consensus 269 p~f~~~~~~~ 278 (515)
|||+...+..
T Consensus 439 p~~~~~~~~~ 448 (467)
T PTZ00284 439 PYVLKYYPEC 448 (467)
T ss_pred ccccccCCcc
Confidence 9999865544
No 110
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=7.7e-45 Score=372.57 Aligned_cols=256 Identities=24% Similarity=0.443 Sum_probs=218.4
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3589999999999999999999999999999999986542 23445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence 999999999999999888899999999999999999999974 7999999999999999999999999998765332 23
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH------------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------------ 229 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i------------------------ 229 (515)
...+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.......+...+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 45579999999999988766 78999999999999999999999765433322111
Q ss_pred --------------------hcC-ccCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 230 --------------------KGG-IYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 230 --------------------~~~-~~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
... ....+ ..++.++++||.+||+.||.+|||+.|++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 01111 1357889999999999999999999999999999754
No 111
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=8e-45 Score=390.19 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=225.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC-CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998887 788999977433 33445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 95 VMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
||||++||+|.+++.. ..++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999998754 346899999999999999999999999999999999999999999999999999876543
Q ss_pred C---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHH
Q 010214 171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARD 246 (515)
Q Consensus 171 ~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~ 246 (515)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+..+.. ..|..+++++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 2 2345689999999999988776 7899999999999999999999999888888887776654 456788999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
+|.+||..||.+|||+.+++.|||++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
No 112
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=7.9e-45 Score=391.32 Aligned_cols=262 Identities=29% Similarity=0.485 Sum_probs=230.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
......++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3345568999999999999999999999999999999999776543 345677889999999999999999998775332
Q ss_pred --------eEEEEEeccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 91 --------DIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 91 --------~~~iVmEy~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
.+++||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 378999999999999999753 46899999999999999999999999999999999999999999999
Q ss_pred eeccccccccc---CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-
Q 010214 159 ADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY- 234 (515)
Q Consensus 159 ~DFGls~~~~~---~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~- 234 (515)
+|||+++.... .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 99999976543 223456789999999999998776 7899999999999999999999999888888777776654
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+|..+++++.+++.+||+.||.+|||+.++++|||++..
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 4678899999999999999999999999999999999764
No 113
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=2e-45 Score=360.69 Aligned_cols=251 Identities=41% Similarity=0.698 Sum_probs=216.0
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987654332 233445699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~ 177 (515)
+++++|.+++...+.+++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998763 3344556678
Q ss_pred CCCCccCCCccc-CCccCCCcceeehhHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCccCCC----CCCChhHHHHhc
Q 010214 178 GSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI---PNLFKKIKGGIYTLP----SHLSPGARDLIP 249 (515)
Q Consensus 178 gt~~Y~aPE~i~-~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~---~~~~~~i~~~~~~~p----~~~s~~~~~li~ 249 (515)
+++.|+|||++. +.. .+.++||||||+++|+|++|..||..... .....+........+ ...++++.++|.
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKK-YTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSGGGSCHHHHTTTSS-BSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccc-ccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 999999999998 444 47999999999999999999999998732 333333333222111 122489999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+||+.||.+|||+.++++||||
T Consensus 239 ~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999998
No 114
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=6e-45 Score=358.11 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=229.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||++++++++++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 69999999999999999999999999999999987666555567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
|+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999888899999999999999999999999999999999999999999999999999988776554455677
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCccCCCCCCChhHHHHhcccCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+ ...............|..++.++.++|.+||..
T Consensus 161 ~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 161 GTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence 8999999999987765 789999999999999999999998876 344444444466677888999999999999999
Q ss_pred CCCCCCCH--HHHhcCccc
Q 010214 255 DPMKRITI--PEIRQHPWF 271 (515)
Q Consensus 255 dP~~Rpt~--~eil~hp~f 271 (515)
||.+||++ .|+++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999998
No 115
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=2.3e-44 Score=362.89 Aligned_cols=260 Identities=27% Similarity=0.504 Sum_probs=218.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.++.+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 67899999999999999999999999999999998654322 2234577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 99997 5899988753 56899999999999999999999999999999999999999999999999998764332 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~ 234 (515)
....+++.|+|||++.+....+.++|||||||++|+|++|.+||...+..+....+.... .
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 345678999999998776555789999999999999999999998877655444332210 1
Q ss_pred CCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccCcc
Q 010214 235 TLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (515)
Q Consensus 235 ~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~~~ 278 (515)
..| ..+++++++||.+||+.||.+|||++|+++||||+....++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence 111 24688999999999999999999999999999998664443
No 116
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=6.6e-45 Score=380.90 Aligned_cols=253 Identities=32% Similarity=0.462 Sum_probs=217.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-C-----CCccEEEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H-----PHIIRLYEVIE 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-h-----pnIv~l~~~~~ 87 (515)
.+..+|.+.+.||+|+||+|-+|.+..|++.||||+++... ....+...|+++|..++ | -|+|+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 34458999999999999999999999999999999996543 44567778999999998 3 38999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--CceEEeeccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--WNVKIADFGL 163 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--~~vKL~DFGl 163 (515)
..+++|||+|.++ -+|.++|+.+. +++...++.++.||+.||.+||+.||||+|||||||||... ..|||+|||.
T Consensus 259 fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999999995 49999999764 58899999999999999999999999999999999999754 4799999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC--------
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------- 235 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-------- 235 (515)
|......- .+.+-|..|+|||++.|.+| +.+.||||||||++||++|.+.|.+++..+++..|..-...
T Consensus 338 Sc~~~q~v--ytYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 338 SCFESQRV--YTYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccccCCcc--eeeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 98765543 38889999999999999999 78999999999999999999999999877777666432110
Q ss_pred --------------------------------------------CCC-----------CCChhHHHHhcccCCCCCCCCC
Q 010214 236 --------------------------------------------LPS-----------HLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 236 --------------------------------------------~p~-----------~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.|. .-...+.|||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 110 0123568999999999999999
Q ss_pred CHHHHhcCcccccc
Q 010214 261 TIPEIRQHPWFQAH 274 (515)
Q Consensus 261 t~~eil~hp~f~~~ 274 (515)
|..++|+||||...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999843
No 117
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-46 Score=367.83 Aligned_cols=261 Identities=37% Similarity=0.584 Sum_probs=244.5
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCe
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD 91 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 91 (515)
.....+|.++.+||+|+||+|-+|..+.|.+.||||++.++.+...+..+--..|-++|.... -|++++++..|++.+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345689999999999999999999999999999999999988777777777788999998876 6789999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~ 170 (515)
+|+||||+.||+|-..|++-|++.|..|..++.+|+-||-+||++||++||||..||++|.+|+|||+|||++.. +.++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999874 3456
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
...+|.||||.|+|||++..++| +.++|.||+||+||||+.|.+||++++..+++..|......+|..+|.++.++.+.
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg 583 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKG 583 (683)
T ss_pred cceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHH
Confidence 67889999999999999999988 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCH-----HHHhcCcccccc
Q 010214 251 MLIVDPMKRITI-----PEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~-----~eil~hp~f~~~ 274 (515)
+|.+.|.+|..+ .+|..||||+..
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999865 689999999864
No 118
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-46 Score=407.37 Aligned_cols=261 Identities=33% Similarity=0.559 Sum_probs=235.3
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|.++++||+|+||.|.+++++.|++.||+|+++|-.........-+..|-.+|.--+.+-|++++..|+++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34578999999999999999999999999999999998755444445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~ 172 (515)
+||||++||+|..++.+.+++||..++.++..|+.||+-||+.|+|||||||+|||||..|+|||+|||.+-.+.. |..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999887764 433
Q ss_pred c-ccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCC--CCCChh
Q 010214 173 L-KTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPG 243 (515)
Q Consensus 173 ~-~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~ 243 (515)
. .+.+|||.|.|||++. ++..+|+.+|.||+||++|||++|..||..++..+.+.+|.+- .+.+| ..+|++
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 2 3568999999999985 3244589999999999999999999999999999999999876 67788 578999
Q ss_pred HHHHhcccCCCCCCCCCC---HHHHhcCccccccc
Q 010214 244 ARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL 275 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~~ 275 (515)
+++||.+++ -+|..|.. ++++..||||...-
T Consensus 312 akdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 312 AKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred HHHHHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 999999987 57889998 99999999998653
No 119
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=1.9e-44 Score=370.63 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=213.8
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|++.+.||.|+||+||+|.+..+++.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 346899999999999999999999999999999999875432 223346678999999999999999999987543
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|++||++ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 779988775 467999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
.. ...+.+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 43 23456799999999999875445789999999999999999999998766544443332110
Q ss_pred ---------cCCC--------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---------YTLP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---------~~~p--------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...| ...++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0011 2356778999999999999999999999999999864
No 120
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=9e-44 Score=348.98 Aligned_cols=252 Identities=29% Similarity=0.558 Sum_probs=220.8
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeEEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVM 96 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iVm 96 (515)
+|++.+.||.|++|.||+|.++.+++.||+|.+...... ......+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999998754432 2345678899999999999999999998864 44689999
Q ss_pred eccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
||+++++|.+++... ..+++.+++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999999999763 45899999999999999999999999999999999999999999999999999876432 233
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL 252 (515)
.+..|++.|+|||++.+..+ +.++|+||+||++|+|++|..||+..+.......+..+.. ..+..+++.+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 45678999999999988766 6899999999999999999999998877766666655544 556778999999999999
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 010214 253 IVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f 271 (515)
+.||.+|||+.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
No 121
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=7.7e-44 Score=361.38 Aligned_cols=257 Identities=36% Similarity=0.586 Sum_probs=227.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+++++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554456678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---
Q 010214 97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--- 171 (515)
||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 569999999999999999999999999999999999999999999999999986543211
Q ss_pred ---------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH
Q 010214 172 ---------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224 (515)
Q Consensus 172 ---------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~ 224 (515)
......||..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1123468889999999987766 789999999999999999999999888777
Q ss_pred HHHHHhcCccCCCCC--CChhHHHHhcccCCCCCCCCCC----HHHHhcCcccccc
Q 010214 225 LFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRIT----IPEIRQHPWFQAH 274 (515)
Q Consensus 225 ~~~~i~~~~~~~p~~--~s~~~~~li~~mL~~dP~~Rpt----~~eil~hp~f~~~ 274 (515)
.+.++.......|.. ++.++.++|.+||..||.+||| ++|++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666555544 6999999999999999999999 9999999999864
No 122
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=7.3e-44 Score=351.18 Aligned_cols=249 Identities=36% Similarity=0.692 Sum_probs=224.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.++..+|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999877665555678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccC
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~a 184 (515)
.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............|++.|+|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999999999999999999987765543445678999999
Q ss_pred CCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHh--cCccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 185 PE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
||.+.+..+ +.++|+||+|+++|+|++|..||.... ......++. ......|...++++.++|.+||..||.+||
T Consensus 161 PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 161 PEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 999887665 689999999999999999999998766 556666666 445667777899999999999999999999
Q ss_pred C-----HHHHhcCcccccc
Q 010214 261 T-----IPEIRQHPWFQAH 274 (515)
Q Consensus 261 t-----~~eil~hp~f~~~ 274 (515)
| +.|+++||||++.
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999854
No 123
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=1.2e-43 Score=359.48 Aligned_cols=254 Identities=25% Similarity=0.475 Sum_probs=217.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986432 2345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...... ...+
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 999999999999988889999999999999999999997 69999999999999999999999999998765332 2355
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc----------------------
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------- 233 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 233 (515)
.+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 689999999999987765 689999999999999999999997655433322221110
Q ss_pred ---------------cCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---------------YTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---------------~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...| ..++.++++|+.+||..||++|||+.++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111 1367889999999999999999999999999999753
No 124
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=1.6e-43 Score=357.55 Aligned_cols=256 Identities=34% Similarity=0.600 Sum_probs=225.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987665444445678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC------
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~------ 170 (515)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988642110
Q ss_pred ----------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC--
Q 010214 171 ----------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-- 238 (515)
Q Consensus 171 ----------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~-- 238 (515)
.......|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+....+....+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 01123467889999999987665 78999999999999999999999988877777777766544433
Q ss_pred -CCChhHHHHhcccCCCCCCCCCC---HHHHhcCccccc
Q 010214 239 -HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQA 273 (515)
Q Consensus 239 -~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~ 273 (515)
.++.++.++|.+||+.||.+||| +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 57899999999999999999998 799999999965
No 125
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=1.4e-43 Score=349.88 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=220.8
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh------HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM------EMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~------~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
+|.+.+.||.|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 57889999999999999999999999999999876543321 234678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987664211
Q ss_pred -------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChh
Q 010214 172 -------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (515)
Q Consensus 172 -------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (515)
......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.+.+......++... ...+|..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1123468899999999987766 68899999999999999999999876655444444433 34567788999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+.++|++||+.||.+|||+.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 126
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=2.6e-43 Score=345.23 Aligned_cols=252 Identities=31% Similarity=0.518 Sum_probs=224.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 589999999999999999999999999999998765443 3456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999764 578999999999999999999999999999999999999999999999999988665432 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+......++..+.. .++..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 5678999999999988766 6899999999999999999999998887777777766543 4455788999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|++||++.+++.|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999995
No 127
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1.3e-43 Score=353.41 Aligned_cols=252 Identities=30% Similarity=0.509 Sum_probs=210.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|++|.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654322 2234677899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 98 YVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
|++ ++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 5898888642 468999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------------- 232 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--------------------- 232 (515)
....+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 34467899999999877654578999999999999999999999876543322211100
Q ss_pred --------ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 233 --------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 233 --------~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.......+++++.++|.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001123578999999999999999999999999999997
No 128
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=1.5e-43 Score=352.91 Aligned_cols=254 Identities=28% Similarity=0.505 Sum_probs=215.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998654322 123456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||++++.|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 999998888887777789999999999999999999999999999999999999999999999999998765443 2334
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------cCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------YTL 236 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~ 236 (515)
..++..|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+....+.... ...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 5688999999998775444789999999999999999999998766544333222100 000
Q ss_pred C------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 P------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 p------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
| +.++..+.+|+.+||+.||.+|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1 2467889999999999999999999999999998
No 129
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=1.1e-43 Score=353.57 Aligned_cols=249 Identities=36% Similarity=0.569 Sum_probs=218.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|+||+||+|.+..+|+.||+|++.+...........+.+|+++++.++||||++++++++..+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554444556678899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCc
Q 010214 105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182 (515)
Q Consensus 105 ~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y 182 (515)
.+++.+.+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99998766 7999999999999999999999999999999999999999999999999998876554444556788999
Q ss_pred cCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCC
Q 010214 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258 (515)
Q Consensus 183 ~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~ 258 (515)
+|||++.+..+ +.++|+||+||++|+|++|..||..... ..+...+.......|..+++++.++|.+||+.||.+
T Consensus 161 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 161 MAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred CCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999987765 7899999999999999999999977543 333344444455677788999999999999999999
Q ss_pred CC-----CHHHHhcCcccccc
Q 010214 259 RI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 259 Rp-----t~~eil~hp~f~~~ 274 (515)
|| ++.+++.||||+..
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 88889999999754
No 130
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=1.4e-43 Score=349.74 Aligned_cols=254 Identities=31% Similarity=0.562 Sum_probs=218.6
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC---hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+|+..+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5889999999999999999999999999999987544222 2345788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccC---
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDG--- 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~--- 170 (515)
||||++|++|.+++.+.+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||.+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999999888999999999999999999999999999999999999998776 5999999998766432
Q ss_pred --CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH-----hcCccCCCCCCChh
Q 010214 171 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHLSPG 243 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i-----~~~~~~~p~~~s~~ 243 (515)
.......|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+ .......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 12234568899999999987766 78999999999999999999999765433222222 12234566778999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
No 131
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=1.3e-43 Score=363.58 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=206.7
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999986432 223456788999999999 899999999988764
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh---------------------------------------------------------
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~--------------------------------------------------------- 111 (515)
..+|+||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4589999999999999999753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---ccccCCCCCCcc
Q 010214 112 -----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYA 183 (515)
Q Consensus 112 -----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~ 183 (515)
.++++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...+..+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 247788899999999999999999999999999999999999999999999997653321 112334678899
Q ss_pred CCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH-HHHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCC
Q 010214 184 APEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 184 aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+..+ ....|...++++.+++.+||..||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999988776 789999999999999997 999998765433 33444433 3455678899999999999999999999
Q ss_pred CHHHHhc
Q 010214 261 TIPEIRQ 267 (515)
Q Consensus 261 t~~eil~ 267 (515)
|+.|+++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
No 132
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=2e-43 Score=352.77 Aligned_cols=250 Identities=30% Similarity=0.464 Sum_probs=209.2
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHH---hCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR---LFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++++.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997765443333333445554444 4479999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCC
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~ 180 (515)
||+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....|++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 99999999988899999999999999999999999999999999999999999999999999987554332 23457999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~ 257 (515)
.|+|||.+.+....+.++||||+||++|+|++|..||.... ..............+|..++++++++|.+||..||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 239 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence 99999998743334789999999999999999999997543 222222333344567778999999999999999999
Q ss_pred CCC-----CHHHHhcCcccccc
Q 010214 258 KRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rp-----t~~eil~hp~f~~~ 274 (515)
+|+ |+.|+++||||+..
T Consensus 240 ~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 240 KRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HhcCCCCCCHHHHHhCccccCC
Confidence 999 69999999999863
No 133
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=1.3e-43 Score=359.82 Aligned_cols=244 Identities=30% Similarity=0.498 Sum_probs=195.4
Q ss_pred eeeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iVmE 97 (515)
++.||+|+||.||+|.++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999999865432 2456789999999999999999999854 456899999
Q ss_pred ccCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCceEEeecccc
Q 010214 98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (515)
Q Consensus 98 y~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~vKL~DFGls 164 (515)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5898888632 258999999999999999999999999999999999999 45678999999999
Q ss_pred cccccC----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------HHHHHHhc
Q 010214 165 NIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIKG 231 (515)
Q Consensus 165 ~~~~~~----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------~~~~~i~~ 231 (515)
...... ......+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 876432 12345678999999999987655588999999999999999999999643311 11111111
Q ss_pred C----------------------------ccC----------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 232 G----------------------------IYT----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 232 ~----------------------------~~~----------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. ... .....+.++.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 000 001235678999999999999999999999999998
No 134
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=6.1e-43 Score=342.55 Aligned_cols=252 Identities=34% Similarity=0.600 Sum_probs=224.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999998765443 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccccccccCCccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~~~~~~~ 174 (515)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999764 358999999999999999999999999999999999999865 458999999998776555555
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ..++..+++++.+++.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 6678999999999987765 689999999999999999999999888777776665543 35677789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.||.+|||+.|++.||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999996
No 135
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=4.2e-43 Score=345.55 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=220.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999987554332 5678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
|+++|++|.+++... +.+++..++.++.||+.||.|||++|++||||+|+||++++++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999876654322
Q ss_pred ----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCC-----CCCCh
Q 010214 173 ----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLP-----SHLSP 242 (515)
Q Consensus 173 ----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p-----~~~s~ 242 (515)
.....|++.|+|||++......+.++|+||+||++|+|++|..||...+......++..... .++ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 23457899999999988764447899999999999999999999988766655555544322 111 25678
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.+++.+||..||.+|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
No 136
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=3.5e-43 Score=346.88 Aligned_cols=252 Identities=27% Similarity=0.463 Sum_probs=217.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC---ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+|++.+.||.|+||.||+|.+ .+|+.+|+|.+...... .......+.+|+.+++.++||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 48899999998654322 12334678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-----
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD----- 169 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~----- 169 (515)
||||++|++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred --CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhH
Q 010214 170 --GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGA 244 (515)
Q Consensus 170 --~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 244 (515)
........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 112234568999999999988766 68999999999999999999999875544433333322 234667789999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.++|.+||..+|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
No 137
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=2.3e-43 Score=394.35 Aligned_cols=267 Identities=26% Similarity=0.443 Sum_probs=223.7
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~ 88 (515)
....+...++|++++.||.|+||+||+|.+..++..||+|++....... .....+.+|+.+++.++||||++++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 3456677899999999999999999999999999999999997654433 345778999999999999999999998854
Q ss_pred --CCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEECC---
Q 010214 89 --PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-------MVVHRDLKPENLLLDS--- 152 (515)
Q Consensus 89 --~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~-------gIvHrDLkpeNILl~~--- 152 (515)
...+||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4579999999999999999975 35799999999999999999999984 4999999999999964
Q ss_pred --------------CCceEEeecccccccccCCccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCC
Q 010214 153 --------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPF 217 (515)
Q Consensus 153 --------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf 217 (515)
.+.+||+|||++............+||+.|+|||++.+. ...++++||||||||||+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 234899999999877655555667899999999998643 23378999999999999999999999
Q ss_pred CCCCh-HHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 218 DDENI-PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 218 ~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
..... ..+...+...........+.++.+||..||..+|.+|||+.|+|.|||++...+
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 76544 344444444332223457899999999999999999999999999999975533
No 138
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=5.8e-44 Score=356.08 Aligned_cols=252 Identities=29% Similarity=0.548 Sum_probs=210.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999875432 22234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccccc
Q 010214 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~ 175 (515)
|+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9975 88888765 567999999999999999999999999999999999999999999999999998765432 22334
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCC-CCCChHHHHHHHhcCc---------------------
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGI--------------------- 233 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf-~~~~~~~~~~~i~~~~--------------------- 233 (515)
..+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+.......+....
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 567899999999887655578999999999999999998885 4444444433332110
Q ss_pred --------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......+++++++||.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00113478899999999999999999999999999998
No 139
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=3.2e-43 Score=350.92 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=213.1
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHH---HHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI---KILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
.||+|+||.||+|.+..+++.||+|++.+..............|. ..++...||+|+++++++.+.+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999999876544322222333343 44555679999999999999999999999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCC
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~ 180 (515)
||+|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... ...+.+|+.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence 9999999988889999999999999999999999999999999999999999999999999998765332 234568999
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCC
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~ 257 (515)
.|+|||++.+....+.++||||+||++|+|++|..||.+. ........+......+|..+++++.+++.+||..||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence 9999999975533478999999999999999999999876 3344444555556677888899999999999999999
Q ss_pred CCC-----CHHHHhcCcccccc
Q 010214 258 KRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rp-----t~~eil~hp~f~~~ 274 (515)
+|| ++.++++||||+..
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hccCCCCCCHHHHHhCccccCC
Confidence 999 99999999999764
No 140
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=5.6e-43 Score=346.12 Aligned_cols=254 Identities=33% Similarity=0.550 Sum_probs=216.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 92 (515)
.+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999999999999999998755332 22345678999999999999999999999865 3678
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
+++|||+++++|.+++...+.+++...+.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998755321
Q ss_pred --CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHH
Q 010214 171 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (515)
.......++..|+|||.+.+..+ +.++|+||+||++|+|++|..||..........++... ...+|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 12233568899999999988765 78999999999999999999999876554444443322 24456678899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
++ +||..+|.+|||++|+++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
No 141
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=2e-43 Score=349.06 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=213.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986542 22345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
|||+++++|.+++...+.+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999998765432 1223
Q ss_pred cCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC-----CCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~ 246 (515)
...|++.|+|||++. +..+ +.++|+||+||++|+|++|..||...........+.......+ ..++..+.+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred cccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 457899999999974 2334 6899999999999999999999976543333222222222211 246788999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
++.+||..||++|||++++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
No 142
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=3.7e-43 Score=351.95 Aligned_cols=240 Identities=18% Similarity=0.265 Sum_probs=211.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEEEEec
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEY 98 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iVmEy 98 (515)
..||+|++|.||+|.. +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999987 789999999987655454556788899999999999999999999866 4578999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
++||+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cccc
Confidence 9999999999988889999999999999999999998 599999999999999999999999999988664332 3457
Q ss_pred CCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHhcccCC
Q 010214 178 GSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 178 gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~mL~ 253 (515)
|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+...+...+... ...+|...++++.+++.+||+
T Consensus 182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 8999999999976 444 78999999999999999999999998888877777443 445566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.|+++
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999985
No 143
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.6e-43 Score=368.19 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=209.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+..+|.+++.||.|+||.||+|... .++..||+|.+... ....+|+++|+.++||||+++++++.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 4567999999999999999999764 35678999987543 2346899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+|||++. ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 69999998788899999999999999999999999999999999999999999999999999876544322
Q ss_pred ---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---HHHHHHhcC--------------
Q 010214 173 ---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGG-------------- 232 (515)
Q Consensus 173 ---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---~~~~~i~~~-------------- 232 (515)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.... ..+..+...
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 234579999999999988877 68999999999999999999999764321 111111110
Q ss_pred ---------------ccCCC-----CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 233 ---------------IYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 233 ---------------~~~~p-----~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
.+..| ..++.++.+||.+||..||.+|||+.|++.||||+..-+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 01111 134678899999999999999999999999999986533
No 144
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=2e-43 Score=360.68 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=208.0
Q ss_pred Eeeeeccc--CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 21 LGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 21 i~~~LG~G--~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
++++||+| +||+||++.++.+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7899999999999999999998765433 34556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CC----
Q 010214 99 VKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GH---- 171 (515)
Q Consensus 99 ~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~---- 171 (515)
+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+..... +.
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999753 4589999999999999999999999999999999999999999999999986543221 11
Q ss_pred ---ccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------
Q 010214 172 ---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------ 235 (515)
Q Consensus 172 ---~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------ 235 (515)
......++..|+|||++.+. ...+.++||||+||++|+|++|..||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11234577889999999763 22378999999999999999999999875544333222221110
Q ss_pred ----------------------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 236 ----------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 236 ----------------------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
....+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 112356789999999999999999999999999999753
No 145
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=6e-43 Score=352.28 Aligned_cols=260 Identities=31% Similarity=0.499 Sum_probs=223.5
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..+.....+|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 34555678999999999999999999999999999999998764432 346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
...|+||||++|++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999999999854 5689999999999999999999999999999999999999999999999999876543
Q ss_pred CC-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHh-cCc--cCCCCCCChhHH
Q 010214 170 GH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK-GGI--YTLPSHLSPGAR 245 (515)
Q Consensus 170 ~~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~-~~~--~~~p~~~s~~~~ 245 (515)
.. ......|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+. ... ...|..+++.+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 32 2234578999999999987765 689999999999999999999998776543332222 222 234567889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+++.+||..||.+|||+.+++.||||...
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999764
No 146
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=4.8e-43 Score=349.25 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=217.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999999999999999997654322 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--ccc
Q 010214 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~ 174 (515)
|+ +++|.+++.. ...+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 9999999865 4568999999999999999999999999999999999999999999999999988765433 234
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------- 234 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------- 234 (515)
...|+..|+|||.+.+....++++||||+||++|+|++|.+||.+.........+.....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 567899999999987665557899999999999999999999987665554444322100
Q ss_pred ----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 235 ----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+..+.++.+||.+||..||.+|||+++++.||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01124578899999999999999999999999999983
No 147
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=6.1e-43 Score=348.75 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=213.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|++++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999986542 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... .....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 99999999654 35789999999999999999999999999999999999999999999999999765433 34456
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCc-cCC-CCCCChhHHHH
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-------PNLFKKIKGGI-YTL-PSHLSPGARDL 247 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-------~~~~~~i~~~~-~~~-p~~~s~~~~~l 247 (515)
+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||..... ......+.... ... ....+++++++
T Consensus 154 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 89999999999988766 7899999999999999999999965321 12222222222 122 23578899999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+||+.||.+||+++|+++||||+..
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999754
No 148
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=2.4e-43 Score=351.13 Aligned_cols=256 Identities=31% Similarity=0.446 Sum_probs=222.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.+..+++.||+|++... .....+.+.+|+++++.++||||+++++++.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 36799999999999999999999989999999998543 334557788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
|||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999998764 569999999999999999999999999999999999999999999999999887653322 22
Q ss_pred ccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 246 (515)
....|++.|+|||++.+. ...+.++|+||+||++|+|++|..||.+.+......++..+.. ..|..++.++.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 345689999999998532 2235789999999999999999999988776666666665532 345678999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+||..||.+|||+.++++||||...
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999754
No 149
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=7.3e-43 Score=342.77 Aligned_cols=252 Identities=34% Similarity=0.603 Sum_probs=223.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iV 95 (515)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765443 3445778899999999999999999998753 4568999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCH-----RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH-----~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
|||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 367999999999999999999999 89999999999999999999999999999987
Q ss_pred cccCCc-cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhH
Q 010214 167 MRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244 (515)
Q Consensus 167 ~~~~~~-~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~ 244 (515)
...... ..+..|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+..+.. .+|...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 755443 455679999999999988765 6899999999999999999999998887777777776654 4677889999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+++.+||..+|.+|||+.++++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999995
No 150
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=6.4e-43 Score=342.48 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=222.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+|+..+.||+|+||+||+|.+..+++.||+|.+...... ..+....+.+|+.+++.++||||+++++++.+...+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 578889999999999999999989999999998754322 234567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999887655444556
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc--CccCCCCCCChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~mL~ 253 (515)
..|++.|+|||.+......+.++|+||+||++|+|++|..||..........++.. ....+|..+++++.+++.+||+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 77999999999987665237899999999999999999999987664444444433 2345667789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|.+|||+.+++.|||+
T Consensus 241 ~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 241 RDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999996
No 151
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=9.9e-43 Score=343.95 Aligned_cols=254 Identities=33% Similarity=0.569 Sum_probs=217.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc--cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 92 (515)
.+|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 22233457889999999999999999999998763 568
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
+++|||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999988888999999999999999999999999999999999999999999999999998765321
Q ss_pred --CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHH
Q 010214 171 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (515)
Q Consensus 171 --~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (515)
.......|+..|+|||++.+..+ +.++|+|||||++|+|++|+.||..........++... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 12334568999999999987765 78999999999999999999999876544444444332 23456678889999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+|.+|+. +|.+|||++|+++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999994 999999999999999973
No 152
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.4e-42 Score=340.66 Aligned_cols=252 Identities=33% Similarity=0.528 Sum_probs=224.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||.+.+..+++.+++|.+....... .....+.+|+.++++++||||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987655443 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999765 468999999999999999999999999999999999999999999999999987664433 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 5678999999999987765 68899999999999999999999998888877777666543 345678999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|.+|||+.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999986
No 153
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=6.5e-43 Score=352.15 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=224.6
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.......+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 334445789999999999999999999999999999999865432 23567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|+|+||+++++|.+++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999998864 46899999999999999999999999999999999999999999999999998765443
Q ss_pred Cc-cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHH
Q 010214 171 HF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~-~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~ 246 (515)
.. .....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... ....|..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 22 334578999999999987766 68999999999999999999999887665444444332 23346678999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
+|.+||..||.+|||+.+++.||||+...
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999999999998654
No 154
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=8.3e-43 Score=342.23 Aligned_cols=252 Identities=29% Similarity=0.566 Sum_probs=223.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|+||.||++.+..+|+.||+|.+....... .....+.+|+.+++.++||||++++++++..+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999999999999999987654433 345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~ 174 (515)
|+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999999997643 589999999999999999999999999999999999999999999999999876644322 23
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..|..++.++.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 4468899999999987765 6799999999999999999999998888777777766554 4667889999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 010214 254 VDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f 271 (515)
.+|.+||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
No 155
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=3.9e-43 Score=347.00 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=213.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999864432 2345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 9999999999999888899999999999999999999999999999999999999999999999999998664322 223
Q ss_pred cCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC-----CCCCChhHHHH
Q 010214 175 TSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-----PSHLSPGARDL 247 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~l 247 (515)
...|++.|+|||.+.+. ...+.++|+||+||++|+|++|..||...........+....... +..++..+.+|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 45789999999998532 222678999999999999999999997654333222222222221 23568899999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
+.+||..||.+|||++++++|+|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999987
No 156
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=9.4e-43 Score=342.43 Aligned_cols=250 Identities=30% Similarity=0.455 Sum_probs=218.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.....+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999975432 24678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999999999999876 789999999999999999999999999999999999999999999999999987654332 334
Q ss_pred cCCCCCCccCCCcccCC---ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-----CCCCCChhHHH
Q 010214 175 TSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~---~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~ 246 (515)
...++..|+|||.+.+. .+ +.++|+||+||++|+|++|..||.+.+.......+....+. .+...+.++.+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred cccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 55789999999998765 55 67999999999999999999999887655544444433222 23346788999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
++.+||..||.+|||+.+++.|||
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
No 157
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=4.6e-43 Score=348.03 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=222.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~ 175 (515)
||+++++|.+++... ++++..++.++.|++.|+.|||+.+++||||+|+||+++.++.++|+|||++...... .....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999999765 8999999999999999999999999999999999999999999999999999876543 23345
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCC-CChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSH-LSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~-~s~~~~~li~~mL~ 253 (515)
..|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+.. +++++.+++.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 578899999999988775 789999999999999999999998766555554444443 233444 78999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.||++|||++++++||||+..
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CChhhCcCHHHHhhChhhcCC
Confidence 999999999999999999754
No 158
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=1.1e-42 Score=348.91 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=219.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+..+..+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 47799999999999999999999999999999998643 334567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||++|++|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 999999999988765 456899999999999999999999999999999999999999999999999988654322 222
Q ss_pred ccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhHHH
Q 010214 174 KTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD 246 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~ 246 (515)
....+++.|+|||++.+.. ..+.++|+|||||++|+|++|..||...+......++..... ..+..++.++.+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHH
Confidence 3456889999999985321 125789999999999999999999988766555555544322 335678899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+||..||.+||+++++++||||...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999999999754
No 159
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=4.9e-43 Score=349.98 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=218.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999886432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~---~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++...... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence 999999999998763 379999999999999999999997 59999999999999999999999999998765332 3
Q ss_pred cccCCCCCCccCCCcccCCcc-----CCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH---HhcC-ccCCCCCCChh
Q 010214 173 LKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK---IKGG-IYTLPSHLSPG 243 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~-----~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~s~~ 243 (515)
..+..+++.|+|||.+.+... .+.++|+||+||++|+|++|..||........... +..+ ....|..++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 345678999999999865432 26789999999999999999999977655444333 3332 34567778999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+||.+||+.+|.+||++.+++.||||...
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999765
No 160
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=7.9e-43 Score=360.24 Aligned_cols=257 Identities=33% Similarity=0.549 Sum_probs=216.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 5689999999999999999999999999999999986543 2334456778899999999999999999998644
Q ss_pred -CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...|+||||+.+ +|.+++... +++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999964 888888654 8999999999999999999999999999999999999999999999999998765
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (515)
......+..+++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+......++......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 5544456678999999999988776 78999999999999999999999876654443333211000
Q ss_pred -----------------------C-------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 236 -----------------------L-------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 236 -----------------------~-------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
. +...++.+++||.+||+.||.+|||+.|++.||||+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 1124567899999999999999999999999999986544
No 161
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.6e-43 Score=363.71 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=202.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||+|+||.||+|.+..+++.||+|+..+. ....|+.+++.++||||+++++++......|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4699999999999999999999999999999985432 2346999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........+
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 9995 588888865 45799999999999999999999999999999999999999999999999999976544444455
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCC-CCCCCChH---------HHHHHHhcC----ccCCC----
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL-PFDDENIP---------NLFKKIKGG----IYTLP---- 237 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~-Pf~~~~~~---------~~~~~i~~~----~~~~p---- 237 (515)
..||+.|+|||++.+..+ +.++||||+||++|+|+++.. +|...... ..+.++... ...+|
T Consensus 216 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 679999999999988877 789999999999999998544 44432110 011111110 00011
Q ss_pred --------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 238 --------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 238 --------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 135677888999999999999999999999999975
No 162
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-44 Score=366.02 Aligned_cols=253 Identities=38% Similarity=0.700 Sum_probs=228.0
Q ss_pred CCceE--eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 17 PNYKL--GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 17 ~~Y~i--~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.-|++ .++||+|-||+||-|.|+.||+.||||+|+|-.+... ....++.|+.||..+.||.||.+-..|++++.+|+
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 34555 5789999999999999999999999999998877654 34889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC---CceEEeeccccccccc
Q 010214 95 VMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRD 169 (515)
Q Consensus 95 VmEy~~gg~L~~~i~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~---~~vKL~DFGls~~~~~ 169 (515)
|||-+.| ++.+.|- ++++++|...+.++.||+.||.|||.++|+|+||||||||+.+. -.+||||||+++++..
T Consensus 641 VMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 641 VMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred Eehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 9999966 6666553 57899999999999999999999999999999999999999765 3699999999999999
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 245 (515)
..+-++.+|||.|.|||++..+.| ...-|+||.|||+|.-|+|..||..+ +++.++|++..+-+| ..+++++.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccc-cccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHH
Confidence 999999999999999999999988 68899999999999999999999764 345567777766555 47899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|||..+|++.-.+|.|+++.+.|||+++.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999864
No 163
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=3e-43 Score=351.00 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=216.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.++.+++.||+|++.+..... ...+.+.+|+++++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999987644332 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||++++.|..++...+.+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 999999998887777779999999999999999999999999999999999999999999999999987654432 2334
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------c--
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y-- 234 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~-- 234 (515)
..++..|+|||++.+....+.++||||+||++|+|++|.+||..........++.... .
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 5688999999998765545789999999999999999999998765444333322100 0
Q ss_pred ----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
..++.++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123568889999999999999999999999999998
No 164
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=1.4e-42 Score=346.23 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=218.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+++++.++||||+++++++......|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999985432 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccccc
Q 010214 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~ 175 (515)
|+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999999998865 457999999999999999999999999999999999999999999999999998765332 22345
Q ss_pred CCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHH
Q 010214 176 SCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDL 247 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 247 (515)
..|++.|+|||++. +..+ +.++|+||+||++|+|++|..||...+......++.... ...|..++.++.+|
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 57899999999984 2223 578999999999999999999998877666555554432 23456788999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||..||.+|||+.++++||||+..
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999999999999999754
No 165
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=3.4e-43 Score=348.64 Aligned_cols=254 Identities=36% Similarity=0.697 Sum_probs=230.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV 95 (515)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++.++..........+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998766655555678899999999999 99999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC----
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---- 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---- 171 (515)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987654321
Q ss_pred -----------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc
Q 010214 172 -----------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (515)
Q Consensus 172 -----------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~ 234 (515)
......|+..|+|||++.+..+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 1223457899999999887655 7899999999999999999999998887777788888888
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCH----HHHhcCccc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF 271 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~----~eil~hp~f 271 (515)
.+|..+++.+.+||.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8999999999999999999999999999 999999997
No 166
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=6e-43 Score=352.44 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=223.3
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.......+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 445566899999999999999999999999999999999865432 23467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999999999864 56899999999999999999999999999999999999999999999999998765443
Q ss_pred C-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-C--ccCCCCCCChhHHH
Q 010214 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-G--IYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~-~--~~~~p~~~s~~~~~ 246 (515)
. ......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.. + ....|..++..+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 2 2234578999999999988766 7899999999999999999999987654333222222 1 12345678899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
|+.+||..||.+|||+.++++||||+...+
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999999999986543
No 167
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=7.2e-43 Score=350.87 Aligned_cols=256 Identities=33% Similarity=0.501 Sum_probs=218.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC--ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+|++.+.||.|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765543 123456678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+ +++|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999998766 7999999999999999999999999999999999999999999999999999876543 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------- 234 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------------- 234 (515)
....+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+......++.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 3446788999999987654457899999999999999999999987766555444432110
Q ss_pred ---------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
......+.++.++|.+||..||.+|||+.|++.||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0113457889999999999999999999999999999865
No 168
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=6.2e-43 Score=343.30 Aligned_cols=249 Identities=37% Similarity=0.645 Sum_probs=224.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.++++++||||+++++.+.+....|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776554455678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---------cccc
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKT 175 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---------~~~~ 175 (515)
.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887889999999999999999999999999999999999999999999999999987653321 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCC--ChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~mL~ 253 (515)
..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........+..+..+....|... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999987764 7899999999999999999999999888888888887777777665 9999999999999
Q ss_pred CCCCCCCCH---HHHhcCcccccc
Q 010214 254 VDPMKRITI---PEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~---~eil~hp~f~~~ 274 (515)
.+|.+|||+ .++++||||++.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 999999999 999999999753
No 169
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-45 Score=369.59 Aligned_cols=260 Identities=33% Similarity=0.614 Sum_probs=246.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
..+.+.+.+.+||.|+||.|-++..+.....+|+|++++..+.+....+.+..|-.||..++.|+||++|..|.+..++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 44678889999999999999999877665669999999999988888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
+.||-|-||+|+..+..++.+.+..++.++.-+++|++|||++||++|||||||.++|.+|-+||.|||+++.+..+...
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~m 251 (515)
-|.||||.|.|||++..+.. +.++|.||||+++||||+|.+||.+.+....+..|.+|. ..+|..++..+.+||+++
T Consensus 577 wTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKL 655 (732)
T ss_pred eeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHH
Confidence 99999999999999998876 789999999999999999999999999999999999986 678999999999999999
Q ss_pred CCCCCCCCCC-----HHHHhcCcccccc
Q 010214 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt-----~~eil~hp~f~~~ 274 (515)
...+|.+|.. +.+|.+|.||...
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 9999999986 8999999999765
No 170
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1.1e-42 Score=347.06 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=217.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2334578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--ccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~ 174 (515)
||++++.+..++.+...+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 999987777777666779999999999999999999999999999999999999999999999999988765443 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------- 233 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--------------------- 233 (515)
...+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 56788999999999887444789999999999999999999998765544333222100
Q ss_pred -----------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -----------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...|..+++++++||.+||..+|++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458899999999999999999999999999997
No 171
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=1.2e-42 Score=351.85 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=216.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 92 (515)
-.++|++.+.||.|+||.||+|.++.+|+.||+|++....... .....+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3678999999999999999999999999999999986543322 2233456899999999999999999998654 568
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+.+ +|.+++.. ...+++.+++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 89888875 4679999999999999999999999999999999999999999999999999998765432
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-----------------
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------- 233 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~----------------- 233 (515)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22333568889999998775545789999999999999999999999888777666554321
Q ss_pred --cCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 --YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 --~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+..+ ...++++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 1111 1258889999999999999999999999999999753
No 172
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=1e-42 Score=347.03 Aligned_cols=252 Identities=30% Similarity=0.534 Sum_probs=212.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999999865432 22334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 98 YVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|+. ++|.+++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 589998865 3568999999999999999999999999999999999999999999999999987654322 223
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---------------------
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------- 233 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--------------------- 233 (515)
...+++.|+|||++.+....+.++|||||||++|+|++|..||...+......++....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 44678899999998876655788999999999999999999998766544333222100
Q ss_pred --------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......++++++++|.+||+.||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123478899999999999999999999999999998
No 173
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.3e-42 Score=343.91 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=211.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC-----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP----- 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~----- 89 (515)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467999999999999999999999999999999986543 2235678999999998 699999999998642
Q ss_pred -CeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999863 3689999999999999999999999999999999999999999999999999876
Q ss_pred cccC-CccccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCC
Q 010214 167 MRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSH 239 (515)
Q Consensus 167 ~~~~-~~~~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 239 (515)
.... ....+..|++.|+|||++.+. ...+.++|+||+||++|+|++|..||...........+.... ...+..
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 5432 233456799999999998632 123678999999999999999999998765444333333222 122346
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.++.+|+.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78899999999999999999999999999997
No 174
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=1.5e-42 Score=344.99 Aligned_cols=249 Identities=31% Similarity=0.521 Sum_probs=209.0
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC--CeEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDIYVV 95 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~iV 95 (515)
|++.+.||.|+||.||+|.+..+++.||+|++.+... .... ....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999865432 2222 23457888888886 99999999999887 889999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+++ +|.+++.. .+.+++..++.++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++..........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 999975 88888875 457899999999999999999999999999999999999999 999999999998765544445
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------------ccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------------IYTL 236 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~------------------~~~~ 236 (515)
...+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+... .+.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 5678999999998765445578999999999999999999999887665544443221 1111
Q ss_pred C-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 P-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
| ..++.++.++|.+||++||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1 2568999999999999999999999999999997
No 175
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=2e-42 Score=340.54 Aligned_cols=248 Identities=35% Similarity=0.579 Sum_probs=213.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..+ ....+|||+++++++++..+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999976544333333344455444 4556899999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~ 181 (515)
++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++..... .....|++.
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999999888899999999999999999999999999999999999999999999999999875433 234568899
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC----CCCCChhHHHHhcccCCCCCC
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~mL~~dP~ 257 (515)
|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+....... +..+++++.+++.+||+.||.
T Consensus 159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999988765 789999999999999999999999888877777776554332 335789999999999999999
Q ss_pred CCC---CHHHHhcCcccccc
Q 010214 258 KRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rp---t~~eil~hp~f~~~ 274 (515)
+|| +++|++.||||++.
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HccCCCcHHHHHcChHhhcC
Confidence 999 45799999999754
No 176
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=3.5e-42 Score=342.80 Aligned_cols=255 Identities=27% Similarity=0.471 Sum_probs=210.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHH-HHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
++|++.+.||+|+||.||+|.++.+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++..++.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653322 23445556554 6778899999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|||++ |+|.+++.. +..+++..++.++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 588888764 34689999999999999999999997 9999999999999999999999999999876544
Q ss_pred CccccCCCCCCccCCCcccCC---ccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCccCCC-CCCChhH
Q 010214 171 HFLKTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYTLP-SHLSPGA 244 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~---~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~~~~~~p-~~~s~~~ 244 (515)
.......|+..|+|||++.+. ...+.++|+||+||++|+|++|..||.... ...+...+......+| ..+|.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 333445789999999998652 123678999999999999999999997532 2333333333333343 3578999
Q ss_pred HHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 245 ~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++|.+||..+|.+|||+.++++||||+..
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 999999999999999999999999999865
No 177
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1.1e-42 Score=340.74 Aligned_cols=249 Identities=32% Similarity=0.517 Sum_probs=217.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ..+.+.+|+++++.++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 68999999999999999999999889999999986432 2578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99999999999975 4568999999999999999999999999999999999999999999999999988765443 233
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~m 251 (515)
...|+..|+|||++.+..+ +.++||||+|+++|+|++|..||...........+... ....+..++.++.+++.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 4568899999999988766 78999999999999999999999876554433333222 2234456788999999999
Q ss_pred CCCCCCCCCCHHHHhcCccc
Q 010214 252 LIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f 271 (515)
|+.||.+|||+.|++.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
No 178
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=5.5e-42 Score=343.51 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=216.5
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
......++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33445789999999999999999999999999999999986432 2345678899999988 799999999998653
Q ss_pred -----CeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 90 -----SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 90 -----~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
...|+||||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 358999999999999998863 45789999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-ccccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--
Q 010214 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 233 (515)
Q Consensus 161 FGls~~~~~~~-~~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-- 233 (515)
||++....... ......|+..|+|||++.... ..+.++||||+||++|+|++|..||...........+....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99987654332 223457899999999986432 13689999999999999999999998776554444444332
Q ss_pred -cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 234 -~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+...+..+.+||.+||+.||.+|||+.|+++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 223556778899999999999999999999999999984
No 179
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=6.2e-43 Score=344.57 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=220.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478899999999999999999999999999999876532 245677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-h
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999876643322 2
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcC-ccCCCCC-CChhHHHH
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGARDL 247 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~~l 247 (515)
...++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||... ......+.+... ....+.. ++++++++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2678999999999988766 78999999999999999999999754 233334444333 2334444 88999999
Q ss_pred hcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|.+||..||.+|||+.+++.||||+..
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999754
No 180
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=2.3e-42 Score=348.32 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=211.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.+....++|++.+.||.|+||.||+|.+..+++.||||.+....... .....+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 45556789999999999999999999999999999999986543222 22345678999999999999999999986643
Q ss_pred --------eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeec
Q 010214 91 --------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 91 --------~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DF 161 (515)
..|+||||+.+ +|.+++... ..+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 46999999964 888888654 37899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCC-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--
Q 010214 162 GLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-- 234 (515)
Q Consensus 162 Gls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-- 234 (515)
|++....... ......++..|+|||.+.+....+.++||||+|+++|+|++|..||.+.+.......+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9997654322 123346788999999987755447899999999999999999999987765443332222110
Q ss_pred -----------------CCC-------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 -----------------TLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 -----------------~~p-------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+| ...+..+.+||.+||..||.+|||++|+++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 011 1235678899999999999999999999999998
No 181
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=5.7e-42 Score=337.26 Aligned_cols=253 Identities=31% Similarity=0.571 Sum_probs=218.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999999999999999765443 3467889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-----
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----- 172 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~----- 172 (515)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999998887899999999999999999999999999999999999999999999999999887644322
Q ss_pred cccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhc-CccCCCCCC--ChhHHH
Q 010214 173 LKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKG-GIYTLPSHL--SPGARD 246 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~-~~~~~p~~~--s~~~~~ 246 (515)
.....+++.|+|||++.+.. ..+.++||||+|+++|+|++|..||.... .......+.. ....+|... ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999998664 13689999999999999999999997653 2222222332 233455544 899999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+|.+||+.+|.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
No 182
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=3.5e-42 Score=337.85 Aligned_cols=248 Identities=33% Similarity=0.554 Sum_probs=219.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+++.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 98 y~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
|+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+...... ....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99999999998753 35899999999999999999999999999999999999999999999999998766432 2334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL~ 253 (515)
...|++.|+|||++.+..+ ++++|+||+|+++|+|++|..||...+.......+..+.. ..|..++..+.+||.+||+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 5678999999999987765 7899999999999999999999998887777777766544 4677889999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 010214 254 VDPMKRITIPEIRQH 268 (515)
Q Consensus 254 ~dP~~Rpt~~eil~h 268 (515)
.||.+|||+.+++.-
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999863
No 183
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=1.1e-42 Score=348.79 Aligned_cols=254 Identities=33% Similarity=0.481 Sum_probs=215.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 93 (515)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999755433 22334567899999999999999999998777 8899
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-C
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~ 171 (515)
+||||+++ +|.+++.... .+++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...... .
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999975 9999887644 5899999999999999999999999999999999999999999999999998876543 2
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (515)
......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||..........++....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 33445688999999998876555789999999999999999999998876655544432211
Q ss_pred -------------cCCCCC-CChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -------------YTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -------------~~~p~~-~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
..+|.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 58889999999999999999999999999998
No 184
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=3.4e-42 Score=341.20 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=215.0
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-------ChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-------NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-------~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688999999999999999999999999999988543211 1123457889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+++||||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred ---CccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCC----CCC
Q 010214 171 ---HFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP----SHL 240 (515)
Q Consensus 171 ---~~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p----~~~ 240 (515)
.......|+..|+|||.+.+.. ..+.++|+||||+++|++++|..||...........+... ...++ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1223456889999999987654 2378999999999999999999999765544433333222 22223 245
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+.++.++|.+||..+|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
No 185
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=2.8e-42 Score=341.52 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=214.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|++.+.||+|+||.||+|.++ .++..||+|.+.... .......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 367999999999999999999875 456789999986542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999999764 578999999999999999999999999999999999999999999999999876543322
Q ss_pred ccc--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
... ...++..|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.....+.+..+. .+.|..++..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 222 2345678999999988766 789999999999999775 999999888887777776653 45677889999999
Q ss_pred hcccCCCCCCCCCCHHHHhc
Q 010214 248 IPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+||+.+|.+|||+.+|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999875
No 186
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=3.8e-42 Score=343.33 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=214.1
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE--
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE-- 87 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~-- 87 (515)
......++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 44456789999999999999999999999999999999875432 1235678899999999 6999999999873
Q ss_pred ---cCCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 88 ---TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 88 ---~~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
.....|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 44579999999999999998753 35689999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC-ccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-
Q 010214 161 FGLSNIMRDGH-FLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI- 233 (515)
Q Consensus 161 FGls~~~~~~~-~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~- 233 (515)
||++....... ......|++.|+|||++.+ ..+ +.++||||+||++|+|++|..||..........++....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence 99987654322 2345579999999999853 223 679999999999999999999998766544443333222
Q ss_pred --cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
...|..++..+.+|+.+||+.||.+|||+.|+++|+||
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22355678899999999999999999999999999997
No 187
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=5.2e-42 Score=337.22 Aligned_cols=255 Identities=34% Similarity=0.562 Sum_probs=224.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999998765432 45678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcc-c
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-~ 174 (515)
||+++++|.+++.....+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++......... .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999888899999999999999999999999 99999999999999999999999999998876543332 2
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcC-ccCCCCC-CChhHHHHhc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGG-IYTLPSH-LSPGARDLIP 249 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~li~ 249 (515)
...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++|.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 5568899999999987755 78999999999999999999999876 444555555543 3344555 8899999999
Q ss_pred ccCCCCCCCCCCHHHHhcCcccccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+||..+|.+|||+.++++||||+..
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999753
No 188
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=3.5e-42 Score=340.13 Aligned_cols=252 Identities=32% Similarity=0.488 Sum_probs=213.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCC----
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS---- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 90 (515)
.++|++.+.||.|++|.||+|.++.+++.+|+|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5899999999999999999999999999999999875432 346788999999999 6999999999996644
Q ss_pred --eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 --DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 --~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
.+|+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999999865 357999999999999999999999999999999999999999999999999998
Q ss_pred cccccC-CccccCCCCCCccCCCcccCC----ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---CC
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TL 236 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~----~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---~~ 236 (515)
...... .......|++.|+|||++.+. ...+.++|||||||++|+|++|..||...........+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 765432 223455689999999988542 2236789999999999999999999987665555455544422 22
Q ss_pred CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+..++.++++||.+||..||.+|||+.++++|||+
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 33477899999999999999999999999999996
No 189
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-43 Score=358.27 Aligned_cols=244 Identities=30% Similarity=0.536 Sum_probs=215.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..+++++.||+|-||.||+|.+. ...+||+|.+....... +.+.+|+++|++|+|+|||++++++..+..+||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 34567889999999999999986 33489999987654433 56679999999999999999999999988999999
Q ss_pred eccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||++.|+|.+|+.. ++.++..+...++.||++|++||+++++|||||-..|||+++++.+||+|||+++...++....
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999999999987 5579999999999999999999999999999999999999999999999999999666555433
Q ss_pred cCC--CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 175 TSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 175 ~~~--gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
..- -..-|.|||.+....+ +.++||||+||+||||+| |+.||.+.+..+..+.+..|. .+-|..+|+++-+++..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred cCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 322 2346999999998877 789999999999999999 999999999999999998875 57788999999999999
Q ss_pred cCCCCCCCCCCHHHHh
Q 010214 251 MLIVDPMKRITIPEIR 266 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil 266 (515)
||..+|++|||++.+.
T Consensus 440 CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLR 455 (468)
T ss_pred HhhCCcccCCCHHHHH
Confidence 9999999999999664
No 190
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=2.4e-42 Score=344.30 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468999999999999999999986655 689999986432 3345577899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
..|++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999999764 4578899999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||++....... ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999987654332 2234467889999999887766 789999999999999998 999999888888887776
Q ss_pred cCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+. ...|..+++++.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 654 35577899999999999999999999999999874
No 191
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=2.1e-42 Score=350.48 Aligned_cols=244 Identities=29% Similarity=0.480 Sum_probs=194.3
Q ss_pred eeeecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE--cCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iVmE 97 (515)
+..||+|+||.||+|.++. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999764 568999999865432 245678999999999999999999984 4567899999
Q ss_pred ccCCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE----CCCCceEEeecccc
Q 010214 98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (515)
Q Consensus 98 y~~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl----~~~~~vKL~DFGls 164 (515)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9964 888887532 248899999999999999999999999999999999999 56678999999999
Q ss_pred cccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------HHHHHHhc
Q 010214 165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIKG 231 (515)
Q Consensus 165 ~~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------~~~~~i~~ 231 (515)
....... ......||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8764322 2334578999999999987555578999999999999999999999653211 00100000
Q ss_pred ----------------------------Ccc----------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 232 ----------------------------GIY----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 232 ----------------------------~~~----------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
... ......+..+.+||.+||+.||.+|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
No 192
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=4.9e-42 Score=343.62 Aligned_cols=253 Identities=31% Similarity=0.546 Sum_probs=208.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|++|.||+|.++.+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 589999999999999999999999999999999986543221 223466899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
|||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999975 999988764 46899999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI------------------- 233 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~------------------- 233 (515)
....+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. ..+....+....
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 234578899999998765544789999999999999999999997654 222222221100
Q ss_pred c-----------CCCCCCC--hhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 Y-----------TLPSHLS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 ~-----------~~p~~~s--~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. .....++ .++.+++.+||+.||.+|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0001234 788999999999999999999999999998
No 193
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-43 Score=342.32 Aligned_cols=258 Identities=29% Similarity=0.563 Sum_probs=239.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i 94 (515)
+++|.++++||+|+|++|.+++++.|.+.||+|++.++-..+.+..+-++.|..+..+. +||++|-++.+|+++..+|+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 68999999999999999999999999999999999998888877788888998888765 59999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc-cccCCcc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~-~~~~~~~ 173 (515)
|.||++||+|--++++..+++|+.++.+..+|+.||.|||++||++||||..|+|+|..|++||+|+|+++. +.++...
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999874 5678889
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC--------CChHHHHHHHhcCccCCCCCCChhHH
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--------ENIPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~--------~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
.|.||||+|.|||++.|..| +..+|.|+|||+++||+.|+.||+- .+..-+++-|......+|..+|-.+.
T Consensus 409 stfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas 487 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKAS 487 (593)
T ss_pred ccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhH
Confidence 99999999999999999998 8999999999999999999999962 23445788888889999999999999
Q ss_pred HHhcccCCCCCCCCCC------HHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRIT------IPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt------~~eil~hp~f~~~ 274 (515)
.+++..|++||.+|.. +.++..|+||+..
T Consensus 488 ~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 488 HVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 9999999999999975 5899999999854
No 194
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=6e-42 Score=345.82 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=206.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcC----------------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998642 34579999986543 23445678899999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------------RLQEDEARNFFQQIISGVEYCHRNMVVH 140 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~-------------------~l~e~~~~~i~~qil~aL~yLH~~gIvH 140 (515)
+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999996532 3677889999999999999999999999
Q ss_pred ccCCCCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCC
Q 010214 141 RDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTL 215 (515)
Q Consensus 141 rDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~ 215 (515)
|||||+|||++.++.+||+|||++.....+.. .....++..|+|||++.+..+ +.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999976644322 223456789999999887766 789999999999999986 678
Q ss_pred CCCCCChHHHHHHHhc--------CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHh
Q 010214 216 PFDDENIPNLFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266 (515)
Q Consensus 216 Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil 266 (515)
||...+..+....+.. .....|+.++..+.+|+.+||+.||.+|||+.+|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887665555443321 11234567889999999999999999999999994
No 195
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.8e-44 Score=366.54 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=226.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.|.|+..||.|+||+||+|.++.++-..|-|+|.. +..+..+.+.-||.||..+.||+|+++++.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 568899999999999999999999999999999854 34456777888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-cCCccc
Q 010214 97 EYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~-~~~~~~ 174 (515)
|||.||-....+..-+ .++|.++..+++|++.||.|||+++|+|||||..|||++-+|.|+|+|||.+.... .-..-.
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 9999999999888754 69999999999999999999999999999999999999999999999999986543 233446
Q ss_pred cCCCCCCccCCCccc-----CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC---CCCCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~-----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~ 246 (515)
++.|||+|||||++. ..+| +.++||||||++|.+|..+.+|-...+....+-+|.+...+ -|++.+..+.|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred cccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 789999999999874 4555 78999999999999999999999999888888888766543 47889999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+++||.+||..||+++++++||||++.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999754
No 196
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3e-42 Score=366.83 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=205.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++++||||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999996321 235689999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 95 VMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
|||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 6899988764 469999999999999999999999999999999999999999999999999997654322
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-C-------ChHHHHHHHhcCcc---CCC--
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-E-------NIPNLFKKIKGGIY---TLP-- 237 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~-------~~~~~~~~i~~~~~---~~p-- 237 (515)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..|+-. . ....+.+.+..... .+|
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1234579999999999998876 7899999999999999998765422 1 12222232222111 011
Q ss_pred -----------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 238 -----------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 238 -----------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 134668999999999999999999999999999974
No 197
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=4.5e-42 Score=347.09 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=211.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE--EEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.++|++.+.||+|+||.||+|.++.++.. +|+|.+.. .........+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 46899999999999999999999888765 57766542 22334567788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 93 YVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
|+||||+++++|.+++.+.+ .+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999997543 47899999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-c
Q 010214 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (515)
Q Consensus 157 KL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (515)
||+|||++.............++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+. .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence 9999999864322111122234667999999987765 789999999999999998 999998887777777776542 3
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..|...++++.+|+.+||+.+|.+|||+++++.+
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566788999999999999999999999999876
No 198
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=3.5e-42 Score=341.59 Aligned_cols=250 Identities=30% Similarity=0.537 Sum_probs=209.8
Q ss_pred ccccCCCceEeeee--cccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 12 VDMFLPNYKLGKTL--GIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 12 ~~~~~~~Y~i~~~L--G~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
...+.++|.+.+.+ |.|+||.||++.++.++..+|+|++.+...... |+.....+ +||||+++++.+..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEec
Confidence 34456788888777 999999999999999999999999876543221 22222222 69999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeeccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIM 167 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~ 167 (515)
++..|+||||++|++|.+++..++.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999999998888999999999999999999999999999999999999999988 9999999998765
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH----HHHHHhcCccCCCCCCChh
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~ 243 (515)
... ....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||....... ............+..+++.
T Consensus 161 ~~~---~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 161 GTP---SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred CCC---ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 432 23468999999999988776 689999999999999999999997543322 1222223344566689999
Q ss_pred HHHHhcccCCCCCCCCCC-HHHHhcCccccc
Q 010214 244 ARDLIPRMLIVDPMKRIT-IPEIRQHPWFQA 273 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt-~~eil~hp~f~~ 273 (515)
+.+||.+||+.||.+||+ ++++++||||++
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999996 699999999963
No 199
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=4.2e-42 Score=335.46 Aligned_cols=246 Identities=42% Similarity=0.718 Sum_probs=225.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|+||.||++.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.++.+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887666656678899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-CccccCCCCCCcc
Q 010214 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYA 183 (515)
Q Consensus 105 ~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~Y~ 183 (515)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999998888999999999999999999999999999999999999999999999999998776443 2344567899999
Q ss_pred CCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCH-
Q 010214 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI- 262 (515)
Q Consensus 184 aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~- 262 (515)
|||.+.+... +.++|+||||+++|+|++|..||...........+......+|..++.++.+++++||..||.+|||+
T Consensus 161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 9999987665 78999999999999999999999888877778888877888899999999999999999999999999
Q ss_pred --HHHhcCccc
Q 010214 263 --PEIRQHPWF 271 (515)
Q Consensus 263 --~eil~hp~f 271 (515)
.++++||||
T Consensus 240 ~~~~l~~~~~f 250 (250)
T cd05123 240 GAEEIKAHPFF 250 (250)
T ss_pred cHHHHHhCCCC
Confidence 999999998
No 200
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=1.4e-41 Score=331.53 Aligned_cols=252 Identities=36% Similarity=0.579 Sum_probs=223.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iV 95 (515)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999998765543 34568889999999999999999999999888 899999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
+||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987765543
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHh--cCccCCCCCCChhHHHHhc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK--GGIYTLPSHLSPGARDLIP 249 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~li~ 249 (515)
.....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||.... .......+. .....+|..++..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 456678999999999987765 789999999999999999999998765 233333333 2345677788999999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+||..||.+|||+.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
No 201
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=5.9e-42 Score=341.48 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=211.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEE----
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIE---- 87 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~---- 87 (515)
..-.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 344689999999999999999999999999999999986532 2345678899999988 6999999999984
Q ss_pred --cCCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 88 --TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 88 --~~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
....+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 346789999999999999999753 4588999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-CccccCCCCCCccCCCcccC-----CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc--C
Q 010214 164 SNIMRDG-HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--T 235 (515)
Q Consensus 164 s~~~~~~-~~~~~~~gt~~Y~aPE~i~~-----~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--~ 235 (515)
+...... .......|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 8765321 22345678999999999863 233 6789999999999999999999977654443333332221 1
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+..++.++.+||.+||+.||.+|||+.|+++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223578999999999999999999999999999997
No 202
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.3e-41 Score=332.28 Aligned_cols=252 Identities=34% Similarity=0.611 Sum_probs=225.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 689999999999999999999999999999999765432 3456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-c
Q 010214 98 YVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (515)
Q Consensus 98 y~~gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~ 172 (515)
|+++++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999999864 679999999999999999999999999999999999999999999999999988765443 3
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhccc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~m 251 (515)
....+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||+..+.......+... ...+|..++.++.+++.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 445678999999999887765 68999999999999999999999988777776666554 3456678899999999999
Q ss_pred CCCCCCCCCCHHHHhcCccc
Q 010214 252 LIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f 271 (515)
|..+|.+|||+.++++||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
No 203
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.3e-42 Score=344.13 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=218.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+++++.++||||+++++++.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 478999999999999999999999999999999986542 233467889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~ 160 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IAD 160 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccC
Confidence 9999999999999888889999999999999999999997 69999999999999999999999999998655332 223
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-----------HHHHHHhcCc-cCCCC-CCC
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-----------NLFKKIKGGI-YTLPS-HLS 241 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~-~~s 241 (515)
..+|+..|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+.... ..++. .++
T Consensus 161 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 5679999999999987655 78999999999999999999999865432 2333333222 22333 377
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++.+|+.+||+.||.+|||+.|+++||||..
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 89999999999999999999999999999964
No 204
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=8.7e-42 Score=342.09 Aligned_cols=253 Identities=28% Similarity=0.490 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc-CCcc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-~~~~ 173 (515)
|||+. ++|.+++.. .+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..... ....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 99996 577777654 35688999999999999999999999999999999999999999999999999875432 2223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH-HHHHHHhcCc-------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGI------------------- 233 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~-~~~~~i~~~~------------------- 233 (515)
....+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.. +...++....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 44567999999999976554478899999999999999999999865432 2222211000
Q ss_pred --c--CCC---------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 --Y--TLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 --~--~~p---------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. ..+ -..++++.+++.+||..||.+|||+.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 000 0125688999999999999999999999999997
No 205
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=6.8e-42 Score=343.02 Aligned_cols=254 Identities=31% Similarity=0.474 Sum_probs=209.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCe----
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD---- 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 91 (515)
++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 2223456788999999996 6999999999877665
Q ss_pred -EEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccc
Q 010214 92 -IYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLS 164 (515)
Q Consensus 92 -~~iVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls 164 (515)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 899988653 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccC-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------
Q 010214 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------- 234 (515)
Q Consensus 165 ~~~~~~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------- 234 (515)
...... .......+++.|+|||++.+....+.++||||+|+++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 755322 2223346788999999987654447899999999999999999999987765554443322100
Q ss_pred -------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 235 -------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 235 -------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
...+.+++++.+||.+||..||.+|||+.|++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00134788999999999999999999999999999985
No 206
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=8.3e-42 Score=350.13 Aligned_cols=257 Identities=36% Similarity=0.593 Sum_probs=211.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4579999999999999999999999999999999986422 223456678899999999999999999987544
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
...|+|+||+.+ +|.+++. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 358999999964 8888774 45799999999999999999999999999999999999999999999999999876543
Q ss_pred CC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 170 GH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 170 ~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
.. .....+|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 22 12345789999999987654444789999999999999999999998765433222221100
Q ss_pred --------------cC-----CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 --------------YT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 --------------~~-----~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.. ..+..++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00 1134678899999999999999999999999999998654
No 207
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=5.3e-42 Score=341.43 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=220.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|+..+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999875432 234678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 99999999999864 579999999999999999999999999999999999999999999999999987664433 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~ 254 (515)
..++..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+... ...++..++..+.+++.+||..
T Consensus 161 ~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred ccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence 468889999999987765 78999999999999999999999877655554444333 2344556788999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+|||+.+++.||||...
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 240 DPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred CcccCcCHHHHHhChHhhhc
Confidence 99999999999999999654
No 208
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=3.4e-42 Score=358.72 Aligned_cols=249 Identities=28% Similarity=0.462 Sum_probs=207.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++.+.||+|+||.||+|.+..+| ..||+|++.... ..+....+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 357999999999999999999865444 579999987543 223456788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHh----------------------------------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------- 111 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~---------------------------------------------------------- 111 (515)
..+|+|||||++|+|.+++..+
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---cccC
Q 010214 112 ------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTS 176 (515)
Q Consensus 112 ------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~ 176 (515)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....+.. ..+.
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 2478889999999999999999999999999999999999999999999999876543321 1223
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~mL~ 253 (515)
.+++.|+|||++.+..+ +.++||||+||++|+|++ |..||..........++... ....|..+++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 35668999999987766 789999999999999997 99999876544433333322 334566789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
No 209
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=7.4e-42 Score=340.63 Aligned_cols=251 Identities=32% Similarity=0.561 Sum_probs=213.4
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|++|.||+|.+..+|+.||||++...... .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 689999999999999999999999999999998754322 224567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 98 YVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
|+++ +|.+++...+ .+++..+..++.||+.||.|||+.|++||||||+||++++++.++|+|||++....... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9975 8999887643 58999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------cC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------YT 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------~~ 235 (515)
....+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+...++.... ..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 345678999999998776555789999999999999999999998877665544433210 00
Q ss_pred -----------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 -----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 -----------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+.+.+++.+++++.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112457889999999999999999999999999998
No 210
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=8e-42 Score=350.51 Aligned_cols=258 Identities=33% Similarity=0.527 Sum_probs=215.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+..+|.+.+.||+|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45789999999999999999999999999999999875432 223345677899999999999999999988654
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
..+|+|+||+. ++|.+++...+++++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999995 69999998888999999999999999999999999999999999999999999999999999876644
Q ss_pred C-CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC----------------
Q 010214 170 G-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---------------- 232 (515)
Q Consensus 170 ~-~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---------------- 232 (515)
. ....+..++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 33445678999999999875433578999999999999999999999876543322221100
Q ss_pred -------c--------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 -------I--------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 -------~--------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ....+.+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 01124578999999999999999999999999999999754
No 211
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=6.9e-42 Score=339.89 Aligned_cols=254 Identities=27% Similarity=0.503 Sum_probs=218.1
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~i 94 (515)
.|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999999865432 234567889999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~ 173 (515)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999999865 579999999999999999999999999999999999999999999999999987765433 23
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCC-CCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~li~~m 251 (515)
....|+..|+|||.+.+....+.++|+||+||++|+|++|..||.+.........+.... ..++. .++.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence 345789999999998765555789999999999999999999998876555444433322 22333 3788999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.||.+|||+.+++.||||++.
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhcc
Confidence 99999999999999999999764
No 212
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=2.2e-41 Score=334.37 Aligned_cols=253 Identities=33% Similarity=0.573 Sum_probs=218.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc--cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 92 (515)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999885432 12234557889999999999999999999998764 468
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc---
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--- 169 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~--- 169 (515)
+++|||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532
Q ss_pred -CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHH
Q 010214 170 -GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (515)
Q Consensus 170 -~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 246 (515)
........|+..|+|||.+.+... +.++|+|||||++|+|++|..||.+........++... ...+|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 122234568999999999988765 78999999999999999999999887655555554433 24568889999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.+||+ +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
No 213
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=1.3e-41 Score=335.76 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=216.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|.++.+++.||||.+......+......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765555555667788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999998853 3458999999999999999999999999999999999999999999999999988764432
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCcc-CC-CCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIY-TL-PSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~-p~~~s~~~~~ 246 (515)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..... +. +...+..+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 2234578999999999987765 689999999999999999999996543 3344555544332 22 2357788999
Q ss_pred HhcccCCCCCCCCCCHHHHhcC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~h 268 (515)
++.+||..+|.+|||+.++++.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999999999999999863
No 214
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=5.9e-42 Score=350.91 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~ 91 (515)
.++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4799999999999999999999999999999999875432 22345677889999999999999999998753 356
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 599999988888999999999999999999999999999999999999999999999999998765332
Q ss_pred ----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------
Q 010214 171 ----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------- 232 (515)
Q Consensus 171 ----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-------------- 232 (515)
....+..|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 12234578999999999876444578999999999999999999999876544332221110
Q ss_pred ------------ccCC-----CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 ------------IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 ------------~~~~-----p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.... ....++++.++|.+||+.||.+|||+.+++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0001 13468899999999999999999999999999999765
No 215
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=2.7e-41 Score=329.89 Aligned_cols=252 Identities=33% Similarity=0.552 Sum_probs=223.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|++++++++|||++++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876543 2455789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-cccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~ 176 (515)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999999888999999999999999999999999999999999999999999999999999987654432 2345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHH-HhcCccCCCCCCChhHHHHhcccCCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK-IKGGIYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~-i~~~~~~~p~~~s~~~~~li~~mL~~d 255 (515)
.++..|+|||...+..+ +.++|+||+|+++|+|++|..||..........+ .......+|..++..+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 78999999999887764 7899999999999999999999987654433333 334455677888999999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 010214 256 PMKRITIPEIRQHPWF 271 (515)
Q Consensus 256 P~~Rpt~~eil~hp~f 271 (515)
|++|||+.+++.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
No 216
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=3.2e-42 Score=346.43 Aligned_cols=255 Identities=29% Similarity=0.519 Sum_probs=218.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3456666788999999999999999999999999985432 3345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Ccc
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~ 173 (515)
||||+++++|.+++. .+.+++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 97 v~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 97 VMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999999999999875 457999999999999999999999999999999999999999999999999998755322 223
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhcc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~ 250 (515)
....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+...+..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 44578999999999987766 689999999999999999999998877665555544332 22233578899999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..||.+|||++++++||||+..
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhcc
Confidence 999999999999999999999854
No 217
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=8e-42 Score=339.69 Aligned_cols=249 Identities=28% Similarity=0.432 Sum_probs=216.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++.... ..+..+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 46789999986442 2234578899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
..|+||||++|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997643 47889999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC
Q 010214 157 KIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232 (515)
Q Consensus 157 KL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~ 232 (515)
||+|||++....... ......+++.|+|||++.+..+ ++++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999987543322 1223456788999999988776 789999999999999998 99999888888888888776
Q ss_pred ccC-CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 233 IYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 233 ~~~-~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... .|..++..+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 553 45678999999999999999999999999975
No 218
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=9.9e-42 Score=334.18 Aligned_cols=252 Identities=29% Similarity=0.574 Sum_probs=219.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||.|+||.||+|.++.+|..||+|.+....... ...+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999987654322 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-eEEeecccccccccCC-cc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGH-FL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~-vKL~DFGls~~~~~~~-~~ 173 (515)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||++++++. +||+|||.+....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999997643 4799999999999999999999999999999999999998864 6999999987765432 22
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL 252 (515)
....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+..++.++.++|.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 34468999999999887665 689999999999999999999999877766666555443 2345677899999999999
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 010214 253 IVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f 271 (515)
..+|++|||+.++++||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
No 219
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.8e-42 Score=353.68 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=212.8
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~ 90 (515)
+.+....|++++.||+||.++||++.... .+.||+|.+... ..+.....-+.+||..|.+|+ |.+||++|+|-.+++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 44456789999999999999999998654 456677765432 335567888999999999997 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCH-HHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQE-DEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e-~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.+||||||-+ .+|..+|.+++...+ -..+.+..||+.|+.++|.+||||.||||.|+|+-. |.+||+|||.|+.+..
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9999999875 599999988766444 588999999999999999999999999999999854 6999999999998865
Q ss_pred CC---ccccCCCCCCccCCCcccCCcc----------CCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCc--
Q 010214 170 GH---FLKTSCGSPNYAAPEVISGKLY----------AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI-- 233 (515)
Q Consensus 170 ~~---~~~~~~gt~~Y~aPE~i~~~~~----------~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~-- 233 (515)
.. ...+.+||++|||||.+....+ .++++||||||||||+|+.|+.||..-. ..+-+..|....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 43 2357799999999998853222 2678999999999999999999997632 344455555543
Q ss_pred cCCCCCCChh-HHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 234 YTLPSHLSPG-ARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 234 ~~~p~~~s~~-~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++|..-+.. +.++++.||..||++|||+.|+|+|||++-
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3566655555 999999999999999999999999999874
No 220
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=2.4e-41 Score=342.02 Aligned_cols=257 Identities=28% Similarity=0.365 Sum_probs=218.5
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.....|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34577999999999999999999999999999999987655445455677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9999997 477777754 457999999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCC-CCCCChhHHHHh
Q 010214 173 LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTL-PSHLSPGARDLI 248 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~-p~~~s~~~~~li 248 (515)
.+..+++.|+|||++.+ ....+.++||||+|+++|+|++|..||.+.+.......+... .... +..++.+++++|
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence 34578899999998842 222368999999999999999999999887765544444332 2222 235688999999
Q ss_pred cccCCCCCCCCCCHHHHhcCcccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+||..||.+|||+.+++.||||...
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999754
No 221
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=2e-41 Score=332.91 Aligned_cols=245 Identities=29% Similarity=0.524 Sum_probs=212.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||+|+||.||+|.++ ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999876 4568999988644322 356788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc-
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~- 174 (515)
||+++|+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999999975 3568999999999999999999999999999999999999999999999999987654333222
Q ss_pred -cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhccc
Q 010214 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 -~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~m 251 (515)
...++..|+|||++.+..+ +.++|+||+|+++|+|++ |..||...+..+....+..+.. ..|...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2234568999999987766 689999999999999999 9999999888888888776543 34667788999999999
Q ss_pred CCCCCCCCCCHHHHhc
Q 010214 252 LIVDPMKRITIPEIRQ 267 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~ 267 (515)
|..||.+|||+.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999975
No 222
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=3.5e-41 Score=333.42 Aligned_cols=253 Identities=30% Similarity=0.441 Sum_probs=211.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++......||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345555678999999999999999999999999886443 23456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccCC
Q 010214 96 MEYVKSGELFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l--~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~~ 171 (515)
+||+++++|.+++... +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999999764 455 88899999999999999999999999999999999986 6799999999987654322
Q ss_pred -ccccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHH--HHHH-HhcCccCCCCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKK-IKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~~~~~ 246 (515)
......|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||....... .... .......+|..+++++++
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 233446889999999986543 23689999999999999999999997643221 1111 223334567788999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
++.+||..+|.+|||+.|++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
No 223
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=6.7e-42 Score=356.59 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=208.6
Q ss_pred CCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~ 89 (515)
.++|++.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 35899999999999999999974 35677899999864432 23456788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC---------------------------------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG--------------------------------------------------------- 112 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~--------------------------------------------------------- 112 (515)
...|+|||||+||+|.+++.+..
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999996532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc--
Q 010214 113 ------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-- 172 (515)
Q Consensus 113 ------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-- 172 (515)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 467888999999999999999999999999999999999999999999999976543321
Q ss_pred -cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 -~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
..+..++..|+|||++.+..+ +.++|||||||++|+|++ |..||...... ...+.+..+. ...|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 122345667999999988776 789999999999999998 99999876543 3344444432 234566788999999
Q ss_pred cccCCCCCCCCCCHHHHhcC
Q 010214 249 PRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~h 268 (515)
.+||+.||.+|||+.|+++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
No 224
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=1.9e-41 Score=334.56 Aligned_cols=247 Identities=25% Similarity=0.443 Sum_probs=216.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..+|.+.+.||.|+||.||+|.++.+++.||+|++.... .....+.+|+++++.++||||+++++++.....++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 467999999999999999999999999999999986432 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999999764 35899999999999999999999999999999999999999999999999999876543322
Q ss_pred c--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 174 K--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 ~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
. ...+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ....|..+++++.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1 2234568999999987766 689999999999999998 99999988887777777654 45567788999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.||++|||+.++++
T Consensus 240 ~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999875
No 225
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=1e-41 Score=344.89 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=207.6
Q ss_pred CceEeeeecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY 93 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 93 (515)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999999875433333456778999999999999999999999888 8899
Q ss_pred EEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC----CCceEEeecccc
Q 010214 94 VVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS----KWNVKIADFGLS 164 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~----~~~vKL~DFGls 164 (515)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 787777532 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH---------HHHHHh-
Q 010214 165 NIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---------LFKKIK- 230 (515)
Q Consensus 165 ~~~~~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~---------~~~~i~- 230 (515)
........ ....++++.|+|||++.+....+.++|||||||++|+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543221 2345688999999998775544789999999999999999999997644321 000000
Q ss_pred -------------------------cCccCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 231 -------------------------GGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 231 -------------------------~~~~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......+ ...+.++.+++.+||+.||.+|||+.|++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000111 1567789999999999999999999999999998
No 226
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=1.9e-41 Score=331.73 Aligned_cols=243 Identities=28% Similarity=0.486 Sum_probs=216.0
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+++++.++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999987654322 4678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 100 KSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 100 ~gg~L~~~i~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999877543
Q ss_pred C---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHH
Q 010214 171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR 245 (515)
Q Consensus 171 ~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (515)
. ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+ ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2 2344567889999999987755 789999999999999999 69999998888888877754 3456778899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..||.+|||+.|++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
No 227
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=1.8e-41 Score=340.25 Aligned_cols=257 Identities=29% Similarity=0.489 Sum_probs=212.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|++|.||+|.++.+|+.||+|.+...... ......+.+|+++++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654322 23346678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccC-C
Q 010214 96 MEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~-~ 171 (515)
|||++ ++|.+++..... +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 99996 588888865443 578899999999999999999999999999999999985 567999999999765332 2
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------ 233 (515)
......+++.|+|||++.+....+.++||||+||++|+|++|..||......+...++....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22345678999999998775545789999999999999999999998766544444332100
Q ss_pred ---c--------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ---Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ---~--------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. .....+++++.+++.+||+.||.+|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123568899999999999999999999999999999753
No 228
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=1.1e-41 Score=339.47 Aligned_cols=251 Identities=31% Similarity=0.542 Sum_probs=211.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++.+.||.|++|.||+|.++.+|..||+|++...... ......+.+|+.+++.++|||++++++++.+....|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998765422 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 99 VKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 99 ~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 69999998765 78999999999999999999999999999999999999999999999999987653221 2233
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc----------------------
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------- 233 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---------------------- 233 (515)
..+++.|+|||++.+....+.++|+||+|+++|+|++|..||...+......++....
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 4578899999998765444789999999999999999999998765543332221110
Q ss_pred -------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 234 -------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 234 -------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
......++.++.++|.+||+.||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01124577899999999999999999999999999998
No 229
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=5.8e-43 Score=357.15 Aligned_cols=235 Identities=28% Similarity=0.464 Sum_probs=211.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
++-||.|+.|.||+|+. .++.||||.++ +.-..+|+.|++|+|||||.+.++|...-.+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 56699999999999986 57889999764 2224689999999999999999999999999999999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~ 181 (515)
|.|...++....++......|..+|+.|+.|||.+.|+|||||.-||||+.+..|||+|||-++...+....-.++||..
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHh
Confidence 99999999999999999999999999999999999999999999999999999999999999998877766678899999
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--cCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
|||||+|...+. +.++||||+||+|||||||..||.+-+..+++.-+-... .+.|+.++..++=||++||+-.|..|
T Consensus 277 WMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 277 WMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred hhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 999999998876 799999999999999999999999876665544433332 46688999999999999999999999
Q ss_pred CCHHHHhcCc
Q 010214 260 ITIPEIRQHP 269 (515)
Q Consensus 260 pt~~eil~hp 269 (515)
|++.+|+.|-
T Consensus 356 PSFrqil~Hl 365 (904)
T KOG4721|consen 356 PSFRQILLHL 365 (904)
T ss_pred ccHHHHHHHH
Confidence 9999999994
No 230
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=3.2e-41 Score=337.71 Aligned_cols=252 Identities=32% Similarity=0.557 Sum_probs=218.9
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.|...+.||.|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4566689999999999999999999999999885332 2335668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccC
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~ 176 (515)
|++|++|.+++.. +++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999999999876 679999999999999999999999999999999999999999999999999887553322 22345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC---CCCCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~mL~ 253 (515)
.|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+....... +..++..+.+++.+||+
T Consensus 176 ~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 176 VGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred cCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 68999999999988766 689999999999999999999998877666666666553222 33478899999999999
Q ss_pred CCCCCCCCHHHHhcCcccccc
Q 010214 254 VDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.+|.+|||+.++++||||+..
T Consensus 255 ~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 255 RDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred cChhhCcCHHHHccCcccccC
Confidence 999999999999999999764
No 231
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=2.2e-41 Score=338.92 Aligned_cols=257 Identities=32% Similarity=0.589 Sum_probs=220.5
Q ss_pred CceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||.|+||.||+|.+. .+|..||+|++...... .....+.+.+|+++++.+ +||||++++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999998754322 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999987664432
Q ss_pred -ccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
......|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||.... .......+.......|..+++.+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 22345689999999998753 233678999999999999999999997432 344445555556667788999999
Q ss_pred HHhcccCCCCCCCCC-----CHHHHhcCcccccc
Q 010214 246 DLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (515)
Q Consensus 246 ~li~~mL~~dP~~Rp-----t~~eil~hp~f~~~ 274 (515)
+++.+||+.||.+|| ++.+++.||||+..
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 999999999999997 89999999999765
No 232
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=1.2e-41 Score=347.44 Aligned_cols=256 Identities=35% Similarity=0.555 Sum_probs=221.0
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----eE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 92 (515)
+|++.+.||.|+||.||+|.+..+|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6899999999999999999999999999999987543 22345578899999999999999999999987775 79
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
|++|||++ ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 4899999887899999999999999999999999999999999999999999999999999998765543
Q ss_pred ---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-------------
Q 010214 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------- 235 (515)
Q Consensus 172 ---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------- 235 (515)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 2445568999999999988744588999999999999999999999888766655554432111
Q ss_pred ------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 236 ------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 236 ------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
....+++++.++|.+||+.||.+|||+++++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1134678899999999999999999999999999998653
No 233
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=1.6e-41 Score=347.52 Aligned_cols=260 Identities=32% Similarity=0.444 Sum_probs=216.7
Q ss_pred cCCCceE-eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----------HHHHHHHHHHHHHhCCCCCccEE
Q 010214 15 FLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------MEEKVRREIKILRLFMHPHIIRL 82 (515)
Q Consensus 15 ~~~~Y~i-~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----------~~~~i~~Ei~il~~l~hpnIv~l 82 (515)
+.++|.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+++++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4577865 57799999999999999999999999998654322200 11257799999999999999999
Q ss_pred EEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 83 YEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 83 ~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
++++...+..|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 5999999888889999999999999999999999999999999999999999999999999
Q ss_pred cccccccC---------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH
Q 010214 163 LSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK 227 (515)
Q Consensus 163 ls~~~~~~---------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~ 227 (515)
++...... .......+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 98765411 112234578899999999876555789999999999999999999998877665544
Q ss_pred HHhcCcc----------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 228 KIKGGIY----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 228 ~i~~~~~----------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.+..... ......+.++.++|.+||+.+|.+|||++|++.||||+...
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 4422110 01124578899999999999999999999999999998663
No 234
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.5e-41 Score=336.59 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=220.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+-|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 347888999999999999999999999999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||+++++|.+++. .+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 9999999999986 4578999999999999999999999999999999999999999999999999987654332 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~ 254 (515)
..++..|+|||.+.+... +.++|+||+||++|+|++|..||...+.......+.... ..++..++.++.+++.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 568899999999987655 689999999999999999999998876655555554432 335567889999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+||++.++++||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999754
No 235
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=1.7e-41 Score=348.99 Aligned_cols=259 Identities=31% Similarity=0.493 Sum_probs=218.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
...+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 4456789999999999999999999999999999999986542 222345677889999999999999999998866554
Q ss_pred ------EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 92 ------IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 92 ------~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.|+|+||+ |++|.+++.. .++++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6699998865 579999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC----------
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------- 235 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~---------- 235 (515)
..... .....+++.|+|||.+.+....+.++||||+||++|+|++|..||.+.+.......+......
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65432 345578899999999876545578999999999999999999999877665555444332110
Q ss_pred ---------------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 236 ---------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 236 ---------------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
....+++++.++|.+||+.||.+|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 1124588999999999999999999999999999998653
No 236
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=3.5e-42 Score=342.52 Aligned_cols=254 Identities=29% Similarity=0.454 Sum_probs=218.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999999999999999865432 234578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||+++++|.+++. .+.+++..++.++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999999885 4578999999999999999999999999999999999999999999999999987664432 2234
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~ 254 (515)
..|+..|+|||++.+..+ +.++|+||+||++|+|++|..||...........+... ...++...+.++.+++.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 468899999999988766 68999999999999999999999876555444444333 2234456788999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
+|.+|||+.++++||||...
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999754
No 237
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=2.7e-41 Score=340.08 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCc--EEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++.+.||.|+||.||+|..+.++. .+++|.+.. .......+.+.+|+.+++++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 589999999999999999999887765 478887752 22334456788999999999 6999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 94 VVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+||||+++++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 488899999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cC
Q 010214 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YT 235 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~ 235 (515)
|+|||++..............+..|+|||++.+..+ +.++|||||||++|+|++ |..||..........++..+. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999864322111112233557999999987766 789999999999999997 999999888887777776653 34
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.|..++.++.+|+.+||..+|.+|||++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 567789999999999999999999999999764
No 238
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=2.4e-41 Score=331.27 Aligned_cols=242 Identities=29% Similarity=0.501 Sum_probs=207.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.++.+++.||+|.+.... ..+....+.+|+++++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999999999999875432 3345678899999999999999999999999999999999999999
Q ss_pred CHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc---cCCC
Q 010214 103 ELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCG 178 (515)
Q Consensus 103 ~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~---~~~g 178 (515)
+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....+.... ...+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999997644 68999999999999999999999999999999999999999999999999987654332111 1122
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....|...+..+.+|+.+||+.||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999988776 789999999999999998 99999877766655555443 345667789999999999999999
Q ss_pred CCCCCHHHHhc
Q 010214 257 MKRITIPEIRQ 267 (515)
Q Consensus 257 ~~Rpt~~eil~ 267 (515)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999874
No 239
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=2.9e-41 Score=338.20 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=214.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+|.+.+.||.|+||+||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 368999999999999999999863 34567999988643 2334567899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG-------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~-------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
..|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 489999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc
Q 010214 158 IADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233 (515)
Q Consensus 158 L~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~ 233 (515)
|+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999876543221 123345778999999987765 789999999999999998 999999888777777777765
Q ss_pred -cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 -~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
...+..+++++.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3456678999999999999999999999999854
No 240
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=1.6e-41 Score=349.16 Aligned_cols=255 Identities=29% Similarity=0.506 Sum_probs=210.4
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~----- 89 (515)
+.++|.+.+.||.|+||.||+|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45899999999999999999999999999999999865443 3456788999999999999999999876543
Q ss_pred ---------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEe
Q 010214 90 ---------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIA 159 (515)
Q Consensus 90 ---------~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~ 159 (515)
...|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35899999997 58988885 457999999999999999999999999999999999999974 5678999
Q ss_pred ecccccccccC----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--
Q 010214 160 DFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 233 (515)
Q Consensus 160 DFGls~~~~~~----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-- 233 (515)
|||++...... .......++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99998765322 122334688899999987654445789999999999999999999998766544443332211
Q ss_pred -----------------------c-----CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 -----------------------Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 -----------------------~-----~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. .....++.++.+||.+||+.||.+|||+.+++.||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123578899999999999999999999999999999753
No 241
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=2.6e-41 Score=336.17 Aligned_cols=251 Identities=23% Similarity=0.376 Sum_probs=212.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~ 89 (515)
..++|++.+.||+|+||+||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999998752 35689999985432 223456688999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
...++||||+++++|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999997532 35678889999999999999999999999999999999999999999
Q ss_pred ecccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-c
Q 010214 160 DFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (515)
Q Consensus 160 DFGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (515)
|||++......... ....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998765432221 22355788999999987766 789999999999999999 799999887777666655543 4
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..|...+..+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5677889999999999999999999999999864
No 242
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=5.5e-41 Score=326.09 Aligned_cols=249 Identities=34% Similarity=0.572 Sum_probs=217.5
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|.+.+.||.|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++|||++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999876443 346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC
Q 010214 98 YVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (515)
Q Consensus 98 y~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~ 176 (515)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999999999876 68999999999999999999999999999999999999999999999999999877655434566
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-CccCCCC--CCChhHHHHhcccCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GIYTLPS--HLSPGARDLIPRMLI 253 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~-~~~~~p~--~~s~~~~~li~~mL~ 253 (515)
.++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.. .....+. .++..+.++|.+||+
T Consensus 158 ~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 158 VGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred ecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 78999999999987764 7899999999999999999999988744443333332 2223333 348899999999999
Q ss_pred CCCCCCCCHHHHhcCcc
Q 010214 254 VDPMKRITIPEIRQHPW 270 (515)
Q Consensus 254 ~dP~~Rpt~~eil~hp~ 270 (515)
.||.+|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
No 243
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=2.1e-41 Score=348.42 Aligned_cols=258 Identities=30% Similarity=0.472 Sum_probs=216.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC--
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-- 90 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-- 90 (515)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 346789999999999999999999999999999999986532 23334567889999999999999999999987654
Q ss_pred ----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 91 ----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 91 ----~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
.+++||||+ |++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 469999999 779988875 46799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------------
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------ 234 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (515)
.... .....+++.|+|||++.+....+.++|+||+||++|+|++|..||.+.+......++.....
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 5432 23456789999999987644457899999999999999999999987765444443322111
Q ss_pred -------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 235 -------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 235 -------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
.....+++++.++|.+||..||.+|||+.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235788899999999999999999999999999998653
No 244
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=5.5e-41 Score=331.68 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=215.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++|++.+.||+|+||+||+|.++.+ ...||+|++.... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 6799999999999999999998754 4589999886543 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-C
Q 010214 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~ 171 (515)
+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999999999999764 47899999999999999999999999999999999999999999999999999877421 1
Q ss_pred ccc--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHH
Q 010214 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 247 (515)
... ...+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+...++.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111 2345678999999987766 789999999999999998 99999887777777777655 334566789999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+||+.+|.+|||+.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999864
No 245
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=6.2e-41 Score=330.41 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=216.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
++|++.+.||.|+||.||+|.+..+|+.||+|.+...........+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999987655555555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 97 Ey~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 3458999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCcc-CCCC-CCChhHHHH
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIY-TLPS-HLSPGARDL 247 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~~l 247 (515)
......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||.... .......+..+.. +.|. .++.++.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 2334578999999999988776 689999999999999999999996543 3344445444433 3444 678899999
Q ss_pred hcccCCCCCCCCCCHHHHhc
Q 010214 248 IPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~ 267 (515)
|.+||..+|.+|||+.++++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999875
No 246
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=2.6e-41 Score=336.31 Aligned_cols=251 Identities=31% Similarity=0.537 Sum_probs=213.9
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--CeEEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVVM 96 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iVm 96 (515)
|++.+.||.|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998654 2223446678999999999999999999999888 8899999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--cc
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~ 173 (515)
||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++....... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99975 899988765 579999999999999999999999999999999999999999999999999998765433 23
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC------------------
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------ 235 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~------------------ 235 (515)
....++..|+|||.+.+....++++||||+|+++|+|++|..||...+.......+......
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 34467889999998876544578999999999999999999999987766655554332100
Q ss_pred -------------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 -------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 -------------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+...+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011138889999999999999999999999999997
No 247
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=2.1e-41 Score=334.34 Aligned_cols=251 Identities=29% Similarity=0.504 Sum_probs=215.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|++.+.||.|+||.||+|.+..+++.+|||.+......+......+.+|+.+++.++||||+++++++..++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36899999999999999999999999999999998765555555567888999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|||++|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999999864 3568999999999999999999999999999999999999999999999999987664432
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCccC-C-CCCCChhHHH
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI--PNLFKKIKGGIYT-L-PSHLSPGARD 246 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~~~ 246 (515)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+... ....+.+....+. . +..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred cccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2345579999999999987766 6899999999999999999999976543 3444444433322 2 2457889999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+||..||.+|||+.++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 999999999999999998764
No 248
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=3.4e-41 Score=329.88 Aligned_cols=251 Identities=32% Similarity=0.532 Sum_probs=224.3
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+|++.+.||.|+||.||++.+..+++.+|+|.+....... .....+.+|+++++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999987655433 345677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 98 YVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 98 y~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 9999999999876 356899999999999999999999999999999999999999999999999999877554 44
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcccC
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~mL 252 (515)
....+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+ ..+..++.++++++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 55678999999999988776 6899999999999999999999998887777666665553 456678999999999999
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 010214 253 IVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f 271 (515)
+.+|.+|||+.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999974
No 249
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=8.4e-41 Score=334.66 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=212.7
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CCeEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYV 94 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 94 (515)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++++.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 478999999999999999999999999999999875432 2455778999999999999999999998854 347899
Q ss_pred EEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 95 VMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988753 345899999999999999999999999999999999999999999999999998765432
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-----hHHHHHHHhcCc-cCCC------C
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKGGI-YTLP------S 238 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-----~~~~~~~i~~~~-~~~p------~ 238 (515)
. .....++..|+|||.+.+..+ +.++|||||||++|+|++|..||.... ..+....+.... ..++ .
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred c-cccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 2 234568889999999987776 689999999999999999999998652 233333333311 1122 1
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++.+.+|+.+||..||.+|||+.|++.||||+..
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 345789999999999999999999999999999654
No 250
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-42 Score=359.98 Aligned_cols=245 Identities=36% Similarity=0.587 Sum_probs=217.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
.+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+... ...+|+.++.+. +||||+++++++.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 357889999999999999999999999999999999987632 234577665555 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE-CCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl-~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+|||.+.|+.|.+.|..+..+. .++..|+.||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.+......
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999999999998776665 8888999999999999999999999999999999 58899999999999877654
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCccCCCCCCChhHHHHhcc
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li~~ 250 (515)
..+.|-|..|.|||++....| ++++||||||++||+||+|..||..... .++...|..+.+. ..+|..+++||++
T Consensus 470 -~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQ 545 (612)
T ss_pred -hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHH
Confidence 567788999999999998877 7999999999999999999999976544 4677777766554 7899999999999
Q ss_pred cCCCCCCCCCCHHHHhcCccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f 271 (515)
||++||.+|+++.+++.||||
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 999999999999999999999
No 251
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=2e-41 Score=338.70 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=210.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iV 95 (515)
++|...+.||+|+||.||++.+..+++.||+|.+.+.... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 5677888999999999999999999999999998754432 44567889999999996 99999999999999999999
Q ss_pred EeccCCCCHHHHH---H--HhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 96 MEYVKSGELFDYI---V--EKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 96 mEy~~gg~L~~~i---~--~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
|||+.+ +|.++. . ..+.+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 555433 2 24679999999999999999999997 4999999999999999999999999999976654
Q ss_pred CCccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCc-cCC----CCCCC
Q 010214 170 GHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTL----PSHLS 241 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~----p~~~s 241 (515)
........|++.|+|||++.+. ...+.++||||+||++|+|++|..||..... .+....+..+. ..+ +..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4444455789999999999866 2347899999999999999999999976542 12222222221 122 22478
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++.+|+.+||+.||.+|||++++++||||+..
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 899999999999999999999999999999754
No 252
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=3.6e-41 Score=338.83 Aligned_cols=260 Identities=32% Similarity=0.513 Sum_probs=221.0
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+...++|.+.+.||.|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 13 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred eccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 34445689999999999999999999999899999999986432 233567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+|+||+++++|.+++.+ ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999999999865 46889999999999999999999999999999999999999999999999988765433
Q ss_pred C-ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc-Cc--cCCCCCCChhHHH
Q 010214 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GI--YTLPSHLSPGARD 246 (515)
Q Consensus 171 ~-~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~ 246 (515)
. ......|++.|+|||.+.+..+ +.++|+||+||++|++++|..||...+.......+.. +. ...+..++..+++
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 2 2334568899999999987766 6899999999999999999999987655443332221 11 2234567889999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
++.+||..+|.+|||+.+++.||||+...
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999998653
No 253
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=6.7e-41 Score=335.57 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=215.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 5789999999999999999997653 34589999876433 2233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
..|+||||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999997532 245678899999999999999999999999999999999999999999
Q ss_pred cccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccC
Q 010214 161 FGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 161 FGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
||+++........ ....++..|+|||.+.+..+ +.++|+||+||++|+|++ |..||.+.......+.+..+ ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998765432221 22345678999999987766 789999999999999998 89999988877777766554 345
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc------Cccccc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQA 273 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~------hp~f~~ 273 (515)
.|...++.+.+++.+||+.||.+|||+.++++ ||||..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 66778899999999999999999999999987 888864
No 254
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=6.2e-41 Score=332.75 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=215.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||.|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 578999999999999999999986444 789999986432 2234567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999997532 367889999999999999999999999999999999999999999999
Q ss_pred cccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccC
Q 010214 161 FGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 161 FGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
||+++...... ......++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.....+.+..+ ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 99987654332 2234457889999999987665 789999999999999998 99999988877777766654 346
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.|...+.++.+++.+||+.+|.+|||+.++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67888999999999999999999999999975
No 255
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=6.6e-41 Score=334.33 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=213.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 468999999999999999999853 456789999986432 23445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
.|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999999633 2478889999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||++....... ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999997654332 2234456778999999987765 789999999999999998 999998877666666555
Q ss_pred cCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
... ...|..+++.+.+++.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45667889999999999999999999999999765
No 256
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=2.2e-41 Score=341.33 Aligned_cols=254 Identities=29% Similarity=0.502 Sum_probs=209.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
.++|++.+.||.|+||.||+|.++.+++.||+|++......+ .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 689999999999999999999999999999999987544332 1234567899999999999999999987443
Q ss_pred --CeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..+|+||||+.+ +|...+.. ...+++..++.++.||++||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 347999999965 77777764 45799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCc------------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc
Q 010214 167 MRDGHF------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (515)
Q Consensus 167 ~~~~~~------------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~ 234 (515)
...... .....+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 543221 12235688899999987655457899999999999999999999998776665554432110
Q ss_pred C-----------------------CC-------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 T-----------------------LP-------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ~-----------------------~p-------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
. .+ ..+++++.++|.+||+.||.+|||+.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 00 2345788999999999999999999999999998
No 257
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=4.7e-41 Score=334.56 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=213.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4789999999999999999999987 78899999876432 2334466888999999999999999999999888
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEee
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIAD 160 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~-------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~D 160 (515)
..|+||||++|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997653 489999999999999999999999999999999999998765 599999
Q ss_pred cccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccC
Q 010214 161 FGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYT 235 (515)
Q Consensus 161 FGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~ 235 (515)
||++........ ......+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999986633221 112233568999999987776 789999999999999997 99999988777766665543 345
Q ss_pred CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 236 ~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.|..++..+.+++.+||+.||.+|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 677889999999999999999999999999986
No 258
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=2e-41 Score=341.48 Aligned_cols=254 Identities=30% Similarity=0.541 Sum_probs=218.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|.....||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3455666789999999999999999999999999865432 2346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999999987754 578999999999999999999999999999999999999999999999999987554322 234
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhccc
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~m 251 (515)
..+|++.|+|||++.+..+ +.++||||+||++|+|++|..||...........+.... ...+..++..+.++|.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 5678999999999987766 789999999999999999999998776666555554432 223346788999999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.+|.+|||+.++++||||.+.
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccC
Confidence 99999999999999999999754
No 259
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=2.8e-41 Score=339.78 Aligned_cols=256 Identities=31% Similarity=0.528 Sum_probs=213.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC---
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~--- 90 (515)
...++|++.+.||.|+||.||+|.++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45689999999999999999999999999999999987543222 23356778999999999999999999987655
Q ss_pred -------eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 91 -------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 91 -------~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
.+|+|+||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999976 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------
Q 010214 163 LSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------ 234 (515)
Q Consensus 163 ls~~~~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------ 234 (515)
++....... ......+++.|+|||.+.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 988664432 122335678899999987654457899999999999999999999987765554444433110
Q ss_pred ------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 235 ------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 235 ------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.....+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112468899999999999999999999999999997
No 260
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=7e-41 Score=329.45 Aligned_cols=241 Identities=25% Similarity=0.423 Sum_probs=207.9
Q ss_pred eecccCceEEEEEEE--cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 24 TLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
.||+|+||.||+|.+ +.++..+|+|++.... ......+.+.+|+.+++.++||||++++++++ ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4678899999986443 33445678899999999999999999999885 4567899999999
Q ss_pred CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc----cccCC
Q 010214 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSC 177 (515)
Q Consensus 102 g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~ 177 (515)
|+|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++........ .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999998888899999999999999999999999999999999999999999999999999987643321 12233
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~d 255 (515)
+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+.......+..+. ...|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876655 689999999999999998 999999887777777777654 4667789999999999999999
Q ss_pred CCCCCCHHHHhc
Q 010214 256 PMKRITIPEIRQ 267 (515)
Q Consensus 256 P~~Rpt~~eil~ 267 (515)
|.+|||+.+|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
No 261
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=9.3e-41 Score=332.64 Aligned_cols=250 Identities=33% Similarity=0.509 Sum_probs=211.5
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC---CCCCccEEEEEEEcCCe----
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSD---- 91 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 91 (515)
|++.+.||.|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.+ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999998999999999975433 222345566788877666 59999999999988776
Q ss_pred -EEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 92 -IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 92 -~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
++++|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 58999999999999999999999999999999999999999999999999998775
Q ss_pred cCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----C--------
Q 010214 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----T-------- 235 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-----~-------- 235 (515)
.........+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+...++..... .
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 5544455568899999999988766 6899999999999999999999998877666655533110 0
Q ss_pred ---C-----------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 ---L-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ---~-----------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+ .+.+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 02356788999999999999999999999999997
No 262
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-44 Score=342.40 Aligned_cols=251 Identities=28% Similarity=0.464 Sum_probs=220.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-|.++.+||+|+||.||+|.|+.+|+.+|||.+..+. ..+.+..||.+|+++..|++|++|+.+-...++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3788999999999999999999999999999886543 46788999999999999999999999989999999999
Q ss_pred ccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-cccc
Q 010214 98 YVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~ 175 (515)
||..|+..+.+. ++++++|+++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.+..+.+.- .-+|
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 999999999997 46789999999999999999999999999999999999999999999999999998775532 3467
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhHHHHhcccC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRML 252 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~~mL 252 (515)
..|||.|||||++..-.| +.++||||||++..||.-|++||.+-......--|-.. .+.-|...|.++.||+++||
T Consensus 189 VIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 899999999999998777 67999999999999999999999876543221111111 12335567899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.++|++|.|+.++++|||+++.
T Consensus 268 iK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred cCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999999999999864
No 263
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=8.2e-41 Score=329.27 Aligned_cols=246 Identities=26% Similarity=0.490 Sum_probs=212.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 478999999999999999999875 567899998764332 346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~- 172 (515)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999999753 4688999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 173 -~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
.....++..|+|||.+.+..+ ++++|||||||++|+|++ |..||...........+..+. .+.+..++.++.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMK 238 (261)
T ss_pred ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 122345678999999987766 789999999999999998 999998887777777766542 3344568899999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||..+|++|||++++.+
T Consensus 239 ~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 239 TCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999864
No 264
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=5.3e-41 Score=330.13 Aligned_cols=246 Identities=25% Similarity=0.478 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.+.... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999886 5678999998654332 246778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc-
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~- 174 (515)
||++|++|.+++..+ +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999999763 468999999999999999999999999999999999999999999999999987654332211
Q ss_pred -cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhccc
Q 010214 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 175 -~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~m 251 (515)
...++..|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...+..+....+..+ ....|...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 1123457999999988776 689999999999999999 89999887777777777655 3455677899999999999
Q ss_pred CCCCCCCCCCHHHHhcC
Q 010214 252 LIVDPMKRITIPEIRQH 268 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~h 268 (515)
|..+|++|||+.|+++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999863
No 265
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-41 Score=366.98 Aligned_cols=246 Identities=31% Similarity=0.514 Sum_probs=209.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEE-EE---cC--
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV-IE---TP-- 89 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~---~~-- 89 (515)
-++++.+.|.+|||+.||+|.+...|..||+|++-. .+......+.+||.+|++|. |||||.+++. .. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 456889999999999999999998889999998753 36677899999999999998 9999999993 21 11
Q ss_pred -CeEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEeecccc
Q 010214 90 -SDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 90 -~~~~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
-.++|.||||+||.|-|++.+ ..+|+|.++.+||.|+++||.+||... |+|||||-|||||+.+|++||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 248899999999999999984 456999999999999999999999987 999999999999999999999999987
Q ss_pred cccccCC-c------c---ccCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc
Q 010214 165 NIMRDGH-F------L---KTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG 231 (515)
Q Consensus 165 ~~~~~~~-~------~---~~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~ 231 (515)
....... . + -...-|+.|+|||++. |.. .++|+|||+|||+||.|+....||++... -.|.+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p-I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP-IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC-CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe
Confidence 6432111 0 0 1224689999999984 444 48999999999999999999999988643 35788
Q ss_pred CccCCCC--CCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 232 GIYTLPS--HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 232 ~~~~~p~--~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
+.|.+|+ .++..+++||..||+.||.+||++-+++.+-+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 8998886 68999999999999999999999999887643
No 266
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=6.3e-41 Score=329.99 Aligned_cols=247 Identities=26% Similarity=0.465 Sum_probs=212.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||+||+|.+.. +..+|+|.+...... ...+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 3579999999999999999998753 456999988654322 35688999999999999999999999998899999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999999764 468999999999999999999999999999999999999999999999999987654433221
Q ss_pred --cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHhcc
Q 010214 175 --TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPR 250 (515)
Q Consensus 175 --~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 250 (515)
...++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1234567999999987766 689999999999999998 9999998877777777766543 3456678999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||..||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
No 267
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=1.1e-40 Score=329.84 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=211.1
Q ss_pred ceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe----
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD---- 91 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 91 (515)
|++.+.||+|+||.||.|.+..+ +..||+|.+...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999987654 478999998754332 3445778999999999999999999998865443
Q ss_pred --EEEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 92 --IYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 92 --~~iVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
.+++|||+++|+|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998542 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCC
Q 010214 164 SNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPS 238 (515)
Q Consensus 164 s~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 238 (515)
+......... ....++..|+|||.+.+..+ +.++||||+||++|+|++ |..||.+....+....+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9876443321 12335678999999987766 789999999999999999 99999888777777777654 345678
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.++.++.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999999864
No 268
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=4.4e-41 Score=346.31 Aligned_cols=259 Identities=29% Similarity=0.472 Sum_probs=214.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC---
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--- 89 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--- 89 (515)
..+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 3456899999999999999999999999999999999875422 223356788999999999999999999988543
Q ss_pred ---CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 ---~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
...|++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3478899987 7799887754 4699999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc------------
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------ 234 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~------------ 234 (515)
... ......+++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 533 234457899999999987744447899999999999999999999987665444333322110
Q ss_pred -----------CCC--------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 235 -----------TLP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 235 -----------~~p--------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
..| ...++++++||.+||+.||.+|||+.+++.||||++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 011 135788999999999999999999999999999987544
No 269
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-42 Score=353.72 Aligned_cols=251 Identities=30% Similarity=0.417 Sum_probs=222.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|.=++.||.|+||.||.|++..|.+.||||.++-+.-...+-...+..|++.|++++|||+|.+-++|-.+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66788999999999999999999999999999877766666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCC
Q 010214 99 VKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~ 177 (515)
|-| +-.|++. .++++.|.++..|+.+.+.||.|||+++.+|||||..|||+++.|.|||+|||.+..+.+ .++++
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFv 183 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFV 183 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhccc
Confidence 965 8888775 467899999999999999999999999999999999999999999999999999987754 46789
Q ss_pred CCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCccCCCC-CCChhHHHHhcccC
Q 010214 178 GSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPS-HLSPGARDLIPRML 252 (515)
Q Consensus 178 gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~~~~p~-~~s~~~~~li~~mL 252 (515)
|||+|||||+|. ...| +-++||||||++..+|.-.++|+-..+ ...++.-..+..+.+++ ..|..+++||..||
T Consensus 184 GTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL 262 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 262 (948)
T ss_pred CCccccchhHheecccccc-CCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence 999999999985 3456 569999999999999999999966554 45566555666666653 67899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccccc
Q 010214 253 IVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 253 ~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++-|.+|||.++++.|+|+...
T Consensus 263 qKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 263 QKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred hhCcccCCcHHHHhhcchhccC
Confidence 9999999999999999998643
No 270
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=1.1e-40 Score=333.19 Aligned_cols=255 Identities=33% Similarity=0.535 Sum_probs=222.4
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
...++|++.+.||.|++|.||+|.+..++..||+|++..... ....+.+|+++++.++||||+++++++......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 456789999999999999999999998999999999865432 4567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-
Q 010214 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~- 171 (515)
+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999887554322
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cC--CCCCCChhHHHHh
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YT--LPSHLSPGARDLI 248 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~--~p~~~s~~~~~li 248 (515)
......+++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... .. .+..++.++.++|
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 2234568899999999987766 789999999999999999999998876655555443332 22 2234788999999
Q ss_pred cccCCCCCCCCCCHHHHhcCccccc
Q 010214 249 PRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+||+.+|.+|||+.+++.||||+.
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999986
No 271
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=7.6e-41 Score=339.96 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=211.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcE----EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+|++.+.||+|+||+||+|.+..+++. ||+|++... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 36799999999999999999998766654 899998643 2334557788999999999999999999998764 5
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 78999999999999999874 46899999999999999999999999999999999999999999999999999876543
Q ss_pred Ccc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHH
Q 010214 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 245 (515)
... ....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ..+.|..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 322 22334678999999988776 789999999999999997 99999987766655444433 2345667889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
No 272
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=1.3e-40 Score=333.75 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=216.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI 86 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 86 (515)
..-.++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344578999999999999999999986443 789999987542 223456788999999999 799999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.....++++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999642 358899999999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHH
Q 010214 151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~ 226 (515)
+.++.+||+|||++........ .....++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+....+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999999987654322 122235678999999887766 789999999999999997 99999988887777
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+..+. ...|...+.++.+|+.+||..||.+|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7776654 35567788999999999999999999999999875
No 273
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=7.4e-41 Score=372.83 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=209.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+++++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47899999999999999999999999999999999765444445567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 96 MEYVKSGELFDYIVEK-----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23556778899999999999999999999999999999999999999999999
Q ss_pred cccccC-------------------CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH
Q 010214 165 NIMRDG-------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225 (515)
Q Consensus 165 ~~~~~~-------------------~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~ 225 (515)
...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 765210 01123479999999999988876 7899999999999999999999987554333
Q ss_pred HHHH-hcCccC--CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 226 FKKI-KGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 226 ~~~i-~~~~~~--~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.... ...... ....+++.+.+++.+||..||.+|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2221 111111 123678899999999999999999887666554
No 274
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=7.6e-41 Score=342.44 Aligned_cols=255 Identities=32% Similarity=0.515 Sum_probs=209.9
Q ss_pred CceEeeeecccCceEEEEEEEcCC--CcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc----CC
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALT--GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET----PS 90 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~----~~ 90 (515)
+|++.+.||.|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++.+. ||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 9999999986432 22234566788999999994 9999999987532 24
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.+|++|||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999995 599999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred C-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------
Q 010214 171 H-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (515)
Q Consensus 171 ~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------ 233 (515)
. ......||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 1 22345789999999988764444789999999999999999999998766443333222110
Q ss_pred ----------------c---CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ----------------Y---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ----------------~---~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ......+..+.+|+.+||+.||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 0112357899999999999999999999999999999754
No 275
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=9.7e-41 Score=330.49 Aligned_cols=248 Identities=27% Similarity=0.476 Sum_probs=209.6
Q ss_pred ceEeeeecccCceEEEEEEEcCCCc--EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------C
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------S 90 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------~ 90 (515)
|.+++.||+|+||.||+|.+..++. .||+|.+.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578899999999999999887775 69999886543 2334567888999999999999999999986322 2
Q ss_pred eEEEEEeccCCCCHHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
..+++|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 47899999999999998853 234889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCC
Q 010214 165 NIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSH 239 (515)
Q Consensus 165 ~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~ 239 (515)
.....+... ....+++.|+|||.+.+..+ ++++||||+||++|+|++ |..||...........+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 876543321 23346778999999988766 789999999999999999 899998877777777777654 355677
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
++..+.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
No 276
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=2e-40 Score=326.80 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=211.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|++|.||+|.+. +++.||+|.+...... .+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 4578999998654322 35688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997654 6899999999999999999999999999999999999999999999999999876533221
Q ss_pred cc--CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 174 KT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 ~~--~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
.. ...+..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ....+...+..+.+++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIML 238 (261)
T ss_pred ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 11 122357999999987765 789999999999999999 99999988877777776554 23456678999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.+|.+|||+.++++
T Consensus 239 ~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 239 DCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHhhcCcccCCCHHHHHH
Confidence 999999999999999864
No 277
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=5.7e-41 Score=342.80 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=204.8
Q ss_pred eeeccc--CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G--~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
..||.| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 99999999999999999999987654333 445788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cc-----
Q 010214 101 SGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF----- 172 (515)
Q Consensus 101 gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~----- 172 (515)
+++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+...... ..
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 999999998643 5899999999999999999999999999999999999999999999999865433211 11
Q ss_pred --cccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------------
Q 010214 173 --LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------- 234 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (515)
.....++..|+|||++.+.. ..+.++||||+||++|+|++|..||...........+.....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 01123566799999997642 237899999999999999999999987654443333222111
Q ss_pred --------------------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 --------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 --------------------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+..+++.+.+|+.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0112356789999999999999999999999999999754
No 278
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2e-41 Score=365.69 Aligned_cols=260 Identities=24% Similarity=0.423 Sum_probs=199.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCC-CcEEEEEE--------------ecccccCChHHHHHHHHHHHHHHhCCCC
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKI--------------LNRRKIKNMEMEEKVRREIKILRLFMHP 77 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-g~~vAiK~--------------i~~~~~~~~~~~~~i~~Ei~il~~l~hp 77 (515)
+.+.++|++++.||+|+||+||+|.++.. +...+.|. +.+...........+.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34668999999999999999999876533 22223221 1111112223456788999999999999
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~ 152 (515)
||+++++++++.+..|+|+|++. ++|.+++... .......++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99999999999999999999995 5888887542 23456778899999999999999999999999999999999
Q ss_pred CCceEEeecccccccccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCC-CCCCC--hHHHHH
Q 010214 153 KWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDEN--IPNLFK 227 (515)
Q Consensus 153 ~~~vKL~DFGls~~~~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~P-f~~~~--~~~~~~ 227 (515)
++.+||+|||++..+.... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..+ |.... ......
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999998765432 2234679999999999998877 7899999999999999998754 43221 111111
Q ss_pred HHhcCc----cCCC----------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 228 KIKGGI----YTLP----------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 228 ~i~~~~----~~~p----------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
++.... ..+| ..++.++.++|.+||+.||.+|||+.|++.||||+..
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 111100 0000 1356678889999999999999999999999999753
No 279
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=1.4e-40 Score=333.73 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=212.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC----------------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG----------------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg----------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 478999999999999999999877644 4589999875432 2456788999999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
+++++++..+...+++|||+++++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999998765 689999999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCCCCCCCChH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP 223 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~Pf~~~~~~ 223 (515)
+++.++.++|+|||++....... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999987654332 1224456788999999987665 789999999999999998 78999887766
Q ss_pred HHHHHHhcC--------ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 224 NLFKKIKGG--------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 224 ~~~~~i~~~--------~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.....+... ....|..++.++.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665555432 12345567899999999999999999999999964
No 280
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.6e-40 Score=336.06 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=215.6
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLY 83 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~ 83 (515)
.....++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 33445889999999999999999998743 33579999987542 223456788899999999 799999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeN 147 (515)
+++......|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 47889999999999999999999999999999999
Q ss_pred EEECCCCceEEeecccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH
Q 010214 148 LLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (515)
Q Consensus 148 ILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~ 223 (515)
|+++.++.+||+|||++......... ....+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||.+....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999998765432211 12234578999999987766 789999999999999998 99999988877
Q ss_pred HHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+....+..+. ...|...+.++.+|+.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7777776654 35677889999999999999999999999999874
No 281
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=1.9e-40 Score=325.78 Aligned_cols=243 Identities=28% Similarity=0.549 Sum_probs=213.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 578999999999999999999864 78999999865432 457889999999999999999999999989999999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999999999998765 69999999999999999999999999999999999999999999999999998763322
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~m 251 (515)
....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+...+...+..+ ....|..+++++.++|.+|
T Consensus 157 ~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 23445668999999987665 689999999999999997 99999988877777666554 3455677899999999999
Q ss_pred CCCCCCCCCCHHHHhc
Q 010214 252 LIVDPMKRITIPEIRQ 267 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~ 267 (515)
|..+|.+|||+.++++
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999975
No 282
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=3.9e-40 Score=334.99 Aligned_cols=256 Identities=29% Similarity=0.379 Sum_probs=218.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|...+.||+|+||.||+|.+..++..||+|++.............+.+|+++++.++|||++++++++.++...|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 45589999999999999999999999999999999766555555667889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+.| +|.+.+.. ..++++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++..... ..
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~ 179 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---AN 179 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cc
Confidence 999975 78777754 56799999999999999999999999999999999999999999999999999875433 23
Q ss_pred cCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhHHHHhc
Q 010214 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIP 249 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~li~ 249 (515)
...|++.|+|||.+. +..+ +.++|+||+||++|+|++|..||...+.......+..... . .+...++.+++++.
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred cccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 557899999999974 2333 7899999999999999999999987765555555544332 2 23467889999999
Q ss_pred ccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
+||+.+|.+|||+.++++|+|+....+
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999965533
No 283
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=4.9e-41 Score=330.62 Aligned_cols=247 Identities=25% Similarity=0.489 Sum_probs=215.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..+|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999987 88999999865432 2346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999999776443222
Q ss_pred -ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 174 -KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 174 -~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+.+..+..+ ....|..+++.+.+++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 23345678999999987766 689999999999999998 89999988877777777654 345567889999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||+.||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999875
No 284
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=1.3e-40 Score=331.51 Aligned_cols=250 Identities=36% Similarity=0.532 Sum_probs=211.5
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEe
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmE 97 (515)
|++.+.||.|++|+||+|....+++.||||.+...... .......+|+..+++++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999999999999998654322 12234567999999999 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 779999998765 789999999999999999999999999999999999999999999999999987765544455
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------------------cC-
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------YT- 235 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------------~~- 235 (515)
..++..|+|||++.+....+.++|+||+|+++++|++|..||...+......++.... ..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 6789999999998654444789999999999999999999998776554443332110 00
Q ss_pred ----------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 ----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ----------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.....+.++.++|.+||+.||.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 012336889999999999999999999999999997
No 285
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=1.8e-40 Score=332.99 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=213.3
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999864 345679999875432 234467889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997643 388999999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.++|+|||++........ .....+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+..+.+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999876543321 233456789999999988766 789999999999999998 999998888777777776
Q ss_pred cCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 231 GGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 231 ~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+.. ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6554 345667899999999999999999999999875
No 286
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=2.2e-40 Score=325.67 Aligned_cols=241 Identities=26% Similarity=0.452 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.+.||||++++++++. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876555 78999998765543 455778999999999999999999998764 5689999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc-c---c
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K---T 175 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-~---~ 175 (515)
++|+|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... . .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999998888999999999999999999999999999999999999999999999999999866443221 1 1
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~ 253 (515)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.... ...|..++..+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123457999999987766 789999999999999998 999999887777766665553 35667789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 010214 254 VDPMKRITIPEIRQ 267 (515)
Q Consensus 254 ~dP~~Rpt~~eil~ 267 (515)
.||.+|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
No 287
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=1.6e-40 Score=369.65 Aligned_cols=150 Identities=29% Similarity=0.591 Sum_probs=142.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+++|.+.+.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999999876666666678899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999875
No 288
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=6.8e-41 Score=334.02 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=215.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+|++.+.||.|+||.||+|.+..+ ++.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45688999999999999999987643 5789999987443 2234567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC
Q 010214 91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~ 154 (515)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998632 3478889999999999999999999999999999999999999
Q ss_pred ceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.+||+|||+++....... .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999876543322 234456789999999987766 789999999999999998 899999888888888877
Q ss_pred cCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.... ..|..++..+.+|+.+||+.+|.+|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7654 4577899999999999999999999999999863
No 289
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=4.2e-40 Score=334.34 Aligned_cols=254 Identities=27% Similarity=0.363 Sum_probs=215.4
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+-|...+.||.|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777888999999999999999999999999997665555555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~ 175 (515)
||+. |+|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.... ....
T Consensus 101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~ 176 (313)
T cd06633 101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANS 176 (313)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCC
Confidence 9996 478887765 4578999999999999999999999999999999999999999999999999886432 2345
Q ss_pred CCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhHHHHhccc
Q 010214 176 SCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPRM 251 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~li~~m 251 (515)
..|+..|+|||++.+ ....+.++||||+||++|+|++|..||...+......++..... . ....++..+++|+.+|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 678999999999842 22236799999999999999999999988765554444443322 1 2235678899999999
Q ss_pred CCCCCCCCCCHHHHhcCcccccc
Q 010214 252 LIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+.+|.+|||+.+++.||||+..
T Consensus 257 l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 257 LQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ccCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999754
No 290
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=7.4e-41 Score=332.70 Aligned_cols=251 Identities=34% Similarity=0.560 Sum_probs=214.1
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++.+.||.|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.++...|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765433 23457888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccC
Q 010214 99 VKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (515)
Q Consensus 99 ~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~ 176 (515)
+++ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 975 88888876 4589999999999999999999999999999999999999999999999999987765543 23345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-------------------C--
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------T-- 235 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-------------------~-- 235 (515)
.++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++..... .
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 6888999999998764447899999999999999999999988776555444322100 0
Q ss_pred ---------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 236 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 236 ---------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
..+.++.+++++|.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112467899999999999999999999999999997
No 291
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=2e-40 Score=327.59 Aligned_cols=245 Identities=27% Similarity=0.483 Sum_probs=209.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||+|.+..+ ..||+|++...... .+.+.+|+.+++.++||||+++++++.. ...|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 46899999999999999999998755 46999998754332 3568899999999999999999998754 568999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+.....+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999999763 35899999999999999999999999999999999999999999999999999766443321
Q ss_pred --ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 174 --KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 --~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
....++..|+|||++.+..+ +.++||||+||++|+|++ |..||.+.........+..+. ...+..++..+.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 237 (262)
T ss_pred cccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 23346678999999887766 789999999999999999 899998887777666665542 3445678999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||+.||.+|||+.++++
T Consensus 238 ~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 238 QCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999875
No 292
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=2.2e-40 Score=326.33 Aligned_cols=246 Identities=27% Similarity=0.482 Sum_probs=210.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.++++++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3578999999999999999999876 5677999998764432 356889999999999999999999885 456899
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999999753 3589999999999999999999999999999999999999999999999999987644322
Q ss_pred c--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHh
Q 010214 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 248 (515)
. ....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.|...+..+.+|+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1 12235567999999887765 689999999999999999 99999888777777777654 3456677899999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.++.+
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998863
No 293
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=8.7e-41 Score=342.55 Aligned_cols=258 Identities=34% Similarity=0.516 Sum_probs=214.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcC--C
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP--S 90 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~--~ 90 (515)
.+.++|++.+.||.|+||.||+|.+..+|+.+|+|.+.+... .......+.+|+.+++++ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 356899999999999999999999999999999999865322 223345677899999999 999999999998653 4
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
..|+||||++ ++|.+++..+ .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999997 4999998765 7899999999999999999999999999999999999999999999999998765432
Q ss_pred C------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc----------
Q 010214 171 H------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------- 234 (515)
Q Consensus 171 ~------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---------- 234 (515)
. ......|++.|+|||++.+....+.++|+||+|+++|+|++|..||.+........++.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 2 223456899999999987655557899999999999999999999987655444333221110
Q ss_pred ---------------------CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ---------------------~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.....++.++.++|.+||+.||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0112368899999999999999999999999999999764
No 294
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=1.8e-40 Score=333.83 Aligned_cols=252 Identities=29% Similarity=0.520 Sum_probs=215.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|.....||+|+||.||+|.+..+|+.||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33346799999999999999999999999987532 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccCC
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSC 177 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~ 177 (515)
+++++|.+++. .+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 99999999774 4578999999999999999999999999999999999999999999999999887654322 223456
Q ss_pred CCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhHHHHhcccCCC
Q 010214 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 178 gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~mL~~ 254 (515)
|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+.... ......+++++.+++.+||..
T Consensus 178 ~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 8999999999887665 789999999999999999999998876655544443322 222346789999999999999
Q ss_pred CCCCCCCHHHHhcCccccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~~ 275 (515)
||.+|||+.+++.||||....
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CcccCcCHHHHhcChHHhccC
Confidence 999999999999999998764
No 295
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=2.1e-40 Score=331.57 Aligned_cols=258 Identities=33% Similarity=0.563 Sum_probs=219.3
Q ss_pred CceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccC-ChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||+|++|.||+|.+. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 46789999998754332 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543321
Q ss_pred --cccCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCC----hHHHHHHHhcCccCCCCCCChhHH
Q 010214 173 --LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
....+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||.... .....+.+.......|..+++++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 22346899999999987654 24689999999999999999999996432 234445556666777888999999
Q ss_pred HHhcccCCCCCCCCCC---HHHHhcCccccccc
Q 010214 246 DLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL 275 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt---~~eil~hp~f~~~~ 275 (515)
+++.+||+.||++||| +.++++||||+...
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999999998 56789999998753
No 296
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.7e-40 Score=334.60 Aligned_cols=250 Identities=27% Similarity=0.453 Sum_probs=212.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC-------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI 86 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~ 86 (515)
-.++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 35789999999999999999998642 34579999986432 233456788999999999 599999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.....+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999999753 347889999999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHH
Q 010214 151 DSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF 226 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~ 226 (515)
+.++.+||+|||+++....... .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999976643221 122234568999999987766 789999999999999999 99999988877777
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+..+. ...|..++.++.+++.+||..||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7776654 3556778899999999999999999999999886
No 297
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=3.4e-40 Score=326.41 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=212.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|++.+.||+|+||.||+|.++.++. .+|+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3689999999999999999999875543 79999886532 223456889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999998764432
Q ss_pred c-c---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 F-L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~-~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
. . ....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+....+....+..+. .+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1 1 11223568999999987766 789999999999999886 999998877777767666552 344556789999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||+.+|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
No 298
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=4.1e-40 Score=327.96 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=210.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+|++.+.||.|+||+||+|.+..+|+ .||+|++.... .......+.+|+.+++.+.||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 4689999999999999999999877776 48999986432 334457788999999999999999999998754 5
Q ss_pred EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999976 456999999999999999999999999999999999999999999999999999876432
Q ss_pred Ccc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
... ....+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 221 12235678999999987766 689999999999999998 999998877666665555543 345667899999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||..||.+|||+.+++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
No 299
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=2.9e-40 Score=327.67 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=204.2
Q ss_pred eeecccCceEEEEEEEcCCCc--EEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 4688877532 2334556788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 100 KSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 100 ~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997543 478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCC
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS 241 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s 241 (515)
+..............+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 864322111112234567999999977665 789999999999999997 99999888777777776654 334566788
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++.+++.+||..||.+|||+.+++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999999999999999999999975
No 300
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=2.9e-40 Score=324.66 Aligned_cols=242 Identities=27% Similarity=0.522 Sum_probs=208.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE-EcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-ETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~i 94 (515)
..+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|||++++++++ ......|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 46899999999999999999976 47889999875432 245788999999999999999999975 55667999
Q ss_pred EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++.+.+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999999998654 38899999999999999999999999999999999999999999999999987553322
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
.+..++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+ ....++.+++.+.+++.+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred -CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 33455678999999987766 689999999999999997 99999988877777777654 334567789999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||+.+|.+|||+.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999975
No 301
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=3e-40 Score=329.52 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=212.4
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+|.+.+.||+|+||.||+|... .++..+|+|.+... .....+.+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 367899999999999999999743 35678999987543 2345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG---------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~---------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~ 155 (515)
..+++|||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997643 4889999999999999999999999999999999999999999
Q ss_pred eEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhc
Q 010214 156 VKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231 (515)
Q Consensus 156 vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~ 231 (515)
+||+|||++........ .....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999876543221 123345788999999988776 789999999999999998 9999988777766666655
Q ss_pred Cc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 232 ~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+. ...|..+++.+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43 4556788999999999999999999999999874
No 302
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=1.3e-40 Score=330.86 Aligned_cols=251 Identities=32% Similarity=0.558 Sum_probs=213.8
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|++.+.||.|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2223346778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccccC
Q 010214 99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (515)
Q Consensus 99 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~ 176 (515)
++ ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... .....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 97 5999999876 589999999999999999999999999999999999999999999999999987664432 33345
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc------------------cCC--
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------YTL-- 236 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~------------------~~~-- 236 (515)
.++..|+|||.+.+....+.++|+||+||++|+|++|..||...+......++.... ..+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 667889999998776444789999999999999999999998877655544433210 000
Q ss_pred ---------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 237 ---------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 237 ---------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.++.++.++|.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 12347889999999999999999999999999997
No 303
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=1.4e-40 Score=341.76 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=206.0
Q ss_pred CCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-C
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET-P 89 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~-~ 89 (515)
++|++.+.||.|+||.||+|.+.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 589999999999999999997543 45789999986432 223456778899999999 79999999998764 4
Q ss_pred CeEEEEEeccCCCCHHHHHHHh----------------------------------------------------------
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK---------------------------------------------------------- 111 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~---------------------------------------------------------- 111 (515)
..++++|||+++++|.++|...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5689999999999999998642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCC
Q 010214 112 ---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAP 185 (515)
Q Consensus 112 ---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aP 185 (515)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ..+..++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2578899999999999999999999999999999999999999999999999987543221 1233456789999
Q ss_pred CcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH-HHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCH
Q 010214 186 EVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITI 262 (515)
Q Consensus 186 E~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~-~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~ 262 (515)
|++.+..+ +.++||||+||++|+|++ |..||.+....+ +...+..+. ...|...++++.+++.+||+.+|.+|||+
T Consensus 245 E~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 99988877 789999999999999998 999998754333 333443332 34466788999999999999999999999
Q ss_pred HHHhcC
Q 010214 263 PEIRQH 268 (515)
Q Consensus 263 ~eil~h 268 (515)
.|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999875
No 304
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=3.9e-40 Score=324.52 Aligned_cols=246 Identities=28% Similarity=0.507 Sum_probs=211.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 4578999999999999999999865 6788999998755432 357889999999999999999999874 457899
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+.+++|.+++... ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999999998753 3689999999999999999999999999999999999999999999999999976653222
Q ss_pred --cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
.....++..|+|||++.+..+ +.++||||+|+++|+|++ |++||.+.+..+....+..+. ...+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM 236 (260)
T ss_pred ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 122345678999999987765 789999999999999999 999999888777777665543 355677889999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..+|++|||++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHccCChhhCCCHHHHHH
Confidence 9999999999999999875
No 305
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-41 Score=302.57 Aligned_cols=256 Identities=29% Similarity=0.524 Sum_probs=221.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|.-.++||+|.||+||+|+++.|++.||+|.+..+.- +........|||-+|+.++|.|||+++++..+++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467778899999999999999999999999999876542 2234567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-ccc
Q 010214 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~~~ 174 (515)
|||.. +|..|... +|.++.+.++.++.|++.||.+||++++.|||+||.|+||+.+|.+|++|||+++.+.-.- ...
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99976 89888865 7889999999999999999999999999999999999999999999999999998775432 334
Q ss_pred cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-----------CCC-----
Q 010214 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-----------TLP----- 237 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-----------~~p----- 237 (515)
..+-|.+|.+|.++.|...++...|+||.|||+.|+.. |.+.|.+.+...+.++|..... .+|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 55678999999999987777899999999999999986 8888999988888877753211 111
Q ss_pred -------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 -------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 -------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.++..-+||++++|.-+|.+|++++++++||||.+.
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 2345566899999999999999999999999999765
No 306
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=3.1e-40 Score=339.57 Aligned_cols=256 Identities=32% Similarity=0.496 Sum_probs=211.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC----
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~---- 89 (515)
.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 3468999999999999999999999999999999998754322 23345678999999999999999999998654
Q ss_pred --CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+|+||+.. +|..++ ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 346999999964 777765 346899999999999999999999999999999999999999999999999998754
Q ss_pred ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc--------------
Q 010214 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (515)
Q Consensus 168 ~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------------- 233 (515)
.. ......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 32 22345678999999998764444789999999999999999999998876544444332210
Q ss_pred ---------cCC--------CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccccc
Q 010214 234 ---------YTL--------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (515)
Q Consensus 234 ---------~~~--------p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~~ 275 (515)
... .+..++++.+||.+||+.||.+|||+++++.||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 124678899999999999999999999999999998754
No 307
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=5.2e-40 Score=325.21 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=212.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
...|++.+.||+|+||.||+|.++.++. .||+|++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999987765 59999986432 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999763 568999999999999999999999999999999999999999999999999987654322
Q ss_pred cccc---CC---CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChh
Q 010214 172 FLKT---SC---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (515)
Q Consensus 172 ~~~~---~~---gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 243 (515)
.... .. .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 1111 11 2357999999987776 689999999999999886 99999988777777766543 23445678899
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+++.+||..+|.+|||+.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
No 308
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=3.1e-40 Score=346.57 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=209.1
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~ 87 (515)
.-.++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+++++.+. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3367899999999999999999987533 3579999986542 2334577899999999996 999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh--------------------------------------------------------
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK-------------------------------------------------------- 111 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~-------------------------------------------------------- 111 (515)
+...+|+|||||++|+|.++|.++
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999998653
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEC
Q 010214 112 ----------------------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (515)
Q Consensus 112 ----------------------------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~ 151 (515)
..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1377888899999999999999999999999999999999
Q ss_pred CCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HHH
Q 010214 152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLF 226 (515)
Q Consensus 152 ~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~~ 226 (515)
.++.+||+|||++........ .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999876543221 223456788999999988766 789999999999999997 99999875433 334
Q ss_pred HHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+..+ ....|..++.++.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 444443 24456778999999999999999999999998865
No 309
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.7e-40 Score=331.97 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=218.1
Q ss_pred CCCccccCCCceEeeeecccCceEEEEEEEc-------CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCcc
Q 010214 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHII 80 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv 80 (515)
........++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCch
Confidence 3445666899999999999999999999753 234579999886432 223457789999999999 799999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCCHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 81 RLYEVIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 81 ~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~----------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
++++++......|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 9999999999999999999999999999764 246788899999999999999999999999999
Q ss_pred CCcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCC
Q 010214 145 PENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDE 220 (515)
Q Consensus 145 peNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~ 220 (515)
|+||+++.++.+||+|||++........ .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999986643221 223346778999999987766 689999999999999998 89999998
Q ss_pred ChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 221 NIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 221 ~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+..++...+..+. ...|..++.++.+|+.+||..+|.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8888888776554 34567789999999999999999999999999874
No 310
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=2.3e-40 Score=335.32 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=215.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
...|...+.||.|+||.||+|.++.+++.+|+|.+.............+.+|+++++.++|||++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 45688899999999999999999999999999998765444444556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~ 169 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---c
Confidence 99996 588877754 456899999999999999999999999999999999999999999999999998765432 3
Q ss_pred cCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhHHHHhcc
Q 010214 175 TSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPR 250 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~li~~ 250 (515)
...|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..+.. . .+..++..+.+||.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 4568899999999752 12236799999999999999999999987655444444433322 2 234678899999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..+|.+|||+.++++|||+...
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999764
No 311
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=4.6e-40 Score=323.69 Aligned_cols=247 Identities=27% Similarity=0.477 Sum_probs=213.9
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||.|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3578999999999999999999976 5578999998754432 3568899999999999999999999999899999
Q ss_pred EEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999999997643 689999999999999999999999999999999999999999999999999876643221
Q ss_pred --cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 --~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
.....++..|+|||.+.+..+ ++++|+||+||++|+|++ |+.||.+.+.......+..+. ...|...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM 237 (261)
T ss_pred hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 112234578999999987765 789999999999999998 999999888777777776553 355667789999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||+.+|.+|||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 238 LQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHcccCcccCCCHHHHHH
Confidence 9999999999999999864
No 312
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=6.8e-40 Score=327.02 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=201.4
Q ss_pred CCCc-eEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--
Q 010214 16 LPNY-KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-- 88 (515)
Q Consensus 16 ~~~Y-~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-- 88 (515)
.++| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3556 999999999999998865 34578899999986542 22345678899999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999965 469999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH--H-------------HHHHH
Q 010214 169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP--N-------------LFKKI 229 (515)
Q Consensus 169 ~~~~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~--~-------------~~~~i 229 (515)
.+.. .....++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... . ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 4321 122345677999999987765 78999999999999999999998643211 0 11111
Q ss_pred hc-CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~-~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.. ...+.|..++.++.+++.+||+.||++|||+++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 112345678899999999999999999999999975
No 313
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-41 Score=317.35 Aligned_cols=254 Identities=30% Similarity=0.415 Sum_probs=210.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE----
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE---- 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~---- 87 (515)
+-.-..+|++.+.||.|||+.||++++..+++.||+|.+.... .+..+...+||+..++++|||+++++++.-
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3344578999999999999999999999999999999986544 456789999999999999999999988752
Q ss_pred -cCCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEee
Q 010214 88 -TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 88 -~~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~D 160 (515)
.....|++++|...|+|.+.|.. +..++|.++..|+.+|++||++||... ++||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 23459999999999999999975 236999999999999999999999998 99999999999999999999999
Q ss_pred cccccccccC---C-------ccccCCCCCCccCCCcccCCcc--CCCcceeehhHHHHHHHHhCCCCCCCCC--hHHHH
Q 010214 161 FGLSNIMRDG---H-------FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLF 226 (515)
Q Consensus 161 FGls~~~~~~---~-------~~~~~~gt~~Y~aPE~i~~~~~--~~~~~DIwSlGvily~lltG~~Pf~~~~--~~~~~ 226 (515)
||.++...-. . .......|..|+|||.+.-+.+ .+.++|||||||+||+|+.|..||+..- ...+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998765311 0 1122346889999999864433 3689999999999999999999997421 11122
Q ss_pred HHHhcCccCCC--CCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 227 KKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 227 ~~i~~~~~~~p--~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
-.+.++.+.+| ..+|..+.+||+.||++||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 23455566666 3589999999999999999999999999874
No 314
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=3e-41 Score=319.02 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=218.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i 94 (515)
+++.+++..||.|+.|+|++++++.+|...|||.+.+.. +.+..+++...+.++.... .|+||+.+++|-++.+++|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 345667888999999999999999999999999998655 4456788888888876655 8999999999999999999
Q ss_pred EEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
.||.+.. .+..++.+ +++++|..+-++...++.||.||-. +||+|||+||+|||+|+.|+|||||||+|..+-++..
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999843 45555543 5689999999999999999999995 6999999999999999999999999999999988887
Q ss_pred cccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCcc-CCCC--CCChhHHH
Q 010214 173 LKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIY-TLPS--HLSPGARD 246 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~~~~~i~~~~~-~~p~--~~s~~~~~ 246 (515)
.....|.+.|||||.+.-. .-++.++||||||+.++||.||..||.+-+ .-+...++.+... .+|. .+|+++.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~ 327 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS 327 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence 7888999999999998632 223789999999999999999999998833 3345556655433 3332 48999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|+..||++|+.+||...++|+|||+...
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999999999754
No 315
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=4.8e-40 Score=330.63 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=212.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~ 92 (515)
...++|++.+.||.|+||.||+|.+..+++.||||.+.+.... .....+.+|+.++.... ||||+++++++.+....
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3468999999999999999999999999999999999754322 23455666777666554 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
|++|||+. ++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 90 ~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99999985 478777765 4578999999999999999999997 69999999999999999999999999999876554
Q ss_pred CccccCCCCCCccCCCcccCCc---cCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCc-cCCC--CCCChh
Q 010214 171 HFLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTLP--SHLSPG 243 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~---~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~-~~~p--~~~s~~ 243 (515)
.......+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+....+.... ...+ ..++.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 4444456888999999987653 236789999999999999999999976332 23333333332 2233 246889
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+.+|+.+||..||.+|||+.+++.||||+..
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 9999999999999999999999999999754
No 316
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=6e-40 Score=321.12 Aligned_cols=246 Identities=31% Similarity=0.512 Sum_probs=214.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCC----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+++.+.||.|+||.||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457889999999999999998776 8999999865432 2256788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++..... +++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999987655432
Q ss_pred ccc--CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 LKT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~~~--~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
... ..+++.|+|||.+.+..+ +.++|+||+|+++|+|++ |..||...+.......+.... ...+...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 222 336789999999976655 789999999999999998 899999888777777776554 345667899999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.|+++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999975
No 317
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=5.2e-40 Score=331.99 Aligned_cols=250 Identities=30% Similarity=0.462 Sum_probs=209.9
Q ss_pred cCCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~ 88 (515)
..++|.+.+.||+|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 346899999999999999999975 3345689999986542 233456789999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
.+..|+||||+++|+|.+++.... .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999999997643 389999999999999999999999999999999999999999999999999876
Q ss_pred cccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhc-C-ccCCCCCC
Q 010214 167 MRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG-G-IYTLPSHL 240 (515)
Q Consensus 167 ~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~-~-~~~~p~~~ 240 (515)
..... ......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||........+.+... + ....|...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 54322 1123346788999999988776 789999999999999998 9999987765554433332 2 22345677
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++++.+++.+||..+|++|||+.|+++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999975
No 318
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=7.5e-40 Score=334.92 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=211.9
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-CCeE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~~~~ 92 (515)
.+.++|++.+.||.|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 457899999999999999999999999999999999865432 22345677899999999999999999999865 5678
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
|++|||+ +++|.+++. ..++++..+..++.||++||.|||+.||+||||+|+||+++.++.++|+|||.+..... .
T Consensus 86 ~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--Q 161 (328)
T ss_pred EEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--C
Confidence 9999999 568988875 45689999999999999999999999999999999999999999999999999875432 2
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcC--------------------
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------------- 232 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~-------------------- 232 (515)
..+..+++.|+|||.+.+....++++||||+||++|+|++|..||...........+.+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 345568899999999876444478999999999999999999999876543222111100
Q ss_pred ------ccCC-----CCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 233 ------IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 233 ------~~~~-----p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
.... ...+++++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0011 13467899999999999999999999999999999754
No 319
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=1.2e-40 Score=329.18 Aligned_cols=245 Identities=37% Similarity=0.560 Sum_probs=207.0
Q ss_pred eEeeeecccCceEEEEEEEc----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.+.||.|+||.||+|.+. ..+..|+||++.. .......+.+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 4567899999943 23344578899999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--
Q 010214 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-- 171 (515)
|||+++|+|.+++... ..+++.....++.||+.||.|||+++++|+||+++|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999986 689999999999999999999999999999999999999999999999999998763221
Q ss_pred -ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhHHHHh
Q 010214 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLI 248 (515)
Q Consensus 172 -~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 248 (515)
......+...|+|||.+.+..+ +.++||||||+++|||++ |..||.+.+......++..+.. ..|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 1233456778999999987766 789999999999999999 7899999888888888766544 45677899999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..||.+|||+.++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999874
No 320
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=8.3e-40 Score=320.91 Aligned_cols=246 Identities=26% Similarity=0.488 Sum_probs=212.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+|++.+.||.|+||.||+|.+. ++..+|+|++...... ...+.+|+++++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 57999999999999999999875 4778999998654332 346788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||+++++|.+++... +.++++.++.++.|++.|++|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999999764 56899999999999999999999999999999999999999999999999998765432211
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+. ...|...+..+.+|+.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 12235568999999987766 689999999999999998 999999888777777776653 334666799999999999
Q ss_pred CCCCCCCCCCHHHHhcC
Q 010214 252 LIVDPMKRITIPEIRQH 268 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~h 268 (515)
|..+|.+|||+.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999864
No 321
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.3e-41 Score=351.48 Aligned_cols=251 Identities=29% Similarity=0.553 Sum_probs=222.4
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEeccccc-CChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe--EEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD--IYVVM 96 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~iVm 96 (515)
++...||+|+|-+||+|.+..+|..||.--+....+ +.....+++..|+.+|+.|+||||+++|+.+.+... +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 556789999999999999999999999776654433 344567999999999999999999999999987655 88999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEECCC-CceEEeecccccccccCCcc
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~~~~~~ 173 (515)
|.+.+|+|..|+++.++++...++.|++||+.||.|||++ .|+|||||.+||+|+.+ |.|||+|+|+|..+......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak 202 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK 202 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc
Confidence 9999999999999999999999999999999999999987 59999999999999864 89999999999998766544
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcCccC--CCCCCChhHHHHhcc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYT--LPSHLSPGARDLIPR 250 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~ 250 (515)
...|||.|||||+.. ..| +..+||||||+++.||+|+..||.. .+..++++++..|.-+ +..--.+++++||.+
T Consensus 203 -svIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek 279 (632)
T KOG0584|consen 203 -SVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK 279 (632)
T ss_pred -eeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence 478999999999997 446 7899999999999999999999986 7778889999888642 233447999999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
||.. ...|+|+.|+|+||||...
T Consensus 280 Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HhcC-chhccCHHHHhhChhhccc
Confidence 9999 9999999999999999875
No 322
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=7.1e-40 Score=322.85 Aligned_cols=245 Identities=29% Similarity=0.484 Sum_probs=208.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|.+.+.||.|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999988655 4699998765432 2356788999999999999999999885 4568999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.....+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999999997643 4789999999999999999999999999999999999999999999999999766443221
Q ss_pred --ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhc
Q 010214 174 --KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIP 249 (515)
Q Consensus 174 --~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 249 (515)
....++..|+|||.+.+..+ +.++||||+|+++|+|++ |..||.+....+....+..+ ....|...+..+.++++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK 237 (260)
T ss_pred ccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence 22345678999999887765 789999999999999999 99999988777777776654 33456678999999999
Q ss_pred ccCCCCCCCCCCHHHHhc
Q 010214 250 RMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~ 267 (515)
+||..||.+|||++++++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 238 LCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999864
No 323
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=6.1e-40 Score=328.74 Aligned_cols=247 Identities=30% Similarity=0.463 Sum_probs=209.7
Q ss_pred CceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 23579999886433 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 93 YVVMEYVKSGELFDYIVEK------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~------------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~ 224 (515)
|+++++.+||+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999876533221 123346778999999887765 789999999999999998 999999888777
Q ss_pred HHHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+...+... ....|..++.++.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77666554 33456778999999999999999999999999975
No 324
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=5.9e-40 Score=329.85 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=207.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCC--------------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTG--------------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg--------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~ 81 (515)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 368999999999999999999875432 359999986542 2345567899999999999999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCCHHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 010214 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL 149 (515)
Q Consensus 82 l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNIL 149 (515)
+++++......|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999996532 3678899999999999999999999999999999999
Q ss_pred ECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCCCCCCCChHH
Q 010214 150 LDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPN 224 (515)
Q Consensus 150 l~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~Pf~~~~~~~ 224 (515)
++.++.+||+|||++........ .....+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999876543322 122345678999999887766 789999999999999988 778998876655
Q ss_pred HHHHHhc--------CccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~--------~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+.. .....+...++.+.+|+.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5444321 112345567899999999999999999999999964
No 325
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=2.6e-40 Score=325.56 Aligned_cols=252 Identities=28% Similarity=0.510 Sum_probs=215.6
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC--hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+|.+.+.||+|+||.||+|.+..++..+++|++....... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5899999999999999999998888888888775433221 12345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 96 mEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 356999999999999999999999999999999999999975 57999999998766433
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..+. ...|..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 23345668999999999877665 678999999999999999999998877766666665443 3456678899999999
Q ss_pred ccCCCCCCCCCCHHHHhcCccc
Q 010214 250 RMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f 271 (515)
+||..||.+||++.|+++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
No 326
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=8.1e-40 Score=321.17 Aligned_cols=241 Identities=28% Similarity=0.458 Sum_probs=207.6
Q ss_pred eeecccCceEEEEEEEcC-CCc--EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHAL-TGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~-tg~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.||+|++|.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999766543 567889999999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC----cc
Q 010214 100 KSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FL 173 (515)
Q Consensus 100 ~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~----~~ 173 (515)
++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999998754 68999999999999999999999999999999999999999999999999998764321 11
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhHHHHhcc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 250 (515)
....++..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+..+....+... ....|...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457789999999987766 789999999999999998 99999888777776666532 234456778999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||..+|.+|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999875
No 327
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1.1e-39 Score=322.39 Aligned_cols=249 Identities=26% Similarity=0.436 Sum_probs=212.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|+..+.||+|+||.||+|.++.++. .+|+|.+.... .....+.+.+|+++++.++||||+++.+++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4689999999999999999999886665 79999886432 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++++|.+++..+ +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999999764 578999999999999999999999999999999999999999999999999987654322
Q ss_pred cc--c--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 FL--K--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~~--~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. . ....++.|+|||++.+..+ +.++||||+||++|+|++ |..||...+.......+..+. .+.+...+.++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11 1 1123457999999987766 789999999999999997 999998887777777776542 334456789999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||+.+|.+||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
No 328
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=1.4e-39 Score=324.01 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=213.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||+|+||+||+|.++.+|. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4789999999999999999999877765 589998765432 3455778899999999999999999999987 78
Q ss_pred EEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 89999999999999999864 46999999999999999999999999999999999999999999999999999876433
Q ss_pred Ccc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
... ....++..|+|||.+.+..+ +.++|+||+||++|++++ |..||.+....++...+..+. .+.|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221 11223568999999877665 689999999999999998 999999988777777776553 456677889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||..||.+|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999865
No 329
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=1.5e-39 Score=318.06 Aligned_cols=241 Identities=27% Similarity=0.464 Sum_probs=206.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||+|+||.||+|.+. ++..+|+|++.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 68899999986543 2334557889999999999999999999999999999999999999
Q ss_pred CHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc--ccCCCC
Q 010214 103 ELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGS 179 (515)
Q Consensus 103 ~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt 179 (515)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....+... ....++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999998753 46899999999999999999999999999999999999999999999999998765433221 122446
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~ 257 (515)
..|+|||++.+..+ +.++||||+|+++|++++ |..||...........+..+. ...|..++..+.+++.+||..+|+
T Consensus 158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999987765 689999999999999998 999998877776666665543 355677899999999999999999
Q ss_pred CCCCHHHHhc
Q 010214 258 KRITIPEIRQ 267 (515)
Q Consensus 258 ~Rpt~~eil~ 267 (515)
+|||+.|+++
T Consensus 237 ~Rp~~~~l~~ 246 (250)
T cd05085 237 NRPKFSELQK 246 (250)
T ss_pred cCCCHHHHHH
Confidence 9999999875
No 330
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=1.1e-39 Score=321.67 Aligned_cols=240 Identities=26% Similarity=0.444 Sum_probs=203.1
Q ss_pred eecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCC
Q 010214 24 TLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~g 101 (515)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||++++++++. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999775 445679999986542 23445778999999999999999999999864 578999999999
Q ss_pred CCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc-c---ccC
Q 010214 102 GELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-L---KTS 176 (515)
Q Consensus 102 g~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~---~~~ 176 (515)
++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ . ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999975 45799999999999999999999999999999999999999999999999999976543321 1 112
Q ss_pred CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCC
Q 010214 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 177 ~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~ 254 (515)
.+++.|+|||.+.+..+ +.++|||||||++|++++ |..||.+.........+..+. ...|...++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23578999999887665 789999999999999996 999999887777766666543 456778899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 010214 255 DPMKRITIPEIRQ 267 (515)
Q Consensus 255 dP~~Rpt~~eil~ 267 (515)
||.+||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
No 331
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=7.4e-40 Score=327.61 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=212.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4689999999999999999998753 67899999986432 2344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG----------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~----------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999997432 367888999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~ 224 (515)
+++.++.++|+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999876533221 122345667999999987776 789999999999999997 889998887777
Q ss_pred HHHHHhcCcc-CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 LFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ~~~~i~~~~~-~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+..+.. ..|..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766543 446778999999999999999999999999864
No 332
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=2.7e-40 Score=322.15 Aligned_cols=229 Identities=24% Similarity=0.395 Sum_probs=196.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHH
Q 010214 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY 107 (515)
Q Consensus 28 G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~ 107 (515)
|.+|+||+|.++.+++.||+|.+.+.. ...+|...+....||||+++++++......|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999986543 123455555666799999999999999999999999999999999
Q ss_pred HHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCc
Q 010214 108 IVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187 (515)
Q Consensus 108 i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~ 187 (515)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 988888999999999999999999999999999999999999999999999999987665432 234556788999999
Q ss_pred ccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCH-----
Q 010214 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----- 262 (515)
Q Consensus 188 i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~----- 262 (515)
+.+..+ ++++|+||+|+++|+|++|..||........ ......+|..+++.++++|.+||+.||.+|||+
T Consensus 154 ~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 154 GGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred cCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 987766 6899999999999999999998865332110 112235677899999999999999999999985
Q ss_pred HHHhcCccc
Q 010214 263 PEIRQHPWF 271 (515)
Q Consensus 263 ~eil~hp~f 271 (515)
+++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
No 333
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=1.5e-39 Score=324.45 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=207.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.++|++.+.||.|+||+||+|.+..+++ ++++|.+... ........+..|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 3689999999999999999999987776 4677776432 122334677889999999999999999998754 45
Q ss_pred EEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999976 457899999999999999999999999999999999999999999999999999865433
Q ss_pred Cc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.......+.+..+. ...|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 21 223456778999999987766 789999999999999998 999998877666555555443 344556788999
Q ss_pred HHhcccCCCCCCCCCCHHHHhc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+||..||.+|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
No 334
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=9.9e-40 Score=324.04 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=214.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCC-----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+|++.+.||.|+||.||+|+++.+ .+.||+|.+.... .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 6899999999999999999997643 4679999876432 22355778999999999999999999999999899
Q ss_pred EEEEEeccCCCCHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecc
Q 010214 92 IYVVMEYVKSGELFDYIVEKG---------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~---------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFG 162 (515)
.|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998765 68999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC--ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCcc--CCC
Q 010214 163 LSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY--TLP 237 (515)
Q Consensus 163 ls~~~~~~~--~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~--~~p 237 (515)
++....... ......+++.|+|||.+.+... ++++||||||+++|+|++ |..||.+.........+..+.. ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 986543222 2234456778999999887665 689999999999999998 8999988777777777765553 345
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..++..+.+++.+||+.||.+|||+.|++.+
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6788999999999999999999999999864
No 335
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=5.4e-40 Score=332.68 Aligned_cols=245 Identities=23% Similarity=0.357 Sum_probs=199.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHH
Q 010214 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108 (515)
Q Consensus 29 ~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i 108 (515)
++|.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|++|||+++|+|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 556677777778999999999976533 3345678999999999999999999999999999999999999999999999
Q ss_pred HHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--------ccccCCC
Q 010214 109 VEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCG 178 (515)
Q Consensus 109 ~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--------~~~~~~g 178 (515)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+....... ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 763 468999999999999999999999999999999999999999999999999886543211 1234457
Q ss_pred CCCccCCCcccCC-ccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-HHHHhcCc-----------------------
Q 010214 179 SPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGI----------------------- 233 (515)
Q Consensus 179 t~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-~~~i~~~~----------------------- 233 (515)
+..|+|||++.+. ...+.++|+||+||++|+|++|..||........ ..++....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 7889999998763 2236899999999999999999999987543332 22221110
Q ss_pred ----------cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 234 ----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 234 ----------~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
...+..++.++.+|+.+||..||.+|||+.++++||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00112345678999999999999999999999999999754
No 336
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-41 Score=351.42 Aligned_cols=248 Identities=30% Similarity=0.494 Sum_probs=216.4
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGE 103 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~ 103 (515)
+||+|.||+||.|++..|...+|||.+..+. ....+-+.+||.+.+.++|.|||++++.+..++++-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986433 3456788999999999999999999999999999999999999999
Q ss_pred HHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeeccccccccc-CCccccCCC
Q 010214 104 LFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD-GHFLKTSCG 178 (515)
Q Consensus 104 L~~~i~~~-~~l--~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~-~~~~~~~~g 178 (515)
|.+.+..+ |++ +|..+-.+.+||++||.|||++.|||||||=.|||++. .|.+||+|||-++.... .....|..|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999864 667 88899999999999999999999999999999999975 68999999999876643 345678899
Q ss_pred CCCccCCCccc-CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHH--HHHH-HhcCccCCCCCCChhHHHHhcccCCC
Q 010214 179 SPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKK-IKGGIYTLPSHLSPGARDLIPRMLIV 254 (515)
Q Consensus 179 t~~Y~aPE~i~-~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~~~~~li~~mL~~ 254 (515)
|..|||||++. |...+++++|||||||++.||.||++||.....++ +++- +.+.-.++|..+|.+++.||.+|+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 99999999995 44445899999999999999999999997654332 2221 22334678899999999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 010214 255 DPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 255 dP~~Rpt~~eil~hp~f~~~ 274 (515)
||..||++.++|..||++..
T Consensus 819 d~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcccCccHHHhccCcccccC
Confidence 99999999999999999754
No 337
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.4e-39 Score=333.36 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=215.5
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCC-------CcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccE
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR 81 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~ 81 (515)
........+|++++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34445567899999999999999999986432 2369999876432 223457888999999999 7999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 010214 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP 145 (515)
Q Consensus 82 l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkp 145 (515)
+++++.....+|++|||+++|+|.+++.+.. .++...+..++.||+.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999997532 367788899999999999999999999999999
Q ss_pred CcEEECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCC
Q 010214 146 ENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221 (515)
Q Consensus 146 eNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~ 221 (515)
+|||++.++.+||+|||+++....... .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999876544321 122234567999999988776 689999999999999998 899999988
Q ss_pred hHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 222 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+....+.... ...|...+.++.+++.+||..+|.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888887776653 35667788999999999999999999999999875
No 338
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=1.4e-39 Score=318.33 Aligned_cols=241 Identities=27% Similarity=0.447 Sum_probs=207.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
+.||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999887 999999998654432 35678899999999999999999999999999999999999999
Q ss_pred CHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc---ccCCC
Q 010214 103 ELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCG 178 (515)
Q Consensus 103 ~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~g 178 (515)
+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....+... ....+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999976 356899999999999999999999999999999999999999999999999998765432211 12234
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcccCCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP 256 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP 256 (515)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|...+..+.+++.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999987765 789999999999999998 89999887766666666554 345567889999999999999999
Q ss_pred CCCCCHHHHhc
Q 010214 257 MKRITIPEIRQ 267 (515)
Q Consensus 257 ~~Rpt~~eil~ 267 (515)
.+|||+.|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
No 339
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1.3e-39 Score=327.40 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=206.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcC----------------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3679999999999999999986543 34579999986442 23455788999999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~-----------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNI 148 (515)
+++++++...+..|+||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997643 366788999999999999999999999999999999
Q ss_pred EECCCCceEEeecccccccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh--CCCCCCCCChH
Q 010214 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP 223 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt--G~~Pf~~~~~~ 223 (515)
|++.++.++|+|||++..+..... .....+++.|+|||+..+..+ +.++|+|||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999876543321 122344678999998877666 789999999999999998 78999876655
Q ss_pred HHHHHHh--------cCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 224 NLFKKIK--------GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 224 ~~~~~i~--------~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+...... ....+.|..+++.+.+|+.+||+.||.+|||+.++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443321 1123445678899999999999999999999999864
No 340
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=2.9e-40 Score=325.49 Aligned_cols=239 Identities=20% Similarity=0.295 Sum_probs=200.3
Q ss_pred eeecccCceEEEEEEEcCCCcE-------EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTGHK-------VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~-------vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
+.||.|+||.||+|.++.++.. ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998765544 8888875432 23456788999999999999999999999998999999
Q ss_pred EeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--------eEEeecccccc
Q 010214 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--------VKIADFGLSNI 166 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--------vKL~DFGls~~ 166 (515)
|||+++|+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999999865
Q ss_pred cccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCccCCCCCCChhHH
Q 010214 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR 245 (515)
Q Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 245 (515)
.... ....+++.|+|||++.+....+.++||||+||++|+|++| ..||......... .+......+|...+.++.
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELA 233 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHH
Confidence 5432 3456888999999998755447899999999999999998 5677665544332 333445667777889999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+|+.+||+.||.+|||++++++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999863
No 341
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.4e-41 Score=345.03 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=223.3
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
..-|..++.||-|+||.|.++...+|...||+|.+.|...-.......++.|-.||...+.+-||+||..|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35688899999999999999999999999999999988877777788889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-------
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------- 168 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~------- 168 (515)
|||++||++-.+|.+.+-++|+.++.++.++.+|+++.|..|+|||||||.|||||.+|+|||+|||++.-++
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999986431
Q ss_pred --cCC----------------------------------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh
Q 010214 169 --DGH----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212 (515)
Q Consensus 169 --~~~----------------------------------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt 212 (515)
.++ .....+||++|+|||++....| +..+|.||.|||||+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhh
Confidence 000 0124579999999999998877 689999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcCc----cCCCCCCChhHHHHhcccCCCCCCCCCC---HHHHhcCcccccc
Q 010214 213 GTLPFDDENIPNLFKKIKGGI----YTLPSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (515)
Q Consensus 213 G~~Pf~~~~~~~~~~~i~~~~----~~~p~~~s~~~~~li~~mL~~dP~~Rpt---~~eil~hp~f~~~ 274 (515)
|..||-+.+.-+...++.+-. +..-..+|+++.++|.++. .+++.|.. ++|+..||||+..
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 999998876655444444321 2233578999999998854 67788874 6789999999864
No 342
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=2.7e-39 Score=320.33 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=211.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+|.+.+.||.|+||.||+|.+..+ ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 46799999999999999999987644 3579999875432 23456788999999999999999999999876 457
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999998644 58999999999999999999999999999999999999999999999999987664433
Q ss_pred ccc--cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHH
Q 010214 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (515)
Q Consensus 172 ~~~--~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 247 (515)
... ...+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..++.++.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240 (270)
T ss_pred ceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 222 2234568999999987766 789999999999999986 999999887777666666553 45677889999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
+.+|+..+|.+|||+.+++..
T Consensus 241 i~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 241 MTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999998764
No 343
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-42 Score=379.16 Aligned_cols=260 Identities=29% Similarity=0.491 Sum_probs=225.4
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
..+.-+++-+.+||.|.||+||.|.+..||+-.|+|-+.-.... ......+.+|.+++..++|||+|++|++-.+.+.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455777888999999999999999999999999988655443 34457788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC--
Q 010214 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-- 170 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-- 170 (515)
+|.||||+||+|.+.+...+-.+|...+.+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|......
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999999987777888899999999999999999999999999999999999999999999999876543
Q ss_pred ---CccccCCCCCCccCCCcccCCc--cCCCcceeehhHHHHHHHHhCCCCCCCCC-hHH-HHHHHhcCccCCCCCCChh
Q 010214 171 ---HFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN-IPN-LFKKIKGGIYTLPSHLSPG 243 (515)
Q Consensus 171 ---~~~~~~~gt~~Y~aPE~i~~~~--~~~~~~DIwSlGvily~lltG~~Pf~~~~-~~~-~~~~i~~~~~~~p~~~s~~ 243 (515)
..++...|||.|||||++.|.. ..+-+.|||||||++.||+||+.||...+ .-+ +++--..-.+++|..+|++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 2356678999999999998654 23568999999999999999999997532 223 3433344467899999999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 244 ~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.++||.+||..||++|.++.|+++|-|-+.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999999988654
No 344
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=4.9e-39 Score=316.86 Aligned_cols=246 Identities=26% Similarity=0.475 Sum_probs=209.8
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4689999999999999999999865 55679999876432 234678899999999999999999999887 77899
Q ss_pred EEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
+|||+++++|.+++.+. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||.+.....+..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999763 3578889999999999999999999999999999999999999999999999876544322
Q ss_pred c--ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~--~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
. ....++..|+|||++.+..+ +.++|+|||||++|++++ |..||.+.+.......+..+. ...+...+.++.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 1 12335677999999987665 789999999999999998 999999887777777666543 344567889999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||+.+|.+|||+.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 237 MRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999998864
No 345
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=3.1e-39 Score=321.60 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=212.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcC----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-C
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-P 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~ 89 (515)
-.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35789999999999999999999876 3588999987532 244556788999999999999999999998755 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeec
Q 010214 90 SDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~--------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DF 161 (515)
...++++||+++++|.+++... ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 6789999999999999999753 45899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCC
Q 010214 162 GLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTL 236 (515)
Q Consensus 162 Gls~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~ 236 (515)
|+++.+..+... ....++..|+|||++.+..+ +.++|||||||++|++++ |..||...+...+...+..+. ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 999866443221 22345678999999987766 789999999999999998 999999887777666665543 244
Q ss_pred CCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 237 p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+..+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999999999999999999975
No 346
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=3.1e-39 Score=322.60 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=204.5
Q ss_pred CCceEeeeecccCceEEEEEEE----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC--C
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEH----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~--~ 90 (515)
..|++.+.||+|+||.||+|.. +.++..||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578999999999999999974 4678899999986442 234457889999999999999999999998775 5
Q ss_pred eEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
..++||||++|++|.+++.+.. .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 6899999999999999997653 589999999999999999999999999999999999999999999999999886643
Q ss_pred CC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---------------hHHHHHHHh
Q 010214 170 GH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIK 230 (515)
Q Consensus 170 ~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---------------~~~~~~~i~ 230 (515)
.. ......++..|+|||++.+..+ ++++||||+||++|+|+++..|+.... .......+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 32 1234456778999999987766 689999999999999999877653211 111112222
Q ss_pred cC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+ ..+.+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 22 234466789999999999999999999999999864
No 347
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=1.7e-39 Score=334.25 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=205.2
Q ss_pred CCCceEeeeecccCceEEEEEEE-----cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-CCCCccEEEEEEEc-
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET- 88 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~hpnIv~l~~~~~~- 88 (515)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999984 35678999999865432 23456788999999999 58999999998754
Q ss_pred CCeEEEEEeccCCCCHHHHHHHh---------------------------------------------------------
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~--------------------------------------------------------- 111 (515)
...+++||||+++|+|.+++..+
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999999999998653
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---cccCCC
Q 010214 112 ----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCG 178 (515)
Q Consensus 112 ----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~g 178 (515)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1367788889999999999999999999999999999999999999999999876533211 122345
Q ss_pred CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChH-HHHHHHhcC-ccCCCCCCChhHHHHhcccCCCC
Q 010214 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVD 255 (515)
Q Consensus 179 t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~mL~~d 255 (515)
++.|+|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....|...++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 678999999988766 789999999999999997 99999875433 333333333 34556678899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 010214 256 PMKRITIPEIRQH 268 (515)
Q Consensus 256 P~~Rpt~~eil~h 268 (515)
|.+|||+.|+++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
No 348
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=2.9e-39 Score=319.66 Aligned_cols=239 Identities=21% Similarity=0.304 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEEcC------------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 23 KTLGIGSFGKVKIAEHAL------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~------------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998542 23368999875432 234567888999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc-------eEEeecc
Q 010214 91 DIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-------VKIADFG 162 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~-------vKL~DFG 162 (515)
..++||||+++|+|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999999875 456999999999999999999999999999999999999987664 8999999
Q ss_pred cccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH-hCCCCCCCCChHHHHHHHhcCccCCCCCCC
Q 010214 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLPSHLS 241 (515)
Q Consensus 163 ls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 241 (515)
++...... ....++..|+|||++.+....+.++||||+||++|+|+ +|..||......+.. .+...........+
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC 233 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence 98654322 23467889999999875444478999999999999998 589999876554432 33334444444567
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+|+.+||+.||.+||++.+|+.+
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 889999999999999999999999875
No 349
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=2.2e-39 Score=340.10 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=209.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
-.++|.+.+.||+|+||.||+|.+. .++..||+|++..... ....+.+.+|+++|.++. ||||+++++++.+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3467889999999999999999864 3456899999975432 233457889999999998 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC--------------------------------------------------------
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG-------------------------------------------------------- 112 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~-------------------------------------------------------- 112 (515)
.+.+|+||||+++|+|.+++.+.+
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999996532
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 010214 113 ------------------------------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL 150 (515)
Q Consensus 113 ------------------------------------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl 150 (515)
.+++..+..++.||+.||.|||+.+++||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788999999999999999999999999999999
Q ss_pred CCCCceEEeecccccccccCC---ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHH-
Q 010214 151 DSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNL- 225 (515)
Q Consensus 151 ~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~- 225 (515)
+.++.+||+|||++....... ...+..+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 999999999999997653221 1223467889999999987766 789999999999999998 8999987554444
Q ss_pred HHHHhcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 226 FKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 226 ~~~i~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
...+..+ ....|..++.++.+|+.+||..+|.+||++.+|+..
T Consensus 352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3334433 234567789999999999999999999999999864
No 350
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=7e-41 Score=321.44 Aligned_cols=258 Identities=31% Similarity=0.488 Sum_probs=210.2
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc-C
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-P 89 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~-~ 89 (515)
....|++.+.||+|.||.||+|..+.++. .+|||.+..++-.+ ..-...-||+.+++.++|||++.+..++-+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 36789999999999999999997665543 68999887653221 233566799999999999999999999866 8
Q ss_pred CeEEEEEeccCCCCHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC----CceEEee
Q 010214 90 SDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIAD 160 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~-----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~----~~vKL~D 160 (515)
..+++++||.+. +|+..|+- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 889999999986 99999963 2358999999999999999999999999999999999999887 8999999
Q ss_pred cccccccccCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC---------hHHHHH
Q 010214 161 FGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------IPNLFK 227 (515)
Q Consensus 161 FGls~~~~~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~---------~~~~~~ 227 (515)
||+++.+.+.- .....+-|.+|+|||.+.|...+++++|||++|||+.||++-.+.|.+.. ..+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876531 23445678999999999998877999999999999999999998886532 112222
Q ss_pred HHhcCcc-----------CCC--------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcc
Q 010214 228 KIKGGIY-----------TLP--------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 270 (515)
Q Consensus 228 ~i~~~~~-----------~~p--------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~ 270 (515)
+|..-.. .+| ..-++.+.+|+.+||+.||.+|+|++++++|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 3321110 011 113556889999999999999999999999999
Q ss_pred cccc
Q 010214 271 FQAH 274 (515)
Q Consensus 271 f~~~ 274 (515)
|...
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 9865
No 351
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=5.7e-39 Score=317.55 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=214.3
Q ss_pred CceEeeeecccCceEEEEEEEcC-CCcEEEEEEeccccc-------CChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEc
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI-------KNMEMEEKVRREIKILRL-FMHPHIIRLYEVIET 88 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~ 88 (515)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58899999999999999999987 688999998864321 222345667788888864 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeeccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
.+..|++|||++|++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCC-CC-CCC
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-PS-HLS 241 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~-p~-~~s 241 (515)
+.............|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+....... +. ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 987665544556678999999999987765 789999999999999999999999887777777766655432 22 578
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+++.+||+.||++|||+.|+..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999998754
No 352
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-40 Score=341.90 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=214.0
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.-.+...+...||+|+||+||+|.+-. .||||+++...... +..+.+++|+.++++-+|.||+-+.+++..+..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 3445677889999999999999999742 59999998877665 478999999999999999999999999988877
Q ss_pred EEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc---
Q 010214 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--- 168 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~--- 168 (515)
.||+-+|+|.+|..+|.- ..++.....+.|++||++|+.|||.++|+|||||..||++.+++.|||+|||++....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999999999963 4578899999999999999999999999999999999999999999999999987542
Q ss_pred cCCccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc-----CCCCCCC
Q 010214 169 DGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLS 241 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s 241 (515)
....+....|+..|||||++.. ....++.+||||+|+++|||+||.+||...+..+++-.+-.|.. ......+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 3344566779999999999963 22337899999999999999999999997776666555555522 1224567
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++++|+..||..++++||++.+|+.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 79999999999999999999999987
No 353
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=3.6e-39 Score=321.15 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=196.2
Q ss_pred eecccCceEEEEEEEcCC------------------------CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc
Q 010214 24 TLGIGSFGKVKIAEHALT------------------------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~t------------------------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI 79 (515)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2458999886432 2345678889999999999999
Q ss_pred cEEEEEEEcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC----
Q 010214 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---- 154 (515)
Q Consensus 80 v~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---- 154 (515)
+++++++.+....|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 56789999999999999999999999999999999999997654
Q ss_pred ---ceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH-hCCCCCCCCChHHHHHHHh
Q 010214 155 ---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 155 ---~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll-tG~~Pf~~~~~~~~~~~i~ 230 (515)
.+|++|||++...... ....++..|+|||.+.+....++++|||||||++|+|+ +|..||.......... ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~ 234 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY 234 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence 3899999987544222 23457888999999876544478999999999999985 6999998766544333 22
Q ss_pred cCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
......|...++++.++|.+||+.+|.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33445566677899999999999999999999999874
No 354
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=6.4e-39 Score=314.72 Aligned_cols=241 Identities=27% Similarity=0.502 Sum_probs=206.9
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 4679999999999999999986 478899999985432 235788999999999999999999998654 57999
Q ss_pred EeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCcc
Q 010214 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~ 173 (515)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence 99999999999997654 4899999999999999999999999999999999999999999999999998764332 2
Q ss_pred ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhccc
Q 010214 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~m 251 (515)
.....+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. ...+..+++.+.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence 23344678999999987766 689999999999999997 999999888777777766553 334567889999999999
Q ss_pred CCCCCCCCCCHHHHhc
Q 010214 252 LIVDPMKRITIPEIRQ 267 (515)
Q Consensus 252 L~~dP~~Rpt~~eil~ 267 (515)
|+.+|.+|||+++++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999875
No 355
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=8.8e-39 Score=318.97 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=201.2
Q ss_pred CCceEeeeecccCceEEEEEE----EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--CC
Q 010214 17 PNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PS 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~~ 90 (515)
.+|++.+.||+|+||.||+|. +..++..||+|.+... .......+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 589999999999999999997 4457889999998643 23445778999999999999999999998744 34
Q ss_pred eEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.+++||||+++++|.+++.+. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999987644
Q ss_pred CCcc----ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----------------HHHHHH
Q 010214 170 GHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----------------NLFKKI 229 (515)
Q Consensus 170 ~~~~----~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----------------~~~~~i 229 (515)
+... ....++..|+|||++.+..+ +.++||||+||++|+|++|..|+...... .+...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11223456999999987766 78999999999999999988776433211 011111
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... ..+.+..++.++.+|+.+||..+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 23445678899999999999999999999999975
No 356
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=5.4e-39 Score=317.48 Aligned_cols=242 Identities=26% Similarity=0.440 Sum_probs=205.2
Q ss_pred eeecccCceEEEEEEEcCCC------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTG------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.||+|+||.||+|.++.++ +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999886432 1233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-----ceEEeecccc
Q 010214 97 EYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-----NVKIADFGLS 164 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~-------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-----~vKL~DFGls 164 (515)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999742 2478899999999999999999999999999999999999887 8999999998
Q ss_pred cccccCCc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCC
Q 010214 165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSH 239 (515)
Q Consensus 165 ~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 239 (515)
........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 76543322 123345788999999987766 789999999999999998 99999887777766666543 3456778
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++..+.+++.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
No 357
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2e-39 Score=337.72 Aligned_cols=251 Identities=28% Similarity=0.426 Sum_probs=218.2
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc---E-EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---K-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+-.+.+.||+|+||.||+|..+..+. . ||+|....+..........+.+|.++|++++|||||++||+......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4556677999999999999998876432 3 89999876554566778999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
+|+|||+|+||+|.+|+.+++ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.-..-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 999999999999999999877 4999999999999999999999999999999999999999999999999998765421
Q ss_pred CccccCC-CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc--cCCCCCCChhHHH
Q 010214 171 HFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~-gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~ 246 (515)
......+ -...|+|||.+....| ++++||||+||++||+.+ |..||.+....+...+|.... .+.|...+.++..
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 2222122 4568999999998877 799999999999999998 899999999999999995443 3456677889999
Q ss_pred HhcccCCCCCCCCCCHHHHhc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+|+..||++|||+.++.+
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHhccCChhhccCHHHHHH
Confidence 999999999999999998864
No 358
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=1.2e-38 Score=313.76 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=200.7
Q ss_pred eeecccCceEEEEEEEcC---CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEE-cCCeEEEEEec
Q 010214 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDIYVVMEY 98 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~iVmEy 98 (515)
+.||+|+||.||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998654 3457999987532 23345678889999999999999999999765 45568999999
Q ss_pred cCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-----c
Q 010214 99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----F 172 (515)
Q Consensus 99 ~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-----~ 172 (515)
+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++....... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999764 356788889999999999999999999999999999999999999999999987653321 1
Q ss_pred cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcc
Q 010214 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 250 (515)
.....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+...+...+..+. ...|..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123346778999999887766 789999999999999999 577788777666666665543 34456678999999999
Q ss_pred cCCCCCCCCCCHHHHhcC
Q 010214 251 MLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~h 268 (515)
||..+|++|||+.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999763
No 359
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=6.9e-39 Score=314.39 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=196.1
Q ss_pred eeecccCceEEEEEEEcCCC----------cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeE
Q 010214 23 KTLGIGSFGKVKIAEHALTG----------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg----------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 92 (515)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998777 3588887654321 15778899999999999999999999887 778
Q ss_pred EEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-------ceEEeecccc
Q 010214 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-------NVKIADFGLS 164 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-------~vKL~DFGls 164 (515)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 799999999999999999999999999999999999999887 7999999998
Q ss_pred cccccCCccccCCCCCCccCCCcccCC-ccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCccCCCCCCCh
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~-~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 242 (515)
..... .....++..|+|||++.+. ...+.++||||+||++|+|++ |..||...+......... .....|...+.
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA 231 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence 76543 2334577889999999876 234789999999999999999 688887765433333222 22223333458
Q ss_pred hHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 243 GARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 243 ~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999975
No 360
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=1.8e-38 Score=314.46 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+...+++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 355789999886543 22334578889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 101 gg~L~~~i~~~~-----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
+|+|.+++.... ..++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999997532 456778889999999999999999999999999999999999999999999875433322
Q ss_pred cccCCCCCCccCCCcccCCc------cCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHH-HhcCccCCC-----CC
Q 010214 173 LKTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK-IKGGIYTLP-----SH 239 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~~------~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~-i~~~~~~~p-----~~ 239 (515)
.....+++.|+|||++.+.. ..+.++||||+||++|+|++ |..||......+.... +.......+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 12346788899999986432 12679999999999999996 9999987665544332 222222222 24
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++.+.+++++|+ .+|++|||++|++.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
No 361
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=1.2e-38 Score=321.84 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=208.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..+|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++..+ .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999987776 57888876433 223345688999999999999999999998754 4
Q ss_pred EEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~ 170 (515)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 679999999999999997654 6899999999999999999999999999999999999999999999999999876433
Q ss_pred Cc---cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 171 ~~---~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
.. .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22 123345778999999987766 789999999999999997 999998876555555444432 344566789999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcC
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~h 268 (515)
+++.+||..+|.+|||+.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998774
No 362
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=2e-38 Score=314.11 Aligned_cols=248 Identities=26% Similarity=0.455 Sum_probs=207.0
Q ss_pred ceEeeeecccCceEEEEEEEc---CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----
Q 010214 19 YKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----- 90 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~----- 90 (515)
|.+.++||+|+||.||+|.++ .+++.||||++..+.. .....+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 3578999999865433 3344677889999999999999999999885532
Q ss_pred -eEEEEEeccCCCCHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 91 -DIYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 91 -~~~iVmEy~~gg~L~~~i~~~------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887532 2478999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcc---ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCC
Q 010214 164 SNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPS 238 (515)
Q Consensus 164 s~~~~~~~~~---~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 238 (515)
+.....+... ....+++.|++||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8866433221 23345678999999987766 689999999999999999 999998887777766665543 34556
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999763
No 363
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=1.8e-38 Score=314.25 Aligned_cols=242 Identities=22% Similarity=0.344 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996533 34578888775432 23345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc---
Q 010214 101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (515)
Q Consensus 101 gg~L~~~i~~~~-----~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~--- 172 (515)
+|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997643 246788899999999999999999999999999999999999999999999865433221
Q ss_pred cccCCCCCCccCCCcccCC------ccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh-cCccC-----CCCC
Q 010214 173 LKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYT-----LPSH 239 (515)
Q Consensus 173 ~~~~~gt~~Y~aPE~i~~~------~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~-~~~~~-----~p~~ 239 (515)
.....+++.|+|||++... ...+.++||||+||++|+|++ |..||......+....+. ..... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999987531 223679999999999999999 889998776555544433 33222 3346
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++.+.+++..|+ .||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999875
No 364
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=3.1e-38 Score=317.76 Aligned_cols=252 Identities=18% Similarity=0.207 Sum_probs=196.6
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHH--------HHHHHHHHHHHHhCCCCCccE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEM--------EEKVRREIKILRLFMHPHIIR 81 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~--------~~~i~~Ei~il~~l~hpnIv~ 81 (515)
+...++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...+..+.|++|++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 44558999999999999999999999877 6778888654322111000 011223444566778999999
Q ss_pred EEEEEEcCC----eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 82 LYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 82 l~~~~~~~~----~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+++.+.... ..++++|++. .++.+.+......++..++.++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 999765443 4578899884 47777777666678999999999999999999999999999999999999999999
Q ss_pred EeecccccccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HH----
Q 010214 158 IADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PN---- 224 (515)
Q Consensus 158 L~DFGls~~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~---- 224 (515)
|+|||+++...... ......||+.|+|||+..+..+ +.++||||+||++|+|++|.+||.+... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999997653221 1233469999999999998877 7999999999999999999999987632 22
Q ss_pred ----HHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 225 ----LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 225 ----~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
....+..+...+ ...++.+.++++.|+..+|++||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 223344333333 356889999999999999999999999875
No 365
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=2.8e-38 Score=314.29 Aligned_cols=249 Identities=30% Similarity=0.459 Sum_probs=206.0
Q ss_pred CCCceEeeeecccCceEEEEEEEcC----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc--C
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--P 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~--~ 89 (515)
.++|++.+.||+|+||.||+|.+.. ++..||+|++...... .....+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578899999999999999998653 4789999998755432 356789999999999999999999999877 5
Q ss_pred CeEEEEEeccCCCCHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
...++||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997654 69999999999999999999999999999999999999999999999999998765
Q ss_pred cCCcc----ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH---------------HHHHHH
Q 010214 169 DGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------NLFKKI 229 (515)
Q Consensus 169 ~~~~~----~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~---------------~~~~~i 229 (515)
..... ....++..|+|||.+.+..+ +.++||||+|+++|+|++|..||...... .+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 32211 12344567999999887765 78999999999999999999998653221 122222
Q ss_pred hcC-ccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 230 ~~~-~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
... ..+.+..++.++.+++.+||+.+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222 23345567889999999999999999999999975
No 366
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=7.6e-39 Score=343.54 Aligned_cols=248 Identities=29% Similarity=0.484 Sum_probs=219.2
Q ss_pred CCCceEeeeecccCceEEEEEEEc-----CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
..+-++.+.||+|+||+||+|+.. .....||||.++... +......|+||+++|..++|||||++++++..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 456778899999999999999754 234579999986443 4457789999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 91 DIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~--------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
.+|||+|||..|||.+++...+ +++..+...++.||+.|+.||-++.+|||||-..|+|+.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999999999999997432 27889999999999999999999999999999999999999999
Q ss_pred EEeecccccccccCCcccc---CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC
Q 010214 157 KIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232 (515)
Q Consensus 157 KL~DFGls~~~~~~~~~~~---~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~ 232 (515)
||+|||+++..-..++.+- ..-...|||||.|....+ +.++||||+||+|||+++ |..||.+.+..+..+-|..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999987655444332 234568999999998888 789999999999999998 99999999999999999888
Q ss_pred c-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHh
Q 010214 233 I-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR 266 (515)
Q Consensus 233 ~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil 266 (515)
. .+-|...+.++.+|+..||+.+|.+|||+.||-
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 6 466889999999999999999999999999984
No 367
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-39 Score=319.93 Aligned_cols=255 Identities=31% Similarity=0.496 Sum_probs=209.2
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--C----CccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--P----HIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--p----nIv~l~~~ 85 (515)
.|.+..+|.+++++|+|.||+|-.+.+..++..||||++..-. ...+..+-||++|.++.+ | -++++.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3456889999999999999999999999999999999985321 234566779999999953 3 37888899
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-----------
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS----------- 152 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~----------- 152 (515)
|+-.+++|||+|.+ |-++++++.+++ +++...++.+..|++.+++|||+.+++|-||||||||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999998 669999998765 5889999999999999999999999999999999999832
Q ss_pred ---------CCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH
Q 010214 153 ---------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP 223 (515)
Q Consensus 153 ---------~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~ 223 (515)
+..|+|+|||.|+...... .+.+.|..|.|||++.|-.+ +..+||||+||||+|+.+|...|......
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcH
Confidence 2359999999998754433 67789999999999999887 68999999999999999999999765433
Q ss_pred H---HHHHHhcCc------------------cCCCC-------------------------CCChhHHHHhcccCCCCCC
Q 010214 224 N---LFKKIKGGI------------------YTLPS-------------------------HLSPGARDLIPRMLIVDPM 257 (515)
Q Consensus 224 ~---~~~~i~~~~------------------~~~p~-------------------------~~s~~~~~li~~mL~~dP~ 257 (515)
+ +.+.|.... ...|. .-..++.|||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 3 344443211 11110 0113467999999999999
Q ss_pred CCCCHHHHhcCcccccc
Q 010214 258 KRITIPEIRQHPWFQAH 274 (515)
Q Consensus 258 ~Rpt~~eil~hp~f~~~ 274 (515)
+|+|+.|++.||||+..
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999753
No 368
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-38 Score=324.41 Aligned_cols=249 Identities=28% Similarity=0.419 Sum_probs=201.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-eE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DI 92 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 92 (515)
...++|.-...||+|+||.||+|.... |..||||.+....... ...+.+|+.++.+++|||+|+++++|.+.+ ..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 345788888999999999999999764 4899999876544332 345999999999999999999999999888 59
Q ss_pred EEEEeccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 93 YVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNM---VVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 93 ~iVmEy~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~g---IvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
++|+||+++|+|.+++.... .+++....+|+.+++.||+|||... |+||||||+|||||++++.||+|||+|...
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999998654 8999999999999999999999854 999999999999999999999999999766
Q ss_pred cc-CCccccC-CCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC------hHHHHH-HHhcCc-----
Q 010214 168 RD-GHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------IPNLFK-KIKGGI----- 233 (515)
Q Consensus 168 ~~-~~~~~~~-~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~------~~~~~~-~i~~~~----- 233 (515)
.. .....+. .||.+|+|||.+..... +.++||||+||+|.|++||+.|.+... ...+.. .+..+.
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 54 4444444 89999999999976544 789999999999999999998887532 222211 222211
Q ss_pred -cCCC-CCCC--hh---HHHHhcccCCCCCCCCCCHHHHhc
Q 010214 234 -YTLP-SHLS--PG---ARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 234 -~~~p-~~~s--~~---~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
..+. ...+ .. +..+..+|++.+|.+||++.|+++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1222 22 456778999999999999999744
No 369
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=1.6e-37 Score=307.89 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=194.0
Q ss_pred eeecccCceEEEEEEEcCCC--cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
+.||+|+||.||+|....++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36999999999999754332 356677665432 22345788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC---cc
Q 010214 101 SGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FL 173 (515)
Q Consensus 101 gg~L~~~i~~~----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~---~~ 173 (515)
+|+|.+++.+. ...++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999764 246677888999999999999999999999999999999999999999999976432221 12
Q ss_pred ccCCCCCCccCCCcccCCc------cCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc------cCCCCCC
Q 010214 174 KTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI------YTLPSHL 240 (515)
Q Consensus 174 ~~~~gt~~Y~aPE~i~~~~------~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~ 240 (515)
...++++.|+|||++.+.. ..+.++|||||||++|+|++ |..||...+..+....+..+. ..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12578999999999999996 678998777666665543332 2233457
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
++.+.+++..|| .+|.+|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 68999999999864
No 370
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=5.6e-39 Score=352.49 Aligned_cols=253 Identities=32% Similarity=0.557 Sum_probs=208.6
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------ 88 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------ 88 (515)
...+|+.++.||+||||.||+++++.+|..||||.|.... ......++.+|++.|.+|+|||||++|..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 5667889999999999999999999999999999998665 44567889999999999999999998742100
Q ss_pred --------------------------------------------------------------------------------
Q 010214 89 -------------------------------------------------------------------------------- 88 (515)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (515)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEeccCCCCHHHHHHHhCCC-CHHHHHHHHHHHHHHHHHHH
Q 010214 89 -------------------------P--------SDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYCH 134 (515)
Q Consensus 89 -------------------------~--------~~~~iVmEy~~gg~L~~~i~~~~~l-~e~~~~~i~~qil~aL~yLH 134 (515)
+ ..+||-||||+...|.++|.++... ....++++|+||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1368999999987777777665544 57899999999999999999
Q ss_pred HCCceeccCCCCcEEECCCCceEEeecccccccc------------------cC-CccccCCCCCCccCCCcccCCc--c
Q 010214 135 RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------------------DG-HFLKTSCGSPNYAAPEVISGKL--Y 193 (515)
Q Consensus 135 ~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~------------------~~-~~~~~~~gt~~Y~aPE~i~~~~--~ 193 (515)
+.|||||||||.||++|+++.|||+|||+++... .+ ....+.+||..|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998621 01 1345668999999999998766 3
Q ss_pred CCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCccCCCCCC----ChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 194 AGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLPSHL----SPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 194 ~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
++.++|+||||+||+||+. ||... .......++.++..+.|..+ -+.-..+|..||+.||.+|||+.|+|++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 4789999999999999994 57543 34456677777777666322 3456789999999999999999999999
Q ss_pred cccc
Q 010214 269 PWFQ 272 (515)
Q Consensus 269 p~f~ 272 (515)
.||.
T Consensus 872 ~llp 875 (1351)
T KOG1035|consen 872 ELLP 875 (1351)
T ss_pred cCCC
Confidence 9985
No 371
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-39 Score=310.01 Aligned_cols=253 Identities=32% Similarity=0.531 Sum_probs=216.6
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc------C
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET------P 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~------~ 89 (515)
..+|.-++.+|.|+- .|..|.+..+++.||+|..... ..+.....+..||..++..++|+||++++.+|.- .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 468999999999999 8899999999999999998776 4444567889999999999999999999999843 2
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
..+|+|||++.. +|...+. -.++.+.++.++.|++.|++|||+.||+||||||+||++..++.+||.|||+++....
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 458999999965 9999887 4578899999999999999999999999999999999999999999999999988766
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------------
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------------- 234 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~--------------- 234 (515)
.-.+...+.|..|.|||++.|..| .+.+||||+|||+.||++|+..|.+.+.-..+.++.....
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred ccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 656677789999999999999886 7899999999999999999999998765555555432111
Q ss_pred ------------C----CCC-----------CCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 ------------T----LPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ------------~----~p~-----------~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. +|+ .-+..+++|+.+||..||++|.|++++|.||||+.+
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 0 111 123468899999999999999999999999999844
No 372
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=9.8e-39 Score=335.57 Aligned_cols=242 Identities=32% Similarity=0.498 Sum_probs=200.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC------
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS------ 90 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~------ 90 (515)
..+...+.||+|+||.||+++++.||+.||||.+++.. .....++.-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 56778889999999999999999999999999998755 3345678889999999999999999999866544
Q ss_pred eEEEEEeccCCCCHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC--C--ceEEeeccc
Q 010214 91 DIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK--W--NVKIADFGL 163 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~--~--~vKL~DFGl 163 (515)
.-.+|||||.||+|..++.+ ...++|.+.+.++..+..||.|||++||+||||||+||++-.. | ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 35799999999999999974 3479999999999999999999999999999999999998432 3 479999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChH----HHHHHHhcC-------
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGG------- 232 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~----~~~~~i~~~------- 232 (515)
|+...++....+.+||+.|.+||+.....+++..+|.||+||++|++.||.+||-....+ +....+...
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 999999999999999999999999986445588999999999999999999999643222 122222111
Q ss_pred --------------ccCCCCCCChhH----HHHhcccCCCCCCCCC
Q 010214 233 --------------IYTLPSHLSPGA----RDLIPRMLIVDPMKRI 260 (515)
Q Consensus 233 --------------~~~~p~~~s~~~----~~li~~mL~~dP~~Rp 260 (515)
.++.|-++++.+ ..++..+|..+|.+|-
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 123344555544 3567788999999998
No 373
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=3e-37 Score=297.36 Aligned_cols=240 Identities=51% Similarity=0.873 Sum_probs=214.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHH
Q 010214 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108 (515)
Q Consensus 29 ~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i 108 (515)
+||.||+|.+..+|+.+|+|++........ .+.+.+|++.+++++|+||+++++.+......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999876543321 578899999999999999999999999999999999999999999999
Q ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcc
Q 010214 109 VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188 (515)
Q Consensus 109 ~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i 188 (515)
.....+++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||.+.............++..|+|||.+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 87767999999999999999999999999999999999999999999999999999887665556677899999999999
Q ss_pred cCCccCCCcceeehhHHHHHHHHhCCCCCCC-CChHHHHHHHhcCccCCCCC---CChhHHHHhcccCCCCCCCCCCHHH
Q 010214 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIVDPMKRITIPE 264 (515)
Q Consensus 189 ~~~~~~~~~~DIwSlGvily~lltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~mL~~dP~~Rpt~~e 264 (515)
.+..+ ++++||||+|+++|+|++|..||.. .........+.......+.. ++.++.+++.+||..+|.+|||+.+
T Consensus 159 ~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 87666 6799999999999999999999988 66666666666665554433 8899999999999999999999999
Q ss_pred HhcCccc
Q 010214 265 IRQHPWF 271 (515)
Q Consensus 265 il~hp~f 271 (515)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
No 374
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=4e-37 Score=335.14 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=180.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCC----CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEE-----
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALT----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV----- 85 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~t----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~----- 85 (515)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ....| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467999999999999999999999988 9999999875432111 11111 1111222222222111
Q ss_pred -EEcCCeEEEEEeccCCCCHHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 86 -IETPSDIYVVMEYVKSGELFDYIVEKGR--------------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 86 -~~~~~~~~iVmEy~~gg~L~~~i~~~~~--------------------l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
......+++||||+.+++|.+++..... ..+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456679999999999999999875421 1234567899999999999999999999999
Q ss_pred CCcEEECC-CCceEEeecccccccccC--CccccCCCCCCccCCCcccCCcc---------------------CCCccee
Q 010214 145 PENLLLDS-KWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLY---------------------AGPEVDV 200 (515)
Q Consensus 145 peNILl~~-~~~vKL~DFGls~~~~~~--~~~~~~~gt~~Y~aPE~i~~~~~---------------------~~~~~DI 200 (515)
|+|||++. ++.+||+|||++..+..+ ....+.++|+.|+|||.+..... .+.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 579999999999865432 23346689999999997643221 1345699
Q ss_pred ehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCcc---------------------CCCCCCChhHHHHhcccCCCCCCCC
Q 010214 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------------------TLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 201 wSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
||+||++|+|+++..|++... ......+..... ......+....+||.+||++||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999999887765431 111111111110 0111123345589999999999999
Q ss_pred CCHHHHhcCccccccc
Q 010214 260 ITIPEIRQHPWFQAHL 275 (515)
Q Consensus 260 pt~~eil~hp~f~~~~ 275 (515)
||+.|+++||||+...
T Consensus 442 ~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 442 ISAKAALAHPYFDREG 457 (566)
T ss_pred CCHHHHhCCcCcCCCC
Confidence 9999999999998653
No 375
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.8e-39 Score=318.50 Aligned_cols=264 Identities=31% Similarity=0.482 Sum_probs=219.3
Q ss_pred CccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC----hHHHHHHHHHHHHHHhCCCCCccEEEEEE
Q 010214 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFMHPHIIRLYEVI 86 (515)
Q Consensus 11 ~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~ 86 (515)
+-..+.++|-++.+||+|||+.||+|.+....+.||+|+-...+... ....+..-||.+|.+.|+||.||++|++|
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 34456789999999999999999999999899999999976543322 12345567999999999999999999999
Q ss_pred Ec-CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEECC---CCceEEee
Q 010214 87 ET-PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--MVVHRDLKPENLLLDS---KWNVKIAD 160 (515)
Q Consensus 87 ~~-~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--gIvHrDLkpeNILl~~---~~~vKL~D 160 (515)
.- .+.+|-|+|||+|.+|.-|++++.-++|.+++.|+.||+.||.||... .|+|-||||.|||+-. .|.+||+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 64 556899999999999999999999999999999999999999999975 6999999999999953 57899999
Q ss_pred cccccccccCCc--------cccCCCCCCccCCCccc-C--CccCCCcceeehhHHHHHHHHhCCCCCCCCChHH-H--H
Q 010214 161 FGLSNIMRDGHF--------LKTSCGSPNYAAPEVIS-G--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-L--F 226 (515)
Q Consensus 161 FGls~~~~~~~~--------~~~~~gt~~Y~aPE~i~-~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~-~--~ 226 (515)
||++.++.+... .....||.+|++||.+. + .+-.+.++||||+|||+|.++.|+.||....... + .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 999999865432 34557999999999874 3 2234679999999999999999999998654322 1 1
Q ss_pred HHH-hcCccCCC--CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 227 KKI-KGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 227 ~~i-~~~~~~~p--~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..| ......+| +.+++++++||++||+.--+.|..+.++..||+|...
T Consensus 697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 122 22334454 5789999999999999999999999999999999654
No 376
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-37 Score=342.20 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=217.8
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCc-----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~ 90 (515)
-.+-++.+.||+|+||.||.|....-.. .||||.+. +..+......+.+|..+|+.++||||+++++++-+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 3567889999999999999998754332 48888875 4456677899999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 91 DIYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~-------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
..+|++|||+||+|..||.+. ..++..+...++.||+.|++||+++++|||||...|+||+....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999865 3488999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccC-C--CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHH-HHhcCccCCCC
Q 010214 164 SNIMRDGHFLKTS-C--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK-KIKGGIYTLPS 238 (515)
Q Consensus 164 s~~~~~~~~~~~~-~--gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~-~i~~~~~~~p~ 238 (515)
|+.+.+.++.+.. . -...|||||.+....+ +.++|||||||++||+++ |..||.+.+..+... -...+....|.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 9955444433222 1 2357999999998777 789999999999999999 999999988777777 55666788899
Q ss_pred CCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 239 ~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+++..+.+++..||+.+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999987
No 377
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.5e-39 Score=304.26 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=212.4
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcC------
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~------ 89 (515)
.+.|.-..+||+|.||.||+|+++.+|++||+|++--+.-+ ...-....+|+++|..+.|+|++.+++++.+.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 46788888999999999999999999999999976432111 12234567999999999999999999887432
Q ss_pred --CeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 90 --SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 90 --~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
..+|+|+.+|+. +|.-.+... .+++..++++++++++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 348999999976 899888754 6899999999999999999999999999999999999999999999999999977
Q ss_pred cccCC-----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCc-------c
Q 010214 167 MRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------Y 234 (515)
Q Consensus 167 ~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~-------~ 234 (515)
+.... .....+-|.+|.+||.+.|...+++..|||..|||+.+|++|.+.|.+.+......-|..-. +
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 64322 23344569999999999998877999999999999999999999999887666655543211 1
Q ss_pred C---------------CC-------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 235 T---------------LP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 235 ~---------------~p-------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+ +| ..-++++.+|+.+||..||.+|++++++++|.||...
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 11 1124588999999999999999999999999999754
No 378
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=3e-38 Score=292.04 Aligned_cols=251 Identities=27% Similarity=0.503 Sum_probs=212.3
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCC--e
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS--D 91 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~--~ 91 (515)
..++|++.+.+|+|.++.||.|.+..++++++||++.+-+ .+++.||++||..|+ ||||++++++..++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3689999999999999999999999999999999986533 578999999999998 999999999997764 4
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccccccccC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDG 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~~~ 170 (515)
.-+|+||+++.+.... -..++..+++.++.|++.||.|||+.||.|||+||.|++||.. ..++|+|+|++.+..++
T Consensus 110 paLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 6799999987554433 3458889999999999999999999999999999999999964 57999999999999999
Q ss_pred CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCC-CCChHHHHHHHhc-------------CccCC
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKG-------------GIYTL 236 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~-~~~~~~~~~~i~~-------------~~~~~ 236 (515)
...+-.+.+..|--||.+..-..++..-|+||+||++..|+..+.||- +.+...+.-+|.+ -...+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 888888999999999999877767889999999999999999999983 3333333322211 01111
Q ss_pred C------------------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 237 P------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 237 p------------------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+ ...++++.||+.++|..|..+|+|+.|++.||||...
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 1 1357999999999999999999999999999999754
No 379
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-38 Score=296.52 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=209.9
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH-HhCCCCCccEEEEEEEcCCeEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL-RLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
++.+-+..||.|+||+|++-.|+.+|+..|||.|..... .....++..|.... +.-+.||||++|+..-.++..||.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 344556789999999999999999999999999976554 33456777777754 555699999999999999999999
Q ss_pred EeccCCCCHHHHH-----HHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 96 MEYVKSGELFDYI-----VEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 96 mEy~~gg~L~~~i-----~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
||.|+- +|..+- .++..++|+..-.+..-.+.||+||-. ..|+|||+||+|||++..|.|||||||.+..+.+
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 999954 665433 356789999999999999999999995 5899999999999999999999999999988766
Q ss_pred CCccccCCCCCCccCCCcccC--CccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhcCccCC---CC---CC
Q 010214 170 GHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTL---PS---HL 240 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~--~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~~~~~~---p~---~~ 240 (515)
+-......|...|||||.+.. ..| +.++|+||||++|||+.||..|+.+- +.-++...+..+.++. +. ++
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gy-DiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGY-DIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCc-chhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 655566689999999999963 334 78999999999999999999999763 3334444455554332 22 47
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
|..++.+|..||.+|-..||...+++++||++..
T Consensus 300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred CHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 8999999999999999999999999999999754
No 380
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-36 Score=322.09 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=217.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE-----cC
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE-----TP 89 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~-----~~ 89 (515)
.+.|+|.++||.|.+|+||+++++.+|+..|+|+.+... +..+.++-|.++|+... |||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 477999999999999999999999999999999987544 34577888999998876 999999999984 34
Q ss_pred CeEEEEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.+|+|||||.||+.-|+++. ..++.|+.+..|+..++.|+.+||++.++|||||=.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 679999999999999999975 457999999999999999999999999999999999999999999999999999877
Q ss_pred ccC-CccccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhCCCCCCCCChHHH-HHHHhcCccC--CCCC
Q 010214 168 RDG-HFLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYT--LPSH 239 (515)
Q Consensus 168 ~~~-~~~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~-~~~i~~~~~~--~p~~ 239 (515)
... ..-.|..|||.|||||++.... -++.++|+||||++..||.-|.+|+-+...... |.-..+.... -|..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 543 3456889999999999996422 125689999999999999999999988765543 3333332222 2456
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.+.++.+||..||.+|-.+||+..++++|||++.
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 7899999999999999999999999999999973
No 381
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=2.1e-35 Score=315.05 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=192.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEc----------------CCCcEEEEEEecccccCCh-----------HHHHHHHH
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHA----------------LTGHKVAIKILNRRKIKNM-----------EMEEKVRR 66 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~----------------~tg~~vAiK~i~~~~~~~~-----------~~~~~i~~ 66 (515)
.-.++|.+.+.||+|+||+||+|.+. ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34689999999999999999999752 2356799999864321110 01122345
Q ss_pred HHHHHHhCCCCCc-----cEEEEEEEc--------CCeEEEEEeccCCCCHHHHHHHhC---------------------
Q 010214 67 EIKILRLFMHPHI-----IRLYEVIET--------PSDIYVVMEYVKSGELFDYIVEKG--------------------- 112 (515)
Q Consensus 67 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~iVmEy~~gg~L~~~i~~~~--------------------- 112 (515)
|+.++.+++|.++ +++++++.. ....++||||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777776554 666666642 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccC--CCCCCccCCCc
Q 010214 113 ---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEV 187 (515)
Q Consensus 113 ---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~--~gt~~Y~aPE~ 187 (515)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+..+....+. .+|+.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 2356778899999999999999999999999999999999999999999999766544333333 34899999999
Q ss_pred ccCCc--------------------cC-CCcceeehhHHHHHHHHhCCC-CCCCCC-----------hHHHHHHHhcCcc
Q 010214 188 ISGKL--------------------YA-GPEVDVWSCGVILYALLCGTL-PFDDEN-----------IPNLFKKIKGGIY 234 (515)
Q Consensus 188 i~~~~--------------------~~-~~~~DIwSlGvily~lltG~~-Pf~~~~-----------~~~~~~~i~~~~~ 234 (515)
+.... |. ...+|+||+||++|+|++|.+ ||.+.. ....++.+....+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 86422 11 135799999999999999986 775421 1111222333333
Q ss_pred CC--CCCCChhHHHHhcccCCCCC---CCCCCHHHHhcCccccc
Q 010214 235 TL--PSHLSPGARDLIPRMLIVDP---MKRITIPEIRQHPWFQA 273 (515)
Q Consensus 235 ~~--p~~~s~~~~~li~~mL~~dP---~~Rpt~~eil~hp~f~~ 273 (515)
.+ ....++.+.||+.+||..+| .+|+|++|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 33 35678999999999999876 68999999999999953
No 382
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-36 Score=308.13 Aligned_cols=244 Identities=31% Similarity=0.507 Sum_probs=212.5
Q ss_pred eEeeeecccCceEEEEEEEcCC--C--cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALT--G--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~t--g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.+.+.||.|-||.||.|....- | -.||||..+.+. +.+..+++..|..+|+.++|||||++++++.+ ...|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 4467899999999999976433 3 358899876433 34557899999999999999999999999965 468999
Q ss_pred EeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||.++-|+|..|++.+ ..++......++.||..||.|||+..+|||||-..|||+.+.--|||+|||+|+.+.+....+
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999999864 479999999999999999999999999999999999999999899999999999998887766
Q ss_pred cCCCC--CCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhHHHHhcc
Q 010214 175 TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (515)
Q Consensus 175 ~~~gt--~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 250 (515)
...|. .-|||||.+.-..+ +.++|||-|||++||++. |..||.+-...+..-.|.+| ..+.|+.+++.+..|+.+
T Consensus 549 aS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred ccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence 65554 46999999998877 689999999999999987 99999987766666667666 468899999999999999
Q ss_pred cCCCCCCCCCCHHHHhc
Q 010214 251 MLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~ 267 (515)
||..+|.+||++.+|..
T Consensus 628 cWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HhccCcccCCcHHHHHH
Confidence 99999999999988743
No 383
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=2.7e-36 Score=305.95 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=215.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC------CCccEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEV 85 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h------pnIv~l~~~ 85 (515)
.+.+-.+|.+....|+|-|++|..|.+...|+.||||+|.... -+.+.=..|+++|++|+. -|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3455688999999999999999999999999999999997543 344566789999999973 489999999
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeec
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADF 161 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DF 161 (515)
|...+++|||+|-+. .+|.+.+++-| .|....++.+++|++.||..|-..||+|.||||.|||+++. ..+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999994 59999998755 58889999999999999999999999999999999999875 46899999
Q ss_pred ccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC---
Q 010214 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--- 238 (515)
Q Consensus 162 Gls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~--- 238 (515)
|.|......+ +....-+..|.|||++.|.+| +...|+||.||+||||.||+..|.+.+...+++-.......+|.
T Consensus 582 GSA~~~~ene-itPYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 582 GSASFASENE-ITPYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccccc-ccHHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 9998776544 445566778999999999998 68899999999999999999999998766665544332222220
Q ss_pred --------------------------------------------------CCC-------hhHHHHhcccCCCCCCCCCC
Q 010214 239 --------------------------------------------------HLS-------PGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 239 --------------------------------------------------~~s-------~~~~~li~~mL~~dP~~Rpt 261 (515)
.++ ..+++|+.+||..||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 011 35789999999999999999
Q ss_pred HHHHhcCccccc
Q 010214 262 IPEIRQHPWFQA 273 (515)
Q Consensus 262 ~~eil~hp~f~~ 273 (515)
+.++|.||||+.
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999963
No 384
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-37 Score=290.90 Aligned_cols=256 Identities=30% Similarity=0.520 Sum_probs=215.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCC-----e
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----D 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~-----~ 91 (515)
.+.+-.+-||-|+||+||.+++..+|+.||+|.+.. ...+...-+++.+|+++|..++|.|++..+++.+-+. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344557889999999999999999999999998853 3344455688999999999999999999999876553 4
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
+|+++|.+.. +|...|..-..++.+.++-+..||+.||+|||+.+|.||||||.|+|++++..+||||||+++.....+
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 7899999965 999999988899999999999999999999999999999999999999999999999999999875443
Q ss_pred c--cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhc------------------
Q 010214 172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG------------------ 231 (515)
Q Consensus 172 ~--~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~------------------ 231 (515)
. +...+-|.+|.|||++.|...++.++||||.|||+.|++..+..|...+..+..+-|..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 2 33446788999999999877778999999999999999999999988766555544422
Q ss_pred -----CccCCC-----------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 232 -----GIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 232 -----~~~~~p-----------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
+....| ..-..+..+++..||..||.+|++.++++.|++..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111 2344578899999999999999999999999998754
No 385
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-35 Score=303.64 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=211.5
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
+.-.+++.||+|-||.|.+++-. .+.+||+|+++..... +....+.+||++|.+|+||||++++++|..++.+++|+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34578999999999999999854 4689999999765433 45688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
||++.|+|.+|+.++. .+......+++.||++|++||.+.++|||||.+.|+|++.++++||+|||+++.+-.+...+
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 9999999999998873 33456677899999999999999999999999999999999999999999999776665443
Q ss_pred c---CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH--hCCCCCCCCChHHHHHHHhcC--------ccCCCCCCC
Q 010214 175 T---SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL--CGTLPFDDENIPNLFKKIKGG--------IYTLPSHLS 241 (515)
Q Consensus 175 ~---~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll--tG~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s 241 (515)
. .+-...|||||.+.-..+ +.++|+|++|+++||++ |...||...+.++..++...- ....|.-++
T Consensus 695 vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 2 245678999999877667 68999999999999975 689999988777766655332 235577889
Q ss_pred hhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 242 ~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.++.+++-+||..|..+|||++++..
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 99999999999999999999999844
No 386
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-35 Score=307.86 Aligned_cols=252 Identities=28% Similarity=0.427 Sum_probs=219.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCC---cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
++..+.++||+|+||+|++|.++..+ ..||||++....... ....|.+|+.+|.+|+|||+++||+++-+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 45667889999999999999987543 369999997665443 56889999999999999999999999987 6789
Q ss_pred EEEeccCCCCHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
||||.+++|+|.+.+.+ +..+.......++.||+.|+.||..+++|||||-..|+|+.....|||+|||+.+.+..++
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999986 4568889999999999999999999999999999999999999999999999999886654
Q ss_pred ccccCC----CCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHH
Q 010214 172 FLKTSC----GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (515)
Q Consensus 172 ~~~~~~----gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 245 (515)
...... -...|+|||.+....+ +.++|+|++||++|||++ |..||.+-....++++|..+. .+-|..++.++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 333222 2346999999998888 789999999999999998 999999999999999987653 567889999999
Q ss_pred HHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 246 DLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 246 ~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+++..||..+|.+|||+..|.+.-+..
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999998665544
No 387
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=9.3e-36 Score=305.50 Aligned_cols=204 Identities=33% Similarity=0.583 Sum_probs=186.1
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----HHHHHHHHHHHHHhCC---CCCccEEEEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----MEEKVRREIKILRLFM---HPHIIRLYEVI 86 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~---hpnIv~l~~~~ 86 (515)
....|...+.+|.|+||+|++|.|+.+...|+||.|.|+++--.. ....+-.||.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 356699999999999999999999999999999999887654221 2345678999999998 99999999999
Q ss_pred EcCCeEEEEEecc-CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 87 ETPSDIYVVMEYV-KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 87 ~~~~~~~iVmEy~-~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
++++++|++||-- +|-+|+++|..+.+++|.+++.||.|++.|+++||+.||||||||-||+.++.+|-+||+|||.+.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999975 567999999999999999999999999999999999999999999999999999999999999988
Q ss_pred ccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCC
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
....| ...+.+||..|+|||++.|..|.+..-|||+||++||.++....||..
T Consensus 719 ~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 77665 457889999999999999999999999999999999999999999864
No 388
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.2e-34 Score=336.48 Aligned_cols=239 Identities=21% Similarity=0.297 Sum_probs=190.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
+...|...+.||+|+||.||+|.+..+|..||+|.+..... ...+|++++++++||||+++++++.+....|+
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 34567778899999999999999999999999999864321 11346889999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEECCCCceEEeecccccccccCC
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH---RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH---~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~ 171 (515)
||||+++|+|.+++. .+++..+..++.||+.|++||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999999995 3889999999999999999999 6699999999999999998888776 665543321
Q ss_pred ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC-----hHHHHHHHhc---------Ccc---
Q 010214 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKG---------GIY--- 234 (515)
Q Consensus 172 ~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~-----~~~~~~~i~~---------~~~--- 234 (515)
..+..||+.|+|||++.+..+ +.++||||+||++|||++|+.||+... .....+.... ...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 123468899999999988777 789999999999999999999996432 1111111100 000
Q ss_pred -CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 235 -TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 235 -~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..+.....++.+++.+||+.||.+|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011112356789999999999999999999864
No 389
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-35 Score=310.58 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=219.2
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCc---EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
..-.|.++||.|.||.|+.|+.+..|+ .||||.++.-. .......+..|..||-+++||||++|.++....+.+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345788999999999999999987774 69999985432 3345678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCc
Q 010214 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~ 172 (515)
||+|||++|+|..+|.+ .+.++..+..-+++-|++|++||-+.|+|||||-..|||++.+..+|++|||+|+...++..
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999999986 46799999999999999999999999999999999999999999999999999998866542
Q ss_pred --cccCCC--CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHH
Q 010214 173 --LKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (515)
Q Consensus 173 --~~~~~g--t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 246 (515)
..+.-| ...|.|||.|....+ +.++||||+|++|||.++ |..||-+.+..+.++.|..+. .+.|..++..+.+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred ccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 122222 358999999998888 689999999999999886 999999999999999988764 5667799999999
Q ss_pred HhcccCCCCCCCCCCHHHHhcC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~h 268 (515)
|+..||++|-.+||.+.+|+.+
T Consensus 866 LMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999998774
No 390
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-34 Score=297.40 Aligned_cols=268 Identities=26% Similarity=0.463 Sum_probs=227.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
.+.....+||-|-||.||.|.++...-.||||.+..+.+ ..+.+..|..+|+.+.|||+|+++++|..+-.+|||+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 345567889999999999999999989999998854432 3688999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccc
Q 010214 97 EYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~ 174 (515)
|||..|+|.+|+.+.. .++.-....++.||.+|++||..++++||||-..|+|+.++..||++|||+++.+....+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT- 421 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT- 421 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-
Confidence 9999999999998744 4677788899999999999999999999999999999999999999999999998655432
Q ss_pred cCCC---CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhc
Q 010214 175 TSCG---SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (515)
Q Consensus 175 ~~~g---t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 249 (515)
...| ..-|.|||.+.-..+ +.++|||+|||+|||+.| |-.||.+-+..+.+.-+.++. ..-|..+++.+.+|+.
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2233 346999999987766 789999999999999998 999999999888888776653 4668899999999999
Q ss_pred ccCCCCCCCCCCHHHHhcCcccccccCcccCCCCCCchhhhhccCHHHHHHHHHcC
Q 010214 250 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 305 (515)
Q Consensus 250 ~mL~~dP~~Rpt~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (515)
.||+++|..||++.|+-+ -|.. +...+.|.+|+-+++.+.+
T Consensus 501 aCW~WsPsDRPsFaeiHq--afEt-------------mf~~sSisdEV~keLgk~~ 541 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQ--AFET-------------MFSSSSISDEVQKELGKNN 541 (1157)
T ss_pred HHhcCCcccCccHHHHHH--HHHH-------------HhccccccHHHHHHHhhcc
Confidence 999999999999999843 2322 2334456677777776544
No 391
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-35 Score=315.46 Aligned_cols=243 Identities=33% Similarity=0.488 Sum_probs=200.0
Q ss_pred eEeeeecccCce-EEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEe
Q 010214 20 KLGKTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 20 ~i~~~LG~G~fg-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmE 97 (515)
.-.+.+|.|+-| .||+|.. .|+.||||.+-.+ -...+.|||..|+..+ |||||++|+.-.+....||+.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 335678999888 6788976 6889999986432 3467889999999987 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---C--CceEEeecccccccc
Q 010214 98 YVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---K--WNVKIADFGLSNIMR 168 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~----l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~--~~vKL~DFGls~~~~ 168 (515)
.|.. +|.+++...+. ......+.+..|+++||++||+.+||||||||.||||+. + ..++|+|||++..+.
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9965 99999987421 122456889999999999999999999999999999976 2 479999999999876
Q ss_pred cCC----ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhC-CCCCCCCChHHHHHHHhcCccCCCC---CC
Q 010214 169 DGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPS---HL 240 (515)
Q Consensus 169 ~~~----~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG-~~Pf~~~~~~~~~~~i~~~~~~~p~---~~ 240 (515)
.+. ...+..||-+|+|||++.+... ..++||||+||++|+.++| .+||.+.-.. ..+|..+.+.+-. ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCc
Confidence 542 2456789999999999987765 5799999999999999985 9999875433 3567777665432 22
Q ss_pred ChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 241 s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++++||.+||.+||..|||+.++|.||+|...
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 2289999999999999999999999999999754
No 392
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-34 Score=290.85 Aligned_cols=136 Identities=27% Similarity=0.448 Sum_probs=117.9
Q ss_pred CccccC-CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-----C---CCccE
Q 010214 11 GVDMFL-PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----H---PHIIR 81 (515)
Q Consensus 11 ~~~~~~-~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----h---pnIv~ 81 (515)
-.+.+. ++|.+.++||+|.|++||+|.+..+.+.||+|+..... ...+....||++|++++ | .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 345566 89999999999999999999999999999999986433 34577789999999886 2 47999
Q ss_pred EEEEEEc----CCeEEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEC
Q 010214 82 LYEVIET----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLD 151 (515)
Q Consensus 82 l~~~~~~----~~~~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~ 151 (515)
|++.|.. ..++|||+|++ |.+|..+|... ..++...+++|++||+.||.|||+ .||+|-||||||||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999964 46799999999 77999999864 469999999999999999999996 5999999999999983
No 393
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-32 Score=297.16 Aligned_cols=248 Identities=31% Similarity=0.523 Sum_probs=211.6
Q ss_pred CCceEeeeecccCceEEEEEEEc---C----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEc
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHA---L----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~---~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~ 88 (515)
.+..+.+.||.|+||+|++|.-. . ....||||.+...... ...+.+..|+++|+.+. ||||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34467779999999999999643 1 1457999988654332 56788999999999987 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC
Q 010214 89 PSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~ 152 (515)
...+++|+||+..|+|.+++.++. .++..+...++.||+.|++||++.+++||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998765 3889999999999999999999999999999999999999
Q ss_pred CCceEEeecccccccccCCccc--cCCCC--CCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCC-hHHHH
Q 010214 153 KWNVKIADFGLSNIMRDGHFLK--TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN-IPNLF 226 (515)
Q Consensus 153 ~~~vKL~DFGls~~~~~~~~~~--~~~gt--~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~-~~~~~ 226 (515)
+..+||+|||+++...+..... ...|+ ..|||||.+....| +.++||||+||+|||+++ |..||.+-. ..++.
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999999998655443332 22332 34999999998766 789999999999999998 999998854 56667
Q ss_pred HHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 227 KKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 227 ~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
+.+..|. ...|.++++++.++++.||+.+|++||++.++.+
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7777775 4788999999999999999999999999999865
No 394
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=99.98 E-value=2.3e-31 Score=249.51 Aligned_cols=212 Identities=49% Similarity=0.817 Sum_probs=188.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCH
Q 010214 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (515)
Q Consensus 25 LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L 104 (515)
||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654322 357889999999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccccccCC-ccccCCCCCC
Q 010214 105 FDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPN 181 (515)
Q Consensus 105 ~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~~~~~~-~~~~~~gt~~ 181 (515)
.+++... ..+++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......++..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9999875 57899999999999999999999999999999999999999 8999999999998665432 2334568889
Q ss_pred ccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCC
Q 010214 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 182 Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt 261 (515)
|++||.+......+.+.|+|++|+++++| ..+.+++.+|+..||.+|||
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999998762347899999999999999 67899999999999999999
Q ss_pred HHHHhcCc
Q 010214 262 IPEIRQHP 269 (515)
Q Consensus 262 ~~eil~hp 269 (515)
+.++++|+
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999875
No 395
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=99.98 E-value=2e-32 Score=250.00 Aligned_cols=216 Identities=24% Similarity=0.434 Sum_probs=178.5
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHh-CCCCCccEEEEEEEcCC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPS 90 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~hpnIv~l~~~~~~~~ 90 (515)
++.-.+...-+..||+|++|.|-+.+|..+|+..|+|.+...- . ....+++.+|+.+..+ ...|++|.+|+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4444566666788999999999999999999999999986543 3 3445677788887654 45999999999999999
Q ss_pred eEEEEEeccCCCCHHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCCCceEEeeccccc
Q 010214 91 DIYVVMEYVKSGELFDYI----VEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i----~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
+++|.||.+.- +|..+- .+.+.++|..+-+++..++.||.|||++ .++|||+||+|||++.+|+||+||||.|.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999964 776554 3467899999999999999999999975 89999999999999999999999999998
Q ss_pred ccccCCccccCCCCCCccCCCcccC----CccCCCcceeehhHHHHHHHHhCCCCCCCC-ChHHHHHHHhc
Q 010214 166 IMRDGHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKG 231 (515)
Q Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~i~~----~~~~~~~~DIwSlGvily~lltG~~Pf~~~-~~~~~~~~i~~ 231 (515)
.+.++-......|...|||||.+.. +.| +-++||||||+.+.||.+++.||+.- +.-++++++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 8876655555778899999999863 234 78999999999999999999999763 33344555544
No 396
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.98 E-value=4e-31 Score=252.66 Aligned_cols=215 Identities=49% Similarity=0.812 Sum_probs=189.3
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|++.++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765433 2467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC--cccc
Q 010214 99 VKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKT 175 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~ 175 (515)
+++++|.+++..... +++..+..++.|++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999987766 8999999999999999999999999999999999999999999999999998775543 4456
Q ss_pred CCCCCCccCCCcc-cCCccCCCcceeehhHHHHHHHHhCCCCCCC--CChHHHHHHHhcCccCC
Q 010214 176 SCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTL 236 (515)
Q Consensus 176 ~~gt~~Y~aPE~i-~~~~~~~~~~DIwSlGvily~lltG~~Pf~~--~~~~~~~~~i~~~~~~~ 236 (515)
..++..|++||.+ .+..+ +.++|+||||+++++|++|+.||+. .+...+.+.+..+....
T Consensus 159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 6788999999998 54444 5699999999999999999999987 55557778887776443
No 397
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.97 E-value=2.2e-32 Score=273.28 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=203.3
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcC---CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEE
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~ 87 (515)
+..+...|..+..||.|+|++||+|.+.. .++.||+|.+..... ..++.+|+++|..+. +.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 44567789999999999999999999887 788999999875442 367899999999987 899999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-CCceEEeecccccc
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNI 166 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~~ 166 (515)
.++.+.+|+||++..+-.++.. .++-.+++.++..++.||.++|.+|||||||||+|+|.+. .+.-.|+|||++..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999877777764 4678999999999999999999999999999999999985 46789999999861
Q ss_pred cc-----------------c--C---------------Cc-----------cccCCCCCCccCCCcccCCccCCCcceee
Q 010214 167 MR-----------------D--G---------------HF-----------LKTSCGSPNYAAPEVISGKLYAGPEVDVW 201 (515)
Q Consensus 167 ~~-----------------~--~---------------~~-----------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIw 201 (515)
.. . + .. .....|||+|.|||++..-.-.++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 0 00 01235999999999998777678899999
Q ss_pred hhHHHHHHHHhCCCCCCCCC--hHHHHH--HH-----------hcCc---------------------------cC----
Q 010214 202 SCGVILYALLCGTLPFDDEN--IPNLFK--KI-----------KGGI---------------------------YT---- 235 (515)
Q Consensus 202 SlGvily~lltG~~Pf~~~~--~~~~~~--~i-----------~~~~---------------------------~~---- 235 (515)
|.|||+..++++..||-... ...+.+ .| .-+. ..
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999993211 000000 00 0000 00
Q ss_pred ------CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 236 ------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 236 ------~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..+..+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 01234558899999999999999999999999999973
No 398
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=99.97 E-value=5.4e-33 Score=289.37 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=219.7
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
.++|.+...+|.|++|-||+|+++.+++..|+|+++.. ..+...-+++||-+++.++||||+.+++-+-....++++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 58999999999999999999999999999999999644 334567788999999999999999999999888999999
Q ss_pred EeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-Cccc
Q 010214 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK 174 (515)
Q Consensus 96 mEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~-~~~~ 174 (515)
||||.||+|.+.-.-.++++|.++....+..+.|++|||+.|=+|||||=.|||+++.|.+|++|||.+..+... ..-+
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 999999999998777889999999999999999999999999999999999999999999999999998766432 2235
Q ss_pred cCCCCCCccCCCccc---CCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCC-----CCCChhHHH
Q 010214 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARD 246 (515)
Q Consensus 175 ~~~gt~~Y~aPE~i~---~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~ 246 (515)
...|||.|||||+-. ...| ...+|||++|+...|+---.+|.-+........-..+..+..| ...++.+-+
T Consensus 171 sfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred cccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 678999999999863 2234 6899999999999999887777555444443333334444433 457889999
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccccccC
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~~~~~ 276 (515)
|++.+|.++|++|||++.+|.|||....+.
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~l~ 279 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQTLS 279 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccchh
Confidence 999999999999999999999999976543
No 399
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.97 E-value=2.4e-32 Score=258.52 Aligned_cols=252 Identities=31% Similarity=0.505 Sum_probs=198.7
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEE-EEcCCe
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV-IETPSD 91 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~-~~~~~~ 91 (515)
.+.+.|.|.+.||+|.||++.+|+|+.+++.+++|.+++... ....+.+|...--.|. |.||+.-|++ |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 356889999999999999999999999999999999987653 3467788877654444 8999999886 788889
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC--CCceEEeeccccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRD 169 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~~~~ 169 (515)
++++|||++.|+|.+-+.. ..+-|...+.++.|+++||.|+|++++||||||.+||||-. ..+|||||||+++..
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~-- 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV-- 173 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--
Confidence 9999999999999887754 45889999999999999999999999999999999999942 348999999998754
Q ss_pred CCccccCCCCCCccCCCccc----CCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCccCCCC--
Q 010214 170 GHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-----PNLFKKIKGGIYTLPS-- 238 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~----~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-----~~~~~~i~~~~~~~p~-- 238 (515)
+......-.+..|.+||++. ++....+.+|+|.||+++|.+++|.+||..... .+..+-........|.
T Consensus 174 g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 33333444566899999874 333346889999999999999999999964321 1222222233334553
Q ss_pred -CCChhHHHHhcccCCCCCCCC---CCHHHHhcCcccc
Q 010214 239 -HLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQ 272 (515)
Q Consensus 239 -~~s~~~~~li~~mL~~dP~~R---pt~~eil~hp~f~ 272 (515)
.+|+.+..+.++-|..+|++| -++...+...|..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 578999999999999999999 4444455555543
No 400
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=2.5e-31 Score=281.78 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=210.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCc----EEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.+-.++||+|+||+||+|.+--.|+ +||||++...... .....+.+|+-+|.+++|||++++++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456789999999999998865554 6888988654433 34578889999999999999999999997765 889
Q ss_pred EEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCC-c
Q 010214 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~-~ 172 (515)
|++|+++|.|.+|++. ++.+.......|..||++|+.|||.+.+|||||-..|||+.+-..+||.|||+++...... .
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999985 5678999999999999999999999999999999999999999999999999999875433 2
Q ss_pred cccCCC--CCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHh
Q 010214 173 LKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (515)
Q Consensus 173 ~~~~~g--t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 248 (515)
..+..| .+-|||-|.+....| +.++||||+||++||++| |..|+++....++-+.+..+. .+-|+..+-++--++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 222222 457999999988888 789999999999999998 999999988888777776654 566888999999999
Q ss_pred cccCCCCCCCCCCHHHHhc
Q 010214 249 PRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 249 ~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||..|++.||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999998754
No 401
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.97 E-value=4.8e-31 Score=264.54 Aligned_cols=254 Identities=25% Similarity=0.436 Sum_probs=194.9
Q ss_pred CCCCCCCccc-----cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHH--HhCCCC
Q 010214 5 SNRSSSGVDM-----FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL--RLFMHP 77 (515)
Q Consensus 5 ~~~~~~~~~~-----~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il--~~l~hp 77 (515)
++||.++..- +.++-++.+.||+|.||.||+|.+ .|+.||||++.... +....||.+|. ..|+|+
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHE 265 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHE 265 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccc
Confidence 4455555553 457789999999999999999998 58999999986432 34455555555 578999
Q ss_pred CccEEEEEEEcC----CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCC
Q 010214 78 HIIRLYEVIETP----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN--------MVVHRDLKP 145 (515)
Q Consensus 78 nIv~l~~~~~~~----~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDLkp 145 (515)
||+.+++.-..+ ..+|+|++|.+.|+|+||+.+ ..++.+...+++..+++||++||.. .|.|||||.
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 999998875333 359999999999999999987 6799999999999999999999942 499999999
Q ss_pred CcEEECCCCceEEeecccccccccCC-----ccccCCCCCCccCCCcccCCcc----C-CCcceeehhHHHHHHHHhC--
Q 010214 146 ENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLY----A-GPEVDVWSCGVILYALLCG-- 213 (515)
Q Consensus 146 eNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~Y~aPE~i~~~~~----~-~~~~DIwSlGvily~lltG-- 213 (515)
.|||+..+|.+-|+|+|+|-...... ..+..+||..|||||++..... . -..+||||||.++||++..
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999997665431 3467799999999999965321 1 1468999999999999852
Q ss_pred --------CCCCCC-----CChHHHHHHHhcC--ccCCCCCC--Ch---hHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 214 --------TLPFDD-----ENIPNLFKKIKGG--IYTLPSHL--SP---GARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 214 --------~~Pf~~-----~~~~~~~~~i~~~--~~~~p~~~--s~---~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+||.+ .+.+++.+-+... ...+|... .+ .+..+++.||..||.-|.|+--|.+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 578864 3444444433322 23444332 22 3456789999999999999876643
No 402
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=99.97 E-value=1.2e-30 Score=263.34 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=189.5
Q ss_pred CCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHH--hCCCCCccEEEEEEEcCC---
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR--LFMHPHIIRLYEVIETPS--- 90 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~--~l~hpnIv~l~~~~~~~~--- 90 (515)
...-++.+.||+|.||.||+|.. +++.||||+++.. ..+.+..|-.|.+ .+.|+||++++++-+..+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 67888999999999999999975 5699999998643 3456666666665 456999999999876555
Q ss_pred -eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEEECCCCceEEee
Q 010214 91 -DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---------MVVHRDLKPENLLLDSKWNVKIAD 160 (515)
Q Consensus 91 -~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~---------gIvHrDLkpeNILl~~~~~vKL~D 160 (515)
.+++|+||.+.|+|.+|++.+ .+++.+..+++..|+.||+|||+. .|+|||||..|||+.+++..-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 799999999999999999765 689999999999999999999952 499999999999999999999999
Q ss_pred cccccccccCCc---cccCCCCCCccCCCcccCCccCC-----CcceeehhHHHHHHHHhCCC------------CCCC-
Q 010214 161 FGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAG-----PEVDVWSCGVILYALLCGTL------------PFDD- 219 (515)
Q Consensus 161 FGls~~~~~~~~---~~~~~gt~~Y~aPE~i~~~~~~~-----~~~DIwSlGvily~lltG~~------------Pf~~- 219 (515)
||+|..+..+.. ....+||..|||||++.|...-. .+.||||+|.+||||++... ||..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999998865533 34478999999999998754321 36899999999999997432 3321
Q ss_pred ----CChHHHHHHH--hcCccCCCCC-----CChhHHHHhcccCCCCCCCCCCHHH
Q 010214 220 ----ENIPNLFKKI--KGGIYTLPSH-----LSPGARDLIPRMLIVDPMKRITIPE 264 (515)
Q Consensus 220 ----~~~~~~~~~i--~~~~~~~p~~-----~s~~~~~li~~mL~~dP~~Rpt~~e 264 (515)
.+..++...+ .+....+|+. .-..+++.+..||..||+-|.|+.=
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 1233333332 2333445532 2356789999999999999999753
No 403
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.96 E-value=2e-30 Score=294.74 Aligned_cols=196 Identities=17% Similarity=0.219 Sum_probs=147.1
Q ss_pred CCC-CCccEEEEEE-------EcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 010214 74 FMH-PHIIRLYEVI-------ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (515)
Q Consensus 74 l~h-pnIv~l~~~~-------~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk 144 (515)
++| +||.++++.+ .....++.++|++ +++|.++|.. ...+++.+++.++.||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 5777777776 2234577889988 5699999975 3469999999999999999999999999999999
Q ss_pred CCcEEECC-------------------CCceEEeecccccccccC-----------------CccccCCCCCCccCCCcc
Q 010214 145 PENLLLDS-------------------KWNVKIADFGLSNIMRDG-----------------HFLKTSCGSPNYAAPEVI 188 (515)
Q Consensus 145 peNILl~~-------------------~~~vKL~DFGls~~~~~~-----------------~~~~~~~gt~~Y~aPE~i 188 (515)
|+||||+. ++.+|++|||+++..... ......+||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965 345666666666532110 001124689999999999
Q ss_pred cCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 189 ~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.+..| +.++|||||||+||||++|..|+.... .....+.....+ .+....+...+++.+||.+||.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 98887 789999999999999999999876432 122222221111 11122456789999999999999999999999
Q ss_pred Cccccc
Q 010214 268 HPWFQA 273 (515)
Q Consensus 268 hp~f~~ 273 (515)
||||..
T Consensus 265 h~~~~~ 270 (793)
T PLN00181 265 SEFINE 270 (793)
T ss_pred chhhhh
Confidence 999975
No 404
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.96 E-value=1.5e-30 Score=283.31 Aligned_cols=258 Identities=35% Similarity=0.558 Sum_probs=210.8
Q ss_pred CCCc-eEeeeecccCceEEEEEEEcCCCcEEEEEEeccc---ccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 16 LPNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRR---KIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 16 ~~~Y-~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
.+.| .....+|.|++|.|+.+......+.++.|.+... ..........+..|..+-..+.|||++.....+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4556 5678899999999999988877777777765421 11222223337778888889999999887777766655
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccC-
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG- 170 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~- 170 (515)
.+-.||||++ +|+..+...+.++..++..+++|++.||+|||..||.|||+||+|++++.+|.+||+|||.+.....+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 5566999999 99999998889999999999999999999999999999999999999999999999999998876533
Q ss_pred ----CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHH---------HHHHhcCccCCC
Q 010214 171 ----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL---------FKKIKGGIYTLP 237 (515)
Q Consensus 171 ----~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~---------~~~i~~~~~~~p 237 (515)
......+|+..|+|||++.+..|....+||||+|+++..|.+|+.||........ ..++..+...+-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 2345678999999999999999999999999999999999999999975433221 112222333344
Q ss_pred CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 238 ~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++...+.+|.+||++||.+|+|+++|++.+||+..
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 5678899999999999999999999999999999875
No 405
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.95 E-value=5.8e-27 Score=232.48 Aligned_cols=252 Identities=39% Similarity=0.650 Sum_probs=214.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEEe
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iVmE 97 (515)
|.+.+.||.|+||.||.+.+. ..+|+|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999987 78999999877655544678899999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC-ceEEeecccccccccCC--
Q 010214 98 YVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-- 171 (515)
Q Consensus 98 y~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~~~-- 171 (515)
++.++++.+++.... .+++..+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887665 799999999999999999999999999999999999999988 79999999987654432
Q ss_pred -----ccccCCCCCCccCCCcccCC--ccCCCcceeehhHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCccC-CCCC
Q 010214 172 -----FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYT-LPSH 239 (515)
Q Consensus 172 -----~~~~~~gt~~Y~aPE~i~~~--~~~~~~~DIwSlGvily~lltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~ 239 (515)
.....+||+.|+|||.+.+. .+.+...|+||+|++++++++|..||..... ......+...... ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 34677899999999999874 3557899999999999999999999887763 4455555444433 2222
Q ss_pred CC--------hhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LS--------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s--------~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
.. ..+.+++.+++..+|..|.+..+...+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 47899999999999999999999999866653
No 406
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.95 E-value=1.4e-28 Score=228.17 Aligned_cols=158 Identities=24% Similarity=0.297 Sum_probs=130.9
Q ss_pred CCHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCCC
Q 010214 102 GELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (515)
Q Consensus 102 g~L~~~i~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~ 180 (515)
|+|.+++... ..+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999874 46999999999999999999999999 999999999999999 9998876442 236899
Q ss_pred CccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCCh-HHHHHHHhcCccCC-------CCCCCh--hHHHHhcc
Q 010214 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTL-------PSHLSP--GARDLIPR 250 (515)
Q Consensus 181 ~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~li~~ 250 (515)
.|+|||++.+..+ +.++||||+||++|+|++|..||..... ......+....... +..++. ++.+++.+
T Consensus 69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999998877 6899999999999999999999976533 23333333322211 122333 69999999
Q ss_pred cCCCCCCCCCCHHHHhcCcccc
Q 010214 251 MLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 251 mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
||..||.+|||+.|+++|+|+.
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999975
No 407
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.94 E-value=9.3e-29 Score=258.58 Aligned_cols=242 Identities=31% Similarity=0.553 Sum_probs=214.7
Q ss_pred eecccCceEEEEEE---EcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEecc
Q 010214 24 TLGIGSFGKVKIAE---HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~---~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
++|.|+||+|+++. -.+.|+-+|+|+..+......... .-..|-.++...+ ||++++++..++++...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999999864 335678899999987766554433 5566778888887 999999999999999999999999
Q ss_pred CCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccccCCccccCCCC
Q 010214 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179 (515)
Q Consensus 100 ~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt 179 (515)
.||+|+..+.+...+.+...+.+...++-|++++|+.||+|||+|++||+++.+|++++.|||+++..-+.... |||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence 99999999988888999999999999999999999999999999999999999999999999999877554433 999
Q ss_pred CCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 180 ~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
..|||||++.|. ..++|.||+|+++++|++|..||.. +..+.|......+|..++..+++++..++..+|.+|
T Consensus 157 ~eymApEI~~gh---~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 157 YEYRAPEIINGH---LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhhHhhhcc---CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 999999999843 5789999999999999999999988 677888888999999999999999999999999999
Q ss_pred CCH-----HHHhcCcccccccC
Q 010214 260 ITI-----PEIRQHPWFQAHLP 276 (515)
Q Consensus 260 pt~-----~eil~hp~f~~~~~ 276 (515)
... .|+++|+||+....
T Consensus 230 Lg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hccCcchhHHHhccchheeeeH
Confidence 854 79999999987643
No 408
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.94 E-value=1.5e-26 Score=237.63 Aligned_cols=170 Identities=18% Similarity=0.194 Sum_probs=136.4
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcC-CCcEEEEEEeccccc--CChHHHHHHHHHHHHHHhCCCCCccE-EEEE
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI--KNMEMEEKVRREIKILRLFMHPHIIR-LYEV 85 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~hpnIv~-l~~~ 85 (515)
+....+.++|.+.+.||+|+||+||+|.++. +++.||||++..... ........+.+|+++|+.++|+|++. +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3455677899999999999999999999876 678889998753311 12334677999999999999999985 5442
Q ss_pred EEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCceEEeecccc
Q 010214 86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDL-kpeNILl~~~~~vKL~DFGls 164 (515)
...|+||||++|++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||++
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45799999999999963 21 111 2578899999999999999999999 999999999999999999999
Q ss_pred cccccCC---------ccccCCCCCCccCCCcccC
Q 010214 165 NIMRDGH---------FLKTSCGSPNYAAPEVISG 190 (515)
Q Consensus 165 ~~~~~~~---------~~~~~~gt~~Y~aPE~i~~ 190 (515)
....... ...+.++++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 8664332 1245678899999999864
No 409
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.94 E-value=3.4e-27 Score=233.18 Aligned_cols=251 Identities=19% Similarity=0.287 Sum_probs=208.6
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCC-----cEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEE-E
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-E 87 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~-~ 87 (515)
....++++...+-+|.||.||.|.+++.. +.|-+|.+... ...-....+..|...+..+.|||+..+.++. +
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34566888889999999999999776443 33555554321 2233567788999999999999999999986 5
Q ss_pred cCCeEEEEEeccCCCCHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 88 TPSDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 88 ~~~~~~iVmEy~~gg~L~~~i~~~--------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
+...-++++.+..-|+|..++... ..++..+...++.|+..|++|||++||+|.||-..|.+||+...+||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 556678889999889999999731 237788889999999999999999999999999999999999999999
Q ss_pred ecccccccccCCccc---cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHhcCc-c
Q 010214 160 DFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (515)
Q Consensus 160 DFGls~~~~~~~~~~---~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~~~~-~ 234 (515)
|=.+|+-..++++.. ..-....||+||.+....| +.++|+|||||+||||+| |+.|+.+-+..++..-+++|. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 999998776654321 1123457999999999988 789999999999999998 999999998888888888774 4
Q ss_pred CCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 235 ~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.-|-++++++..++..||..+|++||+++|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 667899999999999999999999999998754
No 410
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=6.1e-25 Score=224.35 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=191.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCC-cEEEEEEecccccCChHHHHHHHHHHHHHHhCCC----CCccEEEEEE-EcCCe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH----PHIIRLYEVI-ETPSD 91 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 91 (515)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+........ . ..+..|+.+++.+.. +++.++++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--C-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988775 679999876543222 1 157788888888873 6999999999 58888
Q ss_pred EEEEEeccCCCCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-----~~vKL~DFGls 164 (515)
-|+||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 78999988554 579999999999999999999999999999999999999765 46999999999
Q ss_pred cccc---cCC----c----cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHH---HHh
Q 010214 165 NIMR---DGH----F----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK---KIK 230 (515)
Q Consensus 165 ~~~~---~~~----~----~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~---~i~ 230 (515)
+... ... . .....||..|+++.+..+... +++.|+||++.++.+++.|.+||.......... +..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8322 111 1 123459999999999998876 899999999999999999999997654322222 222
Q ss_pred cCccC--CCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 231 GGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 231 ~~~~~--~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
..... .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 21111 223345667777766666777888877666543
No 411
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=6.3e-25 Score=213.54 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=199.1
Q ss_pred CCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEE
Q 010214 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVI 86 (515)
Q Consensus 8 ~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~ 86 (515)
+++++-++.-+|+++++||+|+||..+.|.+..+++.||||.-..+. ..-.++.|.+..+.|. .++|...|.+.
T Consensus 19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred CCCCceEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeec
Confidence 44566688899999999999999999999999999999999765433 2356778888888887 79999999999
Q ss_pred EcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-----CceEEee
Q 010214 87 ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIAD 160 (515)
Q Consensus 87 ~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-----~~vKL~D 160 (515)
....+-.+|||.+ |-+|.|+..- ..+++...+..++.|++.-++|+|++.+|+|||||+|+||..- ..|-|+|
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 9999999999999 7788888764 4469999999999999999999999999999999999999643 4599999
Q ss_pred cccccccccCCc--------cccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 010214 161 FGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKI 229 (515)
Q Consensus 161 FGls~~~~~~~~--------~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i 229 (515)
||+++.+.+... .++..||..||+-....|+.. +.+.|+-|||.++++.|-|.+||.+. +..+-+++|
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 999998866532 346679999999999988876 78999999999999999999999764 445556666
Q ss_pred hcCccCCC-----CCCChhHHHHhcccCCCCCCCCCC
Q 010214 230 KGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRIT 261 (515)
Q Consensus 230 ~~~~~~~p-----~~~s~~~~~li~~mL~~dP~~Rpt 261 (515)
-......| ..++.++...+.-.-..+-.+-|.
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 54433322 345555555554444444444444
No 412
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=2.1e-24 Score=201.75 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=194.0
Q ss_pred CCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC-CCccEEEEEEEc
Q 010214 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIET 88 (515)
Q Consensus 10 ~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h-pnIv~l~~~~~~ 88 (515)
...-...++|.+++.||+|+||-+|+|.+..+|+.||||+-.... .. ..+..|.++.+.|++ ..|..+..+..+
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhccc
Confidence 334456799999999999999999999999999999999865432 22 356678888888884 678888888888
Q ss_pred CCeEEEEEeccCCCCHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC---CCceEEeecccc
Q 010214 89 PSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLS 164 (515)
Q Consensus 89 ~~~~~iVmEy~~gg~L~~~i~-~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~---~~~vKL~DFGls 164 (515)
..+-.+|||.. |-+|.+... ....++...+.-++.|++.-++|+|.++++||||||+|+|+.- ...+.++|||+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88999999999 779988876 3557999999999999999999999999999999999999863 357999999999
Q ss_pred cccccCC--------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC---ChHHHHHHHhcCc
Q 010214 165 NIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGI 233 (515)
Q Consensus 165 ~~~~~~~--------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~---~~~~~~~~i~~~~ 233 (515)
+.+.+.. .-+...||..|++-....|... +.+.|+-|+|.+|.++.-|.+||.+- +..+-+++|....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 8875432 2235579999999888877655 78999999999999999999999874 3344556666555
Q ss_pred cCCC-----CCCChhHHHHhcccCCCCCCCCC
Q 010214 234 YTLP-----SHLSPGARDLIPRMLIVDPMKRI 260 (515)
Q Consensus 234 ~~~p-----~~~s~~~~~li~~mL~~dP~~Rp 260 (515)
.+.| ..++.++.-.+.-|-..--.+-|
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 5444 45677777777766554433333
No 413
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.91 E-value=5.1e-25 Score=240.61 Aligned_cols=219 Identities=36% Similarity=0.634 Sum_probs=179.5
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 94 (515)
.-.+|..+++|..|++|.||+++|+.|.+.+|+ .++++.+. .|- ++.....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li--------lRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI--------LRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh--------hhc--cccccCCccee--------------
Confidence 457899999999999999999999999999999 45554321 111 44444455554
Q ss_pred EEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc------
Q 010214 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------ 168 (515)
Q Consensus 95 VmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~------ 168 (515)
|+=...++.-+.++.+. +.+++|||+.||+|||+||+|++|+.-|++|+.|||++....
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 34444555555666554 789999999999999999999999999999999999986421
Q ss_pred --cC-------Ccc-ccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC
Q 010214 169 --DG-------HFL-KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 238 (515)
Q Consensus 169 --~~-------~~~-~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 238 (515)
.+ ++. +..||||.|.|||++..+.| +.-+|+|++|+|+|+.+.|..||.+++.++++..+.......|.
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 11 112 34599999999999998888 89999999999999999999999999999999999888877774
Q ss_pred ---CCChhHHHHhcccCCCCCCCCC---CHHHHhcCcccccc
Q 010214 239 ---HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ---~~s~~~~~li~~mL~~dP~~Rp---t~~eil~hp~f~~~ 274 (515)
.+++++++++.++|+.+|..|. .+-++.+|+||+..
T Consensus 280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 5789999999999999999996 46789999999864
No 414
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.91 E-value=5.3e-24 Score=204.48 Aligned_cols=176 Identities=15% Similarity=0.143 Sum_probs=138.1
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHH------HHHHHHHHHhCCCCCccEEEEEE
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIKILRLFMHPHIIRLYEVI 86 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~hpnIv~l~~~~ 86 (515)
+.+.++|++.+.||.|+||.||++.. ++..+|+|++............. +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34568999999999999999999765 47789999997665544444344 68999999999999999999986
Q ss_pred EcC--------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 87 ETP--------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 87 ~~~--------~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
... +..++||||++|.+|.++. .+++ ....+++.+|..||+.|++|||+||+||+++.+| ++|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 543 3578999999999998873 2333 2456999999999999999999999999999988 999
Q ss_pred eecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH
Q 010214 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211 (515)
Q Consensus 159 ~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll 211 (515)
+|||.+......... ...+....|. .++|+||||+++....
T Consensus 176 iDfg~~~~~~e~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 999988655322111 1133445564 7899999999876654
No 415
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.91 E-value=4.4e-24 Score=201.46 Aligned_cols=142 Identities=22% Similarity=0.245 Sum_probs=113.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----------------------HHHHHHHHHHHHHhCCCCC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------------------MEEKVRREIKILRLFMHPH 78 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~hpn 78 (515)
...||+|+||.||+|.+. +|+.||||++......... ......+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999999765321111 0123456999999999887
Q ss_pred ccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEECCCCceE
Q 010214 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 79 Iv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDLkpeNILl~~~~~vK 157 (515)
+.....+... ..++||||++|+++...+...+.+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544333222 2389999999988876655567899999999999999999999 799999999999999998 47899
Q ss_pred Eeeccccccc
Q 010214 158 IADFGLSNIM 167 (515)
Q Consensus 158 L~DFGls~~~ 167 (515)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998754
No 416
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.91 E-value=3.3e-25 Score=242.08 Aligned_cols=240 Identities=27% Similarity=0.388 Sum_probs=193.0
Q ss_pred cCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc-cCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 15 ~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
+..+|...+.||.+.|=+|.+|+|. .|. |+||++-+.. .-......+..+|++ .+.+++||++.+..+.++....|
T Consensus 21 ~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 21 LSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred CccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHH
Confidence 3448899999999999999999986 444 9999987654 223333444455666 78889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc--cc--
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM--RD-- 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~--~~-- 169 (515)
||-+|+.. +|+|.|..+..+..-+.+.|+.||+.||.-||+.||+|||||.|||||+.-+-+.|+||..-+.. ..
T Consensus 98 lvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 98 LVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 99999965 99999998888999999999999999999999999999999999999999999999999865432 11
Q ss_pred ----CCccccCCCCCCccCCCcccCCc----------cCCCcceeehhHHHHHHHHh-CCCCCCCC-----------ChH
Q 010214 170 ----GHFLKTSCGSPNYAAPEVISGKL----------YAGPEVDVWSCGVILYALLC-GTLPFDDE-----------NIP 223 (515)
Q Consensus 170 ----~~~~~~~~gt~~Y~aPE~i~~~~----------~~~~~~DIwSlGvily~llt-G~~Pf~~~-----------~~~ 223 (515)
.-+..|...-.+|.|||.+.... .-.++-||||+||+++||++ |.+||+-. +.+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE 256 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence 12345666667999999875421 12578999999999999998 89999521 222
Q ss_pred HHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcC
Q 010214 224 NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 224 ~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~h 268 (515)
.+.++| -+..+++||..|++.||++|.++++.|+.
T Consensus 257 ~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 223332 24578999999999999999999999886
No 417
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.90 E-value=6.6e-23 Score=193.51 Aligned_cols=143 Identities=17% Similarity=0.210 Sum_probs=116.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----------------------HHHHHHHHHHHHHHhCCCCC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------------------EMEEKVRREIKILRLFMHPH 78 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----------------------~~~~~i~~Ei~il~~l~hpn 78 (515)
.+.||+|+||+||+|.+. +|+.||||+++....... .......+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999986532100 01233468999999999998
Q ss_pred ccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceE
Q 010214 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 79 Iv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vK 157 (515)
+.....+.... .|+||||++|+++.........+++.++..++.|++.++.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 85554443332 48999999988665544455678999999999999999999999 9999999999999999 78999
Q ss_pred Eeecccccccc
Q 010214 158 IADFGLSNIMR 168 (515)
Q Consensus 158 L~DFGls~~~~ 168 (515)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999997654
No 418
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.90 E-value=6.8e-24 Score=209.63 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=155.8
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC----------CCccEEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH----------PHIIRLYEVI 86 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h----------pnIv~l~~~~ 86 (515)
.....++.||.|+++.||.++|..||+.+|+|++...........+.+++|.-....+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 456778899999999999999999999999999876654444456777777765555433 1233333332
Q ss_pred E---------cC---C-----eEEEEEeccCCCCHHHHHHH---hCCC----CHHHHHHHHHHHHHHHHHHHHCCceecc
Q 010214 87 E---------TP---S-----DIYVVMEYVKSGELFDYIVE---KGRL----QEDEARNFFQQIISGVEYCHRNMVVHRD 142 (515)
Q Consensus 87 ~---------~~---~-----~~~iVmEy~~gg~L~~~i~~---~~~l----~e~~~~~i~~qil~aL~yLH~~gIvHrD 142 (515)
. .. + ..+++|+-+. ++|.+.+.. .... .......+..|++..+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1 11 1 2477888885 589887652 2222 1222345569999999999999999999
Q ss_pred CCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcccCC-------ccCCCcceeehhHHHHHHHHhCCC
Q 010214 143 LKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-------LYAGPEVDVWSCGVILYALLCGTL 215 (515)
Q Consensus 143 LkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~-------~~~~~~~DIwSlGvily~lltG~~ 215 (515)
|+|+|++++.+|.++|+||+....... .......+..|.+||..... ...+.+.|.|+||+++|.|+||.+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999987654433 22223455789999976431 223678999999999999999999
Q ss_pred CCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCC
Q 010214 216 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (515)
Q Consensus 216 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~R 259 (515)
||+.......... .+..-..++..+++||..||+.||.+|
T Consensus 249 Pf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9986543322111 222223788999999999999999988
No 419
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.87 E-value=5.3e-22 Score=187.12 Aligned_cols=190 Identities=17% Similarity=0.125 Sum_probs=144.2
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-HHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-MEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVm 96 (515)
..+...|++|+||+|+++.. .+.+++.+.+.-....... ....+.+|+++|+++. |+++++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999998875 6788888877544432111 1236889999999996 5889999886 3569999
Q ss_pred eccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEECCCCceEEeecccccccccCCcc--
Q 010214 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDL-kpeNILl~~~~~vKL~DFGls~~~~~~~~~-- 173 (515)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999998754321 1 2457899999999999999999999 799999999999999999999855432210
Q ss_pred --c----------cCCCCCCccCCCcccCCc-cCCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 174 --K----------TSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 174 --~----------~~~gt~~Y~aPE~i~~~~-~~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
. -...++.|++|+...--. ..-.+.+.++.|.-+|.++|+.+|+-+++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 112678888888654321 11257889999999999999999876543
No 420
>PRK10345 hypothetical protein; Provisional
Probab=99.87 E-value=1.9e-21 Score=185.76 Aligned_cols=134 Identities=26% Similarity=0.371 Sum_probs=108.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhC-----CCCCccEEEEEEEcCC---eEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-----MHPHIIRLYEVIETPS---DIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 93 (515)
.+.||+|+||.||. |+.++.. +||++..... ...+.+.+|+++++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 56899999999995 8878776 6999865432 2346789999999999 5799999999999874 434
Q ss_pred -EEEec--cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEECC----CCceEEeecccc
Q 010214 94 -VVMEY--VKSGELFDYIVEKGRLQEDEARNFFQQIISGV-EYCHRNMVVHRDLKPENLLLDS----KWNVKIADFGLS 164 (515)
Q Consensus 94 -iVmEy--~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL-~yLH~~gIvHrDLkpeNILl~~----~~~vKL~DFGls 164 (515)
+|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999965 456666 35678888777 9999999999999999999974 347999995433
No 421
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.86 E-value=3.6e-23 Score=225.67 Aligned_cols=257 Identities=33% Similarity=0.562 Sum_probs=217.1
Q ss_pred CCCceEeeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEE
Q 010214 16 LPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 93 (515)
...|.+.+.||+|+|+.|-++.... +...+|.|.+.... ........+..|..+-+.+. |+|++++++....++..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5789999999999999999988743 44567888776554 34455677778888888888 999999999999999999
Q ss_pred EEEeccCCCCHHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCC-ceEEeeccccccccc
Q 010214 94 VVMEYVKSGELFDYI-VEKG-RLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRD 169 (515)
Q Consensus 94 iVmEy~~gg~L~~~i-~~~~-~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~~~-~vKL~DFGls~~~~~ 169 (515)
++++|..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 5554 6888899999999999999999 99999999999999999999 999999999987765
Q ss_pred -C---CccccCCC-CCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHH-H-HHhc---CccCCCCC
Q 010214 170 -G---HFLKTSCG-SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-K-KIKG---GIYTLPSH 239 (515)
Q Consensus 170 -~---~~~~~~~g-t~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~-~-~i~~---~~~~~p~~ 239 (515)
. ......+| ++.|+|||...+..|.++..|+||+|+++..+++|..|++........ . .+.. ........
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 2 23456688 999999999999888899999999999999999999999764332211 1 1111 12344567
Q ss_pred CChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 240 ~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
++..+.+++.+++..+|..|.+.+++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8999999999999999999999999999999987
No 422
>smart00090 RIO RIO-like kinase.
Probab=99.84 E-value=8e-21 Score=185.32 Aligned_cols=145 Identities=19% Similarity=0.204 Sum_probs=117.4
Q ss_pred CceEeeeecccCceEEEEEE-EcCCCcEEEEEEecccccCC---------------------hHHHHHHHHHHHHHHhCC
Q 010214 18 NYKLGKTLGIGSFGKVKIAE-HALTGHKVAIKILNRRKIKN---------------------MEMEEKVRREIKILRLFM 75 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~-~~~tg~~vAiK~i~~~~~~~---------------------~~~~~~i~~Ei~il~~l~ 75 (515)
.|.+.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 77799999999987543210 001234678999999998
Q ss_pred CC--CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEECC
Q 010214 76 HP--HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDS 152 (515)
Q Consensus 76 hp--nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~g-IvHrDLkpeNILl~~ 152 (515)
+. .+.++++. . ..++||||++|++|.........+.+.++..++.||+.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 63 34455543 2 34899999999888776655566777788999999999999999999 99999999999999
Q ss_pred CCceEEeeccccccc
Q 010214 153 KWNVKIADFGLSNIM 167 (515)
Q Consensus 153 ~~~vKL~DFGls~~~ 167 (515)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 789999999988654
No 423
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.84 E-value=4.3e-21 Score=190.67 Aligned_cols=187 Identities=27% Similarity=0.447 Sum_probs=142.4
Q ss_pred CCCCccEEEEEEEc---------------------------CCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHH
Q 010214 75 MHPHIIRLYEVIET---------------------------PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127 (515)
Q Consensus 75 ~hpnIv~l~~~~~~---------------------------~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil 127 (515)
+|||||++..+|.+ +..+|+||...+. +|..|+-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999887632 3358999998865 999999654 467788899999999
Q ss_pred HHHHHHHHCCceeccCCCCcEEEC--CC--CceEEeecccccccccC----Cc---cccCCCCCCccCCCcccCCc----
Q 010214 128 SGVEYCHRNMVVHRDLKPENLLLD--SK--WNVKIADFGLSNIMRDG----HF---LKTSCGSPNYAAPEVISGKL---- 192 (515)
Q Consensus 128 ~aL~yLH~~gIvHrDLkpeNILl~--~~--~~vKL~DFGls~~~~~~----~~---~~~~~gt~~Y~aPE~i~~~~---- 192 (515)
+|+.|||++||.|||+|.+|||+. ++ -.+.|+|||.+-.-..- .+ .-..-|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999983 33 35899999976432210 01 11224677889999976322
Q ss_pred -cCCCcceeehhHHHHHHHHhCCCCCCCCChHHH--HHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHH
Q 010214 193 -YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL--FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263 (515)
Q Consensus 193 -~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~--~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~ 263 (515)
.+-.++|.|++|.+.||+++...||.......+ ..--......+|+.+++.+++|+..+|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 112479999999999999999999987432222 11112334678899999999999999999999999853
No 424
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.82 E-value=2.8e-20 Score=207.46 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=164.0
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
+..-...|.|.+.||.|+||+||+|.+.. |+.||+|+=..........-.++..-++ ..--+.|+.+...+.-.+.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCc
Confidence 33446789999999999999999999886 9999999976665544333333333222 1113556666666666677
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCceEEeecccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-------~~~vKL~DFGls 164 (515)
.++|+||.+.|+|.+++...+.+++..+..+..||+..|+.||..+|||+||||.|+||.. .--++|+|||.|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 8899999999999999998889999999999999999999999999999999999999943 235999999998
Q ss_pred ccc---ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCC
Q 010214 165 NIM---RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL 215 (515)
Q Consensus 165 ~~~---~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~ 215 (515)
--+ .++...+..++|-.+-.+|+..|+++ +..+|.|.++.+++.||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHH
Confidence 654 46667788899999999999999998 789999999999999999963
No 425
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.82 E-value=3e-19 Score=170.67 Aligned_cols=137 Identities=25% Similarity=0.359 Sum_probs=116.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChH-----HHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----MEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
+.||+|++|.||+|.+ +|..+++|+.......... ...++.+|+.++..+.|+++.....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 7788999987654332221 23567889999999999998877777777778899999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccc
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
|++|++|.+++..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 8889999999999999999999999999999999 78999999998865
No 426
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.80 E-value=1.5e-20 Score=193.89 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=170.1
Q ss_pred CCceEeeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEE-------EE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-------VI 86 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~-------~~ 86 (515)
.-+.+.+..+..+++.+....-..+ .+.++-+.. ...+........+++-.+....|-+..-+.+ .+
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~---~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRA---DVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhh---hccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 3445555556666665554433222 222222222 1222223345556666655555443333332 11
Q ss_pred -----EcCCeEEEEEeccCCCCHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEE
Q 010214 87 -----ETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 87 -----~~~~~~~iVmEy~~gg~L~~~i~~~~---~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL 158 (515)
....++||.|++|..++|.++|..+. ..+......++.|+..|++| +|.+|||+||.||+...+..+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 11235899999999999999997543 36677889999999999999 99999999999999999999999
Q ss_pred eecccccccccCC-------ccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 010214 159 ADFGLSNIMRDGH-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (515)
Q Consensus 159 ~DFGls~~~~~~~-------~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~llt-G~~Pf~~~~~~~~~~~i~ 230 (515)
.|||+........ ......||..||+||.+.|..| +.++||||||+||+|++. -..+|. ....+..+.
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r 473 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFE---RIATLTDIR 473 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhh
Confidence 9999988776554 4566789999999999999988 799999999999999997 232322 223344555
Q ss_pred cCccCCC-CCCChhHHHHhcccCCCCCCCCCCHHHHhcCccc
Q 010214 231 GGIYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (515)
Q Consensus 231 ~~~~~~p-~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f 271 (515)
.+.++.- ..-.++-.+|+.+||...|.+||++.+.--|+|.
T Consensus 474 ~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 5554311 1123455689999999999999988888777775
No 427
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.79 E-value=1.1e-18 Score=165.42 Aligned_cols=134 Identities=22% Similarity=0.294 Sum_probs=108.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEec
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmEy 98 (515)
.||+|+||.||+|.+ +|..+++|+......... ....++.+|+++++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678999998654432221 1246778999999999988765554445556667899999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
++|++|.+++..... .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999998764321 8899999999999999999999999999999 789999999988653
No 428
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.78 E-value=9.2e-19 Score=166.15 Aligned_cols=141 Identities=21% Similarity=0.297 Sum_probs=111.7
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-------------------HHHHHHHHHHHHHHhCCCC-
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-------------------EMEEKVRREIKILRLFMHP- 77 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-------------------~~~~~i~~Ei~il~~l~hp- 77 (515)
.|.+.+.||.|+||.||+|.+. +|+.||||++........ .......+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 899999999765331000 0112367899999999887
Q ss_pred -CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCce
Q 010214 78 -HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 78 -nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~v 156 (515)
.++..++. ...++||||++|++|..... ......++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 44555442 34589999999999876532 14567899999999999999999999999999999999999
Q ss_pred EEeeccccccccc
Q 010214 157 KIADFGLSNIMRD 169 (515)
Q Consensus 157 KL~DFGls~~~~~ 169 (515)
+|+|||++.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865543
No 429
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.78 E-value=7.2e-20 Score=173.94 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=191.3
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEE
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVm 96 (515)
....+..+|.....|..|+|++. |..++.|+++...... ..-..+.+|.--|+-+.||||+.+++.+.++..+.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 45566778999999999999985 5567888887655443 22345778888899999999999999999999999999
Q ss_pred eccCCCCHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEECCCCceEEe--ecccccccccC
Q 010214 97 EYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIA--DFGLSNIMRDG 170 (515)
Q Consensus 97 Ey~~gg~L~~~i~~~~~--l~e~~~~~i~~qil~aL~yLH~~g--IvHrDLkpeNILl~~~~~vKL~--DFGls~~~~~~ 170 (515)
.|++.|+|+..+..... .+..++.+++.+|+.|++|||+.. |.---|....+++|++...+|+ |--+|..
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 99999999999986543 677899999999999999999853 4444688899999998766654 3222211
Q ss_pred CccccCCCCCCccCCCcccCCccC--CCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHH--hcCccCCCCCCChhHHH
Q 010214 171 HFLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLSPGARD 246 (515)
Q Consensus 171 ~~~~~~~gt~~Y~aPE~i~~~~~~--~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~ 246 (515)
.....-+|.||+||.++.++.+ -.++|+||+++++||+.|...||.+-+..+.--+| ......+|+.+|+....
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k 420 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK 420 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence 0123457899999999876542 35799999999999999999999987665543333 33456889999999999
Q ss_pred HhcccCCCCCCCCCCHHHHh
Q 010214 247 LIPRMLIVDPMKRITIPEIR 266 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil 266 (515)
|++-|+..||.+||.++.+.
T Consensus 421 lm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhcCCCCcCCCcceeh
Confidence 99999999999999877653
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.76 E-value=9.3e-18 Score=182.90 Aligned_cols=140 Identities=21% Similarity=0.259 Sum_probs=114.0
Q ss_pred CCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCC-----hHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCe
Q 010214 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (515)
Q Consensus 17 ~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~ 91 (515)
..|...+.||+|+||.||+|.+. +..+++|+........ ....+++.+|+++++.++|++++....+..+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44566889999999999999874 3345555433222211 1234678899999999999999988877777777
Q ss_pred EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 92 ~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
.++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999999885 457899999999999999999999999999999 5779999999998653
No 431
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.74 E-value=9.7e-18 Score=157.14 Aligned_cols=140 Identities=21% Similarity=0.306 Sum_probs=102.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHH---------------------HHHHHHHHHhCCCCC--
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK---------------------VRREIKILRLFMHPH-- 78 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~---------------------i~~Ei~il~~l~hpn-- 78 (515)
.+.||+|+||+||+|.+. +|+.||||++............. ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 89999999987643222111111 145677776665443
Q ss_pred ccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceE
Q 010214 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 79 Iv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vK 157 (515)
+.+++++ ...++||||++|+.+.......... ..+++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 5555543 2358999999985432211111111 16789999999999999999 9999999999999999 88999
Q ss_pred Eeecccccccc
Q 010214 158 IADFGLSNIMR 168 (515)
Q Consensus 158 L~DFGls~~~~ 168 (515)
|+|||.+....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999986553
No 432
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.72 E-value=2e-17 Score=173.67 Aligned_cols=197 Identities=29% Similarity=0.480 Sum_probs=157.4
Q ss_pred HHhCCCCCccEEEEEEEcCCeEEEEEeccCCCCHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCcE
Q 010214 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV-VHRDLKPENL 148 (515)
Q Consensus 71 l~~l~hpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~-~~~l~e~~~~~i~~qil~aL~yLH~~gI-vHrDLkpeNI 148 (515)
|+.+.|.|+.++++.+-++...++|.+||..|+|.|.+.. .-.++..-...++++|+.||.|||+..| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4578899999999999999999999999999999999986 4467777888899999999999998766 9999999999
Q ss_pred EECCCCceEEeecccccccccC---CccccCCCCCCccCCCcccCCcc------CCCcceeehhHHHHHHHHhCCCCCCC
Q 010214 149 LLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY------AGPEVDVWSCGVILYALLCGTLPFDD 219 (515)
Q Consensus 149 Ll~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~Y~aPE~i~~~~~------~~~~~DIwSlGvily~lltG~~Pf~~ 219 (515)
++|....+||+|||+....... .......-...|.|||.+.+... .+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998776421 11111223456899999987422 25679999999999999999999976
Q ss_pred CC----hHHHHHHHhc-CccC-CCC-----CCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 220 EN----IPNLFKKIKG-GIYT-LPS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 220 ~~----~~~~~~~i~~-~~~~-~p~-----~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
.. ..++...+.+ +... .|. ...+++..++..||..+|.+||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 2345555555 2211 121 34557899999999999999999999865
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.71 E-value=1.3e-16 Score=155.97 Aligned_cols=138 Identities=19% Similarity=0.259 Sum_probs=106.8
Q ss_pred eeec-ccCceEEEEEEEcCCCcEEEEEEeccccc-----C-----ChHHHHHHHHHHHHHHhCCCCCc--cEEEEEEEcC
Q 010214 23 KTLG-IGSFGKVKIAEHALTGHKVAIKILNRRKI-----K-----NMEMEEKVRREIKILRLFMHPHI--IRLYEVIETP 89 (515)
Q Consensus 23 ~~LG-~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-----~-----~~~~~~~i~~Ei~il~~l~hpnI--v~l~~~~~~~ 89 (515)
..|| .||.|+||.+... +..+++|.+.+... . +.....++.+|+.++..+.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888763 77899998865322 1 11234678899999999998875 7777765432
Q ss_pred C-e---EEEEEeccCC-CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 90 S-D---IYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 90 ~-~---~~iVmEy~~g-g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
. . .++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 2599999997 689888754 4566543 578999999999999999999999999999889999999988
Q ss_pred ccc
Q 010214 165 NIM 167 (515)
Q Consensus 165 ~~~ 167 (515)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
No 434
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.67 E-value=4.7e-16 Score=138.60 Aligned_cols=132 Identities=23% Similarity=0.293 Sum_probs=113.2
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCCeEEEEEec
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~iVmEy 98 (515)
+++.||.|.++.||++.... ..+++|....... ...+.+|+..++.+++ +++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999743 7899999865432 4578899999999987 5999999998888889999999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEECCCCceEEeecccccc
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~---gIvHrDLkpeNILl~~~~~vKL~DFGls~~ 166 (515)
++|+++..+ +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877654 5567788899999999999984 799999999999999989999999998864
No 435
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.67 E-value=2e-17 Score=181.75 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=214.0
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 93 (515)
.-.+.+.+.+-+-+|+++.++.+.-..+|...++|+..+...-.....+.+.++-.++-...+|.++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45678888899999999999999988889888888765433222222344445555544455676666555445566789
Q ss_pred EEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccccccc-----
Q 010214 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR----- 168 (515)
Q Consensus 94 iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~----- 168 (515)
++++|..|++|...+..-+..+++-++..+..+..+++|||...+.|||++|.|+|...+|+.+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999999999999988889999999999999999999999999999999999999999999999998322110
Q ss_pred ----------------c---------C--CccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 169 ----------------D---------G--HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 169 ----------------~---------~--~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
. + .......||+.|.+||...+... +..+|+|+.|+++++.++|..||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0 01223468999999999998876 789999999999999999999999999
Q ss_pred hHHHHHHHhcCccCCC---CCCChhHHHHhcccCCCCCCCCCCHH---HHhcCcccccccC
Q 010214 222 IPNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQAHLP 276 (515)
Q Consensus 222 ~~~~~~~i~~~~~~~p---~~~s~~~~~li~~mL~~dP~~Rpt~~---eil~hp~f~~~~~ 276 (515)
....+++|.++..+.| ...++++++++.++|..+|.+|..+. +...||||+..-.
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 9999999999887766 46799999999999999999999987 8999999986533
No 436
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.64 E-value=1.5e-16 Score=167.21 Aligned_cols=261 Identities=22% Similarity=0.243 Sum_probs=203.9
Q ss_pred CCCccccCCCceEeeeecc--cCceEEEEEEE--cCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEE
Q 010214 9 SSGVDMFLPNYKLGKTLGI--GSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLY 83 (515)
Q Consensus 9 ~~~~~~~~~~Y~i~~~LG~--G~fg~Vy~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~ 83 (515)
+.....+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-... .........=.+|+...+.++ |++.++.+
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccC
Confidence 3444556677888999999 99999999998 889999999973221 111111222345666666666 99999999
Q ss_pred EEEEcCCeEEEEEeccCCCCHHHHHHHhCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEEECCC-CceE
Q 010214 84 EVIETPSDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIIS----GVEYCHRNMVVHRDLKPENLLLDSK-WNVK 157 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~-l~e~~~~~i~~qil~----aL~yLH~~gIvHrDLkpeNILl~~~-~~vK 157 (515)
..++..+..|+-+|+|. .+|..+...... +++..++..+.+..+ ||.++|..+++|-|+||.||++..+ ...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 99999999999999995 699999887655 899999999999999 9999999999999999999999998 8999
Q ss_pred EeecccccccccCCccc------cCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 010214 158 IADFGLSNIMRDGHFLK------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFKKI 229 (515)
Q Consensus 158 L~DFGls~~~~~~~~~~------~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~--~~~~~~~~i 229 (515)
++|||+...+.++.+.. ...|...|++||...+.. +...|++|+|.+..+..+|..++... +.-..++..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 99999998887766432 225788999999998753 78999999999999988887666543 111111111
Q ss_pred hcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 230 KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 230 ~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
. ...++-...+.++...+..|+..+|..|++++.++.|+++...
T Consensus 342 ~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 342 Y-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred c-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 1 1111223456677779999999999999999999999998744
No 437
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.52 E-value=7e-15 Score=158.03 Aligned_cols=148 Identities=23% Similarity=0.346 Sum_probs=103.9
Q ss_pred cccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC---------------------------Ch----HHH
Q 010214 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---------------------------NM----EME 61 (515)
Q Consensus 13 ~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~---------------------------~~----~~~ 61 (515)
+.+...|.. +-||+|++|+||+|+.+.+|+.||||+..+.-.. .. +..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 444566776 7899999999999999988999999999754210 00 111
Q ss_pred HH------HHHHHHHHHhCC----CCCccEEEEEEEc-CCeEEEEEeccCCCCHHHH--HHHhC----CCCHHHHHHHHH
Q 010214 62 EK------VRREIKILRLFM----HPHIIRLYEVIET-PSDIYVVMEYVKSGELFDY--IVEKG----RLQEDEARNFFQ 124 (515)
Q Consensus 62 ~~------i~~Ei~il~~l~----hpnIv~l~~~~~~-~~~~~iVmEy~~gg~L~~~--i~~~~----~l~e~~~~~i~~ 124 (515)
+. +.+|...+.+++ +...+.+-.++.+ .+..++||||++|+.+.++ +...+ .+.+..+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 22 334555554443 4444444444432 4556899999999999874 33333 255555666666
Q ss_pred HHHHHHHHHHHCCceeccCCCCcEEECCCC----ceEEeecccccccc
Q 010214 125 QIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMR 168 (515)
Q Consensus 125 qil~aL~yLH~~gIvHrDLkpeNILl~~~~----~vKL~DFGls~~~~ 168 (515)
|++ ..|++|+|+||.||+++.+| .++++|||++....
T Consensus 275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 665 59999999999999999888 99999999987653
No 438
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.50 E-value=1.4e-13 Score=145.98 Aligned_cols=142 Identities=23% Similarity=0.304 Sum_probs=98.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCCh---------------------------HH----------HHHHH
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM---------------------------EM----------EEKVR 65 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~---------------------------~~----------~~~i~ 65 (515)
+.||+|++|+||+|+.+ +|+.||||+..+.-.... .. +-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999975 799999999854311100 00 01234
Q ss_pred HHHHHHHhCC----CCCccEEEEEE-EcCCeEEEEEeccCCCCHHHHHHHh-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 010214 66 REIKILRLFM----HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIIS-GVEYCHRNMV 138 (515)
Q Consensus 66 ~Ei~il~~l~----hpnIv~l~~~~-~~~~~~~iVmEy~~gg~L~~~i~~~-~~l~e~~~~~i~~qil~-aL~yLH~~gI 138 (515)
+|.+.+.+++ |.+-+.+-.++ +..+..++||||++|++|.++.... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 5666665553 22223333333 2234568999999999998876532 122 23456666665 4678999999
Q ss_pred eeccCCCCcEEECCCCceEEeecccccccc
Q 010214 139 VHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 139 vHrDLkpeNILl~~~~~vKL~DFGls~~~~ 168 (515)
+|+|+||.||+++.+|.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999986653
No 439
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.46 E-value=6.8e-13 Score=141.13 Aligned_cols=185 Identities=21% Similarity=0.313 Sum_probs=141.2
Q ss_pred CceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 18 ~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-|.+ ...+-++.+..-.|..+.++.+|.|.++..+.- ...+.+.+-++-|+.++||||+++++.+++.+.+|+|+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 3555 334444444222467778899999999865432 456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCCceEEeecccccccccCCc-ccc
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKT 175 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~ 175 (515)
.+. .|..++++.+ .......+.||+.||.||| +.+++|++|.-..|+++..|..||++|.++........ ...
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~ 164 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS 164 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc
Confidence 984 6788887654 7788888999999999998 67899999999999999999999999998754432211 111
Q ss_pred CCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCC
Q 010214 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 214 (515)
Q Consensus 176 ~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~ 214 (515)
..---.|..|+.+.... -..|.|-|||++++++.|.
T Consensus 165 ~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred chhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc
Confidence 11222456666654322 3579999999999999993
No 440
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.46 E-value=7.3e-13 Score=124.77 Aligned_cols=142 Identities=18% Similarity=0.215 Sum_probs=105.0
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEeccccc--CC-----------------hHHHHHH----HHHHHHHH
Q 010214 22 GKTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKI--KN-----------------MEMEEKV----RREIKILR 72 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~------tg~~vAiK~i~~~~~--~~-----------------~~~~~~i----~~Ei~il~ 72 (515)
...||.|.-+.||.|.... .+..+|||++..... ++ ......+ ++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357999999753211 00 1112233 38999999
Q ss_pred hCCC--CCccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEE
Q 010214 73 LFMH--PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLL 149 (515)
Q Consensus 73 ~l~h--pnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDLkpeNIL 149 (515)
++.. -++.+++++ ..-++||||+.++.+..-..+...+++.++..++.|++.+|..| |+.|++|+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8873 567777765 34579999997654433222344566777888999999999999 8999999999999999
Q ss_pred ECCCCceEEeecccccccc
Q 010214 150 LDSKWNVKIADFGLSNIMR 168 (515)
Q Consensus 150 l~~~~~vKL~DFGls~~~~ 168 (515)
++. +.+.|+|||.+....
T Consensus 158 ~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEC-CcEEEEECCCceeCC
Confidence 974 689999999886543
No 441
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.44 E-value=1.1e-13 Score=145.60 Aligned_cols=254 Identities=18% Similarity=0.156 Sum_probs=192.8
Q ss_pred ccccCCCceEeeeecccCceEEEEEEEc-CCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcC
Q 010214 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHA-LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP 89 (515)
Q Consensus 12 ~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~ 89 (515)
......+|..+..||.|.|+.|+..... .++..|++|-..+......+. ..-..|+.+...+. |.|++..+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3345688999999999999999987755 678899999876544443332 33345555555554 99999999998888
Q ss_pred CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCC-CceEEeecccccccc
Q 010214 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMR 168 (515)
Q Consensus 90 ~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~-~~vKL~DFGls~~~~ 168 (515)
...|+--|||+++++...+.....+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 8889999999999988887666678999999999999999999999999999999999999886 789999999886421
Q ss_pred cCCccccCCCCCCcc-CCCcccCCccCCCcceeehhHHHHHHHHhCCCC-CCCCChHHHHHHHhcCccCCCCCCChhHHH
Q 010214 169 DGHFLKTSCGSPNYA-APEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARD 246 (515)
Q Consensus 169 ~~~~~~~~~gt~~Y~-aPE~i~~~~~~~~~~DIwSlGvily~lltG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 246 (515)
-. .......-.+. .+|++........+.|++|||.-+++..+|... .... ....|..+...........+..
T Consensus 419 ~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 419 FS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQLQV 492 (524)
T ss_pred ee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhhhh
Confidence 11 11112233344 355555444447899999999999999988643 2222 2234555655555555588899
Q ss_pred HhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 247 li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+.+.++..++..|+.+.++..|.=|-
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhh
Confidence 99999999999999999998886553
No 442
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.44 E-value=3.2e-14 Score=139.23 Aligned_cols=204 Identities=17% Similarity=0.255 Sum_probs=149.1
Q ss_pred HHHHHHHHhCCCCCccEEEEEEEcCC-----eEEEEEeccCCCCHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH
Q 010214 65 RREIKILRLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR 135 (515)
Q Consensus 65 ~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~iVmEy~~gg~L~~~i~~----~~~l~e~~~~~i~~qil~aL~yLH~ 135 (515)
+.-...|-++-|.||++++.|+.+.+ ...++.||+..|+|..++++ ...+.....++|+.||++||.|||+
T Consensus 115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 33344566677999999999985543 47889999999999999975 3458888999999999999999997
Q ss_pred C--CceeccCCCCcEEECCCCceEEeeccccccccc-----CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHH
Q 010214 136 N--MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (515)
Q Consensus 136 ~--gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~-----~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily 208 (515)
. -|+|+++...-|++..+|-||+.--........ ........+-++|.|||.=.-... .-++|||++|....
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHH
Confidence 6 599999999999999999888864332221110 011122346789999997544433 45899999999999
Q ss_pred HHHhCCCCC-CCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 209 ALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 209 ~lltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
+|..|..-- ...+....-..|.+..+.+. .+.-++++.+||+-.|..||++.+++-||.+-
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 999887542 33333333334433333222 22346799999999999999999999999764
No 443
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.42 E-value=8.2e-13 Score=121.39 Aligned_cols=127 Identities=20% Similarity=0.218 Sum_probs=96.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEeccC
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy~~ 100 (515)
++.|+.|.++.||+++.. +..|++|+...... ......+|+.+++.+.+.++ .+++.+.. ..-++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 78899998754421 12245789999988875443 45665543 23479999999
Q ss_pred CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEECCCCceEEeeccccc
Q 010214 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV-----VHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 101 gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gI-----vHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
|.++.+. .......+.+++.+|..||+.++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11224567899999999999885 9999999999999 6689999999875
No 444
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.29 E-value=4.2e-11 Score=109.77 Aligned_cols=135 Identities=22% Similarity=0.325 Sum_probs=101.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHH-----HHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEEEe
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-----EEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~-----~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iVmE 97 (515)
..+++|+-+.++.+.. -|.++.+|.=.++....+.. ..+..+|.+++..+.--.|.-.+=+..++....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 34457777654444444443 3555689999988875555444444456677789999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
|++|..|.+++... ...++..+=.-+.-||..||+|+||.++||++..+ ++.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 99998888888765 24566667777788999999999999999999876 4999999998643
No 445
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.26 E-value=1.4e-10 Score=105.96 Aligned_cols=145 Identities=21% Similarity=0.253 Sum_probs=109.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----HHHHHHHHHHHHHHhCCCCCccEEEEEEEcCCeEEEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iV 95 (515)
....|-+|+-+.|+++.. .|+.+.||.=..+....+ -...+..+|++.|.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999976 688888886444333332 2456778999999988855554444455566666799
Q ss_pred EeccCC-CCHHHHHHHhC-CCCHHH-HHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccccc
Q 010214 96 MEYVKS-GELFDYIVEKG-RLQEDE-ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM 167 (515)
Q Consensus 96 mEy~~g-g~L~~~i~~~~-~l~e~~-~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~~~ 167 (515)
|||++| .++.+++.... .-.+++ ...++.+|-+.+.-||.++|+|+||..+||++..++ .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 47888887543 223333 378999999999999999999999999999997654 3589999998643
No 446
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.21 E-value=6.2e-11 Score=113.41 Aligned_cols=140 Identities=21% Similarity=0.312 Sum_probs=107.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC--CCccEEEEEEEcCC---eEEEEEe
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPS---DIYVVME 97 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h--pnIv~l~~~~~~~~---~~~iVmE 97 (515)
+.||.|..+.||++... +|..+++|+....... .....+.+|.++++.+.+ ..+.+++.+..... ..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999875 3688999997654321 124567899999999986 44677887765532 5689999
Q ss_pred ccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010214 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------------ 135 (515)
Q Consensus 98 y~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~------------------------------------------ 135 (515)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888775432 456777777778888888888873
Q ss_pred --------------CCceeccCCCCcEEECC--CCceEEeecccccc
Q 010214 136 --------------NMVVHRDLKPENLLLDS--KWNVKIADFGLSNI 166 (515)
Q Consensus 136 --------------~gIvHrDLkpeNILl~~--~~~vKL~DFGls~~ 166 (515)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998754
No 447
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.13 E-value=5.2e-10 Score=116.03 Aligned_cols=211 Identities=16% Similarity=0.280 Sum_probs=158.5
Q ss_pred ceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccEEEEEEEc----CCeEEEEEeccCC-CCH
Q 010214 30 FGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEYVKS-GEL 104 (515)
Q Consensus 30 fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~iVmEy~~g-g~L 104 (515)
-.+.|++....+|..|++|.++-.+.... .+...-.+.++++.|+|+|++.+++.+ +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 45789999999999999999954443322 233345778899999999999999864 3458999999876 467
Q ss_pred HHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 105 FDYIVE---------------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 105 ~~~i~~---------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
.++--. +...+|+..|.++.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+..|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 664421 22478999999999999999999999999999999999999999999999888776644
Q ss_pred CCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCC-CCChHHH-HHHHhcCccCCCCCCChhHHHH
Q 010214 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNL-FKKIKGGIYTLPSHLSPGARDL 247 (515)
Q Consensus 170 ~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~-~~~~~~~-~~~i~~~~~~~p~~~s~~~~~l 247 (515)
.. + |-+.+. .+-|.=-||.++..|.||..--. .+..... .+.| -..+|.+++++
T Consensus 446 d~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~rn~ 501 (655)
T KOG3741|consen 446 DP------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDLRNV 501 (655)
T ss_pred CC------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHHHHH
Confidence 32 0 112222 35688899999999999964321 1111221 2222 24578999999
Q ss_pred hcccCCCCCCCCCCHHHHhcC
Q 010214 248 IPRMLIVDPMKRITIPEIRQH 268 (515)
Q Consensus 248 i~~mL~~dP~~Rpt~~eil~h 268 (515)
|.-+...++.+ -++.+++.|
T Consensus 502 v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 502 VEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHhcCccc-ccHHHHHHH
Confidence 99999998887 788888875
No 448
>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.
Probab=99.11 E-value=1e-10 Score=83.42 Aligned_cols=44 Identities=36% Similarity=0.697 Sum_probs=39.6
Q ss_pred ceEEEEEEEeeec-CCceeEEeecccCCceehHHHHHHHHHHHhc
Q 010214 471 NVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV 514 (515)
Q Consensus 471 ~~~k~~lQLyk~~-~~~yllDf~~~~g~~~~f~~~c~~~i~~l~~ 514 (515)
..++||||+||++ .+.|.|||||++|+++.|.++|++++++|+.
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~L 47 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELRL 47 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT-
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHccC
Confidence 4699999999999 8999999999999999999999999999974
No 449
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.03 E-value=7.2e-09 Score=102.82 Aligned_cols=134 Identities=15% Similarity=0.137 Sum_probs=96.6
Q ss_pred eEEEEEEEcCCCcEEEEEEecccccCC----h----HHHHHHHHHHHHHHhCCCCC--ccEEEEEEEc-----CCeEEEE
Q 010214 31 GKVKIAEHALTGHKVAIKILNRRKIKN----M----EMEEKVRREIKILRLFMHPH--IIRLYEVIET-----PSDIYVV 95 (515)
Q Consensus 31 g~Vy~a~~~~tg~~vAiK~i~~~~~~~----~----~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~iV 95 (515)
..|..+.. .|+.|.||......... . .....+.+|...+..+..-+ .+.+..+.+. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33555543 67789999764333110 0 01124778999988875333 3344445443 2357899
Q ss_pred EeccCCC-CHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECC-------CCceEEeeccccc
Q 010214 96 MEYVKSG-ELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIADFGLSN 165 (515)
Q Consensus 96 mEy~~gg-~L~~~i~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~-------~~~vKL~DFGls~ 165 (515)
||++++. +|.+++.. ....++.....++.+++..+.-||.+||+|+|+++.|||++. ++.+.++||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 79998864 345677788899999999999999999999999999999975 4689999999875
Q ss_pred c
Q 010214 166 I 166 (515)
Q Consensus 166 ~ 166 (515)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
No 450
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.03 E-value=1.2e-09 Score=102.47 Aligned_cols=128 Identities=25% Similarity=0.345 Sum_probs=86.1
Q ss_pred EEEEEEEcCCCcEEEEEEeccccc-----------------------CChHHHHHHHHHHHHHHhCCCC--CccEEEEEE
Q 010214 32 KVKIAEHALTGHKVAIKILNRRKI-----------------------KNMEMEEKVRREIKILRLFMHP--HIIRLYEVI 86 (515)
Q Consensus 32 ~Vy~a~~~~tg~~vAiK~i~~~~~-----------------------~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~ 86 (515)
.||.|... .|..+|+|+...... .........++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 678999999753210 1111345678999999999865 577777653
Q ss_pred EcCCeEEEEEeccC--CCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 87 ETPSDIYVVMEYVK--SGELFDYIVEKGRLQEDEARNFFQQIISGVEY-CHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 87 ~~~~~~~iVmEy~~--gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~y-LH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
.-++||||++ |..+..+.. ..++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~--~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKD--VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHH--CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHh--ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 655544332 122355678888899886665 579999999999999999987 999999998
Q ss_pred cccc
Q 010214 164 SNIM 167 (515)
Q Consensus 164 s~~~ 167 (515)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7654
No 451
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=98.95 E-value=3.2e-10 Score=121.41 Aligned_cols=150 Identities=22% Similarity=0.379 Sum_probs=114.1
Q ss_pred HHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEEeecccccccccCCcc-----c-----cCCCCCCccCCCcccCCc
Q 010214 124 QQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----K-----TSCGSPNYAAPEVISGKL 192 (515)
Q Consensus 124 ~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~~~~~-----~-----~~~gt~~Y~aPE~i~~~~ 192 (515)
.+...|+.|+|+ .++||++|.|++|.++.+|.+||+.|+++.....+... . ...-...|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 344499999996 58999999999999999999999999987654332110 0 112356899999999854
Q ss_pred cCCCcceeehhHHHHHHHH-hCCCCCCCCChHHHHHH----HhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhc
Q 010214 193 YAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKK----IKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (515)
Q Consensus 193 ~~~~~~DIwSlGvily~ll-tG~~Pf~~~~~~~~~~~----i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~ 267 (515)
. ++++|++|+||++|.+. .|+..+...+....... ...+....+..+++++++=+.++|..++..||++.++..
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4 79999999999999999 56666655432221111 112234455788999999999999999999999999999
Q ss_pred Ccccccc
Q 010214 268 HPWFQAH 274 (515)
Q Consensus 268 hp~f~~~ 274 (515)
-|||++-
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999864
No 452
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.89 E-value=2.2e-08 Score=95.66 Aligned_cols=127 Identities=17% Similarity=0.223 Sum_probs=95.4
Q ss_pred CCcEEEEEEecccccCC----hHHHHHHHHHHHHHHhCCCC--CccEEEEEEEcC----CeEEEEEeccCCC-CHHHHHH
Q 010214 41 TGHKVAIKILNRRKIKN----MEMEEKVRREIKILRLFMHP--HIIRLYEVIETP----SDIYVVMEYVKSG-ELFDYIV 109 (515)
Q Consensus 41 tg~~vAiK~i~~~~~~~----~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~~~~----~~~~iVmEy~~gg-~L~~~i~ 109 (515)
.++.+-+|.....-..+ .-...+..+|...+..|..- .+.+.+.+.+.. ...++|+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221111 12345678898888777633 345666666543 2468999999884 7999998
Q ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---ceEEeeccccccc
Q 010214 110 EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM 167 (515)
Q Consensus 110 ~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~---~vKL~DFGls~~~ 167 (515)
.....+......++.++...+.-||.+||+|+|++|.|||++.++ .+.++||+-+...
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 755678888999999999999999999999999999999999887 8999999977643
No 453
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.84 E-value=2.7e-08 Score=96.59 Aligned_cols=138 Identities=23% Similarity=0.333 Sum_probs=105.4
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccc------------------cC-ChHHHHHHHHHHHHHHhCCCC--
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK------------------IK-NMEMEEKVRREIKILRLFMHP-- 77 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~------------------~~-~~~~~~~i~~Ei~il~~l~hp-- 77 (515)
+.++..||.|.-|.||.|.+. .|.++|||.-..-. .. -.-.....++|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 467889999999999999976 78999999742100 00 011235568999999998755
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
.+.+.+++ +.-.+|||+++|-.|... +++.+.+..++..|+.-+.-.-+.||||+|+.+-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67776664 345799999999777542 234666777788888877777799999999999999999999999
Q ss_pred Eeecccccc
Q 010214 158 IADFGLSNI 166 (515)
Q Consensus 158 L~DFGls~~ 166 (515)
++||--+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976543
No 454
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.84 E-value=4.8e-08 Score=99.36 Aligned_cols=235 Identities=18% Similarity=0.188 Sum_probs=156.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCccE--------EEEEEEcCCe
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR--------LYEVIETPSD 91 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnIv~--------l~~~~~~~~~ 91 (515)
..++.||+|+-+.+|..-.. ...+-|++.+..... ..+... .+-+--.||-+-. +++- .....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~---~aqk~a--~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA---QAQKVA--ELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchH---HHHHHH--HhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 45678999999999965422 224568877654221 111111 1122234554332 1111 11223
Q ss_pred EEEEEeccCCCCHH-HHHH---Hh---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 92 IYVVMEYVKSGELF-DYIV---EK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 92 ~~iVmEy~~gg~L~-~~i~---~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
+-+.|..++|..-- ++.. +. ....++-+.+.++.|+.+.+-||..|.+-+|++++|+|+++++.|.|+|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 78899998875322 2221 11 23667888999999999999999999999999999999999999999997665
Q ss_pred cccccCCccccCCCCCCccCCCcccCCc----cCCCcceeehhHHHHHHHHhC-CCCCCCCC----hH-HHHHHHhcCcc
Q 010214 165 NIMRDGHFLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCG-TLPFDDEN----IP-NLFKKIKGGIY 234 (515)
Q Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~i~~~~----~~~~~~DIwSlGvily~lltG-~~Pf~~~~----~~-~~~~~i~~~~~ 234 (515)
....++......+|.+.|.+||...-.. ..+...|.|.|||+++++|.| ++||.+-. .+ -.-..|..+.+
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 5556677777889999999999765211 125679999999999999986 99997631 11 11123433332
Q ss_pred C-----------CC-----CCCChhHHHHhcccCCC--CCCCCCCHH
Q 010214 235 T-----------LP-----SHLSPGARDLIPRMLIV--DPMKRITIP 263 (515)
Q Consensus 235 ~-----------~p-----~~~s~~~~~li~~mL~~--dP~~Rpt~~ 263 (515)
. .| +-+++++..|..+|+.. ++.-|||++
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1 11 24678888999888875 466899875
No 455
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.72 E-value=1e-07 Score=90.77 Aligned_cols=141 Identities=21% Similarity=0.261 Sum_probs=95.2
Q ss_pred ccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHH------HHHHHHHHHHHhCC---CCCccEEEE
Q 010214 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME------EKVRREIKILRLFM---HPHIIRLYE 84 (515)
Q Consensus 14 ~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~------~~i~~Ei~il~~l~---hpnIv~l~~ 84 (515)
.+.++|.+.+.+-......|.+.. .+|+.+++|............. ....+++..+..++ -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456789999999988888787775 3678999998754322111111 11234444444443 233333333
Q ss_pred EEE-----cCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEe
Q 010214 85 VIE-----TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (515)
Q Consensus 85 ~~~-----~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~ 159 (515)
+.+ -....+++|||++|.+|.+... +++ .+...|.+++.-+|+.|++|+|.+|.|++++.+ .++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 332 2345678999999988876532 333 345677788999999999999999999999965 59999
Q ss_pred eccccc
Q 010214 160 DFGLSN 165 (515)
Q Consensus 160 DFGls~ 165 (515)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
No 456
>PRK09902 hypothetical protein; Provisional
Probab=98.64 E-value=6.2e-07 Score=85.09 Aligned_cols=138 Identities=11% Similarity=0.148 Sum_probs=100.8
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeccc---ccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEEEE---cC--CeEEEE
Q 010214 26 GIGSFGKVKIAEHALTGHKVAIKILNRR---KIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIE---TP--SDIYVV 95 (515)
Q Consensus 26 G~G~fg~Vy~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~---~~--~~~~iV 95 (515)
|+||-+.|+.... .|+.+-+|.-... ...-......+.+|+..+..+..-+ +.++. ++. .+ -.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6688888998765 3456888865311 1111224577889999998886322 44444 222 11 236899
Q ss_pred EeccCC-CCHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCc--eEEeecccccc
Q 010214 96 MEYVKS-GELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNI 166 (515)
Q Consensus 96 mEy~~g-g~L~~~i~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~--vKL~DFGls~~ 166 (515)
+|-+.| -+|.+++.+. .+.++.....++.++..++.-||+.|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997754 5888888653 35678888999999999999999999999999999999987777 99999987653
No 457
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.60 E-value=1.5e-08 Score=107.68 Aligned_cols=250 Identities=19% Similarity=0.151 Sum_probs=176.1
Q ss_pred CCCCCccccCCCceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEE
Q 010214 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEV 85 (515)
Q Consensus 7 ~~~~~~~~~~~~Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~ 85 (515)
...........-|.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d 302 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLED 302 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCccccccc
Confidence 344455566667778888999999999998876555444 5555322 34456889999999999 6666666
Q ss_pred EEcCCeEEEEEeccCCC-CHHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceEEeeccc
Q 010214 86 IETPSDIYVVMEYVKSG-ELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (515)
Q Consensus 86 ~~~~~~~~iVmEy~~gg-~L~~-~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vKL~DFGl 163 (515)
++.+...+++|+++.++ +-.. .-...-.+.+-+...+.+.=+.+++++|+.-=+||| ||+..+ +..|..||+.
T Consensus 303 ~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 303 YDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred CCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccC
Confidence 67778899999999887 2111 111112234445556667778899999998778998 888766 5899999999
Q ss_pred ccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCChHHHHHHHhcCccCCCC-----
Q 010214 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----- 238 (515)
Q Consensus 164 s~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~~~~~~~~i~~~~~~~p~----- 238 (515)
...+.....-++..+++.++|||+..+..+ ....|.||+|+-..+|.-|.+|-... ......+-.+. ..|.
T Consensus 378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p-~s~~L~~~~ 453 (829)
T KOG0576|consen 378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGP-NSPMLTDKS 453 (829)
T ss_pred CcccCcccccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCC-Cccccchhh
Confidence 887776666678899999999999988877 57899999998777777787775441 11000111110 0010
Q ss_pred CCChhH-HHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 239 HLSPGA-RDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 239 ~~s~~~-~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..++.. .++...|+..-|..|++...++.|.+|...
T Consensus 454 aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 454 AWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 011111 257888999999999999999999999754
No 458
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.59 E-value=1.4e-07 Score=101.39 Aligned_cols=138 Identities=23% Similarity=0.351 Sum_probs=91.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccccc---------------------------CChHH----------HHHHH
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI---------------------------KNMEM----------EEKVR 65 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~---------------------------~~~~~----------~~~i~ 65 (515)
+-|+.++-|+||.|+.+ +|+.||||+..+.-. .-... +-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56899999999999987 599999999753210 00011 11134
Q ss_pred HHHHHHHhCC-----CCCccEEEEEE-EcCCeEEEEEeccCCCCHHHHHH-HhCCCCHH-----HHHHHHHHHHHHHHHH
Q 010214 66 REIKILRLFM-----HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIV-EKGRLQED-----EARNFFQQIISGVEYC 133 (515)
Q Consensus 66 ~Ei~il~~l~-----hpnIv~l~~~~-~~~~~~~iVmEy~~gg~L~~~i~-~~~~l~e~-----~~~~i~~qil~aL~yL 133 (515)
+|...+.+++ .|++ ++=.++ +-.+.-.++|||++|-.+.+... +....+.. -+..++.|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~------- 281 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQL------- 281 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHH-------
Confidence 5666665554 2333 333333 33455679999999988888742 22334422 223333333
Q ss_pred HHCCceeccCCCCcEEECCCCceEEeeccccccccc
Q 010214 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (515)
Q Consensus 134 H~~gIvHrDLkpeNILl~~~~~vKL~DFGls~~~~~ 169 (515)
=..|++|.|.+|.||+++.+|.+-+.|||+.....+
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 348999999999999999999999999999876543
No 459
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.59 E-value=4.2e-07 Score=87.54 Aligned_cols=138 Identities=20% Similarity=0.237 Sum_probs=97.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHH---------------------HHHHHHHHHHHHhCC--CCCcc
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM---------------------EEKVRREIKILRLFM--HPHII 80 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~---------------------~~~i~~Ei~il~~l~--hpnIv 80 (515)
.|+.|.-+.||+|.. .++..+|+|++......-... ..-...|...|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677788889999875 468899999986433221111 122356888888876 44556
Q ss_pred EEEEEEEcCCeEEEEEeccCCCCH-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEECCCCceEE
Q 010214 81 RLYEVIETPSDIYVVMEYVKSGEL-FDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKI 158 (515)
Q Consensus 81 ~l~~~~~~~~~~~iVmEy~~gg~L-~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDLkpeNILl~~~~~vKL 158 (515)
+.+.+. .-.+||||+..... .-.+ +.-++..+++..+..+++..+.-|-. .++||+||..-|||+. ++.+.|
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 666664 34699999954311 1111 12234444899999999999998877 9999999999999999 779999
Q ss_pred eecccccccc
Q 010214 159 ADFGLSNIMR 168 (515)
Q Consensus 159 ~DFGls~~~~ 168 (515)
+|||-|....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999886554
No 460
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.53 E-value=1.2e-06 Score=84.87 Aligned_cols=133 Identities=15% Similarity=0.174 Sum_probs=85.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEEEEEcCCeEEEEEeccC
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETPSDIYVVMEYVK 100 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~iVmEy~~ 100 (515)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..- .+.+.+.+.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999974 25568899875422 234578999999988743 35788888888888899999999
Q ss_pred CCC-HH--------------HHHHH-----h----CCCCHHH-HHHHHHH----------HHH-HHHHHH----HCCcee
Q 010214 101 SGE-LF--------------DYIVE-----K----GRLQEDE-ARNFFQQ----------IIS-GVEYCH----RNMVVH 140 (515)
Q Consensus 101 gg~-L~--------------~~i~~-----~----~~l~e~~-~~~i~~q----------il~-aL~yLH----~~gIvH 140 (515)
|.+ +. ..+.+ + ...+... ...+..+ +.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 11111 0 0111000 0111000 111 112222 124789
Q ss_pred ccCCCCcEEECCCCceEEeeccccc
Q 010214 141 RDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 141 rDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999774
No 461
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.50 E-value=9.8e-07 Score=99.82 Aligned_cols=204 Identities=19% Similarity=0.216 Sum_probs=152.2
Q ss_pred HHHHHHHHHHHHhCCCCCccEEEEEEEcCCe----EEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC
Q 010214 61 EEKVRREIKILRLFMHPHIIRLYEVIETPSD----IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136 (515)
Q Consensus 61 ~~~i~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~ 136 (515)
.....-|+..+....|+|++.++.+--.... ..+..|+|.+.++.+.+...+..+.+..+.+..++++|+.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 4445667788889999999999988644333 335568999999999999999999999999999999999999998
Q ss_pred CceeccCCCC---cEEECCCCceEEe--ecccccccccCCccccCCCCCCccCCCcccCCccC-CCcceeehhHHHHHHH
Q 010214 137 MVVHRDLKPE---NLLLDSKWNVKIA--DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYAL 210 (515)
Q Consensus 137 gIvHrDLkpe---NILl~~~~~vKL~--DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~-~~~~DIwSlGvily~l 210 (515)
...|.-+... +-..+..+.+.++ ||+.+....+........-+..+.+||......+. +...|+|.+|..+..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 7666655555 4445566777777 99988877666555555667778888888765542 2236999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcCccCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCccccc
Q 010214 211 LCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (515)
Q Consensus 211 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~ 273 (515)
..|..+-..... ...+ ++.....+..+++.+|+.-++++|+++.+++.|||.+.
T Consensus 386 ~~~~~i~~~~~~---~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 386 SQGEDISEKSAV---PVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhcCcccccccc---hhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 987654221111 1111 11111226788999999999999999999999999864
No 462
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.46 E-value=2.1e-06 Score=82.34 Aligned_cols=137 Identities=22% Similarity=0.308 Sum_probs=83.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEEEE---EcCCeEEEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVI---ETPSDIYVVM 96 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~iVm 96 (515)
++.|+.|..+.||.+.... ..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999998754 48999986543 3457788899998887633 356676644 2334579999
Q ss_pred eccCCCCHHH----------------HHH---Hh----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 010214 97 EYVKSGELFD----------------YIV---EK----GRLQEDE------ARNF---------------FQQIIS-GVE 131 (515)
Q Consensus 97 Ey~~gg~L~~----------------~i~---~~----~~l~e~~------~~~i---------------~~qil~-aL~ 131 (515)
++++|..+.. .+. +. ....... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0001000 0000 111222 233
Q ss_pred HHHH-------CCceeccCCCCcEEEC-CCCceEEeeccccc
Q 010214 132 YCHR-------NMVVHRDLKPENLLLD-SKWNVKIADFGLSN 165 (515)
Q Consensus 132 yLH~-------~gIvHrDLkpeNILl~-~~~~vKL~DFGls~ 165 (515)
.+++ ..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3332 3599999999999999 66777899999774
No 463
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.27 E-value=8.8e-06 Score=79.56 Aligned_cols=133 Identities=14% Similarity=0.071 Sum_probs=82.8
Q ss_pred ecccCc-eEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCccEEEEEEEcCCeEEEEEeccCCC
Q 010214 25 LGIGSF-GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 25 LG~G~f-g~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iVmEy~~gg 102 (515)
|..|.. +.||++... +..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344444 789998753 4688999875432 235678898888875 344668888877766789999999997
Q ss_pred CHHHHH---------H-------H--hC-----CCCHH------HHHHHHH----------------HHHHHHHHHH---
Q 010214 103 ELFDYI---------V-------E--KG-----RLQED------EARNFFQ----------------QIISGVEYCH--- 134 (515)
Q Consensus 103 ~L~~~i---------~-------~--~~-----~l~e~------~~~~i~~----------------qil~aL~yLH--- 134 (515)
+|.... . + .- ++... .....+. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 776431 0 0 00 01100 0000000 0111122221
Q ss_pred ----HCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 135 ----RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 135 ----~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999774
No 464
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.24 E-value=4.8e-06 Score=89.43 Aligned_cols=139 Identities=19% Similarity=0.302 Sum_probs=87.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCCh-----------------------------HHHHH------HHHH
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------------------------EMEEK------VRRE 67 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~-----------------------------~~~~~------i~~E 67 (515)
+.||.-+.|+|++|+.+. |+.||||+-++. +... +..+. +.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 579999999999999875 999999985432 1110 00111 2234
Q ss_pred HHHHH----hCCCCC------ccEEEEEEEcCCeEEEEEeccCCCCHHH--HHHHhCCCCHHHHHHHHHHHHHHHHHHHH
Q 010214 68 IKILR----LFMHPH------IIRLYEVIETPSDIYVVMEYVKSGELFD--YIVEKGRLQEDEARNFFQQIISGVEYCHR 135 (515)
Q Consensus 68 i~il~----~l~hpn------Iv~l~~~~~~~~~~~iVmEy~~gg~L~~--~i~~~~~l~e~~~~~i~~qil~aL~yLH~ 135 (515)
.+... .+.|-+ |.++|--+ .+.-.++||||+|..+.| +|.+. .++...+..-+.+...- -+=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~--qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLE--QIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHH--HHHh
Confidence 44333 333444 44444333 334679999999986654 44443 35555443333332221 1225
Q ss_pred CCceeccCCCCcEEECC----CCceEEeecccccccc
Q 010214 136 NMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMR 168 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~----~~~vKL~DFGls~~~~ 168 (515)
.|++|+|-+|.||+++. ++.+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 78999999999999983 6789999999986553
No 465
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.23 E-value=2.4e-05 Score=74.11 Aligned_cols=130 Identities=24% Similarity=0.382 Sum_probs=94.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccccc-------------CChHHHHHHHHHHHHHHhCC------CCCccEEE
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI-------------KNMEMEEKVRREIKILRLFM------HPHIIRLY 83 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~-------------~~~~~~~~i~~Ei~il~~l~------hpnIv~l~ 83 (515)
..||+|+.-.|| .|.. .....||+...... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy--~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEE--ECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 468999999999 4553 34578999876650 01112456677777776666 78999999
Q ss_pred EEEEcCCeEEEEEeccCC------CCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCC---
Q 010214 84 EVIETPSDIYVVMEYVKS------GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW--- 154 (515)
Q Consensus 84 ~~~~~~~~~~iVmEy~~g------g~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~--- 154 (515)
++.+|+....+|+|.+.. -+|.+++. .+.+++ ..+. .+-.-..||-+++|+.+|++|.||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998632 36888884 445665 4343 344455688899999999999999996432
Q ss_pred -ceEEee
Q 010214 155 -NVKIAD 160 (515)
Q Consensus 155 -~vKL~D 160 (515)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577887
No 466
>PLN02876 acyl-CoA dehydrogenase
Probab=98.12 E-value=3.1e-05 Score=89.03 Aligned_cols=144 Identities=19% Similarity=0.349 Sum_probs=92.4
Q ss_pred EeeeecccCceEEEEEEEcCCC--cEEEEEEecccccCChHHHHHHHHHHHHHHhCC-CCCc--cEEEEEEEcC---CeE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHI--IRLYEVIETP---SDI 92 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~ 92 (515)
-++.++.|.+..+|+......+ ..+++|+........ ....+.+|+++|+.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998765433 468888765432211 2356889999999996 6665 7888887664 457
Q ss_pred EEEEeccCCCCHHH--------------------HHHH-hC------CC---------CHHHHHHHHHH-----------
Q 010214 93 YVVMEYVKSGELFD--------------------YIVE-KG------RL---------QEDEARNFFQQ----------- 125 (515)
Q Consensus 93 ~iVmEy~~gg~L~~--------------------~i~~-~~------~l---------~e~~~~~i~~q----------- 125 (515)
|+||||++|..+.+ .+.. +. .+ ...++..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 1110 00 00 11233332222
Q ss_pred ----HHHHHHHHHH-----------CCceeccCCCCcEEECCC-Cc-eEEeecccccc
Q 010214 126 ----IISGVEYCHR-----------NMVVHRDLKPENLLLDSK-WN-VKIADFGLSNI 166 (515)
Q Consensus 126 ----il~aL~yLH~-----------~gIvHrDLkpeNILl~~~-~~-vKL~DFGls~~ 166 (515)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||+++..
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2234566632 249999999999999853 33 57999998765
No 467
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.09 E-value=1.6e-05 Score=72.94 Aligned_cols=130 Identities=23% Similarity=0.325 Sum_probs=92.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEec
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEY 98 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy 98 (515)
+..+.||+|.+|.||++.+ .|..+|+|+-..+. ....+..|.++|..+...++ .++|.+.+ .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 4567899999999999997 46689999854433 34678899999999987665 45565543 3456999
Q ss_pred cCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEEECCCCceEEeeccccccc
Q 010214 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLK-PENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 99 ~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLk-peNILl~~~~~vKL~DFGls~~~ 167 (515)
+.|-+|.+.-... -++-...++++---|...||-|+.|. |...++-.++.+.|+||.-++..
T Consensus 94 i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998887654211 13334445555555778899999986 44444445559999999988744
No 468
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.08 E-value=6e-05 Score=71.13 Aligned_cols=129 Identities=21% Similarity=0.247 Sum_probs=90.8
Q ss_pred CCCceEeeeecccCc-eEEEEEEEcCCCcEEEEEEecc---ccc-------CCh--------HHHHHHHHHHHHHHhCC-
Q 010214 16 LPNYKLGKTLGIGSF-GKVKIAEHALTGHKVAIKILNR---RKI-------KNM--------EMEEKVRREIKILRLFM- 75 (515)
Q Consensus 16 ~~~Y~i~~~LG~G~f-g~Vy~a~~~~tg~~vAiK~i~~---~~~-------~~~--------~~~~~i~~Ei~il~~l~- 75 (515)
..++++++.||.|+- |.||+++. .|+.||+|++.. ... ... ....-+..|.+..-+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999986 688999999321 110 000 12234566777655554
Q ss_pred --CCCc--cEEEEEEEcC------------------CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHH
Q 010214 76 --HPHI--IRLYEVIETP------------------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133 (515)
Q Consensus 76 --hpnI--v~l~~~~~~~------------------~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yL 133 (515)
+.++ ++++++..-. ...-||.||++... .++ ..-+.+|++-+..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHH
Confidence 5566 9999987211 12467888887643 222 23356677778889
Q ss_pred HHCCceeccCCCCcEEECCCCceEEeecccc
Q 010214 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 134 H~~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
|..||+-+|+++.|.. .=||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999987 3489999864
No 469
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=97.93 E-value=2.8e-07 Score=105.92 Aligned_cols=208 Identities=19% Similarity=0.101 Sum_probs=152.2
Q ss_pred HHHHHHHHHhCCCCCccEEEEEEE--cCCeEEEEEeccCCCCHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC-
Q 010214 64 VRREIKILRLFMHPHIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRN- 136 (515)
Q Consensus 64 i~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iVmEy~~gg~L~~~i~~~~----~l~e~~~~~i~~qil~aL~yLH~~- 136 (515)
+..|..-++...|+++...+.-+. +....|.+++|+.+|.+++.|.+.- .+.+.-+....++.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555556678998877666553 3345789999999999999997532 344444555555558888888854
Q ss_pred C----ceeccCCCCcEEECCCCceEEeeccccccc-ccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHH
Q 010214 137 M----VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211 (515)
Q Consensus 137 g----IvHrDLkpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~ll 211 (515)
+ .+|+++|+-|.+|..+.++|++++|+.++. ..........+++.|++|++...-.+ +.++|+|+.|+-+|...
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHh
Confidence 2 689999999999999999999999999833 33445667789999999999887666 45699999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccc
Q 010214 212 CGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (515)
Q Consensus 212 tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~ 272 (515)
.|..+|.....+.+...+.++. ..++...|.++-.....+|-+.-..||.-...+.-+.|.
T Consensus 1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9998886655555544444443 344444455555556666777778899988888877764
No 470
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=97.92 E-value=5.2e-05 Score=73.82 Aligned_cols=73 Identities=10% Similarity=0.073 Sum_probs=46.7
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC---CccEEEEEEEcCC---eEEEE
Q 010214 23 KTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIETPS---DIYVV 95 (515)
Q Consensus 23 ~~LG~G~fg-~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp---nIv~l~~~~~~~~---~~~iV 95 (515)
+.|+.|+.. .||... ..+++|+..... ....+.+|.++++.+... -+.++++..+..+ ..|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777776 488762 357788754321 235788999999887632 3455555443322 34889
Q ss_pred EeccCCCCHH
Q 010214 96 MEYVKSGELF 105 (515)
Q Consensus 96 mEy~~gg~L~ 105 (515)
||+++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
No 471
>PRK10593 hypothetical protein; Provisional
Probab=97.80 E-value=0.00038 Score=70.36 Aligned_cols=77 Identities=8% Similarity=0.068 Sum_probs=55.7
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC---CCccEEEEEEEc---CCeEEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIET---PSDIYV 94 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~i 94 (515)
-.+.||.|..+.||..... +..+.+|... ... ....+.+|...|+.+.. ..+.++++++.. .+.-++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~-~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMAR-SFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEec-ccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3567999999999998643 2357777742 211 12577899999988863 467888887754 356899
Q ss_pred EEeccCCCCH
Q 010214 95 VMEYVKSGEL 104 (515)
Q Consensus 95 VmEy~~gg~L 104 (515)
|||+++|+++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
No 472
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=97.76 E-value=0.00066 Score=71.14 Aligned_cols=80 Identities=16% Similarity=0.153 Sum_probs=56.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccccc--CC--hHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--KN--MEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV 94 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~--~~--~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~i 94 (515)
.+.||.|.+..||++.....++.|+||.-..... .. .-..++...|.+.|+.+. ..++++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864446899998542211 01 123467778888888764 3568888887 3455789
Q ss_pred EEeccCCCC
Q 010214 95 VMEYVKSGE 103 (515)
Q Consensus 95 VmEy~~gg~ 103 (515)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
No 473
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=97.71 E-value=0.00046 Score=66.87 Aligned_cols=75 Identities=16% Similarity=0.225 Sum_probs=48.9
Q ss_pred eeeecccCceEEEEEEEcC-CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC-CccEEEEEEEcCCeEEEEEecc
Q 010214 22 GKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~iVmEy~ 99 (515)
++.|..|-...+|++.... .++.|++|+....... .-...+|..+++.+... -.++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567888888999987543 3578999987543211 12234788888888533 3455554432 2 3799999
Q ss_pred CCCCH
Q 010214 100 KSGEL 104 (515)
Q Consensus 100 ~gg~L 104 (515)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
No 474
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=97.69 E-value=0.00012 Score=68.95 Aligned_cols=99 Identities=17% Similarity=0.230 Sum_probs=79.5
Q ss_pred HHHHHHHHhCCC-CCccEEEEEEEcCCeEEEEEeccCCCCHHH---HHHHhCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 010214 65 RREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFD---YIVEKGRLQEDEARNFFQQIISGVEYCHR---NM 137 (515)
Q Consensus 65 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iVmEy~~gg~L~~---~i~~~~~l~e~~~~~i~~qil~aL~yLH~---~g 137 (515)
..|.-+|+.+.+ +++++++|.+ .-++|.||...+++.. .+.+-...++....+++.+++..+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999986 6999999998 2367999998765542 12222346899999999999999999997 44
Q ss_pred ceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 138 IvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
+.-.|++|+|+-++++|++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 677999999999999999999999876543
No 475
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=97.63 E-value=0.00018 Score=70.91 Aligned_cols=132 Identities=16% Similarity=0.158 Sum_probs=76.7
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEeccCCC
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVKSG 102 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmEy~~gg 102 (515)
.+..|-.+.+|+.. .++..+++|+....... ..-...+|..+++.+....+ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35667788899887 35678899976432111 00124678888888864333 44444432 26899999986
Q ss_pred CHHHH----------H----HH---h----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCceeccC
Q 010214 103 ELFDY----------I----VE---K----GRLQE-DEARNFFQQI---------ISGVEYCHR--------NMVVHRDL 143 (515)
Q Consensus 103 ~L~~~----------i----~~---~----~~l~e-~~~~~i~~qi---------l~aL~yLH~--------~gIvHrDL 143 (515)
.+..- + .+ . .+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 1 11 0 01111 1222222122 111222222 24899999
Q ss_pred CCCcEEECCCCceEEeeccccc
Q 010214 144 KPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 144 kpeNILl~~~~~vKL~DFGls~ 165 (515)
.|.||++++++ +.|+||+.+.
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccC
Confidence 99999999876 8999999774
No 476
>PRK05231 homoserine kinase; Provisional
Probab=97.45 E-value=0.0015 Score=66.42 Aligned_cols=147 Identities=12% Similarity=0.168 Sum_probs=78.6
Q ss_pred CccccCCCceE-----eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEE
Q 010214 11 GVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLY 83 (515)
Q Consensus 11 ~~~~~~~~Y~i-----~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~ 83 (515)
.+..+...|.+ .+.|+.|....+|..... + ..+++|++.. . . .+.+..|+.+++.|... .+.+++
T Consensus 11 ~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~-g~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 11 ELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-Q-GEYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred HHHHHHHhcCCchhhccchhccccccceEEEEeC-C-CcEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence 33334455544 345667777889988743 3 3689998751 1 1 12333455555444311 133433
Q ss_pred E------EEEcCCeEEEEEeccCCCCHH-----------HHHH---H-hCCC--------C--H--HHHH----------
Q 010214 84 E------VIETPSDIYVVMEYVKSGELF-----------DYIV---E-KGRL--------Q--E--DEAR---------- 120 (515)
Q Consensus 84 ~------~~~~~~~~~iVmEy~~gg~L~-----------~~i~---~-~~~l--------~--e--~~~~---------- 120 (515)
. +....+..++++||++|..+. ..+. . ...+ . . ....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 123355679999999986431 1111 0 0000 0 0 0000
Q ss_pred -HHHHH-HHHHHHHHH-------HCCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 121 -NFFQQ-IISGVEYCH-------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 121 -~i~~q-il~aL~yLH-------~~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
..+.+ +-..++.+. ..++||+|+.|.||+++.+...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11111 111222222 2479999999999999976556899999763
No 477
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=97.42 E-value=0.00051 Score=72.48 Aligned_cols=159 Identities=21% Similarity=0.296 Sum_probs=105.4
Q ss_pred HHHHHHHHHHhCCCCCccEEEEEEEcC-CeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 010214 63 KVRREIKILRLFMHPHIIRLYEVIETP-SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHR 141 (515)
Q Consensus 63 ~i~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHr 141 (515)
++.-...+++.+.|+|....+++.+.. ....+|||++ +.+|.+++..+. +-.... . .+++.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~---~-----------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL---L-----------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh---c-----------cccccee
Confidence 445567788999999999999987543 3478999999 569999887653 211111 0 1222221
Q ss_pred cCCCCcEEECCCCceEEeecccccccccCCccccCCCCCCccCCCcccCCccCCCcceeehhHHHHHHHHhCCCCCCCCC
Q 010214 142 DLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN 221 (515)
Q Consensus 142 DLkpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~Y~aPE~i~~~~~~~~~~DIwSlGvily~lltG~~Pf~~~~ 221 (515)
| .++.+| ..+.. | |- ..++++||||+|.++.++.-|...+....
T Consensus 92 -----~-------~~~~td----~~~t~------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 92 -----N-------IIYITD----HFLTK------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred -----h-------hhhccc----ccccc------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2 233333 00000 0 11 11369999999999999999988876655
Q ss_pred hHHHHHHHhcCccCCC-------------CCCChhHHHHhcccCCCCCCCCCCHHHHhcCcccccc
Q 010214 222 IPNLFKKIKGGIYTLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (515)
Q Consensus 222 ~~~~~~~i~~~~~~~p-------------~~~s~~~~~li~~mL~~dP~~Rpt~~eil~hp~f~~~ 274 (515)
..+....+.+-. ..+ -.++.....+..+|+...|..||...++++++-|.+.
T Consensus 136 ~s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 136 ESEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 555555444322 111 1345667889999999999999999999999998765
No 478
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=97.39 E-value=0.0023 Score=64.27 Aligned_cols=136 Identities=12% Similarity=0.091 Sum_probs=82.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCC--CccEEEE------EEEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYE------VIETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~ 93 (515)
.+.|..|....+|++.. ++..+++|+... .. ...+..|++++..+.+- .+.+++. +....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~---~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK---VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC---CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56677888889998864 345799998754 11 24566788887777532 2445443 223345678
Q ss_pred EEEeccCCCCHHH----HH----------HHh-CCCC--------HHHH------------HHHHHHHHHHHHHHHH---
Q 010214 94 VVMEYVKSGELFD----YI----------VEK-GRLQ--------EDEA------------RNFFQQIISGVEYCHR--- 135 (515)
Q Consensus 94 iVmEy~~gg~L~~----~i----------~~~-~~l~--------e~~~------------~~i~~qil~aL~yLH~--- 135 (515)
+|+++++|..+.. .. +.. ..+. .... ......+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 11 000 0000 0000 0011122334444443
Q ss_pred ----CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 136 ----NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 136 ----~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999763
No 479
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.38 E-value=0.0012 Score=66.96 Aligned_cols=137 Identities=14% Similarity=0.152 Sum_probs=79.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEE------EEcCCeEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEV------IETPSDIY 93 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~------~~~~~~~~ 93 (515)
.+.++.|....+|++.. .+ ..+++|+..... . ...+..|.+++..|.... +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DV-GRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CC-CcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 55677777789998864 23 468889875421 1 234556677776664222 4444432 12245678
Q ss_pred EEEeccCCCCHH----H-------HH---HH-hCCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 010214 94 VVMEYVKSGELF----D-------YI---VE-KGRLQE-------DEAR----------------NFFQQIISGVEYCHR 135 (515)
Q Consensus 94 iVmEy~~gg~L~----~-------~i---~~-~~~l~e-------~~~~----------------~i~~qil~aL~yLH~ 135 (515)
+++||++|.++. + .+ +. ...++. ...+ .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1 11 11 000100 0000 001123334555542
Q ss_pred -------CCceeccCCCCcEEECCCCceEEeeccccc
Q 010214 136 -------NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 136 -------~gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999988777899999763
No 480
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.36 E-value=0.0014 Score=66.10 Aligned_cols=76 Identities=14% Similarity=0.138 Sum_probs=49.2
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEcCCeEEE
Q 010214 22 GKTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIYV 94 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~i 94 (515)
++.|..|-...||++.... +++.+++|+...... ......+|.++++.+.... ..+++.++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556677777899887543 267899999754321 1234567888888776333 3455655532 35
Q ss_pred EEeccCCCCHH
Q 010214 95 VMEYVKSGELF 105 (515)
Q Consensus 95 VmEy~~gg~L~ 105 (515)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887664
No 481
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.30 E-value=0.00023 Score=71.29 Aligned_cols=134 Identities=13% Similarity=0.240 Sum_probs=96.1
Q ss_pred ceEeeeecccCceEEEEEEEcCCCcEEEEEEecccccC-----------------ChH--HHHHHHHHHHHHHhCCC--C
Q 010214 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----------------NME--MEEKVRREIKILRLFMH--P 77 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~-----------------~~~--~~~~i~~Ei~il~~l~h--p 77 (515)
|.++..||-|.-+-||.+-+. .|++.++|+-..-... ..- ..-...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999875 6888999963211000 000 11224578888887763 2
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEECCCCceE
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDLkpeNILl~~~~~vK 157 (515)
-+.+.+++ +.-++|||++.|-.|...-. ...+..+...++.-+.-|-++|+||+|..--||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 34455544 34579999999977755321 234556677777778889999999999999999999999999
Q ss_pred Eeeccc
Q 010214 158 IADFGL 163 (515)
Q Consensus 158 L~DFGl 163 (515)
++||--
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999964
No 482
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.12 E-value=0.0041 Score=64.08 Aligned_cols=76 Identities=16% Similarity=0.046 Sum_probs=50.8
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccccc----CChHHHHHHHHHHHHHHhCC--CC-CccEEEEEEEcCCeEEEEE
Q 010214 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----KNMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVVM 96 (515)
Q Consensus 24 ~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~iVm 96 (515)
.||.|....||++.....++.|+||.-...-. .-.-..++..-|...|+... -| +++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999764446899996432111 11223466677888887765 34 56666665 444556999
Q ss_pred eccCC
Q 010214 97 EYVKS 101 (515)
Q Consensus 97 Ey~~g 101 (515)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
No 483
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.09 E-value=0.0049 Score=62.54 Aligned_cols=144 Identities=17% Similarity=0.311 Sum_probs=83.7
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEEEEEEcCC--eEEEE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIETPS--DIYVV 95 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~~~~~~~~--~~~iV 95 (515)
.+++.+..|..-.+|.... +++++++. .+. ............+|..+++.+.--- +...++++.+.. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3444454444444555543 38889888 332 2333445677889999998876422 344555555444 56999
Q ss_pred EeccCCCCHHH----------HHH--------H-h----------CC---CCHHHHHHHHHHH--------------HHH
Q 010214 96 MEYVKSGELFD----------YIV--------E-K----------GR---LQEDEARNFFQQI--------------ISG 129 (515)
Q Consensus 96 mEy~~gg~L~~----------~i~--------~-~----------~~---l~e~~~~~i~~qi--------------l~a 129 (515)
|+|++|..+.+ ++. . + +. ....+...+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 99998842211 111 1 0 00 0111111111111 122
Q ss_pred HHHHHHC--------CceeccCCCCcEEECCCCceEEeeccccccc
Q 010214 130 VEYCHRN--------MVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (515)
Q Consensus 130 L~yLH~~--------gIvHrDLkpeNILl~~~~~vKL~DFGls~~~ 167 (515)
..+|+.+ .++|+|+.+.|++++.++-+-++||+++..-
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3444432 2899999999999999989999999998643
No 484
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.09 E-value=0.0025 Score=64.98 Aligned_cols=143 Identities=21% Similarity=0.237 Sum_probs=97.1
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccC----------------------ChHH-HHHHHHHHHHHHhCCCC
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK----------------------NMEM-EEKVRREIKILRLFMHP 77 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~----------------------~~~~-~~~i~~Ei~il~~l~hp 77 (515)
+-..|..|.-+.||.|... +|..+|||++..+-+. ...+ .--...|++.|++++.-
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999999854 7888999998533111 1111 12245788888888765
Q ss_pred CccEEEEEEEcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECCCCce
Q 010214 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNV 156 (515)
Q Consensus 78 nIv~l~~~~~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~~~~v 156 (515)
.|.-.--+. -. .-.+||+|+.+...-.-.-+...++...++.+-.|++.-+.-|- ..++||.||.--|+|+-. |.+
T Consensus 227 GIP~PePIl-Lk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~l 303 (520)
T KOG2270|consen 227 GIPCPEPIL-LK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKL 303 (520)
T ss_pred CCCCCCcee-ee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEE
Confidence 543221111 11 23589999954222221223456888899999999998888775 579999999999999965 589
Q ss_pred EEeeccccccc
Q 010214 157 KIADFGLSNIM 167 (515)
Q Consensus 157 KL~DFGls~~~ 167 (515)
.|+|-+-|...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99998877543
No 485
>PLN02756 S-methyl-5-thioribose kinase
Probab=96.90 E-value=0.01 Score=62.18 Aligned_cols=77 Identities=21% Similarity=0.118 Sum_probs=53.6
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCCh----HHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEE
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----EMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIY 93 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~----~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~ 93 (515)
-.+.||.|....||+..+. +..++||.-........ ....+...|...|+.+. ..++.+++.+.++ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4678899999999998863 45699997652211110 13456666777777665 3578889988763 457
Q ss_pred EEEeccCC
Q 010214 94 VVMEYVKS 101 (515)
Q Consensus 94 iVmEy~~g 101 (515)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
No 486
>PLN02236 choline kinase
Probab=96.86 E-value=0.0084 Score=61.92 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=81.8
Q ss_pred ceEeeeecccCceEEEEEEEcC----CCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEE
Q 010214 19 YKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIY 93 (515)
Q Consensus 19 Y~i~~~LG~G~fg~Vy~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 93 (515)
..-.+.|-.|-...+|++.... +++.|.+|+..... .....+ .+|..+++.+..-++ .++++.+...
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3344556668888999987532 34789999876532 112222 678888888874443 3556665332
Q ss_pred EEEeccCCCCHHHH-------H-------H---HhC------CCCHHHHHHHHHHH-----------------HHHHHHH
Q 010214 94 VVMEYVKSGELFDY-------I-------V---EKG------RLQEDEARNFFQQI-----------------ISGVEYC 133 (515)
Q Consensus 94 iVmEy~~gg~L~~~-------i-------~---~~~------~l~e~~~~~i~~qi-----------------l~aL~yL 133 (515)
.|.||++|.+|..- + . +.. ....+++..+..++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 58999987665321 1 0 000 01122333333222 1111122
Q ss_pred ----H----HCCceeccCCCCcEEECC-CCceEEeeccccc
Q 010214 134 ----H----RNMVVHRDLKPENLLLDS-KWNVKIADFGLSN 165 (515)
Q Consensus 134 ----H----~~gIvHrDLkpeNILl~~-~~~vKL~DFGls~ 165 (515)
. ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4689999998774
No 487
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=96.64 E-value=0.024 Score=57.25 Aligned_cols=28 Identities=29% Similarity=0.411 Sum_probs=25.1
Q ss_pred CCceeccCCCCcEEECCCCceEEeecccc
Q 010214 136 NMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~~~~vKL~DFGls 164 (515)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 57899999999999988 67899999965
No 488
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=96.54 E-value=0.013 Score=60.09 Aligned_cols=136 Identities=12% Similarity=0.180 Sum_probs=78.3
Q ss_pred eeeecccCceEEEEEEEcCC---CcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeEEEEEe
Q 010214 22 GKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVME 97 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~iVmE 97 (515)
.+.|..|=...+|++..... +..|.+|+.....- .. -.-.+|..+++.+..-++ .++++++. +. +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~-IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YV-IDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eE-echHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeeh
Confidence 44555577788998875432 34899998754321 11 122578888888875444 45666653 22 5899
Q ss_pred ccCCCCHHH-------HH---HH------hCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 010214 98 YVKSGELFD-------YI---VE------KGR------L-QEDEARNFFQQI----------------------ISGVEY 132 (515)
Q Consensus 98 y~~gg~L~~-------~i---~~------~~~------l-~e~~~~~i~~qi----------------------l~aL~y 132 (515)
|++|..|.. .+ .+ ... . ....+..++.++ ...+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998765521 11 10 011 1 122233333222 111222
Q ss_pred HH----HC----CceeccCCCCcEEECC-CCceEEeeccccc
Q 010214 133 CH----RN----MVVHRDLKPENLLLDS-KWNVKIADFGLSN 165 (515)
Q Consensus 133 LH----~~----gIvHrDLkpeNILl~~-~~~vKL~DFGls~ 165 (515)
+. .. -++|+|+.+.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21 12 2799999999999974 5789999999774
No 489
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=96.52 E-value=0.015 Score=58.44 Aligned_cols=74 Identities=12% Similarity=0.179 Sum_probs=48.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCC---CCCccEEEEEEEcCCeEEEEEe
Q 010214 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVME 97 (515)
Q Consensus 21 i~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~iVmE 97 (515)
-.+.++.|....+|... .+++.+.+|+-... ....+..|..-|+.|. .-.+.+++.+.+..+.-|+|||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle 92 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE 92 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence 35678999999999887 67889999986522 1245677888888774 4467899999888777899999
Q ss_pred ccCCC
Q 010214 98 YVKSG 102 (515)
Q Consensus 98 y~~gg 102 (515)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99766
No 490
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=96.47 E-value=0.024 Score=56.74 Aligned_cols=30 Identities=27% Similarity=0.568 Sum_probs=25.1
Q ss_pred CceeccCCCCcEEECCCCc-eEEeecccccc
Q 010214 137 MVVHRDLKPENLLLDSKWN-VKIADFGLSNI 166 (515)
Q Consensus 137 gIvHrDLkpeNILl~~~~~-vKL~DFGls~~ 166 (515)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
No 491
>PRK12396 5-methylribose kinase; Reviewed
Probab=96.40 E-value=0.022 Score=59.55 Aligned_cols=78 Identities=21% Similarity=0.190 Sum_probs=53.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEecccc-c--CChHHHHHHHHHHHHHHhCC--CC-CccEEEEEEEcCCeEEEE
Q 010214 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-I--KNMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVV 95 (515)
Q Consensus 22 ~~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~-~--~~~~~~~~i~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~iV 95 (515)
.+.||.|.-.-||++.+...++.|+||--...- . .-.-..++..-|.+.|+... -| +++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999985445689999643211 1 11224577788888888765 34 57777765 44456789
Q ss_pred EeccCC
Q 010214 96 MEYVKS 101 (515)
Q Consensus 96 mEy~~g 101 (515)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
No 492
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=96.05 E-value=0.1 Score=52.84 Aligned_cols=29 Identities=21% Similarity=0.328 Sum_probs=26.9
Q ss_pred CceeccCCCCcEEECCCCceEEeeccccc
Q 010214 137 MVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (515)
Q Consensus 137 gIvHrDLkpeNILl~~~~~vKL~DFGls~ 165 (515)
+++|+|+.+.|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998764
No 493
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=95.73 E-value=0.016 Score=55.17 Aligned_cols=30 Identities=33% Similarity=0.641 Sum_probs=21.3
Q ss_pred CceeccCCCCcEEE-CCCCceEEeecccccc
Q 010214 137 MVVHRDLKPENLLL-DSKWNVKIADFGLSNI 166 (515)
Q Consensus 137 gIvHrDLkpeNILl-~~~~~vKL~DFGls~~ 166 (515)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998754
No 494
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=95.56 E-value=0.035 Score=56.78 Aligned_cols=86 Identities=24% Similarity=0.310 Sum_probs=62.9
Q ss_pred CCCccEEEEEE-EcCCeEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEECCC
Q 010214 76 HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSK 153 (515)
Q Consensus 76 hpnIv~l~~~~-~~~~~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDLkpeNILl~~~ 153 (515)
-++..+.+-+- ....+.|++|++- |+.|.. ++ --..+++..++.+.++.++-+..+ ..-|||+...||||+ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 44444444443 3345678888886 545532 22 234678889999988888887754 689999999999999 8
Q ss_pred CceEEeeccccccc
Q 010214 154 WNVKIADFGLSNIM 167 (515)
Q Consensus 154 ~~vKL~DFGls~~~ 167 (515)
|+|.|+||-+++.-
T Consensus 358 GnvtLIDfklsRl~ 371 (488)
T COG5072 358 GNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEeeeeecc
Confidence 99999999999843
No 495
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=95.36 E-value=0.053 Score=56.34 Aligned_cols=61 Identities=20% Similarity=0.272 Sum_probs=46.1
Q ss_pred eEEEEEeccCCCCHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEECC
Q 010214 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDS 152 (515)
Q Consensus 91 ~~~iVmEy~~gg~L~~~i~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDLkpeNILl~~ 152 (515)
...++-+|..|-++..+++.. ..+|...+.++.-...|+--+- -.+++|.|++|.||++--
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 356788899999999988654 3566667777776666665443 578999999999999853
No 496
>PTZ00384 choline kinase; Provisional
Probab=95.28 E-value=0.13 Score=53.94 Aligned_cols=78 Identities=15% Similarity=0.123 Sum_probs=46.8
Q ss_pred eEeeeecccCceEEEEEEEcCC-CcE-----EEEEEecccccCChHHHHHHHHHHHHHHhCCCCCc-cEEEEEEEcCCeE
Q 010214 20 KLGKTLGIGSFGKVKIAEHALT-GHK-----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDI 92 (515)
Q Consensus 20 ~i~~~LG~G~fg~Vy~a~~~~t-g~~-----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpnI-v~l~~~~~~~~~~ 92 (515)
...+.|..|-...+|++..... +.. |.+++.... . ...-.-.+|+++++.+..-++ .++++.+..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---N-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---C-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 3445666688889999875433 122 444443211 1 111122568999998875544 566666632
Q ss_pred EEEEeccCCCCHH
Q 010214 93 YVVMEYVKSGELF 105 (515)
Q Consensus 93 ~iVmEy~~gg~L~ 105 (515)
+++.||++|.+|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5999999987653
No 497
>PRK11768 serine/threonine protein kinase; Provisional
Probab=95.00 E-value=0.43 Score=48.87 Aligned_cols=70 Identities=9% Similarity=0.061 Sum_probs=41.2
Q ss_pred CceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCCCC--ccEEE---E--EEEcCCeEEEEEeccCC
Q 010214 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLY---E--VIETPSDIYVVMEYVKS 101 (515)
Q Consensus 29 ~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~hpn--Iv~l~---~--~~~~~~~~~iVmEy~~g 101 (515)
.-..||.+.. .+|..+++|+...... ....+..|...+..|.... ++... + +...++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3456888864 3567899998754332 2345667777776554211 22211 1 22335678889999987
Q ss_pred CC
Q 010214 102 GE 103 (515)
Q Consensus 102 g~ 103 (515)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 54
No 498
>PRK06148 hypothetical protein; Provisional
Probab=94.27 E-value=1.2 Score=52.68 Aligned_cols=31 Identities=29% Similarity=0.457 Sum_probs=26.2
Q ss_pred CCceeccCCCCcEEECCCC--ceE-Eeecccccc
Q 010214 136 NMVVHRDLKPENLLLDSKW--NVK-IADFGLSNI 166 (515)
Q Consensus 136 ~gIvHrDLkpeNILl~~~~--~vK-L~DFGls~~ 166 (515)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 555 999998753
No 499
>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function. All known members of this group are proteins from drosophila and Caenorhabditis elegans.
Probab=93.55 E-value=0.34 Score=48.57 Aligned_cols=74 Identities=19% Similarity=0.216 Sum_probs=44.8
Q ss_pred cccCceEEEEEEEcC----CC----cEEEEEEecccccC--ChHHHHHHHHHHHHHHhCC-------------CCCccEE
Q 010214 26 GIGSFGKVKIAEHAL----TG----HKVAIKILNRRKIK--NMEMEEKVRREIKILRLFM-------------HPHIIRL 82 (515)
Q Consensus 26 G~G~fg~Vy~a~~~~----tg----~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~-------------hpnIv~l 82 (515)
|.|-.|.+|++.-.. ++ ..+.||........ .......+.+|+...+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677788888876533 22 35888887522211 1123456677887765442 1245677
Q ss_pred EEEEEcCCeEEEEEecc
Q 010214 83 YEVIETPSDIYVVMEYV 99 (515)
Q Consensus 83 ~~~~~~~~~~~iVmEy~ 99 (515)
+..-..+...+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 77666666788999865
No 500
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=93.43 E-value=0.91 Score=43.99 Aligned_cols=75 Identities=17% Similarity=0.186 Sum_probs=50.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEecccccCChHHHHHHHHHHHHHHhCCC---CCccEEEEEEEcCCeEEEEEecc
Q 010214 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIETPSDIYVVMEYV 99 (515)
Q Consensus 23 ~~LG~G~fg~Vy~a~~~~tg~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~iVmEy~ 99 (515)
+.+..|.--..|...+ ...++-+|+=. ......+..|+.-|+.+.- -.+.+++.+..+.++.|+||||.
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 3445555555555543 34578888632 2345667777777776654 45778888889999999999999
Q ss_pred CCCCHH
Q 010214 100 KSGELF 105 (515)
Q Consensus 100 ~gg~L~ 105 (515)
+-|.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876554
Done!